{"date": "2024-12-31", "symbol": "MRK", "type": "income_statement_annual", "result": {"date": "2024-12-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2025-02-25", "acceptedDate": "2025-02-25 16:19:11", "fiscalYear": "2024", "period": "FY", "revenue": 64168000000, "costOfRevenue": 15193000000, "grossProfit": 48975000000, "researchAndDevelopmentExpenses": 17938000000, "generalAndAdministrativeExpenses": 7700000000, "sellingAndMarketingExpenses": 2400000000, "sellingGeneralAndAdministrativeExpenses": 10100000000, "otherExpenses": 716000000, "operatingExpenses": 28754000000, "costAndExpenses": 43947000000, "netInterestIncome": -856000000, "interestIncome": 415000000, "interestExpense": 1271000000, "depreciationAndAmortization": 4499000000, "ebitda": 25706000000, "ebit": 21207000000, "nonOperatingIncomeExcludingInterest": -986000000, "operatingIncome": 20221000000, "totalOtherIncomeExpensesNet": -285000000, "incomeBeforeTax": 19936000000, "incomeTaxExpense": 2803000000, "netIncomeFromContinuingOperations": 17133000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 17117000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 17117000000, "eps": 6.76, "epsDiluted": 6.74, "weightedAverageShsOut": 2532000000, "weightedAverageShsOutDil": 2541000000}}
{"date": "2023-12-31", "symbol": "MRK", "type": "income_statement_annual", "result": {"date": "2023-12-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2024-02-26", "acceptedDate": "2024-02-26 09:06:55", "fiscalYear": "2023", "period": "FY", "revenue": 60115000000, "costOfRevenue": 16126000000, "grossProfit": 43989000000, "researchAndDevelopmentExpenses": 30531000000, "generalAndAdministrativeExpenses": 7584000000, "sellingAndMarketingExpenses": 2300000000, "sellingGeneralAndAdministrativeExpenses": 9884000000, "otherExpenses": 620000000, "operatingExpenses": 41035000000, "costAndExpenses": 57161000000, "netInterestIncome": -781000000, "interestIncome": 365000000, "interestExpense": 1146000000, "depreciationAndAmortization": 3872000000, "ebitda": 6907000000, "ebit": 3035000000, "nonOperatingIncomeExcludingInterest": -81000000, "operatingIncome": 2954000000, "totalOtherIncomeExpensesNet": -1065000000, "incomeBeforeTax": 1889000000, "incomeTaxExpense": 1512000000, "netIncomeFromContinuingOperations": 377000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 365000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 365000000, "eps": 0.14, "epsDiluted": 0.14, "weightedAverageShsOut": 2607143000, "weightedAverageShsOutDil": 2547000000}}
{"date": "2022-12-31", "symbol": "MRK", "type": "income_statement_annual", "result": {"date": "2022-12-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2023-02-24", "acceptedDate": "2023-02-24 16:22:30", "fiscalYear": "2022", "period": "FY", "revenue": 59283000000, "costOfRevenue": 17411000000, "grossProfit": 41872000000, "researchAndDevelopmentExpenses": 13548000000, "generalAndAdministrativeExpenses": 7469000000, "sellingAndMarketingExpenses": 2200000000, "sellingGeneralAndAdministrativeExpenses": 9669000000, "otherExpenses": 373000000, "operatingExpenses": 23590000000, "costAndExpenses": 41001000000, "netInterestIncome": -805000000, "interestIncome": 157000000, "interestExpense": 962000000, "depreciationAndAmortization": 3909000000, "ebitda": 21315000000, "ebit": 17406000000, "nonOperatingIncomeExcludingInterest": 876000000, "operatingIncome": 18282000000, "totalOtherIncomeExpensesNet": -1838000000, "incomeBeforeTax": 16444000000, "incomeTaxExpense": 1918000000, "netIncomeFromContinuingOperations": 14526000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 14519000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 14519000000, "eps": 5.73, "epsDiluted": 5.71, "weightedAverageShsOut": 2532000000, "weightedAverageShsOutDil": 2542000000}}
{"date": "2021-12-31", "symbol": "MRK", "type": "income_statement_annual", "result": {"date": "2021-12-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2022-02-25", "acceptedDate": "2022-02-25 16:44:28", "fiscalYear": "2021", "period": "FY", "revenue": 48704000000, "costOfRevenue": 13626000000, "grossProfit": 35078000000, "researchAndDevelopmentExpenses": 12245000000, "generalAndAdministrativeExpenses": 7403000000, "sellingAndMarketingExpenses": 2000000000, "sellingGeneralAndAdministrativeExpenses": 9403000000, "otherExpenses": 231000000, "operatingExpenses": 21879000000, "costAndExpenses": 35505000000, "netInterestIncome": -770000000, "interestIncome": 36000000, "interestExpense": 806000000, "depreciationAndAmortization": 3214000000, "ebitda": 17899000000, "ebit": 14685000000, "nonOperatingIncomeExcludingInterest": -1486000000, "operatingIncome": 13199000000, "totalOtherIncomeExpensesNet": 680000000, "incomeBeforeTax": 13879000000, "incomeTaxExpense": 1521000000, "netIncomeFromContinuingOperations": 12358000000, "netIncomeFromDiscontinuedOperations": 704000000, "otherAdjustmentsToNetIncome": -704000000, "netIncome": 13049000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 13049000000, "eps": 5.16, "epsDiluted": 5.14, "weightedAverageShsOut": 2530000000, "weightedAverageShsOutDil": 2538000000}}
{"date": "2025-09-30", "symbol": "MRK", "type": "income_statement_quarter", "result": {"date": "2025-09-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2025-11-05", "acceptedDate": "2025-11-05 16:08:41", "fiscalYear": "2025", "period": "Q3", "revenue": 17276000000, "costOfRevenue": 3124000000, "grossProfit": 14152000000, "researchAndDevelopmentExpenses": 3997000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 2599000000, "otherExpenses": 0, "operatingExpenses": 6596000000, "costAndExpenses": 9720000000, "netInterestIncome": -238000000, "interestIncome": 0, "interestExpense": 238000000, "depreciationAndAmortization": 1154000000, "ebitda": 8137000000, "ebit": 6983000000, "nonOperatingIncomeExcludingInterest": 573000000, "operatingIncome": 7556000000, "totalOtherIncomeExpensesNet": -811000000, "incomeBeforeTax": 6745000000, "incomeTaxExpense": 958000000, "netIncomeFromContinuingOperations": 5787000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 5785000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 5785000000, "eps": 2.32, "epsDiluted": 2.32, "weightedAverageShsOut": 2498000000, "weightedAverageShsOutDil": 2498000000}}
{"date": "2025-06-30", "symbol": "MRK", "type": "income_statement_quarter", "result": {"date": "2025-06-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2025-08-05", "acceptedDate": "2025-08-05 16:13:52", "fiscalYear": "2025", "period": "Q2", "revenue": 15806000000, "costOfRevenue": 3557000000, "grossProfit": 12249000000, "researchAndDevelopmentExpenses": 4048000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 2649000000, "otherExpenses": 0, "operatingExpenses": 6697000000, "costAndExpenses": 10254000000, "netInterestIncome": -236000000, "interestIncome": 69000000, "interestExpense": 305000000, "depreciationAndAmortization": 1119000000, "ebitda": 6423000000, "ebit": 5304000000, "nonOperatingIncomeExcludingInterest": 248000000, "operatingIncome": 5552000000, "totalOtherIncomeExpensesNet": -553000000, "incomeBeforeTax": 4999000000, "incomeTaxExpense": 571000000, "netIncomeFromContinuingOperations": 4428000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 4427000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 4427000000, "eps": 1.77, "epsDiluted": 1.76, "weightedAverageShsOut": 2503140000, "weightedAverageShsOutDil": 2513000000}}
{"date": "2025-03-31", "symbol": "MRK", "type": "income_statement_quarter", "result": {"date": "2025-03-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2025-05-02", "acceptedDate": "2025-05-02 16:10:22", "fiscalYear": "2025", "period": "Q1", "revenue": 15529000000, "costOfRevenue": 3419000000, "grossProfit": 12110000000, "researchAndDevelopmentExpenses": 3621000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 2552000000, "otherExpenses": 0, "operatingExpenses": 6173000000, "costAndExpenses": 9592000000, "netInterestIncome": -204000000, "interestIncome": 109000000, "interestExpense": 313000000, "depreciationAndAmortization": 1099000000, "ebitda": 7315000000, "ebit": 6216000000, "nonOperatingIncomeExcludingInterest": -279000000, "operatingIncome": 5937000000, "totalOtherIncomeExpensesNet": -34000000, "incomeBeforeTax": 5903000000, "incomeTaxExpense": 818000000, "netIncomeFromContinuingOperations": 5085000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 5079000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 5079000000, "eps": 2.02, "epsDiluted": 2.01, "weightedAverageShsOut": 2516082000, "weightedAverageShsOutDil": 2531000000}}
{"date": "2024-12-31", "symbol": "MRK", "type": "income_statement_quarter", "result": {"date": "2024-12-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2025-02-25", "acceptedDate": "2025-02-25 16:19:11", "fiscalYear": "2024", "period": "Q4", "revenue": 15624000000, "costOfRevenue": 3828000000, "grossProfit": 11796000000, "researchAndDevelopmentExpenses": 4584000000, "generalAndAdministrativeExpenses": 291000000, "sellingAndMarketingExpenses": 2400000000, "sellingGeneralAndAdministrativeExpenses": 2691000000, "otherExpenses": 173000000, "operatingExpenses": 7448000000, "costAndExpenses": 11276000000, "netInterestIncome": -182000000, "interestIncome": 146000000, "interestExpense": 328000000, "depreciationAndAmortization": 1197000000, "ebitda": 5695000000, "ebit": 4498000000, "nonOperatingIncomeExcludingInterest": -150000000, "operatingIncome": 4348000000, "totalOtherIncomeExpensesNet": -178000000, "incomeBeforeTax": 4170000000, "incomeTaxExpense": 426000000, "netIncomeFromContinuingOperations": 3744000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 3743000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 3743000000, "eps": 1.48, "epsDiluted": 1.48, "weightedAverageShsOut": 2541000000, "weightedAverageShsOutDil": 2541000000}}
{"date": "2024-09-30", "symbol": "MRK", "type": "income_statement_quarter", "result": {"date": "2024-09-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2024-11-06", "acceptedDate": "2024-11-06 16:05:36", "fiscalYear": "2024", "period": "Q3", "revenue": 16657000000, "costOfRevenue": 4080000000, "grossProfit": 12577000000, "researchAndDevelopmentExpenses": 5862000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 2731000000, "otherExpenses": 0, "operatingExpenses": 8593000000, "costAndExpenses": 12673000000, "netInterestIncome": -203000000, "interestIncome": 127000000, "interestExpense": 330000000, "depreciationAndAmortization": 1186000000, "ebitda": 5606000000, "ebit": 4420000000, "nonOperatingIncomeExcludingInterest": -436000000, "operatingIncome": 3984000000, "totalOtherIncomeExpensesNet": 106000000, "incomeBeforeTax": 4090000000, "incomeTaxExpense": 929000000, "netIncomeFromContinuingOperations": 3161000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 3157000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 3157000000, "eps": 1.25, "epsDiluted": 1.24, "weightedAverageShsOut": 2541000000, "weightedAverageShsOutDil": 2541000000}}
{"date": "2024-06-30", "symbol": "MRK", "type": "income_statement_quarter", "result": {"date": "2024-06-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2024-08-05", "acceptedDate": "2024-08-05 16:02:11", "fiscalYear": "2024", "period": "Q2", "revenue": 16112000000, "costOfRevenue": 3745000000, "grossProfit": 12367000000, "researchAndDevelopmentExpenses": 3500000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 2739000000, "otherExpenses": 0, "operatingExpenses": 6239000000, "costAndExpenses": 9984000000, "netInterestIncome": -241000000, "interestIncome": 69000000, "interestExpense": 310000000, "depreciationAndAmortization": 1132000000, "ebitda": 7448000000, "ebit": 6316000000, "nonOperatingIncomeExcludingInterest": -188000000, "operatingIncome": 6128000000, "totalOtherIncomeExpensesNet": -122000000, "incomeBeforeTax": 6006000000, "incomeTaxExpense": 545000000, "netIncomeFromContinuingOperations": 5461000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 5455000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 5455000000, "eps": 2.15, "epsDiluted": 2.14, "weightedAverageShsOut": 2534000000, "weightedAverageShsOutDil": 2544000000}}
{"date": "2024-03-31", "symbol": "MRK", "type": "income_statement_quarter", "result": {"date": "2024-03-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2024-05-03", "acceptedDate": "2024-05-03 16:10:43", "fiscalYear": "2024", "period": "Q1", "revenue": 15775000000, "costOfRevenue": 3540000000, "grossProfit": 12235000000, "researchAndDevelopmentExpenses": 3992000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 2483000000, "otherExpenses": 0, "operatingExpenses": 6475000000, "costAndExpenses": 10015000000, "netInterestIncome": -230000000, "interestIncome": 73000000, "interestExpense": 303000000, "depreciationAndAmortization": 984000000, "ebitda": 6957000000, "ebit": 5973000000, "nonOperatingIncomeExcludingInterest": -213000000, "operatingIncome": 5760000000, "totalOtherIncomeExpensesNet": -90000000, "incomeBeforeTax": 5670000000, "incomeTaxExpense": 903000000, "netIncomeFromContinuingOperations": 4767000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 4762000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 4762000000, "eps": 1.88, "epsDiluted": 1.87, "weightedAverageShsOut": 2533000000, "weightedAverageShsOutDil": 2544000000}}
{"date": "2023-12-31", "symbol": "MRK", "type": "income_statement_quarter", "result": {"date": "2023-12-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2024-02-26", "acceptedDate": "2024-02-26 09:06:55", "fiscalYear": "2023", "period": "Q4", "revenue": 14630000000, "costOfRevenue": 3912000000, "grossProfit": 10718000000, "researchAndDevelopmentExpenses": 9627000000, "generalAndAdministrativeExpenses": 341000000, "sellingAndMarketingExpenses": 2300000000, "sellingGeneralAndAdministrativeExpenses": 2641000000, "otherExpenses": 163000000, "operatingExpenses": 12431000000, "costAndExpenses": 16343000000, "netInterestIncome": -240000000, "interestIncome": 70000000, "interestExpense": 310000000, "depreciationAndAmortization": 964000000, "ebitda": -772000000, "ebit": -1736000000, "nonOperatingIncomeExcludingInterest": 23000000, "operatingIncome": -1713000000, "totalOtherIncomeExpensesNet": -333000000, "incomeBeforeTax": -2046000000, "incomeTaxExpense": -820000000, "netIncomeFromContinuingOperations": -1226000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": -1226000000, "netIncomeDeductions": 0, "bottomLineNetIncome": -1226000000, "eps": -0.48, "epsDiluted": -0.48, "weightedAverageShsOut": 2554166667, "weightedAverageShsOutDil": 2554166667}}
{"date": "2023-09-30", "symbol": "MRK", "type": "income_statement_quarter", "result": {"date": "2023-09-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2023-11-03", "acceptedDate": "2023-11-03 16:10:43", "fiscalYear": "2023", "period": "Q3", "revenue": 15962000000, "costOfRevenue": 4264000000, "grossProfit": 11698000000, "researchAndDevelopmentExpenses": 3307000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 2519000000, "otherExpenses": 0, "operatingExpenses": 5826000000, "costAndExpenses": 10090000000, "netInterestIncome": -244000000, "interestIncome": 73000000, "interestExpense": 317000000, "depreciationAndAmortization": 1014000000, "ebitda": 6951000000, "ebit": 5937000000, "nonOperatingIncomeExcludingInterest": -65000000, "operatingIncome": 5872000000, "totalOtherIncomeExpensesNet": -252000000, "incomeBeforeTax": 5620000000, "incomeTaxExpense": 870000000, "netIncomeFromContinuingOperations": 4750000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 4745000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 4745000000, "eps": 1.87, "epsDiluted": 1.86, "weightedAverageShsOut": 2537000000, "weightedAverageShsOutDil": 2546000000}}
{"date": "2023-06-30", "symbol": "MRK", "type": "income_statement_quarter", "result": {"date": "2023-06-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2023-08-07", "acceptedDate": "2023-08-07 16:09:00", "fiscalYear": "2023", "period": "Q2", "revenue": 15035000000, "costOfRevenue": 4024000000, "grossProfit": 11011000000, "researchAndDevelopmentExpenses": 13321000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 2702000000, "otherExpenses": 0, "operatingExpenses": 16023000000, "costAndExpenses": 20047000000, "netInterestIncome": -168000000, "interestIncome": 109000000, "interestExpense": 277000000, "depreciationAndAmortization": 903000000, "ebitda": -4155000000, "ebit": -5058000000, "nonOperatingIncomeExcludingInterest": 46000000, "operatingIncome": -5012000000, "totalOtherIncomeExpensesNet": -323000000, "incomeBeforeTax": -5335000000, "incomeTaxExpense": 637000000, "netIncomeFromContinuingOperations": -5972000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": -5975000000, "netIncomeDeductions": 0, "bottomLineNetIncome": -5975000000, "eps": -2.35, "epsDiluted": -2.35, "weightedAverageShsOut": 2539000000, "weightedAverageShsOutDil": 2539000000}}
{"date": "2023-03-31", "symbol": "MRK", "type": "income_statement_quarter", "result": {"date": "2023-03-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2023-05-05", "acceptedDate": "2023-05-05 07:39:41", "fiscalYear": "2023", "period": "Q1", "revenue": 14487000000, "costOfRevenue": 3926000000, "grossProfit": 10561000000, "researchAndDevelopmentExpenses": 4276000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 2479000000, "otherExpenses": 0, "operatingExpenses": 6755000000, "costAndExpenses": 10681000000, "netInterestIncome": -130000000, "interestIncome": 112000000, "interestExpense": 242000000, "depreciationAndAmortization": 991000000, "ebitda": 4883000000, "ebit": 3892000000, "nonOperatingIncomeExcludingInterest": -86000000, "operatingIncome": 3806000000, "totalOtherIncomeExpensesNet": -156000000, "incomeBeforeTax": 3650000000, "incomeTaxExpense": 825000000, "netIncomeFromContinuingOperations": 2825000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 2821000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 2821000000, "eps": 1.11, "epsDiluted": 1.11, "weightedAverageShsOut": 2538000000, "weightedAverageShsOutDil": 2551000000}}
{"date": "2022-12-31", "symbol": "MRK", "type": "income_statement_quarter", "result": {"date": "2022-12-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2023-02-24", "acceptedDate": "2023-02-24 16:22:30", "fiscalYear": "2022", "period": "Q4", "revenue": 13830000000, "costOfRevenue": 3881000000, "grossProfit": 9949000000, "researchAndDevelopmentExpenses": 3775000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 2687000000, "otherExpenses": 0, "operatingExpenses": 6462000000, "costAndExpenses": 10343000000, "netInterestIncome": -140000000, "interestIncome": 95000000, "interestExpense": 235000000, "depreciationAndAmortization": 892000000, "ebitda": 4640000000, "ebit": 3748000000, "nonOperatingIncomeExcludingInterest": -261000000, "operatingIncome": 3487000000, "totalOtherIncomeExpensesNet": 26000000, "incomeBeforeTax": 3513000000, "incomeTaxExpense": 495000000, "netIncomeFromContinuingOperations": 3018000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 3017000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 3017000000, "eps": 1.19, "epsDiluted": 1.18, "weightedAverageShsOut": 2536000000, "weightedAverageShsOutDil": 2548000000}}
{"date": "2022-09-30", "symbol": "MRK", "type": "income_statement_quarter", "result": {"date": "2022-09-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2022-11-03", "acceptedDate": "2022-11-03 16:28:44", "fiscalYear": "2022", "period": "Q3", "revenue": 14959000000, "costOfRevenue": 3934000000, "grossProfit": 11025000000, "researchAndDevelopmentExpenses": 4399000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 2520000000, "otherExpenses": 0, "operatingExpenses": 6919000000, "costAndExpenses": 10853000000, "netInterestIncome": -204000000, "interestIncome": 40000000, "interestExpense": 244000000, "depreciationAndAmortization": 959000000, "ebitda": 4786000000, "ebit": 3827000000, "nonOperatingIncomeExcludingInterest": 279000000, "operatingIncome": 4106000000, "totalOtherIncomeExpensesNet": -523000000, "incomeBeforeTax": 3583000000, "incomeTaxExpense": 330000000, "netIncomeFromContinuingOperations": 3253000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 3248000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 3248000000, "eps": 1.28, "epsDiluted": 1.28, "weightedAverageShsOut": 2533000000, "weightedAverageShsOutDil": 2542000000}}
{"date": "2022-06-30", "symbol": "MRK", "type": "income_statement_quarter", "result": {"date": "2022-06-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2022-08-05", "acceptedDate": "2022-08-04 17:35:47", "fiscalYear": "2022", "period": "Q2", "revenue": 14593000000, "costOfRevenue": 4216000000, "grossProfit": 10377000000, "researchAndDevelopmentExpenses": 2798000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 2512000000, "otherExpenses": 0, "operatingExpenses": 5310000000, "costAndExpenses": 9526000000, "netInterestIncome": -225000000, "interestIncome": 15000000, "interestExpense": 240000000, "depreciationAndAmortization": 938000000, "ebitda": 5665000000, "ebit": 4727000000, "nonOperatingIncomeExcludingInterest": 340000000, "operatingIncome": 5067000000, "totalOtherIncomeExpensesNet": -580000000, "incomeBeforeTax": 4487000000, "incomeTaxExpense": 538000000, "netIncomeFromContinuingOperations": 3949000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 3944000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 3944000000, "eps": 1.56, "epsDiluted": 1.55, "weightedAverageShsOut": 2531000000, "weightedAverageShsOutDil": 2540000000}}
{"date": "2022-03-31", "symbol": "MRK", "type": "income_statement_quarter", "result": {"date": "2022-03-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2022-05-05", "acceptedDate": "2022-05-05 16:28:37", "fiscalYear": "2022", "period": "Q1", "revenue": 15901000000, "costOfRevenue": 5380000000, "grossProfit": 10521000000, "researchAndDevelopmentExpenses": 2576000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 2323000000, "otherExpenses": 0, "operatingExpenses": 4899000000, "costAndExpenses": 10279000000, "netInterestIncome": -236000000, "interestIncome": 7000000, "interestExpense": 243000000, "depreciationAndAmortization": 1120000000, "ebitda": 6224000000, "ebit": 5104000000, "nonOperatingIncomeExcludingInterest": 518000000, "operatingIncome": 5622000000, "totalOtherIncomeExpensesNet": -761000000, "incomeBeforeTax": 4861000000, "incomeTaxExpense": 554000000, "netIncomeFromContinuingOperations": 4307000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 4310000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 4310000000, "eps": 1.7, "epsDiluted": 1.7, "weightedAverageShsOut": 2528000000, "weightedAverageShsOutDil": 2537000000}}
{"date": "2021-12-31", "symbol": "MRK", "type": "income_statement_quarter", "result": {"date": "2021-12-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2022-02-25", "acceptedDate": "2022-02-25 16:44:28", "fiscalYear": "2021", "period": "Q4", "revenue": 13521000000, "costOfRevenue": 3874000000, "grossProfit": 9647000000, "researchAndDevelopmentExpenses": 3068000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 2830000000, "otherExpenses": 0, "operatingExpenses": 5898000000, "costAndExpenses": 9772000000, "netInterestIncome": -200000000, "interestIncome": 9000000, "interestExpense": 209000000, "depreciationAndAmortization": 835000000, "ebitda": 4953000000, "ebit": 4118000000, "nonOperatingIncomeExcludingInterest": -369000000, "operatingIncome": 3749000000, "totalOtherIncomeExpensesNet": 160000000, "incomeBeforeTax": 3909000000, "incomeTaxExpense": 85000000, "netIncomeFromContinuingOperations": 3824000000, "netIncomeFromDiscontinuedOperations": -62000000, "otherAdjustmentsToNetIncome": 62000000, "netIncome": 3758000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 3758000000, "eps": 1.49, "epsDiluted": 1.48, "weightedAverageShsOut": 2527000000, "weightedAverageShsOutDil": 2535000000}}
{"date": "2021-09-30", "symbol": "MRK", "type": "income_statement_quarter", "result": {"date": "2021-09-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2021-11-05", "acceptedDate": "2021-11-05 16:09:58", "fiscalYear": "2021", "period": "Q3", "revenue": 13154000000, "costOfRevenue": 3450000000, "grossProfit": 9704000000, "researchAndDevelopmentExpenses": 2445000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 2336000000, "otherExpenses": 0, "operatingExpenses": 4781000000, "costAndExpenses": 8231000000, "netInterestIncome": -189000000, "interestIncome": 7000000, "interestExpense": 196000000, "depreciationAndAmortization": 759000000, "ebitda": 6221000000, "ebit": 5462000000, "nonOperatingIncomeExcludingInterest": -539000000, "operatingIncome": 4923000000, "totalOtherIncomeExpensesNet": 343000000, "incomeBeforeTax": 5266000000, "incomeTaxExpense": 695000000, "netIncomeFromContinuingOperations": 4571000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 4567000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 4567000000, "eps": 1.81, "epsDiluted": 1.8, "weightedAverageShsOut": 2530000000, "weightedAverageShsOutDil": 2536000000}}
{"date": "2021-06-30", "symbol": "MRK", "type": "income_statement_quarter", "result": {"date": "2021-06-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2021-08-09", "acceptedDate": "2021-08-09 07:07:53", "fiscalYear": "2021", "period": "Q2", "revenue": 11402000000, "costOfRevenue": 3104000000, "grossProfit": 8298000000, "researchAndDevelopmentExpenses": 4321000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 2281000000, "otherExpenses": 0, "operatingExpenses": 6602000000, "costAndExpenses": 9706000000, "netInterestIncome": -193000000, "interestIncome": 9000000, "interestExpense": 202000000, "depreciationAndAmortization": 728000000, "ebitda": 2647000000, "ebit": 1919000000, "nonOperatingIncomeExcludingInterest": -223000000, "operatingIncome": 1696000000, "totalOtherIncomeExpensesNet": 21000000, "incomeBeforeTax": 1717000000, "incomeTaxExpense": 503000000, "netIncomeFromContinuingOperations": 1214000000, "netIncomeFromDiscontinuedOperations": 332000000, "otherAdjustmentsToNetIncome": -332000000, "netIncome": 1545000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 1545000000, "eps": 0.61, "epsDiluted": 0.61, "weightedAverageShsOut": 2533000000, "weightedAverageShsOutDil": 2540000000}}
{"date": "2021-03-31", "symbol": "MRK", "type": "income_statement_quarter", "result": {"date": "2021-03-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2021-05-05", "acceptedDate": "2021-05-05 16:26:12", "fiscalYear": "2021", "period": "Q1", "revenue": 10627000000, "costOfRevenue": 3199000000, "grossProfit": 7428000000, "researchAndDevelopmentExpenses": 2412000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 2187000000, "otherExpenses": 0, "operatingExpenses": 4599000000, "costAndExpenses": 7798000000, "netInterestIncome": -189000000, "interestIncome": 11000000, "interestExpense": 200000000, "depreciationAndAmortization": 892000000, "ebitda": 4079000000, "ebit": 3187000000, "nonOperatingIncomeExcludingInterest": -358000000, "operatingIncome": 2829000000, "totalOtherIncomeExpensesNet": 158000000, "incomeBeforeTax": 2987000000, "incomeTaxExpense": 238000000, "netIncomeFromContinuingOperations": 2749000000, "netIncomeFromDiscontinuedOperations": 434000000, "otherAdjustmentsToNetIncome": -434000000, "netIncome": 3179000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 3179000000, "eps": 1.26, "epsDiluted": 1.25, "weightedAverageShsOut": 2531303747, "weightedAverageShsOutDil": 2541000000}}
{"date": "2024-12-31", "symbol": "MRK", "type": "balance_sheet_annual", "result": {"date": "2024-12-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2025-02-25", "acceptedDate": "2025-02-25 16:19:11", "fiscalYear": "2024", "period": "FY", "cashAndCashEquivalents": 13242000000, "shortTermInvestments": 447000000, "cashAndShortTermInvestments": 13689000000, "netReceivables": 10278000000, "accountsReceivables": 10278000000, "otherReceivables": 0, "inventory": 6109000000, "prepaids": 0, "otherCurrentAssets": 8706000000, "totalCurrentAssets": 38782000000, "propertyPlantEquipmentNet": 23779000000, "goodwill": 21668000000, "intangibleAssets": 16370000000, "goodwillAndIntangibleAssets": 38038000000, "longTermInvestments": 463000000, "taxAssets": 0, "otherNonCurrentAssets": 16044000000, "totalNonCurrentAssets": 78324000000, "otherAssets": 0, "totalAssets": 117106000000, "totalPayables": 10077000000, "accountPayables": 4079000000, "otherPayables": 5998000000, "accruedExpenses": 15694000000, "shortTermDebt": 2649000000, "capitalLeaseObligationsCurrent": 282000000, "taxPayables": 3914000000, "deferredRevenue": 0, "otherCurrentLiabilities": -282000000, "totalCurrentLiabilities": 28420000000, "longTermDebt": 34462000000, "capitalLeaseObligationsNonCurrent": 877000000, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 1387000000, "otherNonCurrentLiabilities": 5588000000, "totalNonCurrentLiabilities": 42314000000, "otherLiabilities": 0, "capitalLeaseObligations": 1159000000, "totalLiabilities": 70734000000, "treasuryStock": -58303000000, "preferredStock": 0, "commonStock": 1788000000, "retainedEarnings": 63069000000, "additionalPaidInCapital": 44704000000, "accumulatedOtherComprehensiveIncomeLoss": -4945000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 46313000000, "totalEquity": 46372000000, "minorityInterest": 59000000, "totalLiabilitiesAndTotalEquity": 117106000000, "totalInvestments": 910000000, "totalDebt": 38270000000, "netDebt": 25028000000}}
{"date": "2023-12-31", "symbol": "MRK", "type": "balance_sheet_annual", "result": {"date": "2023-12-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2024-02-26", "acceptedDate": "2024-02-26 09:06:55", "fiscalYear": "2023", "period": "FY", "cashAndCashEquivalents": 6841000000, "shortTermInvestments": 252000000, "cashAndShortTermInvestments": 7093000000, "netReceivables": 10349000000, "accountsReceivables": 10349000000, "otherReceivables": 0, "inventory": 6358000000, "prepaids": 0, "otherCurrentAssets": 8368000000, "totalCurrentAssets": 32168000000, "propertyPlantEquipmentNet": 23051000000, "goodwill": 21197000000, "intangibleAssets": 18011000000, "goodwillAndIntangibleAssets": 39208000000, "longTermInvestments": 252000000, "taxAssets": 0, "otherNonCurrentAssets": 11996000000, "totalNonCurrentAssets": 74507000000, "otherAssets": 0, "totalAssets": 106675000000, "totalPayables": 8556000000, "accountPayables": 3922000000, "otherPayables": 4634000000, "accruedExpenses": 15766000000, "shortTermDebt": 1372000000, "capitalLeaseObligationsCurrent": 285000000, "taxPayables": 2649000000, "deferredRevenue": 0, "otherCurrentLiabilities": -285000000, "totalCurrentLiabilities": 25694000000, "longTermDebt": 33683000000, "capitalLeaseObligationsNonCurrent": 928000000, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 871000000, "otherNonCurrentLiabilities": 7864000000, "totalNonCurrentLiabilities": 43346000000, "otherLiabilities": 0, "capitalLeaseObligations": 928000000, "totalLiabilities": 69040000000, "treasuryStock": -57450000000, "preferredStock": 0, "commonStock": 1788000000, "retainedEarnings": 53895000000, "additionalPaidInCapital": 44509000000, "accumulatedOtherComprehensiveIncomeLoss": -5161000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 37581000000, "totalEquity": 37635000000, "minorityInterest": 54000000, "totalLiabilitiesAndTotalEquity": 106675000000, "totalInvestments": 504000000, "totalDebt": 36268000000, "netDebt": 29427000000}}
{"date": "2022-12-31", "symbol": "MRK", "type": "balance_sheet_annual", "result": {"date": "2022-12-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2023-02-24", "acceptedDate": "2023-02-24 16:22:30", "fiscalYear": "2022", "period": "FY", "cashAndCashEquivalents": 12694000000, "shortTermInvestments": 498000000, "cashAndShortTermInvestments": 13192000000, "netReceivables": 9450000000, "accountsReceivables": 9450000000, "otherReceivables": 0, "inventory": 5911000000, "prepaids": 0, "otherCurrentAssets": 7169000000, "totalCurrentAssets": 35722000000, "propertyPlantEquipmentNet": 21422000000, "goodwill": 21204000000, "intangibleAssets": 20269000000, "goodwillAndIntangibleAssets": 41473000000, "longTermInvestments": 1015000000, "taxAssets": 0, "otherNonCurrentAssets": 9528000000, "totalNonCurrentAssets": 73438000000, "otherAssets": 0, "totalAssets": 109160000000, "totalPayables": 8134000000, "accountPayables": 4264000000, "otherPayables": 3870000000, "accruedExpenses": 14159000000, "shortTermDebt": 1946000000, "capitalLeaseObligationsCurrent": 281000000, "taxPayables": 1986000000, "deferredRevenue": 0, "otherCurrentLiabilities": -281000000, "totalCurrentLiabilities": 24239000000, "longTermDebt": 28745000000, "capitalLeaseObligationsNonCurrent": 1013000000, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 1795000000, "otherNonCurrentLiabilities": 7310000000, "totalNonCurrentLiabilities": 38863000000, "otherLiabilities": 0, "capitalLeaseObligations": 1013000000, "totalLiabilities": 63102000000, "treasuryStock": -56489000000, "preferredStock": 0, "commonStock": 1788000000, "retainedEarnings": 61081000000, "additionalPaidInCapital": 44379000000, "accumulatedOtherComprehensiveIncomeLoss": -4768000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 45991000000, "totalEquity": 46058000000, "minorityInterest": 67000000, "totalLiabilitiesAndTotalEquity": 109160000000, "totalInvestments": 1513000000, "totalDebt": 31985000000, "netDebt": 19291000000}}
{"date": "2021-12-31", "symbol": "MRK", "type": "balance_sheet_annual", "result": {"date": "2021-12-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2022-02-25", "acceptedDate": "2022-02-25 16:44:28", "fiscalYear": "2021", "period": "FY", "cashAndCashEquivalents": 8096000000, "shortTermInvestments": 0, "cashAndShortTermInvestments": 8096000000, "netReceivables": 9230000000, "accountsReceivables": 9230000000, "otherReceivables": 0, "inventory": 5953000000, "prepaids": 0, "otherCurrentAssets": 6987000000, "totalCurrentAssets": 30266000000, "propertyPlantEquipmentNet": 19279000000, "goodwill": 21264000000, "intangibleAssets": 22933000000, "goodwillAndIntangibleAssets": 44197000000, "longTermInvestments": 370000000, "taxAssets": 0, "otherNonCurrentAssets": 11582000000, "totalNonCurrentAssets": 75428000000, "otherAssets": 0, "totalAssets": 105694000000, "totalPayables": 7601000000, "accountPayables": 4609000000, "otherPayables": 2992000000, "accruedExpenses": 13859000000, "shortTermDebt": 2412000000, "capitalLeaseObligationsCurrent": 304000000, "taxPayables": 1224000000, "deferredRevenue": 0, "otherCurrentLiabilities": -304000000, "totalCurrentLiabilities": 23872000000, "longTermDebt": 30690000000, "capitalLeaseObligationsNonCurrent": 1225000000, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 3441000000, "otherNonCurrentLiabilities": 8209000000, "totalNonCurrentLiabilities": 43565000000, "otherLiabilities": 0, "capitalLeaseObligations": 1225000000, "totalLiabilities": 67437000000, "treasuryStock": -57109000000, "preferredStock": 0, "commonStock": 1788000000, "retainedEarnings": 53696000000, "additionalPaidInCapital": 44238000000, "accumulatedOtherComprehensiveIncomeLoss": -4429000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 38184000000, "totalEquity": 38257000000, "minorityInterest": 73000000, "totalLiabilitiesAndTotalEquity": 105694000000, "totalInvestments": 370000000, "totalDebt": 34631000000, "netDebt": 26535000000}}
{"date": "2025-09-30", "symbol": "MRK", "type": "balance_sheet_quarter", "result": {"date": "2025-09-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2025-11-05", "acceptedDate": "2025-11-05 16:08:41", "fiscalYear": "2025", "period": "Q3", "cashAndCashEquivalents": 18169000000, "shortTermInvestments": 45000000, "cashAndShortTermInvestments": 18214000000, "netReceivables": 12120000000, "accountsReceivables": 12120000000, "otherReceivables": 0, "inventory": 6444000000, "prepaids": 0, "otherCurrentAssets": 10779000000, "totalCurrentAssets": 47557000000, "propertyPlantEquipmentNet": 25639000000, "goodwill": 21587000000, "intangibleAssets": 15313000000, "goodwillAndIntangibleAssets": 36900000000, "longTermInvestments": 1117000000, "taxAssets": 0, "otherNonCurrentAssets": 18333000000, "totalNonCurrentAssets": 81989000000, "otherAssets": 0, "totalAssets": 129546000000, "totalPayables": 11037000000, "accountPayables": 4147000000, "otherPayables": 6890000000, "accruedExpenses": 16186000000, "shortTermDebt": 1405000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 4848000000, "deferredRevenue": 0, "otherCurrentLiabilities": 0, "totalCurrentLiabilities": 28628000000, "longTermDebt": 39969000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 1381000000, "otherNonCurrentLiabilities": 7661000000, "totalNonCurrentLiabilities": 49011000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 77639000000, "treasuryStock": -61799000000, "preferredStock": 0, "commonStock": 1788000000, "retainedEarnings": 72231000000, "additionalPaidInCapital": 44832000000, "accumulatedOtherComprehensiveIncomeLoss": -5202000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 51850000000, "totalEquity": 51907000000, "minorityInterest": 57000000, "totalLiabilitiesAndTotalEquity": 129546000000, "totalInvestments": 1162000000, "totalDebt": 41374000000, "netDebt": 23205000000}}
{"date": "2025-06-30", "symbol": "MRK", "type": "balance_sheet_quarter", "result": {"date": "2025-06-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2025-08-05", "acceptedDate": "2025-08-05 16:13:52", "fiscalYear": "2025", "period": "Q2", "cashAndCashEquivalents": 8007000000, "shortTermInvestments": 615000000, "cashAndShortTermInvestments": 8622000000, "netReceivables": 11846000000, "accountsReceivables": 11846000000, "otherReceivables": 0, "inventory": 6601000000, "prepaids": 0, "otherCurrentAssets": 9996000000, "totalCurrentAssets": 37065000000, "propertyPlantEquipmentNet": 25236000000, "goodwill": 21591000000, "intangibleAssets": 15193000000, "goodwillAndIntangibleAssets": 36784000000, "longTermInvestments": 774000000, "taxAssets": 0, "otherNonCurrentAssets": 17664000000, "totalNonCurrentAssets": 80458000000, "otherAssets": 0, "totalAssets": 117523000000, "totalPayables": 10101000000, "accountPayables": 3892000000, "otherPayables": 6209000000, "accruedExpenses": 14502000000, "shortTermDebt": 1434000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 4156000000, "deferredRevenue": 0, "otherCurrentLiabilities": 0, "totalCurrentLiabilities": 26037000000, "longTermDebt": 33968000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 1427000000, "otherNonCurrentLiabilities": 7031000000, "totalNonCurrentLiabilities": 42426000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 68463000000, "treasuryStock": -60495000000, "preferredStock": 0, "commonStock": 1788000000, "retainedEarnings": 68477000000, "additionalPaidInCapital": 44644000000, "accumulatedOtherComprehensiveIncomeLoss": -5421000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 48993000000, "totalEquity": 49060000000, "minorityInterest": 67000000, "totalLiabilitiesAndTotalEquity": 117523000000, "totalInvestments": 1389000000, "totalDebt": 35402000000, "netDebt": 27395000000}}
{"date": "2025-03-31", "symbol": "MRK", "type": "balance_sheet_quarter", "result": {"date": "2025-03-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2025-05-02", "acceptedDate": "2025-05-02 16:10:22", "fiscalYear": "2025", "period": "Q1", "cashAndCashEquivalents": 8629000000, "shortTermInvestments": 599000000, "cashAndShortTermInvestments": 9228000000, "netReceivables": 10790000000, "accountsReceivables": 10790000000, "otherReceivables": 0, "inventory": 6196000000, "prepaids": 0, "otherCurrentAssets": 9289000000, "totalCurrentAssets": 35503000000, "propertyPlantEquipmentNet": 24793000000, "goodwill": 21684000000, "intangibleAssets": 15758000000, "goodwillAndIntangibleAssets": 37442000000, "longTermInvestments": 616000000, "taxAssets": 0, "otherNonCurrentAssets": 16768000000, "totalNonCurrentAssets": 79619000000, "otherAssets": 0, "totalAssets": 115122000000, "totalPayables": 11042000000, "accountPayables": 3784000000, "otherPayables": 7258000000, "accruedExpenses": 12772000000, "shortTermDebt": 1360000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 5181000000, "deferredRevenue": 0, "otherCurrentLiabilities": 0, "totalCurrentLiabilities": 25174000000, "longTermDebt": 33484000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 1409000000, "otherNonCurrentLiabilities": 6655000000, "totalNonCurrentLiabilities": 41548000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 66722000000, "treasuryStock": -59401000000, "preferredStock": 0, "commonStock": 1788000000, "retainedEarnings": 66097000000, "additionalPaidInCapital": 44816000000, "accumulatedOtherComprehensiveIncomeLoss": -4965000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 48335000000, "totalEquity": 48400000000, "minorityInterest": 65000000, "totalLiabilitiesAndTotalEquity": 115122000000, "totalInvestments": 1215000000, "totalDebt": 34844000000, "netDebt": 26215000000}}
{"date": "2024-12-31", "symbol": "MRK", "type": "balance_sheet_quarter", "result": {"date": "2024-12-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2025-02-25", "acceptedDate": "2025-02-25 16:19:11", "fiscalYear": "2024", "period": "Q4", "cashAndCashEquivalents": 13242000000, "shortTermInvestments": 447000000, "cashAndShortTermInvestments": 13689000000, "netReceivables": 10278000000, "accountsReceivables": 10278000000, "otherReceivables": 0, "inventory": 6109000000, "prepaids": 0, "otherCurrentAssets": 8706000000, "totalCurrentAssets": 38782000000, "propertyPlantEquipmentNet": 23779000000, "goodwill": 21668000000, "intangibleAssets": 16370000000, "goodwillAndIntangibleAssets": 38038000000, "longTermInvestments": 463000000, "taxAssets": 0, "otherNonCurrentAssets": 16044000000, "totalNonCurrentAssets": 78324000000, "otherAssets": 0, "totalAssets": 117106000000, "totalPayables": 10077000000, "accountPayables": 4079000000, "otherPayables": 5998000000, "accruedExpenses": 15694000000, "shortTermDebt": 2649000000, "capitalLeaseObligationsCurrent": 282000000, "taxPayables": 3914000000, "deferredRevenue": 0, "otherCurrentLiabilities": -282000000, "totalCurrentLiabilities": 28420000000, "longTermDebt": 34462000000, "capitalLeaseObligationsNonCurrent": 877000000, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 1387000000, "otherNonCurrentLiabilities": 5588000000, "totalNonCurrentLiabilities": 42314000000, "otherLiabilities": 0, "capitalLeaseObligations": 1159000000, "totalLiabilities": 70734000000, "treasuryStock": -58303000000, "preferredStock": 0, "commonStock": 1788000000, "retainedEarnings": 63069000000, "additionalPaidInCapital": 44704000000, "accumulatedOtherComprehensiveIncomeLoss": -4945000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 46313000000, "totalEquity": 46372000000, "minorityInterest": 59000000, "totalLiabilitiesAndTotalEquity": 117106000000, "totalInvestments": 910000000, "totalDebt": 38270000000, "netDebt": 25028000000}}
{"date": "2024-09-30", "symbol": "MRK", "type": "balance_sheet_quarter", "result": {"date": "2024-09-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2024-11-06", "acceptedDate": "2024-11-06 16:05:36", "fiscalYear": "2024", "period": "Q3", "cashAndCashEquivalents": 14593000000, "shortTermInvestments": 0, "cashAndShortTermInvestments": 14593000000, "netReceivables": 11381000000, "accountsReceivables": 11381000000, "otherReceivables": 0, "inventory": 6244000000, "prepaids": 0, "otherCurrentAssets": 8143000000, "totalCurrentAssets": 40361000000, "propertyPlantEquipmentNet": 23446000000, "goodwill": 21697000000, "intangibleAssets": 17010000000, "goodwillAndIntangibleAssets": 38707000000, "longTermInvestments": 575000000, "taxAssets": 0, "otherNonCurrentAssets": 14443000000, "totalNonCurrentAssets": 77171000000, "otherAssets": 0, "totalAssets": 117532000000, "totalPayables": 9898000000, "accountPayables": 3586000000, "otherPayables": 6312000000, "accruedExpenses": 16539000000, "shortTermDebt": 3149000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 4330000000, "deferredRevenue": 0, "otherCurrentLiabilities": 0, "totalCurrentLiabilities": 29586000000, "longTermDebt": 34982000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 864000000, "otherNonCurrentLiabilities": 7540000000, "totalNonCurrentLiabilities": 43386000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 72972000000, "treasuryStock": -57829000000, "preferredStock": 0, "commonStock": 1788000000, "retainedEarnings": 61384000000, "additionalPaidInCapital": 44530000000, "accumulatedOtherComprehensiveIncomeLoss": -5371000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 44502000000, "totalEquity": 44560000000, "minorityInterest": 58000000, "totalLiabilitiesAndTotalEquity": 117532000000, "totalInvestments": 575000000, "totalDebt": 38131000000, "netDebt": 23538000000}}
{"date": "2024-06-30", "symbol": "MRK", "type": "balance_sheet_quarter", "result": {"date": "2024-06-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2024-08-05", "acceptedDate": "2024-08-05 16:02:11", "fiscalYear": "2024", "period": "Q2", "cashAndCashEquivalents": 11304000000, "shortTermInvestments": 50000000, "cashAndShortTermInvestments": 11354000000, "netReceivables": 11642000000, "accountsReceivables": 11642000000, "otherReceivables": 0, "inventory": 6469000000, "prepaids": 0, "otherCurrentAssets": 8740000000, "totalCurrentAssets": 38205000000, "propertyPlantEquipmentNet": 23221000000, "goodwill": 21161000000, "intangibleAssets": 16984000000, "goodwillAndIntangibleAssets": 38145000000, "longTermInvestments": 357000000, "taxAssets": 0, "otherNonCurrentAssets": 12702000000, "totalNonCurrentAssets": 74425000000, "otherAssets": 0, "totalAssets": 112630000000, "totalPayables": 8277000000, "accountPayables": 3519000000, "otherPayables": 4758000000, "accruedExpenses": 14712000000, "shortTermDebt": 3071000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 2777000000, "deferredRevenue": 0, "otherCurrentLiabilities": 0, "totalCurrentLiabilities": 26060000000, "longTermDebt": 34717000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 876000000, "otherNonCurrentLiabilities": 7329000000, "totalNonCurrentLiabilities": 42922000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 68982000000, "treasuryStock": -57394000000, "preferredStock": 0, "commonStock": 1788000000, "retainedEarnings": 60187000000, "additionalPaidInCapital": 44362000000, "accumulatedOtherComprehensiveIncomeLoss": -5361000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 43582000000, "totalEquity": 43648000000, "minorityInterest": 66000000, "totalLiabilitiesAndTotalEquity": 112630000000, "totalInvestments": 407000000, "totalDebt": 37788000000, "netDebt": 26484000000}}
{"date": "2024-03-31", "symbol": "MRK", "type": "balance_sheet_quarter", "result": {"date": "2024-03-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2024-05-03", "acceptedDate": "2024-05-03 16:10:43", "fiscalYear": "2024", "period": "Q1", "cashAndCashEquivalents": 5579000000, "shortTermInvestments": 40000000, "cashAndShortTermInvestments": 5619000000, "netReceivables": 11366000000, "accountsReceivables": 11366000000, "otherReceivables": 0, "inventory": 6510000000, "prepaids": 0, "otherCurrentAssets": 7950000000, "totalCurrentAssets": 31445000000, "propertyPlantEquipmentNet": 23045000000, "goodwill": 21181000000, "intangibleAssets": 17572000000, "goodwillAndIntangibleAssets": 38753000000, "longTermInvestments": 280000000, "taxAssets": 0, "otherNonCurrentAssets": 12326000000, "totalNonCurrentAssets": 74404000000, "otherAssets": 0, "totalAssets": 105849000000, "totalPayables": 7920000000, "accountPayables": 3514000000, "otherPayables": 4406000000, "accruedExpenses": 14102000000, "shortTermDebt": 3077000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 2398000000, "deferredRevenue": 0, "otherCurrentLiabilities": 0, "totalCurrentLiabilities": 25099000000, "longTermDebt": 31142000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 922000000, "otherNonCurrentLiabilities": 8262000000, "totalNonCurrentLiabilities": 40326000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 65425000000, "treasuryStock": -57445000000, "preferredStock": 0, "commonStock": 1788000000, "retainedEarnings": 56697000000, "additionalPaidInCapital": 44598000000, "accumulatedOtherComprehensiveIncomeLoss": -5274000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 40364000000, "totalEquity": 40424000000, "minorityInterest": 60000000, "totalLiabilitiesAndTotalEquity": 105849000000, "totalInvestments": 320000000, "totalDebt": 34219000000, "netDebt": 28640000000}}
{"date": "2023-12-31", "symbol": "MRK", "type": "balance_sheet_quarter", "result": {"date": "2023-12-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2024-02-26", "acceptedDate": "2024-02-26 09:06:55", "fiscalYear": "2023", "period": "Q4", "cashAndCashEquivalents": 6841000000, "shortTermInvestments": 252000000, "cashAndShortTermInvestments": 7093000000, "netReceivables": 10349000000, "accountsReceivables": 10349000000, "otherReceivables": 0, "inventory": 6358000000, "prepaids": 0, "otherCurrentAssets": 8368000000, "totalCurrentAssets": 32168000000, "propertyPlantEquipmentNet": 23051000000, "goodwill": 21197000000, "intangibleAssets": 18011000000, "goodwillAndIntangibleAssets": 39208000000, "longTermInvestments": 252000000, "taxAssets": 0, "otherNonCurrentAssets": 11996000000, "totalNonCurrentAssets": 74507000000, "otherAssets": 0, "totalAssets": 106675000000, "totalPayables": 8556000000, "accountPayables": 3922000000, "otherPayables": 4634000000, "accruedExpenses": 15766000000, "shortTermDebt": 1372000000, "capitalLeaseObligationsCurrent": 285000000, "taxPayables": 2649000000, "deferredRevenue": 0, "otherCurrentLiabilities": -285000000, "totalCurrentLiabilities": 25694000000, "longTermDebt": 33683000000, "capitalLeaseObligationsNonCurrent": 928000000, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 871000000, "otherNonCurrentLiabilities": 7864000000, "totalNonCurrentLiabilities": 43346000000, "otherLiabilities": 0, "capitalLeaseObligations": 928000000, "totalLiabilities": 69040000000, "treasuryStock": -57450000000, "preferredStock": 0, "commonStock": 1788000000, "retainedEarnings": 53895000000, "additionalPaidInCapital": 44509000000, "accumulatedOtherComprehensiveIncomeLoss": -5161000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 37581000000, "totalEquity": 37635000000, "minorityInterest": 54000000, "totalLiabilitiesAndTotalEquity": 106675000000, "totalInvestments": 504000000, "totalDebt": 36268000000, "netDebt": 29427000000}}
{"date": "2023-09-30", "symbol": "MRK", "type": "balance_sheet_quarter", "result": {"date": "2023-09-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2023-11-03", "acceptedDate": "2023-11-03 16:10:43", "fiscalYear": "2023", "period": "Q3", "cashAndCashEquivalents": 8605000000, "shortTermInvestments": 168000000, "cashAndShortTermInvestments": 8773000000, "netReceivables": 10394000000, "accountsReceivables": 10394000000, "otherReceivables": 0, "inventory": 6131000000, "prepaids": 0, "otherCurrentAssets": 6656000000, "totalCurrentAssets": 31954000000, "propertyPlantEquipmentNet": 22526000000, "goodwill": 21183000000, "intangibleAssets": 19199000000, "goodwillAndIntangibleAssets": 40382000000, "longTermInvestments": 1306000000, "taxAssets": 0, "otherNonCurrentAssets": 10559000000, "totalNonCurrentAssets": 74773000000, "otherAssets": 0, "totalAssets": 106727000000, "totalPayables": 7367000000, "accountPayables": 3509000000, "otherPayables": 3858000000, "accruedExpenses": 14840000000, "shortTermDebt": 887000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 1981000000, "deferredRevenue": 0, "otherCurrentLiabilities": 0, "totalCurrentLiabilities": 23094000000, "longTermDebt": 33972000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 1018000000, "otherNonCurrentLiabilities": 7343000000, "totalNonCurrentLiabilities": 42333000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 65427000000, "treasuryStock": -57066000000, "preferredStock": 0, "commonStock": 1788000000, "retainedEarnings": 57082000000, "additionalPaidInCapital": 44358000000, "accumulatedOtherComprehensiveIncomeLoss": -4916000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 41246000000, "totalEquity": 41300000000, "minorityInterest": 54000000, "totalLiabilitiesAndTotalEquity": 106727000000, "totalInvestments": 1474000000, "totalDebt": 34859000000, "netDebt": 26254000000}}
{"date": "2023-06-30", "symbol": "MRK", "type": "balance_sheet_quarter", "result": {"date": "2023-06-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2023-08-07", "acceptedDate": "2023-08-07 16:09:00", "fiscalYear": "2023", "period": "Q2", "cashAndCashEquivalents": 5660000000, "shortTermInvestments": 718000000, "cashAndShortTermInvestments": 6378000000, "netReceivables": 11030000000, "accountsReceivables": 11030000000, "otherReceivables": 0, "inventory": 5930000000, "prepaids": 0, "otherCurrentAssets": 6639000000, "totalCurrentAssets": 29977000000, "propertyPlantEquipmentNet": 22231000000, "goodwill": 21195000000, "intangibleAssets": 19665000000, "goodwillAndIntangibleAssets": 40860000000, "longTermInvestments": 1214000000, "taxAssets": 0, "otherNonCurrentAssets": 10187000000, "totalNonCurrentAssets": 74492000000, "otherAssets": 0, "totalAssets": 104469000000, "totalPayables": 6808000000, "accountPayables": 3442000000, "otherPayables": 3366000000, "accruedExpenses": 13747000000, "shortTermDebt": 2839000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 1489000000, "deferredRevenue": 0, "otherCurrentLiabilities": 0, "totalCurrentLiabilities": 23394000000, "longTermDebt": 34072000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 996000000, "otherNonCurrentLiabilities": 7265000000, "totalNonCurrentLiabilities": 42333000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 65727000000, "treasuryStock": -56612000000, "preferredStock": 0, "commonStock": 1788000000, "retainedEarnings": 54198000000, "additionalPaidInCapital": 44219000000, "accumulatedOtherComprehensiveIncomeLoss": -4900000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 38693000000, "totalEquity": 38742000000, "minorityInterest": 49000000, "totalLiabilitiesAndTotalEquity": 104469000000, "totalInvestments": 1932000000, "totalDebt": 36911000000, "netDebt": 31251000000}}
{"date": "2023-03-31", "symbol": "MRK", "type": "balance_sheet_quarter", "result": {"date": "2023-03-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2023-05-05", "acceptedDate": "2023-05-05 07:39:41", "fiscalYear": "2023", "period": "Q1", "cashAndCashEquivalents": 9707000000, "shortTermInvestments": 680000000, "cashAndShortTermInvestments": 10387000000, "netReceivables": 10415000000, "accountsReceivables": 10415000000, "otherReceivables": 0, "inventory": 5863000000, "prepaids": 0, "otherCurrentAssets": 6737000000, "totalCurrentAssets": 33402000000, "propertyPlantEquipmentNet": 21758000000, "goodwill": 21209000000, "intangibleAssets": 19857000000, "goodwillAndIntangibleAssets": 41066000000, "longTermInvestments": 1290000000, "taxAssets": 0, "otherNonCurrentAssets": 10280000000, "totalNonCurrentAssets": 74394000000, "otherAssets": 0, "totalAssets": 107796000000, "totalPayables": 7459000000, "accountPayables": 3680000000, "otherPayables": 3779000000, "accruedExpenses": 13000000000, "shortTermDebt": 2672000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 1872000000, "deferredRevenue": 0, "otherCurrentLiabilities": 0, "totalCurrentLiabilities": 23131000000, "longTermDebt": 28074000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 1442000000, "otherNonCurrentLiabilities": 8244000000, "totalNonCurrentLiabilities": 37760000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 60891000000, "treasuryStock": -56577000000, "preferredStock": 0, "commonStock": 1788000000, "retainedEarnings": 62039000000, "additionalPaidInCapital": 44467000000, "accumulatedOtherComprehensiveIncomeLoss": -4883000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 46834000000, "totalEquity": 46905000000, "minorityInterest": 71000000, "totalLiabilitiesAndTotalEquity": 107796000000, "totalInvestments": 1970000000, "totalDebt": 30746000000, "netDebt": 21039000000}}
{"date": "2022-12-31", "symbol": "MRK", "type": "balance_sheet_quarter", "result": {"date": "2022-12-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2023-02-24", "acceptedDate": "2023-02-24 16:22:30", "fiscalYear": "2022", "period": "Q4", "cashAndCashEquivalents": 12694000000, "shortTermInvestments": 498000000, "cashAndShortTermInvestments": 13192000000, "netReceivables": 9450000000, "accountsReceivables": 9450000000, "otherReceivables": 0, "inventory": 5911000000, "prepaids": 0, "otherCurrentAssets": 7169000000, "totalCurrentAssets": 35722000000, "propertyPlantEquipmentNet": 21422000000, "goodwill": 21204000000, "intangibleAssets": 20269000000, "goodwillAndIntangibleAssets": 41473000000, "longTermInvestments": 1015000000, "taxAssets": 0, "otherNonCurrentAssets": 9528000000, "totalNonCurrentAssets": 73438000000, "otherAssets": 0, "totalAssets": 109160000000, "totalPayables": 8134000000, "accountPayables": 4264000000, "otherPayables": 3870000000, "accruedExpenses": 14159000000, "shortTermDebt": 1946000000, "capitalLeaseObligationsCurrent": 281000000, "taxPayables": 1986000000, "deferredRevenue": 0, "otherCurrentLiabilities": -281000000, "totalCurrentLiabilities": 24239000000, "longTermDebt": 28745000000, "capitalLeaseObligationsNonCurrent": 1013000000, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 1795000000, "otherNonCurrentLiabilities": 7310000000, "totalNonCurrentLiabilities": 38863000000, "otherLiabilities": 0, "capitalLeaseObligations": 1013000000, "totalLiabilities": 63102000000, "treasuryStock": -56489000000, "preferredStock": 0, "commonStock": 1788000000, "retainedEarnings": 61081000000, "additionalPaidInCapital": 44379000000, "accumulatedOtherComprehensiveIncomeLoss": -4768000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 45991000000, "totalEquity": 46058000000, "minorityInterest": 67000000, "totalLiabilitiesAndTotalEquity": 109160000000, "totalInvestments": 1513000000, "totalDebt": 31985000000, "netDebt": 19291000000}}
{"date": "2022-09-30", "symbol": "MRK", "type": "balance_sheet_quarter", "result": {"date": "2022-09-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2022-11-03", "acceptedDate": "2022-11-03 16:28:44", "fiscalYear": "2022", "period": "Q3", "cashAndCashEquivalents": 11145000000, "shortTermInvestments": 103000000, "cashAndShortTermInvestments": 11248000000, "netReceivables": 9482000000, "accountsReceivables": 9482000000, "otherReceivables": 0, "inventory": 5614000000, "prepaids": 0, "otherCurrentAssets": 7217000000, "totalCurrentAssets": 33561000000, "propertyPlantEquipmentNet": 20424000000, "goodwill": 21160000000, "intangibleAssets": 21368000000, "goodwillAndIntangibleAssets": 42528000000, "longTermInvestments": 984000000, "taxAssets": 0, "otherNonCurrentAssets": 9584000000, "totalNonCurrentAssets": 73520000000, "otherAssets": 0, "totalAssets": 107081000000, "totalPayables": 6840000000, "accountPayables": 3371000000, "otherPayables": 3469000000, "accruedExpenses": 14222000000, "shortTermDebt": 1936000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 1698000000, "deferredRevenue": 0, "otherCurrentLiabilities": 0, "totalCurrentLiabilities": 22998000000, "longTermDebt": 28482000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 2417000000, "otherNonCurrentLiabilities": 8660000000, "totalNonCurrentLiabilities": 39559000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 62557000000, "treasuryStock": -56758000000, "preferredStock": 0, "commonStock": 1788000000, "retainedEarnings": 59928000000, "additionalPaidInCapital": 44243000000, "accumulatedOtherComprehensiveIncomeLoss": -4743000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 44458000000, "totalEquity": 44524000000, "minorityInterest": 66000000, "totalLiabilitiesAndTotalEquity": 107081000000, "totalInvestments": 1087000000, "totalDebt": 30418000000, "netDebt": 19273000000}}
{"date": "2022-06-30", "symbol": "MRK", "type": "balance_sheet_quarter", "result": {"date": "2022-06-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2022-08-05", "acceptedDate": "2022-08-04 17:35:47", "fiscalYear": "2022", "period": "Q2", "cashAndCashEquivalents": 9675000000, "shortTermInvestments": 453000000, "cashAndShortTermInvestments": 10128000000, "netReceivables": 9643000000, "accountsReceivables": 9643000000, "otherReceivables": 0, "inventory": 5535000000, "prepaids": 0, "otherCurrentAssets": 6810000000, "totalCurrentAssets": 32116000000, "propertyPlantEquipmentNet": 20059000000, "goodwill": 21213000000, "intangibleAssets": 22497000000, "goodwillAndIntangibleAssets": 43710000000, "longTermInvestments": 238000000, "taxAssets": 0, "otherNonCurrentAssets": 10972000000, "totalNonCurrentAssets": 74979000000, "otherAssets": 0, "totalAssets": 107095000000, "totalPayables": 6688000000, "accountPayables": 3482000000, "otherPayables": 3206000000, "accruedExpenses": 13501000000, "shortTermDebt": 2979000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 1438000000, "deferredRevenue": 0, "otherCurrentLiabilities": 0, "totalCurrentLiabilities": 23168000000, "longTermDebt": 28684000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 2974000000, "otherNonCurrentLiabilities": 8951000000, "totalNonCurrentLiabilities": 40609000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 63777000000, "treasuryStock": -56770000000, "preferredStock": 0, "commonStock": 1788000000, "retainedEarnings": 58437000000, "additionalPaidInCapital": 44115000000, "accumulatedOtherComprehensiveIncomeLoss": -4327000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 43243000000, "totalEquity": 43318000000, "minorityInterest": 75000000, "totalLiabilitiesAndTotalEquity": 107095000000, "totalInvestments": 691000000, "totalDebt": 31663000000, "netDebt": 21988000000}}
{"date": "2022-03-31", "symbol": "MRK", "type": "balance_sheet_quarter", "result": {"date": "2022-03-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2022-05-05", "acceptedDate": "2022-05-05 16:28:37", "fiscalYear": "2022", "period": "Q1", "cashAndCashEquivalents": 8556000000, "shortTermInvestments": 372000000, "cashAndShortTermInvestments": 8928000000, "netReceivables": 9828000000, "accountsReceivables": 9828000000, "otherReceivables": 0, "inventory": 5774000000, "prepaids": 0, "otherCurrentAssets": 6654000000, "totalCurrentAssets": 31184000000, "propertyPlantEquipmentNet": 19747000000, "goodwill": 21258000000, "intangibleAssets": 23022000000, "goodwillAndIntangibleAssets": 44280000000, "longTermInvestments": 316000000, "taxAssets": 0, "otherNonCurrentAssets": 11141000000, "totalNonCurrentAssets": 75484000000, "otherAssets": 0, "totalAssets": 106668000000, "totalPayables": 7057000000, "accountPayables": 3715000000, "otherPayables": 3342000000, "accruedExpenses": 14051000000, "shortTermDebt": 1208000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 1571000000, "deferredRevenue": 0, "otherCurrentLiabilities": 0, "totalCurrentLiabilities": 22316000000, "longTermDebt": 30586000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 3071000000, "otherNonCurrentLiabilities": 9742000000, "totalNonCurrentLiabilities": 43399000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 65715000000, "treasuryStock": -57063000000, "preferredStock": 0, "commonStock": 1788000000, "retainedEarnings": 56252000000, "additionalPaidInCapital": 44275000000, "accumulatedOtherComprehensiveIncomeLoss": -4369000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 40883000000, "totalEquity": 40953000000, "minorityInterest": 70000000, "totalLiabilitiesAndTotalEquity": 106668000000, "totalInvestments": 688000000, "totalDebt": 31794000000, "netDebt": 23238000000}}
{"date": "2021-12-31", "symbol": "MRK", "type": "balance_sheet_quarter", "result": {"date": "2021-12-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2022-02-25", "acceptedDate": "2022-02-25 16:44:28", "fiscalYear": "2021", "period": "Q4", "cashAndCashEquivalents": 8096000000, "shortTermInvestments": 0, "cashAndShortTermInvestments": 8096000000, "netReceivables": 9230000000, "accountsReceivables": 9230000000, "otherReceivables": 0, "inventory": 5953000000, "prepaids": 0, "otherCurrentAssets": 6987000000, "totalCurrentAssets": 30266000000, "propertyPlantEquipmentNet": 19279000000, "goodwill": 21264000000, "intangibleAssets": 22933000000, "goodwillAndIntangibleAssets": 44197000000, "longTermInvestments": 370000000, "taxAssets": 0, "otherNonCurrentAssets": 11582000000, "totalNonCurrentAssets": 75428000000, "otherAssets": 0, "totalAssets": 105694000000, "totalPayables": 7601000000, "accountPayables": 4609000000, "otherPayables": 2992000000, "accruedExpenses": 13859000000, "shortTermDebt": 2412000000, "capitalLeaseObligationsCurrent": 304000000, "taxPayables": 1224000000, "deferredRevenue": 0, "otherCurrentLiabilities": -304000000, "totalCurrentLiabilities": 23872000000, "longTermDebt": 30690000000, "capitalLeaseObligationsNonCurrent": 1225000000, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 3441000000, "otherNonCurrentLiabilities": 8209000000, "totalNonCurrentLiabilities": 43565000000, "otherLiabilities": 0, "capitalLeaseObligations": 1225000000, "totalLiabilities": 67437000000, "treasuryStock": -57109000000, "preferredStock": 0, "commonStock": 1788000000, "retainedEarnings": 53696000000, "additionalPaidInCapital": 44238000000, "accumulatedOtherComprehensiveIncomeLoss": -4429000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 38184000000, "totalEquity": 38257000000, "minorityInterest": 73000000, "totalLiabilitiesAndTotalEquity": 105694000000, "totalInvestments": 370000000, "totalDebt": 34631000000, "netDebt": 26535000000}}
{"date": "2021-09-30", "symbol": "MRK", "type": "balance_sheet_quarter", "result": {"date": "2021-09-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2021-11-05", "acceptedDate": "2021-11-05 16:09:58", "fiscalYear": "2021", "period": "Q3", "cashAndCashEquivalents": 10016000000, "shortTermInvestments": 0, "cashAndShortTermInvestments": 10016000000, "netReceivables": 8571000000, "accountsReceivables": 8571000000, "otherReceivables": 0, "inventory": 7976000000, "prepaids": 0, "otherCurrentAssets": 4495000000, "totalCurrentAssets": 31058000000, "propertyPlantEquipmentNet": 18565000000, "goodwill": 18862000000, "intangibleAssets": 13384000000, "goodwillAndIntangibleAssets": 32246000000, "longTermInvestments": 435000000, "taxAssets": 0, "otherNonCurrentAssets": 11190000000, "totalNonCurrentAssets": 62436000000, "otherAssets": 0, "totalAssets": 93494000000, "totalPayables": 5980000000, "accountPayables": 3366000000, "otherPayables": 2614000000, "accruedExpenses": 14214000000, "shortTermDebt": 3534000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 954000000, "deferredRevenue": 0, "otherCurrentLiabilities": 0, "totalCurrentLiabilities": 23728000000, "longTermDebt": 22907000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 1527000000, "otherNonCurrentLiabilities": 9469000000, "totalNonCurrentLiabilities": 33903000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 57631000000, "treasuryStock": -57244000000, "preferredStock": 0, "commonStock": 1788000000, "retainedEarnings": 51691000000, "additionalPaidInCapital": 44149000000, "accumulatedOtherComprehensiveIncomeLoss": -4590000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 35794000000, "totalEquity": 35863000000, "minorityInterest": 69000000, "totalLiabilitiesAndTotalEquity": 93494000000, "totalInvestments": 435000000, "totalDebt": 26441000000, "netDebt": 16425000000}}
{"date": "2021-06-30", "symbol": "MRK", "type": "balance_sheet_quarter", "result": {"date": "2021-06-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2021-08-09", "acceptedDate": "2021-08-09 07:07:53", "fiscalYear": "2021", "period": "Q2", "cashAndCashEquivalents": 8575000000, "shortTermInvestments": 0, "cashAndShortTermInvestments": 8575000000, "netReceivables": 7843000000, "accountsReceivables": 7843000000, "otherReceivables": 0, "inventory": 7911000000, "prepaids": 0, "otherCurrentAssets": 4336000000, "totalCurrentAssets": 28665000000, "propertyPlantEquipmentNet": 18064000000, "goodwill": 18873000000, "intangibleAssets": 13622000000, "goodwillAndIntangibleAssets": 32495000000, "longTermInvestments": 411000000, "taxAssets": 0, "otherNonCurrentAssets": 11053000000, "totalNonCurrentAssets": 62023000000, "otherAssets": 0, "totalAssets": 90688000000, "totalPayables": 6530000000, "accountPayables": 3897000000, "otherPayables": 2633000000, "accruedExpenses": 12888000000, "shortTermDebt": 2488000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 971000000, "deferredRevenue": 0, "otherCurrentLiabilities": 0, "totalCurrentLiabilities": 21906000000, "longTermDebt": 24033000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 1489000000, "otherNonCurrentLiabilities": 9872000000, "totalNonCurrentLiabilities": 35394000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 57300000000, "treasuryStock": -56682000000, "preferredStock": 0, "commonStock": 1788000000, "retainedEarnings": 48777000000, "additionalPaidInCapital": 44039000000, "accumulatedOtherComprehensiveIncomeLoss": -4628000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 33294000000, "totalEquity": 33388000000, "minorityInterest": 94000000, "totalLiabilitiesAndTotalEquity": 90688000000, "totalInvestments": 411000000, "totalDebt": 26521000000, "netDebt": 17946000000}}
{"date": "2021-03-31", "symbol": "MRK", "type": "balance_sheet_quarter", "result": {"date": "2021-03-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2021-05-05", "acceptedDate": "2021-05-05 16:26:12", "fiscalYear": "2021", "period": "Q1", "cashAndCashEquivalents": 6981000000, "shortTermInvestments": 0, "cashAndShortTermInvestments": 6981000000, "netReceivables": 8235000000, "accountsReceivables": 8235000000, "otherReceivables": 0, "inventory": 8577000000, "prepaids": 0, "otherCurrentAssets": 3116000000, "totalCurrentAssets": 26909000000, "propertyPlantEquipmentNet": 18295000000, "goodwill": 20212000000, "intangibleAssets": 14401000000, "goodwillAndIntangibleAssets": 34613000000, "longTermInvestments": 544000000, "taxAssets": 0, "otherNonCurrentAssets": 10486000000, "totalNonCurrentAssets": 63938000000, "otherAssets": 0, "totalAssets": 90847000000, "totalPayables": 7199000000, "accountPayables": 4034000000, "otherPayables": 3165000000, "accruedExpenses": 11911000000, "shortTermDebt": 7251000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 1490000000, "deferredRevenue": 0, "otherCurrentLiabilities": 0, "totalCurrentLiabilities": 26361000000, "longTermDebt": 24002000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 1204000000, "otherNonCurrentLiabilities": 12241000000, "totalNonCurrentLiabilities": 37447000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 63808000000, "treasuryStock": -56722000000, "preferredStock": 0, "commonStock": 1788000000, "retainedEarnings": 48888000000, "additionalPaidInCapital": 39613000000, "accumulatedOtherComprehensiveIncomeLoss": -6622000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 26945000000, "totalEquity": 27039000000, "minorityInterest": 94000000, "totalLiabilitiesAndTotalEquity": 90847000000, "totalInvestments": 544000000, "totalDebt": 31253000000, "netDebt": 24272000000}}
{"date": "2024-12-31", "symbol": "MRK", "type": "cash_flow_annual", "result": {"date": "2024-12-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2025-02-25", "acceptedDate": "2025-02-25 16:19:11", "fiscalYear": "2024", "period": "FY", "netIncome": 17133000000, "depreciationAndAmortization": 4499000000, "deferredIncomeTax": -1249000000, "stockBasedCompensation": 761000000, "changeInWorkingCapital": -3667000000, "accountsReceivables": -244000000, "inventory": -835000000, "accountsPayables": 182000000, "otherWorkingCapital": -2770000000, "otherNonCashItems": 3991000000, "netCashProvidedByOperatingActivities": 21468000000, "investmentsInPropertyPlantAndEquipment": -3372000000, "acquisitionsNet": -4093000000, "purchasesOfInvestments": -519000000, "salesMaturitiesOfInvestments": 377000000, "otherInvestingActivities": -127000000, "netCashProvidedByInvestingActivities": -7734000000, "netDebtIssuance": 2309000000, "longTermNetDebtIssuance": 2309000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -1306000000, "netCommonStockIssuance": -1306000000, "commonStockIssuance": 0, "commonStockRepurchased": -1306000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -7840000000, "commonDividendsPaid": -7840000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -195000000, "netCashProvidedByFinancingActivities": -7032000000, "effectOfForexChangesOnCash": -293000000, "netChangeInCash": 6409000000, "cashAtEndOfPeriod": 13318000000, "cashAtBeginningOfPeriod": 6909000000, "operatingCashFlow": 21468000000, "capitalExpenditure": -3372000000, "freeCashFlow": 18096000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2023-12-31", "symbol": "MRK", "type": "cash_flow_annual", "result": {"date": "2023-12-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2024-02-26", "acceptedDate": "2024-02-26 09:06:55", "fiscalYear": "2023", "period": "FY", "netIncome": 365000000, "depreciationAndAmortization": 3872000000, "deferredIncomeTax": -1899000000, "stockBasedCompensation": 645000000, "changeInWorkingCapital": -2205000000, "accountsReceivables": -1148000000, "inventory": -816000000, "accountsPayables": -380000000, "otherWorkingCapital": 139000000, "otherNonCashItems": 12228000000, "netCashProvidedByOperatingActivities": 13006000000, "investmentsInPropertyPlantAndEquipment": -3863000000, "acquisitionsNet": -12032000000, "purchasesOfInvestments": -955000000, "salesMaturitiesOfInvestments": 1658000000, "otherInvestingActivities": 1109000000, "netCashProvidedByInvestingActivities": -14083000000, "netDebtIssuance": 4184000000, "longTermNetDebtIssuance": 4184000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -1346000000, "netCommonStockIssuance": -1346000000, "commonStockIssuance": 0, "commonStockRepurchased": -1346000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -7445000000, "commonDividendsPaid": -7445000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -203000000, "netCashProvidedByFinancingActivities": -4810000000, "effectOfForexChangesOnCash": 23000000, "netChangeInCash": -5864000000, "cashAtEndOfPeriod": 6909000000, "cashAtBeginningOfPeriod": 12773000000, "operatingCashFlow": 13006000000, "capitalExpenditure": -3863000000, "freeCashFlow": 9143000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2022-12-31", "symbol": "MRK", "type": "cash_flow_annual", "result": {"date": "2022-12-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2023-02-24", "acceptedDate": "2023-02-24 16:22:30", "fiscalYear": "2022", "period": "FY", "netIncome": 14526000000, "depreciationAndAmortization": 3909000000, "deferredIncomeTax": -1568000000, "stockBasedCompensation": 541000000, "changeInWorkingCapital": -2782000000, "accountsReceivables": -644000000, "inventory": -161000000, "accountsPayables": -289000000, "otherWorkingCapital": -1688000000, "otherNonCashItems": 4469000000, "netCashProvidedByOperatingActivities": 19095000000, "investmentsInPropertyPlantAndEquipment": -4388000000, "acquisitionsNet": -121000000, "purchasesOfInvestments": -1204000000, "salesMaturitiesOfInvestments": 721000000, "otherInvestingActivities": 32000000, "netCashProvidedByInvestingActivities": -4960000000, "netDebtIssuance": -2251000000, "longTermNetDebtIssuance": -2251000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": 384000000, "netCommonStockIssuance": 384000000, "commonStockIssuance": 384000000, "commonStockRepurchased": 0, "netPreferredStockIssuance": 0, "netDividendsPaid": -7012000000, "commonDividendsPaid": -7012000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -240000000, "netCashProvidedByFinancingActivities": -9119000000, "effectOfForexChangesOnCash": -410000000, "netChangeInCash": 4606000000, "cashAtEndOfPeriod": 12773000000, "cashAtBeginningOfPeriod": 8167000000, "operatingCashFlow": 19095000000, "capitalExpenditure": -4388000000, "freeCashFlow": 14707000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2021-12-31", "symbol": "MRK", "type": "cash_flow_annual", "result": {"date": "2021-12-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2022-02-25", "acceptedDate": "2022-02-25 16:44:28", "fiscalYear": "2021", "period": "FY", "netIncome": 12358000000, "depreciationAndAmortization": 3214000000, "deferredIncomeTax": 187000000, "stockBasedCompensation": 479000000, "changeInWorkingCapital": -3839000000, "accountsReceivables": -2033000000, "inventory": -674000000, "accountsPayables": 405000000, "otherWorkingCapital": -1537000000, "otherNonCashItems": 1710000000, "netCashProvidedByOperatingActivities": 14109000000, "investmentsInPropertyPlantAndEquipment": -4448000000, "acquisitionsNet": -12907000000, "purchasesOfInvestments": -1000000, "salesMaturitiesOfInvestments": 1026000000, "otherInvestingActivities": -225000000, "netCashProvidedByInvestingActivities": -16555000000, "netDebtIssuance": 1631000000, "longTermNetDebtIssuance": 5617000000, "shortTermNetDebtIssuance": -3986000000, "netStockIssuance": -840000000, "netCommonStockIssuance": -840000000, "commonStockIssuance": 0, "commonStockRepurchased": -840000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -6610000000, "commonDividendsPaid": -6610000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 8412000000, "netCashProvidedByFinancingActivities": 2593000000, "effectOfForexChangesOnCash": -133000000, "netChangeInCash": 14000000, "cashAtEndOfPeriod": 8167000000, "cashAtBeginningOfPeriod": 8153000000, "operatingCashFlow": 14109000000, "capitalExpenditure": -4448000000, "freeCashFlow": 9661000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2025-09-30", "symbol": "MRK", "type": "cash_flow_quarter", "result": {"date": "2025-09-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2025-11-05", "acceptedDate": "2025-11-05 16:08:41", "fiscalYear": "2025", "period": "Q3", "netIncome": 5787000000, "depreciationAndAmortization": 1154000000, "deferredIncomeTax": -212000000, "stockBasedCompensation": 204000000, "changeInWorkingCapital": 5971000000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": 5971000000, "otherNonCashItems": -5082000000, "netCashProvidedByOperatingActivities": 7822000000, "investmentsInPropertyPlantAndEquipment": -987000000, "acquisitionsNet": 0, "purchasesOfInvestments": -473000000, "salesMaturitiesOfInvestments": 575000000, "otherInvestingActivities": 602000000, "netCashProvidedByInvestingActivities": -283000000, "netDebtIssuance": 0, "longTermNetDebtIssuance": 0, "shortTermNetDebtIssuance": 0, "netStockIssuance": 2490000000, "netCommonStockIssuance": 2490000000, "commonStockIssuance": 0, "commonStockRepurchased": 2490000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2031000000, "commonDividendsPaid": -2031000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 2179000000, "netCashProvidedByFinancingActivities": 2638000000, "effectOfForexChangesOnCash": 10000000, "netChangeInCash": 10187000000, "cashAtEndOfPeriod": 18260000000, "cashAtBeginningOfPeriod": 8073000000, "operatingCashFlow": 7822000000, "capitalExpenditure": -987000000, "freeCashFlow": 6835000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2025-06-30", "symbol": "MRK", "type": "cash_flow_quarter", "result": {"date": "2025-06-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2025-08-05", "acceptedDate": "2025-08-05 16:13:52", "fiscalYear": "2025", "period": "Q2", "netIncome": 4429000000, "depreciationAndAmortization": 1119000000, "deferredIncomeTax": -448000000, "stockBasedCompensation": 216000000, "changeInWorkingCapital": -2259000000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -2259000000, "otherNonCashItems": 236000000, "netCashProvidedByOperatingActivities": 3293000000, "investmentsInPropertyPlantAndEquipment": -764000000, "acquisitionsNet": 0, "purchasesOfInvestments": -612000000, "salesMaturitiesOfInvestments": 601000000, "otherInvestingActivities": 5000000, "netCashProvidedByInvestingActivities": -770000000, "netDebtIssuance": 48000000, "longTermNetDebtIssuance": 48000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -1345000000, "netCommonStockIssuance": -1345000000, "commonStockIssuance": 0, "commonStockRepurchased": -1345000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2077000000, "commonDividendsPaid": -2077000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -182000000, "netCashProvidedByFinancingActivities": -3556000000, "effectOfForexChangesOnCash": 374000000, "netChangeInCash": -659000000, "cashAtEndOfPeriod": 8073000000, "cashAtBeginningOfPeriod": 8732000000, "operatingCashFlow": 3293000000, "capitalExpenditure": -764000000, "freeCashFlow": 2529000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2025-03-31", "symbol": "MRK", "type": "cash_flow_quarter", "result": {"date": "2025-03-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2025-05-02", "acceptedDate": "2025-05-02 16:10:22", "fiscalYear": "2025", "period": "Q1", "netIncome": 5085000000, "depreciationAndAmortization": 1099000000, "deferredIncomeTax": -186000000, "stockBasedCompensation": 195000000, "changeInWorkingCapital": -3712000000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -3712000000, "otherNonCashItems": 19000000, "netCashProvidedByOperatingActivities": 2500000000, "investmentsInPropertyPlantAndEquipment": -1328000000, "acquisitionsNet": 0, "purchasesOfInvestments": -685000000, "salesMaturitiesOfInvestments": 456000000, "otherInvestingActivities": 70000000, "netCashProvidedByInvestingActivities": -1487000000, "netDebtIssuance": -2500000000, "longTermNetDebtIssuance": -2500000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -1145000000, "netCommonStockIssuance": -1145000000, "commonStockIssuance": 19000000, "commonStockRepurchased": -1164000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2050000000, "commonDividendsPaid": -2050000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -60000000, "netCashProvidedByFinancingActivities": -5755000000, "effectOfForexChangesOnCash": 156000000, "netChangeInCash": -4586000000, "cashAtEndOfPeriod": 8732000000, "cashAtBeginningOfPeriod": 13318000000, "operatingCashFlow": 2500000000, "capitalExpenditure": -1328000000, "freeCashFlow": 1172000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2024-12-31", "symbol": "MRK", "type": "cash_flow_quarter", "result": {"date": "2024-12-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2025-02-25", "acceptedDate": "2025-02-25 16:19:11", "fiscalYear": "2024", "period": "Q4", "netIncome": 3744000000, "depreciationAndAmortization": 1197000000, "deferredIncomeTax": -616000000, "stockBasedCompensation": 187000000, "changeInWorkingCapital": -1855000000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -1855000000, "otherNonCashItems": 793000000, "netCashProvidedByOperatingActivities": 3450000000, "investmentsInPropertyPlantAndEquipment": -937000000, "acquisitionsNet": -2000000, "purchasesOfInvestments": -455000000, "salesMaturitiesOfInvestments": 7000000, "otherInvestingActivities": -57000000, "netCashProvidedByInvestingActivities": -1444000000, "netDebtIssuance": -539000000, "longTermNetDebtIssuance": -539000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -489000000, "netCommonStockIssuance": -489000000, "commonStockIssuance": 0, "commonStockRepurchased": -489000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -1951000000, "commonDividendsPaid": -1951000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -30000000, "netCashProvidedByFinancingActivities": -3009000000, "effectOfForexChangesOnCash": -367000000, "netChangeInCash": -1370000000, "cashAtEndOfPeriod": 13318000000, "cashAtBeginningOfPeriod": 14688000000, "operatingCashFlow": 3450000000, "capitalExpenditure": -937000000, "freeCashFlow": 2513000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2024-09-30", "symbol": "MRK", "type": "cash_flow_quarter", "result": {"date": "2024-09-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2024-11-06", "acceptedDate": "2024-11-06 16:05:36", "fiscalYear": "2024", "period": "Q3", "netIncome": 3161000000, "depreciationAndAmortization": 1186000000, "deferredIncomeTax": -401000000, "stockBasedCompensation": 195000000, "changeInWorkingCapital": 2582000000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": 2582000000, "otherNonCashItems": 2568000000, "netCashProvidedByOperatingActivities": 9291000000, "investmentsInPropertyPlantAndEquipment": -783000000, "acquisitionsNet": -3345000000, "purchasesOfInvestments": 0, "salesMaturitiesOfInvestments": 50000000, "otherInvestingActivities": 233000000, "netCashProvidedByInvestingActivities": -3845000000, "netDebtIssuance": -1000000, "longTermNetDebtIssuance": -1000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -444000000, "netCommonStockIssuance": -444000000, "commonStockIssuance": 0, "commonStockRepurchased": -444000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -1953000000, "commonDividendsPaid": -1953000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -27000000, "netCashProvidedByFinancingActivities": -2425000000, "effectOfForexChangesOnCash": 294000000, "netChangeInCash": 3315000000, "cashAtEndOfPeriod": 14688000000, "cashAtBeginningOfPeriod": 11373000000, "operatingCashFlow": 9291000000, "capitalExpenditure": -783000000, "freeCashFlow": 8508000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2024-06-30", "symbol": "MRK", "type": "cash_flow_quarter", "result": {"date": "2024-06-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2024-08-05", "acceptedDate": "2024-08-05 16:02:11", "fiscalYear": "2024", "period": "Q2", "netIncome": 5461000000, "depreciationAndAmortization": 1132000000, "deferredIncomeTax": -181000000, "stockBasedCompensation": 203000000, "changeInWorkingCapital": -1012000000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -1012000000, "otherNonCashItems": 34000000, "netCashProvidedByOperatingActivities": 5637000000, "investmentsInPropertyPlantAndEquipment": -791000000, "acquisitionsNet": 0, "purchasesOfInvestments": -49000000, "salesMaturitiesOfInvestments": 60000000, "otherInvestingActivities": -289000000, "netCashProvidedByInvestingActivities": -1069000000, "netDebtIssuance": 3600000000, "longTermNetDebtIssuance": 3600000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -251000000, "netCommonStockIssuance": -251000000, "commonStockIssuance": 0, "commonStockRepurchased": -251000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -1986000000, "commonDividendsPaid": -1986000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -147000000, "netCashProvidedByFinancingActivities": 1216000000, "effectOfForexChangesOnCash": -82000000, "netChangeInCash": 5702000000, "cashAtEndOfPeriod": 11373000000, "cashAtBeginningOfPeriod": 5671000000, "operatingCashFlow": 5637000000, "capitalExpenditure": -791000000, "freeCashFlow": 4846000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2024-03-31", "symbol": "MRK", "type": "cash_flow_quarter", "result": {"date": "2024-03-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2024-05-03", "acceptedDate": "2024-05-03 16:10:43", "fiscalYear": "2024", "period": "Q1", "netIncome": 4767000000, "depreciationAndAmortization": 984000000, "deferredIncomeTax": -51000000, "stockBasedCompensation": 176000000, "changeInWorkingCapital": -3382000000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -3382000000, "otherNonCashItems": 596000000, "netCashProvidedByOperatingActivities": 3090000000, "investmentsInPropertyPlantAndEquipment": -861000000, "acquisitionsNet": -746000000, "purchasesOfInvestments": -15000000, "salesMaturitiesOfInvestments": 260000000, "otherInvestingActivities": -14000000, "netCashProvidedByInvestingActivities": -1376000000, "netDebtIssuance": -751000000, "longTermNetDebtIssuance": -751000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -122000000, "netCommonStockIssuance": -122000000, "commonStockIssuance": 0, "commonStockRepurchased": -122000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -1950000000, "commonDividendsPaid": -1950000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 9000000, "netCashProvidedByFinancingActivities": -2814000000, "effectOfForexChangesOnCash": -138000000, "netChangeInCash": -1238000000, "cashAtEndOfPeriod": 5671000000, "cashAtBeginningOfPeriod": 6909000000, "operatingCashFlow": 3090000000, "capitalExpenditure": -861000000, "freeCashFlow": 2229000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2023-12-31", "symbol": "MRK", "type": "cash_flow_quarter", "result": {"date": "2023-12-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2024-02-26", "acceptedDate": "2024-02-26 09:06:55", "fiscalYear": "2023", "period": "Q4", "netIncome": -1226000000, "depreciationAndAmortization": 964000000, "deferredIncomeTax": -931000000, "stockBasedCompensation": 167000000, "changeInWorkingCapital": 144000000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": 144000000, "otherNonCashItems": 1128000000, "netCashProvidedByOperatingActivities": 246000000, "investmentsInPropertyPlantAndEquipment": -989000000, "acquisitionsNet": 0, "purchasesOfInvestments": -251000000, "salesMaturitiesOfInvestments": 169000000, "otherInvestingActivities": 1124000000, "netCashProvidedByInvestingActivities": 53000000, "netDebtIssuance": -3000000, "longTermNetDebtIssuance": -3000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -393000000, "netCommonStockIssuance": -393000000, "commonStockIssuance": 0, "commonStockRepurchased": -393000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -1852000000, "commonDividendsPaid": -1852000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 3000000, "netCashProvidedByFinancingActivities": -2245000000, "effectOfForexChangesOnCash": 186000000, "netChangeInCash": -1760000000, "cashAtEndOfPeriod": 6909000000, "cashAtBeginningOfPeriod": 8644000000, "operatingCashFlow": 246000000, "capitalExpenditure": -989000000, "freeCashFlow": -743000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2023-09-30", "symbol": "MRK", "type": "cash_flow_quarter", "result": {"date": "2023-09-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2023-11-03", "acceptedDate": "2023-11-03 16:10:43", "fiscalYear": "2023", "period": "Q3", "netIncome": 4745000000, "depreciationAndAmortization": 1014000000, "deferredIncomeTax": -336000000, "stockBasedCompensation": 164000000, "changeInWorkingCapital": 2177000000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": 2177000000, "otherNonCashItems": -47000000, "netCashProvidedByOperatingActivities": 7717000000, "investmentsInPropertyPlantAndEquipment": -902000000, "acquisitionsNet": 902000000, "purchasesOfInvestments": -117000000, "salesMaturitiesOfInvestments": 704000000, "otherInvestingActivities": -921000000, "netCashProvidedByInvestingActivities": -334000000, "netDebtIssuance": -1945000000, "longTermNetDebtIssuance": -8000000, "shortTermNetDebtIssuance": -1937000000, "netStockIssuance": -466000000, "netCommonStockIssuance": -466000000, "commonStockIssuance": 0, "commonStockRepurchased": -466000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -1855000000, "commonDividendsPaid": -1855000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -3000000, "netCashProvidedByFinancingActivities": -4269000000, "effectOfForexChangesOnCash": -157000000, "netChangeInCash": 2957000000, "cashAtEndOfPeriod": 8644000000, "cashAtBeginningOfPeriod": 5704000000, "operatingCashFlow": 7717000000, "capitalExpenditure": -902000000, "freeCashFlow": 6815000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2023-06-30", "symbol": "MRK", "type": "cash_flow_quarter", "result": {"date": "2023-06-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2023-08-07", "acceptedDate": "2023-08-07 16:09:00", "fiscalYear": "2023", "period": "Q2", "netIncome": -5975000000, "depreciationAndAmortization": 903000000, "deferredIncomeTax": -355000000, "stockBasedCompensation": 169000000, "changeInWorkingCapital": -1636000000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -1636000000, "otherNonCashItems": 10598000000, "netCashProvidedByOperatingActivities": 3704000000, "investmentsInPropertyPlantAndEquipment": -965000000, "acquisitionsNet": -10705000000, "purchasesOfInvestments": -25000000, "salesMaturitiesOfInvestments": 285000000, "otherInvestingActivities": -33000000, "netCashProvidedByInvestingActivities": -11443000000, "netDebtIssuance": 6133000000, "longTermNetDebtIssuance": 4196000000, "shortTermNetDebtIssuance": 1937000000, "netStockIssuance": -338000000, "netCommonStockIssuance": -338000000, "commonStockIssuance": 0, "commonStockRepurchased": -338000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -1885000000, "commonDividendsPaid": -1885000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -152000000, "netCashProvidedByFinancingActivities": 3758000000, "effectOfForexChangesOnCash": -93000000, "netChangeInCash": -4074000000, "cashAtEndOfPeriod": 5712000000, "cashAtBeginningOfPeriod": 9786000000, "operatingCashFlow": 3704000000, "capitalExpenditure": -965000000, "freeCashFlow": 2739000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2023-03-31", "symbol": "MRK", "type": "cash_flow_quarter", "result": {"date": "2023-03-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2023-05-05", "acceptedDate": "2023-05-05 07:39:41", "fiscalYear": "2023", "period": "Q1", "netIncome": 2821000000, "depreciationAndAmortization": 991000000, "deferredIncomeTax": -277000000, "stockBasedCompensation": 145000000, "changeInWorkingCapital": -2890000000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -2890000000, "otherNonCashItems": 549000000, "netCashProvidedByOperatingActivities": 1339000000, "investmentsInPropertyPlantAndEquipment": -1007000000, "acquisitionsNet": -1327000000, "purchasesOfInvestments": -562000000, "salesMaturitiesOfInvestments": 500000000, "otherInvestingActivities": 37000000, "netCashProvidedByInvestingActivities": -2359000000, "netDebtIssuance": -1000000, "longTermNetDebtIssuance": -1000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -149000000, "netCommonStockIssuance": -149000000, "commonStockIssuance": 0, "commonStockRepurchased": -149000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -1853000000, "commonDividendsPaid": -1853000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -51000000, "netCashProvidedByFinancingActivities": -2054000000, "effectOfForexChangesOnCash": 87000000, "netChangeInCash": -2987000000, "cashAtEndOfPeriod": 9738000000, "cashAtBeginningOfPeriod": 12773000000, "operatingCashFlow": 1339000000, "capitalExpenditure": -1007000000, "freeCashFlow": 332000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2022-12-31", "symbol": "MRK", "type": "cash_flow_quarter", "result": {"date": "2022-12-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2023-02-24", "acceptedDate": "2023-02-24 16:22:30", "fiscalYear": "2022", "period": "Q4", "netIncome": 3018000000, "depreciationAndAmortization": 892000000, "deferredIncomeTax": -307000000, "stockBasedCompensation": 145000000, "changeInWorkingCapital": -347000000, "accountsReceivables": -644000000, "inventory": -161000000, "accountsPayables": 41000000, "otherWorkingCapital": 417000000, "otherNonCashItems": 1029000000, "netCashProvidedByOperatingActivities": 4430000000, "investmentsInPropertyPlantAndEquipment": -1149000000, "acquisitionsNet": 0, "purchasesOfInvestments": -494000000, "salesMaturitiesOfInvestments": 12000000, "otherInvestingActivities": -117000000, "netCashProvidedByInvestingActivities": -1748000000, "netDebtIssuance": -1000000, "longTermNetDebtIssuance": -1000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": 265000000, "netCommonStockIssuance": 265000000, "commonStockIssuance": 265000000, "commonStockRepurchased": 0, "netPreferredStockIssuance": 0, "netDividendsPaid": -1750000000, "commonDividendsPaid": -1750000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -68000000, "netCashProvidedByFinancingActivities": -1554000000, "effectOfForexChangesOnCash": 366000000, "netChangeInCash": 1494000000, "cashAtEndOfPeriod": 12773000000, "cashAtBeginningOfPeriod": 11279000000, "operatingCashFlow": 4430000000, "capitalExpenditure": -1149000000, "freeCashFlow": 3281000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2022-09-30", "symbol": "MRK", "type": "cash_flow_quarter", "result": {"date": "2022-09-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2022-11-03", "acceptedDate": "2022-11-03 16:28:44", "fiscalYear": "2022", "period": "Q3", "netIncome": 3252000000, "depreciationAndAmortization": 959000000, "deferredIncomeTax": -661000000, "stockBasedCompensation": 139000000, "changeInWorkingCapital": 263000000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": 263000000, "otherNonCashItems": 1650000000, "netCashProvidedByOperatingActivities": 5602000000, "investmentsInPropertyPlantAndEquipment": -1126000000, "acquisitionsNet": -121000000, "purchasesOfInvestments": -5000000, "salesMaturitiesOfInvestments": 335000000, "otherInvestingActivities": -45000000, "netCashProvidedByInvestingActivities": -962000000, "netDebtIssuance": -1000000000, "longTermNetDebtIssuance": -1000000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": 10000000, "netCommonStockIssuance": 10000000, "commonStockIssuance": 10000000, "commonStockRepurchased": 0, "netPreferredStockIssuance": 0, "netDividendsPaid": -1747000000, "commonDividendsPaid": -1747000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 35000000, "netCashProvidedByFinancingActivities": -2702000000, "effectOfForexChangesOnCash": -412000000, "netChangeInCash": 1526000000, "cashAtEndOfPeriod": 11279000000, "cashAtBeginningOfPeriod": 9753000000, "operatingCashFlow": 5602000000, "capitalExpenditure": -1126000000, "freeCashFlow": 4476000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2022-06-30", "symbol": "MRK", "type": "cash_flow_quarter", "result": {"date": "2022-06-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2022-08-05", "acceptedDate": "2022-08-04 17:35:47", "fiscalYear": "2022", "period": "Q2", "netIncome": 3949000000, "depreciationAndAmortization": 938000000, "deferredIncomeTax": -262000000, "stockBasedCompensation": 137000000, "changeInWorkingCapital": -1399000000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -1399000000, "otherNonCashItems": 939000000, "netCashProvidedByOperatingActivities": 4302000000, "investmentsInPropertyPlantAndEquipment": -1129000000, "acquisitionsNet": 0, "purchasesOfInvestments": -333000000, "salesMaturitiesOfInvestments": 373000000, "otherInvestingActivities": 12000000, "netCashProvidedByInvestingActivities": -1077000000, "netDebtIssuance": 0, "longTermNetDebtIssuance": 0, "shortTermNetDebtIssuance": 0, "netStockIssuance": 97000000, "netCommonStockIssuance": 97000000, "commonStockIssuance": 97000000, "commonStockRepurchased": 0, "netPreferredStockIssuance": 0, "netDividendsPaid": -1770000000, "commonDividendsPaid": -1770000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -104000000, "netCashProvidedByFinancingActivities": -1777000000, "effectOfForexChangesOnCash": -309000000, "netChangeInCash": 1139000000, "cashAtEndOfPeriod": 9753000000, "cashAtBeginningOfPeriod": 8614000000, "operatingCashFlow": 4302000000, "capitalExpenditure": -1129000000, "freeCashFlow": 3173000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2022-03-31", "symbol": "MRK", "type": "cash_flow_quarter", "result": {"date": "2022-03-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2022-05-05", "acceptedDate": "2022-05-05 16:28:37", "fiscalYear": "2022", "period": "Q1", "netIncome": 4307000000, "depreciationAndAmortization": 1120000000, "deferredIncomeTax": -338000000, "stockBasedCompensation": 120000000, "changeInWorkingCapital": -1299000000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -1299000000, "otherNonCashItems": 851000000, "netCashProvidedByOperatingActivities": 4761000000, "investmentsInPropertyPlantAndEquipment": -984000000, "acquisitionsNet": 0, "purchasesOfInvestments": -372000000, "salesMaturitiesOfInvestments": 1000000, "otherInvestingActivities": 182000000, "netCashProvidedByInvestingActivities": -1173000000, "netDebtIssuance": -1250000000, "longTermNetDebtIssuance": -1250000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": 12000000, "netCommonStockIssuance": 12000000, "commonStockIssuance": 12000000, "commonStockRepurchased": 0, "netPreferredStockIssuance": 0, "netDividendsPaid": -1745000000, "commonDividendsPaid": -1745000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -91000000, "netCashProvidedByFinancingActivities": -3086000000, "effectOfForexChangesOnCash": -55000000, "netChangeInCash": 447000000, "cashAtEndOfPeriod": 8614000000, "cashAtBeginningOfPeriod": 8167000000, "operatingCashFlow": 4761000000, "capitalExpenditure": -984000000, "freeCashFlow": 3777000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2021-12-31", "symbol": "MRK", "type": "cash_flow_quarter", "result": {"date": "2021-12-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2022-02-25", "acceptedDate": "2022-02-25 16:44:28", "fiscalYear": "2021", "period": "Q4", "netIncome": 3824000000, "depreciationAndAmortization": 835000000, "deferredIncomeTax": 159000000, "stockBasedCompensation": 119000000, "changeInWorkingCapital": -45000000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -45000000, "otherNonCashItems": 139000000, "netCashProvidedByOperatingActivities": 5031000000, "investmentsInPropertyPlantAndEquipment": -1208000000, "acquisitionsNet": -11264000000, "purchasesOfInvestments": 0, "salesMaturitiesOfInvestments": 529000000, "otherInvestingActivities": -106000000, "netCashProvidedByInvestingActivities": -12049000000, "netDebtIssuance": 6767000000, "longTermNetDebtIssuance": 6770000000, "shortTermNetDebtIssuance": -3000000, "netStockIssuance": -18000000, "netCommonStockIssuance": -18000000, "commonStockIssuance": 0, "commonStockRepurchased": -18000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -1643000000, "commonDividendsPaid": -1643000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 101000000, "netCashProvidedByFinancingActivities": 5207000000, "effectOfForexChangesOnCash": -68000000, "netChangeInCash": -1879000000, "cashAtEndOfPeriod": 8167000000, "cashAtBeginningOfPeriod": 10046000000, "operatingCashFlow": 5031000000, "capitalExpenditure": -1208000000, "freeCashFlow": 3823000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2021-09-30", "symbol": "MRK", "type": "cash_flow_quarter", "result": {"date": "2021-09-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2021-11-05", "acceptedDate": "2021-11-05 16:09:58", "fiscalYear": "2021", "period": "Q3", "netIncome": 4571000000, "depreciationAndAmortization": 759000000, "deferredIncomeTax": -1000000, "stockBasedCompensation": 117000000, "changeInWorkingCapital": -139000000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -139000000, "otherNonCashItems": -510000000, "netCashProvidedByOperatingActivities": 4797000000, "investmentsInPropertyPlantAndEquipment": -1172000000, "acquisitionsNet": 1000000, "purchasesOfInvestments": 1172000000, "salesMaturitiesOfInvestments": 111000000, "otherInvestingActivities": -1173000000, "netCashProvidedByInvestingActivities": -1061000000, "netDebtIssuance": 0, "longTermNetDebtIssuance": 0, "shortTermNetDebtIssuance": 0, "netStockIssuance": -583000000, "netCommonStockIssuance": -583000000, "commonStockIssuance": 0, "commonStockRepurchased": -583000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -1649000000, "commonDividendsPaid": -1649000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -42000000, "netCashProvidedByFinancingActivities": -2274000000, "effectOfForexChangesOnCash": -46000000, "netChangeInCash": 1416000000, "cashAtEndOfPeriod": 10046000000, "cashAtBeginningOfPeriod": 8630000000, "operatingCashFlow": 4797000000, "capitalExpenditure": -1172000000, "freeCashFlow": 3625000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2021-06-30", "symbol": "MRK", "type": "cash_flow_quarter", "result": {"date": "2021-06-30", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2021-08-09", "acceptedDate": "2021-08-09 07:07:53", "fiscalYear": "2021", "period": "Q2", "netIncome": 777000000, "depreciationAndAmortization": 690000000, "deferredIncomeTax": 39000000, "stockBasedCompensation": 132000000, "changeInWorkingCapital": -1551000000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -1551000000, "otherNonCashItems": 2412000000, "netCashProvidedByOperatingActivities": 2490000000, "investmentsInPropertyPlantAndEquipment": -934000000, "acquisitionsNet": -1630000000, "purchasesOfInvestments": 0, "salesMaturitiesOfInvestments": 0, "otherInvestingActivities": -143000000, "netCashProvidedByInvestingActivities": -2707000000, "netDebtIssuance": -4771000000, "longTermNetDebtIssuance": 0, "shortTermNetDebtIssuance": -4771000000, "netStockIssuance": -239000000, "netCommonStockIssuance": -239000000, "commonStockIssuance": 0, "commonStockRepurchased": -239000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -1673000000, "commonDividendsPaid": -1673000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 8441000000, "netCashProvidedByFinancingActivities": 1758000000, "effectOfForexChangesOnCash": 53000000, "netChangeInCash": 1594000000, "cashAtEndOfPeriod": 8575000000, "cashAtBeginningOfPeriod": 6981000000, "operatingCashFlow": 2490000000, "capitalExpenditure": -934000000, "freeCashFlow": 1556000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2021-03-31", "symbol": "MRK", "type": "cash_flow_quarter", "result": {"date": "2021-03-31", "symbol": "MRK", "reportedCurrency": "USD", "cik": "0000310158", "filingDate": "2021-05-05", "acceptedDate": "2021-05-05 16:26:12", "fiscalYear": "2021", "period": "Q1", "netIncome": 2749000000, "depreciationAndAmortization": 892000000, "deferredIncomeTax": 18000000, "stockBasedCompensation": 111000000, "changeInWorkingCapital": -2192000000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -2192000000, "otherNonCashItems": 213000000, "netCashProvidedByOperatingActivities": 1791000000, "investmentsInPropertyPlantAndEquipment": -1134000000, "acquisitionsNet": -14000000, "purchasesOfInvestments": -1000000, "salesMaturitiesOfInvestments": 386000000, "otherInvestingActivities": 25000000, "netCashProvidedByInvestingActivities": -738000000, "netDebtIssuance": -365000000, "longTermNetDebtIssuance": -1153000000, "shortTermNetDebtIssuance": 788000000, "netStockIssuance": 0, "netCommonStockIssuance": 0, "commonStockIssuance": 0, "commonStockRepurchased": 0, "netPreferredStockIssuance": 0, "netDividendsPaid": -1645000000, "commonDividendsPaid": -1645000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -88000000, "netCashProvidedByFinancingActivities": -2098000000, "effectOfForexChangesOnCash": -97000000, "netChangeInCash": -1142000000, "cashAtEndOfPeriod": 7023000000, "cashAtBeginningOfPeriod": 8165000000, "operatingCashFlow": 1791000000, "capitalExpenditure": -1134000000, "freeCashFlow": 657000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2025-09-30", "symbol": "MRK", "type": "ratios_quarter", "result": {"symbol": "MRK", "date": "2025-09-30", "fiscalYear": "2025", "period": "Q3", "reportedCurrency": "USD", "grossProfitMargin": 0.81917110442232, "ebitMargin": 0.39042602454271824, "ebitdaMargin": 0.39042602454271824, "operatingProfitMargin": 0.4373697615188701, "pretaxProfitMargin": 0.39042602454271824, "continuousOperationsProfitMargin": 0.33497337346608014, "netProfitMargin": 0.33485760592729796, "bottomLineProfitMargin": 0.33485760592729796, "receivablesTurnover": 1.4254125412541254, "payablesTurnover": 0.753315649867374, "inventoryTurnover": 0.48479205462445685, "fixedAssetTurnover": 0.6738172315612934, "assetTurnover": 0.15534155179700215, "currentRatio": 1.6612058124912672, "quickRatio": 1.4361114992315216, "solvencyRatio": 0.09745127436281859, "cashRatio": 0.6346583764146989, "priceToEarningsRatio": 9.060377700950736, "priceToEarningsGrowthRatio": 0.29157942783059654, "forwardPriceToEarningsGrowthRatio": 0.29157942783059654, "priceToBookRatio": 4.043532111861138, "priceToSalesRatio": 12.135745542949758, "priceToFreeCashFlowRatio": 30.674051207022682, "priceToOperatingCashFlowRatio": 26.80352083866019, "debtToAssetsRatio": 0.37202485320960677, "debtToEquityRatio": 0.7979556412729026, "debtToCapitalRatio": 0.4438127520810092, "longTermDebtToCapitalRatio": 0.43530206166479707, "financialLeverageRatio": 2.1448987463837996, "workingCapitalTurnoverRatio": 1.1533865206796408, "operatingCashFlowRatio": 0.27322900656699733, "operatingCashFlowSalesRatio": 0.4527668441768928, "freeCashFlowOperatingCashFlowRatio": 0.8738174379953976, "debtServiceCoverageRatio": 3.522215459525259, "interestCoverageRatio": 31.747899159663866, "shortTermOperatingCashFlowCoverageRatio": 5.5672597864768685, "operatingCashFlowCoverageRatio": 0.18905592884420166, "capitalExpenditureCoverageRatio": 7.925025329280649, "dividendPaidAndCapexCoverageRatio": 2.5917826375082837, "dividendPayoutRatio": 0.35108038029386346, "dividendYield": 0.009687244612799734, "dividendYieldPercentage": 0.9687244612799735, "revenuePerShare": 6.915932746196957, "netIncomePerShare": 2.3158526821457164, "interestDebtPerShare": 16.65812650120096, "cashPerShare": 7.291433146517214, "bookValuePerShare": 20.756605284227383, "tangibleBookValuePerShare": 5.984787830264211, "shareholdersEquityPerShare": 20.756605284227383, "operatingCashFlowPerShare": 3.131305044035228, "capexPerShare": 0.39511609287429944, "freeCashFlowPerShare": 2.7361889511609285, "netIncomePerEBT": 0.8576723498888065, "ebtPerEbit": 0.8926680783483325, "priceToFairValue": 4.043532111861138, "debtToMarketCap": 0.1973412400836909, "effectiveTaxRate": 0.14203113417346183, "enterpriseValueMultiple": 34.52366790214975, "dividendPerShare": 0.8130504403522818}}
{"date": "2025-06-30", "symbol": "MRK", "type": "ratios_quarter", "result": {"symbol": "MRK", "date": "2025-06-30", "fiscalYear": "2025", "period": "Q2", "reportedCurrency": "USD", "grossProfitMargin": 0.7749588763760598, "ebitMargin": 0.3355687713526509, "ebitdaMargin": 0.4063646716436796, "operatingProfitMargin": 0.35125901556371, "pretaxProfitMargin": 0.3162723016575984, "continuousOperationsProfitMargin": 0.2801467797039099, "netProfitMargin": 0.2800835125901556, "bottomLineProfitMargin": 0.2800835125901556, "receivablesTurnover": 1.3342900557150092, "payablesTurnover": 0.9139260020554985, "inventoryTurnover": 0.5388577488259355, "fixedAssetTurnover": 0.6263274686955144, "assetTurnover": 0.13449282268151766, "currentRatio": 1.423551100357184, "quickRatio": 1.1700272688865845, "solvencyRatio": 0.08100725939558594, "cashRatio": 0.30752390828436454, "priceToEarningsRatio": 11.189776507793088, "priceToEarningsGrowthRatio": -0.9041339418296814, "forwardPriceToEarningsGrowthRatio": -0.9041339418296814, "priceToBookRatio": 4.044425987385953, "priceToSalesRatio": 12.536287637605973, "priceToFreeCashFlowRatio": 78.35055848161329, "priceToOperatingCashFlowRatio": 60.17265788035226, "debtToAssetsRatio": 0.3012346519404712, "debtToEquityRatio": 0.7225930234931521, "debtToCapitalRatio": 0.4194798270039694, "longTermDebtToCapitalRatio": 0.40944540205638796, "financialLeverageRatio": 2.398771253036148, "workingCapitalTurnoverRatio": 1.4801704359226484, "operatingCashFlowRatio": 0.12647386411644967, "operatingCashFlowSalesRatio": 0.20833860559281286, "freeCashFlowOperatingCashFlowRatio": 0.7679927118129365, "debtServiceCoverageRatio": 3.3651523864289823, "interestCoverageRatio": 18.20327868852459, "shortTermOperatingCashFlowCoverageRatio": 2.2963737796373778, "operatingCashFlowCoverageRatio": 0.09301734365290097, "capitalExpenditureCoverageRatio": 4.310209424083769, "dividendPaidAndCapexCoverageRatio": 1.1590989088349173, "dividendPayoutRatio": 0.4691664784278292, "dividendYield": 0.010482034160849406, "dividendYieldPercentage": 1.0482034160849407, "revenuePerShare": 6.314469026902211, "netIncomePerShare": 1.7685786651965132, "interestDebtPerShare": 14.264883306566952, "cashPerShare": 3.4444737409813273, "bookValuePerShare": 19.599383174732537, "tangibleBookValuePerShare": 4.904240274215585, "shareholdersEquityPerShare": 19.572616793307606, "operatingCashFlowPerShare": 1.3155476721238124, "capexPerShare": 0.3052166478902498, "freeCashFlowPerShare": 1.0103310242335626, "netIncomePerEBT": 0.8855771154230846, "ebtPerEbit": 0.9003962536023055, "priceToFairValue": 4.044425987385953, "debtToMarketCap": 0.17866392554761226, "effectiveTaxRate": 0.11422284456891378, "enterpriseValueMultiple": 35.11498713996575, "dividendPerShare": 0.8297578241728389}}
{"date": "2025-03-31", "symbol": "MRK", "type": "ratios_quarter", "result": {"symbol": "MRK", "date": "2025-03-31", "fiscalYear": "2025", "period": "Q1", "reportedCurrency": "USD", "grossProfitMargin": 0.7798312834052418, "ebitMargin": 0.4002833408461588, "ebitdaMargin": 0.47105415673900447, "operatingProfitMargin": 0.3823169553738167, "pretaxProfitMargin": 0.38012750338077145, "continuousOperationsProfitMargin": 0.32745186425397643, "netProfitMargin": 0.3270654903728508, "bottomLineProfitMargin": 0.3270654903728508, "receivablesTurnover": 1.4392029657089898, "payablesTurnover": 0.9035412262156448, "inventoryTurnover": 0.5518076178179471, "fixedAssetTurnover": 0.626346146089622, "assetTurnover": 0.134891680130644, "currentRatio": 1.4103042821959164, "quickRatio": 1.164177325812346, "solvencyRatio": 0.09259314768741944, "cashRatio": 0.34277429093509176, "priceToEarningsRatio": 11.116534766686355, "priceToEarningsGrowthRatio": 0.30467539730918153, "forwardPriceToEarningsGrowthRatio": 0.30467539730918153, "priceToBookRatio": 4.6724634389159, "priceToSalesRatio": 14.54333957885247, "priceToFreeCashFlowRatio": 192.69924941979522, "priceToOperatingCashFlowRatio": 90.337408128, "debtToAssetsRatio": 0.3026702107329616, "debtToEquityRatio": 0.720885486707355, "debtToCapitalRatio": 0.418903809855853, "longTermDebtToCapitalRatio": 0.4092447964409245, "financialLeverageRatio": 2.3817523533671254, "workingCapitalTurnoverRatio": 1.5010390991252236, "operatingCashFlowRatio": 0.09930881067768332, "operatingCashFlowSalesRatio": 0.16098911713568162, "freeCashFlowOperatingCashFlowRatio": 0.4688, "debtServiceCoverageRatio": 3.8834429169157203, "interestCoverageRatio": 18.968051118210862, "shortTermOperatingCashFlowCoverageRatio": 1.838235294117647, "operatingCashFlowCoverageRatio": 0.07174836413729767, "capitalExpenditureCoverageRatio": 1.8825301204819278, "dividendPaidAndCapexCoverageRatio": 0.7400828892835998, "dividendPayoutRatio": 0.4036227603859027, "dividendYield": 0.009077081322038081, "dividendYieldPercentage": 0.9077081322038082, "revenuePerShare": 6.17189741828764, "netIncomePerShare": 2.0186146556431788, "interestDebtPerShare": 13.972915032180985, "cashPerShare": 3.6676070175773288, "bookValuePerShare": 19.236257005932238, "tangibleBookValuePerShare": 4.355183972541435, "shareholdersEquityPerShare": 19.210423189705264, "operatingCashFlowPerShare": 0.9936083164221198, "capexPerShare": 0.5278047376834301, "freeCashFlowPerShare": 0.46580357873868977, "netIncomePerEBT": 0.8604099610367609, "ebtPerEbit": 0.9942732019538487, "priceToFairValue": 4.6724634389159, "debtToMarketCap": 0.15428381540736338, "effectiveTaxRate": 0.13857360664069118, "enterpriseValueMultiple": 34.45776080929597, "dividendPerShare": 0.8147588194661383}}
{"date": "2024-12-31", "symbol": "MRK", "type": "ratios_quarter", "result": {"symbol": "MRK", "date": "2024-12-31", "fiscalYear": "2024", "period": "Q4", "reportedCurrency": "USD", "grossProfitMargin": 0.7549923195084486, "ebitMargin": 0.2878904249871992, "ebitdaMargin": 0.36450332821300563, "operatingProfitMargin": 0.27828981054787505, "pretaxProfitMargin": 0.26689708141321045, "continuousOperationsProfitMargin": 0.23963133640552994, "netProfitMargin": 0.2395673323092678, "bottomLineProfitMargin": 0.2395673323092678, "receivablesTurnover": 1.520140105078809, "payablesTurnover": 0.9384653101250306, "inventoryTurnover": 0.626616467506957, "fixedAssetTurnover": 0.6570503385340006, "assetTurnover": 0.13341758748484278, "currentRatio": 1.3646023926812103, "quickRatio": 1.1496481351161154, "solvencyRatio": 0.06983911555970254, "cashRatio": 0.46593947923997187, "priceToEarningsRatio": 16.883427731765963, "priceToEarningsGrowthRatio": 0.9175775941177156, "forwardPriceToEarningsGrowthRatio": 0.9175775941177156, "priceToBookRatio": 5.458050223479369, "priceToSalesRatio": 16.178870967741936, "priceToFreeCashFlowRatio": 100.5884122562674, "priceToOperatingCashFlowRatio": 73.26918260869564, "debtToAssetsRatio": 0.3267979437432753, "debtToEquityRatio": 0.8263338587437653, "debtToCapitalRatio": 0.45245498504427606, "longTermDebtToCapitalRatio": 0.4266419065304859, "financialLeverageRatio": 2.5285772893140157, "workingCapitalTurnoverRatio": 1.4783554903723328, "operatingCashFlowRatio": 0.12139338494018297, "operatingCashFlowSalesRatio": 0.2208141321044547, "freeCashFlowOperatingCashFlowRatio": 0.7284057971014493, "debtServiceCoverageRatio": 1.769902586496473, "interestCoverageRatio": 13.25609756097561, "shortTermOperatingCashFlowCoverageRatio": 1.3023782559456398, "operatingCashFlowCoverageRatio": 0.09014894172981448, "capitalExpenditureCoverageRatio": 3.6819637139807897, "dividendPaidAndCapexCoverageRatio": 1.1945983379501386, "dividendPayoutRatio": 0.5212396473417045, "dividendYield": 0.007718214210154116, "dividendYieldPercentage": 0.7718214210154115, "revenuePerShare": 6.148760330578512, "netIncomePerShare": 1.4730421094057458, "interestDebtPerShare": 15.190082644628099, "cashPerShare": 5.3872491145218415, "bookValuePerShare": 18.249508067689884, "tangibleBookValuePerShare": 3.279811097992916, "shareholdersEquityPerShare": 18.2262888626525, "operatingCashFlowPerShare": 1.3577331759149942, "capexPerShare": 0.36875245966155057, "freeCashFlowPerShare": 0.9889807162534435, "netIncomePerEBT": 0.8976019184652279, "ebtPerEbit": 0.9590616375344986, "priceToFairValue": 5.458050223479369, "debtToMarketCap": 0.14681222324604273, "effectiveTaxRate": 0.10215827338129496, "enterpriseValueMultiple": 48.780804214223004, "dividendPerShare": 0.7678079496261314}}
{"date": "2024-09-30", "symbol": "MRK", "type": "ratios_quarter", "result": {"symbol": "MRK", "date": "2024-09-30", "fiscalYear": "2024", "period": "Q3", "reportedCurrency": "USD", "grossProfitMargin": 0.7550579336014889, "ebitMargin": 0.26535390526505376, "ebitdaMargin": 0.33655520201717, "operatingProfitMargin": 0.23917872365972265, "pretaxProfitMargin": 0.24554241460046827, "continuousOperationsProfitMargin": 0.18977006663865043, "netProfitMargin": 0.18952992735786756, "bottomLineProfitMargin": 0.18952992735786756, "receivablesTurnover": 1.4635796502943503, "payablesTurnover": 1.1377579475738986, "inventoryTurnover": 0.6534272901985907, "fixedAssetTurnover": 0.7104410133924763, "assetTurnover": 0.14172310519688255, "currentRatio": 1.3641925234908403, "quickRatio": 1.1531467586020414, "solvencyRatio": 0.059515978731568275, "cashRatio": 0.49324004596768745, "priceToEarningsRatio": 22.85048780487805, "priceToEarningsGrowthRatio": -0.5458727642276423, "forwardPriceToEarningsGrowthRatio": -0.5458727642276423, "priceToBookRatio": 6.48411217473372, "priceToSalesRatio": 17.3234051750015, "priceToFreeCashFlowRatio": 33.91583921015515, "priceToOperatingCashFlowRatio": 31.057578301582176, "debtToAssetsRatio": 0.3244307933158629, "debtToEquityRatio": 0.8568378949260708, "debtToCapitalRatio": 0.4614500260186608, "longTermDebtToCapitalRatio": 0.44011373358160133, "financialLeverageRatio": 2.6410498404566085, "workingCapitalTurnoverRatio": 1.4534904013961605, "operatingCashFlowRatio": 0.3140336645710809, "operatingCashFlowSalesRatio": 0.5577835144383743, "freeCashFlowOperatingCashFlowRatio": 0.9157248950597352, "debtServiceCoverageRatio": 1.3443518252371371, "interestCoverageRatio": 12.072727272727272, "shortTermOperatingCashFlowCoverageRatio": 2.9504604636392506, "operatingCashFlowCoverageRatio": 0.2436600141617057, "capitalExpenditureCoverageRatio": 11.865900383141762, "dividendPaidAndCapexCoverageRatio": 3.3958333333333335, "dividendPayoutRatio": 0.6186252771618626, "dividendYield": 0.006768184583676594, "dividendYieldPercentage": 0.6768184583676594, "revenuePerShare": 6.555293191656828, "netIncomePerShare": 1.2424242424242424, "interestDebtPerShare": 15.136166863439591, "cashPerShare": 5.74301456119638, "bookValuePerShare": 17.536402990948446, "tangibleBookValuePerShare": 2.3034238488783942, "shareholdersEquityPerShare": 17.51357733175915, "operatingCashFlowPerShare": 3.656434474616293, "capexPerShare": 0.30814639905548996, "freeCashFlowPerShare": 3.3482880755608027, "netIncomePerEBT": 0.7718826405867971, "ebtPerEbit": 1.0266064257028114, "priceToFairValue": 6.48411217473372, "debtToMarketCap": 0.1321442121659868, "effectiveTaxRate": 0.2271393643031785, "enterpriseValueMultiple": 55.6714163396361, "dividendPerShare": 0.768595041322314}}
{"date": "2024-06-30", "symbol": "MRK", "type": "ratios_quarter", "result": {"symbol": "MRK", "date": "2024-06-30", "fiscalYear": "2024", "period": "Q2", "reportedCurrency": "USD", "grossProfitMargin": 0.76756454816286, "ebitMargin": 0.3920059582919563, "ebitdaMargin": 0.46226415094339623, "operatingProfitMargin": 0.38033763654419067, "pretaxProfitMargin": 0.3727656405163853, "continuousOperationsProfitMargin": 0.3389399205561073, "netProfitMargin": 0.33856752730883816, "bottomLineProfitMargin": 0.33856752730883816, "receivablesTurnover": 1.383954646967875, "payablesTurnover": 1.0642227905655015, "inventoryTurnover": 0.5789148245478436, "fixedAssetTurnover": 0.6938547004866285, "assetTurnover": 0.1430524726982154, "currentRatio": 1.466039907904835, "quickRatio": 1.2178050652340753, "solvencyRatio": 0.09548867820590878, "cashRatio": 0.4337682271680737, "priceToEarningsRatio": 14.853281393217234, "priceToEarningsGrowthRatio": 1.0342284821943855, "forwardPriceToEarningsGrowthRatio": 1.0342284821943855, "priceToBookRatio": 7.436524253132027, "priceToSalesRatio": 20.11535501489573, "priceToFreeCashFlowRatio": 66.87961205117622, "priceToOperatingCashFlowRatio": 57.494873159482, "debtToAssetsRatio": 0.33550563792950366, "debtToEquityRatio": 0.8670552062778211, "debtToCapitalRatio": 0.4643971979845152, "longTermDebtToCapitalRatio": 0.4433900816102377, "financialLeverageRatio": 2.5843238034050753, "workingCapitalTurnoverRatio": 1.7426856308474392, "operatingCashFlowRatio": 0.21630851880276286, "operatingCashFlowSalesRatio": 0.34986345580933464, "freeCashFlowOperatingCashFlowRatio": 0.8596771332268938, "debtServiceCoverageRatio": 2.04170363797693, "interestCoverageRatio": 19.767741935483873, "shortTermOperatingCashFlowCoverageRatio": 1.8355584500162814, "operatingCashFlowCoverageRatio": 0.14917434106065416, "capitalExpenditureCoverageRatio": 7.126422250316056, "dividendPaidAndCapexCoverageRatio": 2.029888368743248, "dividendPayoutRatio": 0.36406966086159487, "dividendYield": 0.006127764822186828, "dividendYieldPercentage": 0.6127764822186827, "revenuePerShare": 6.358326756116812, "netIncomePerShare": 2.1527229676400945, "interestDebtPerShare": 15.03472770323599, "cashPerShare": 4.480662983425415, "bookValuePerShare": 17.224940805051304, "tangibleBookValuePerShare": 2.1716653512233624, "shareholdersEquityPerShare": 17.19889502762431, "operatingCashFlowPerShare": 2.224546172059984, "capexPerShare": 0.31215469613259667, "freeCashFlowPerShare": 1.9123914759273875, "netIncomePerEBT": 0.9082584082584083, "ebtPerEbit": 0.9800913838120104, "priceToFairValue": 7.436524253132027, "debtToMarketCap": 0.11659414758348231, "effectiveTaxRate": 0.09074259074259074, "enterpriseValueMultiple": 47.07070354457573, "dividendPerShare": 0.7837411207576953}}
{"date": "2024-03-31", "symbol": "MRK", "type": "ratios_quarter", "result": {"symbol": "MRK", "date": "2024-03-31", "fiscalYear": "2024", "period": "Q1", "reportedCurrency": "USD", "grossProfitMargin": 0.775594294770206, "ebitMargin": 0.37863708399366086, "ebitdaMargin": 0.44101426307448494, "operatingProfitMargin": 0.36513470681458005, "pretaxProfitMargin": 0.35942947702060224, "continuousOperationsProfitMargin": 0.30218700475435817, "netProfitMargin": 0.3018700475435816, "bottomLineProfitMargin": 0.3018700475435816, "receivablesTurnover": 1.387911314446595, "payablesTurnover": 1.0073989755264656, "inventoryTurnover": 0.543778801843318, "fixedAssetTurnover": 0.6845302668691691, "assetTurnover": 0.14903305652391616, "currentRatio": 1.2528387585162755, "quickRatio": 0.9934658751344675, "solvencyRatio": 0.08782575468093237, "cashRatio": 0.2222797721024742, "priceToEarningsRatio": 17.419029294414113, "priceToEarningsGrowthRatio": -0.0354285341581304, "forwardPriceToEarningsGrowthRatio": -0.0354285341581304, "priceToBookRatio": 8.220138489743336, "priceToSalesRatio": 21.033132805071315, "priceToFreeCashFlowRatio": 148.8549439210408, "priceToOperatingCashFlowRatio": 107.3778867313916, "debtToAssetsRatio": 0.3232812780470293, "debtToEquityRatio": 0.8477603805371122, "debtToCapitalRatio": 0.4588042851588163, "longTermDebtToCapitalRatio": 0.4355159007635723, "financialLeverageRatio": 2.622361510256664, "workingCapitalTurnoverRatio": 2.4609984399375975, "operatingCashFlowRatio": 0.1231124746005817, "operatingCashFlowSalesRatio": 0.1958795562599049, "freeCashFlowOperatingCashFlowRatio": 0.7213592233009709, "debtServiceCoverageRatio": 1.7911242603550297, "interestCoverageRatio": 19.00990099009901, "shortTermOperatingCashFlowCoverageRatio": 1.0042248943776406, "operatingCashFlowCoverageRatio": 0.09030071013179812, "capitalExpenditureCoverageRatio": 3.5888501742160277, "dividendPaidAndCapexCoverageRatio": 1.0992529348986126, "dividendPayoutRatio": 0.4094918101637967, "dividendYield": 0.005877075628650436, "dividendYieldPercentage": 0.5877075628650437, "revenuePerShare": 6.227793130675089, "netIncomePerShare": 1.8799842084484801, "interestDebtPerShare": 13.628898539281485, "cashPerShare": 2.218318199763127, "bookValuePerShare": 15.958941966048164, "tangibleBookValuePerShare": 0.6596920647453612, "shareholdersEquityPerShare": 15.935254638768258, "operatingCashFlowPerShare": 1.2198973549151204, "capexPerShare": 0.33991314646664034, "freeCashFlowPerShare": 0.87998420844848, "netIncomePerEBT": 0.8398589065255732, "ebtPerEbit": 0.984375, "priceToFairValue": 8.220138489743336, "debtToMarketCap": 0.10313212868553297, "effectiveTaxRate": 0.15925925925925927, "enterpriseValueMultiple": 51.809353169469595, "dividendPerShare": 0.7698381365969207}}
{"date": "2023-12-31", "symbol": "MRK", "type": "ratios_quarter", "result": {"symbol": "MRK", "date": "2023-12-31", "fiscalYear": "2023", "period": "Q4", "reportedCurrency": "USD", "grossProfitMargin": 0.7326042378673958, "ebitMargin": -0.11866028708133972, "ebitdaMargin": -0.052768284347231714, "operatingProfitMargin": -0.11708817498291182, "pretaxProfitMargin": -0.13984962406015036, "continuousOperationsProfitMargin": -0.08380041011619958, "netProfitMargin": -0.08380041011619958, "bottomLineProfitMargin": -0.08380041011619958, "receivablesTurnover": 1.4136631558604695, "payablesTurnover": 0.9974502804691484, "inventoryTurnover": 0.6152878263604907, "fixedAssetTurnover": 0.6346796234436684, "assetTurnover": 0.13714553550503866, "currentRatio": 1.251965439402195, "quickRatio": 1.0045146726862302, "solvencyRatio": -0.003794901506373117, "cashRatio": 0.2662489297112166, "priceToEarningsRatio": -56.78125000741028, "priceToEarningsGrowthRatio": 0.45183377665471164, "forwardPriceToEarningsGrowthRatio": 0.45183377665471164, "priceToBookRatio": 7.40946888151832, "priceToSalesRatio": 19.033168150125768, "priceToFreeCashFlowRatio": -374.77153436923277, "priceToOperatingCashFlowRatio": 1131.9319107168292, "debtToAssetsRatio": 0.339985938598547, "debtToEquityRatio": 0.9650621324605518, "debtToCapitalRatio": 0.49111023845955937, "longTermDebtToCapitalRatio": 0.47265098787606646, "financialLeverageRatio": 2.8385354301375694, "workingCapitalTurnoverRatio": 1.9081779053084649, "operatingCashFlowRatio": 0.009574219662177941, "operatingCashFlowSalesRatio": 0.016814764183185237, "freeCashFlowOperatingCashFlowRatio": -3.0203252032520327, "debtServiceCoverageRatio": 0.028537455410225922, "interestCoverageRatio": -5.525806451612903, "shortTermOperatingCashFlowCoverageRatio": 0.1793002915451895, "operatingCashFlowCoverageRatio": 0.006782838866218154, "capitalExpenditureCoverageRatio": 0.2487360970677452, "dividendPaidAndCapexCoverageRatio": 0.08658922914466737, "dividendPayoutRatio": -1.5106035889070146, "dividendYield": 0.006650978926625745, "dividendYieldPercentage": 0.6650978926625745, "revenuePerShare": 5.727895594684777, "netIncomePerShare": -0.47999999993735726, "interestDebtPerShare": 14.320913538098413, "cashPerShare": 2.7770309947436176, "bookValuePerShare": 14.734747143264633, "tangibleBookValuePerShare": -0.6158564436390399, "shareholdersEquityPerShare": 14.713605218308176, "operatingCashFlowPerShare": 0.09631321369053009, "capexPerShare": 0.3872104404062368, "freeCashFlowPerShare": -0.2908972267157067, "netIncomePerEBT": 0.5992179863147605, "ebtPerEbit": 1.1943957968476357, "priceToFairValue": 7.40946888151832, "debtToMarketCap": 0.12589096451018655, "effectiveTaxRate": 0.40078201368523947, "enterpriseValueMultiple": -398.8112047102849, "dividendPerShare": 0.7250897225807387}}
{"date": "2023-09-30", "symbol": "MRK", "type": "ratios_quarter", "result": {"symbol": "MRK", "date": "2023-09-30", "fiscalYear": "2023", "period": "Q3", "reportedCurrency": "USD", "grossProfitMargin": 0.7328655556947751, "ebitMargin": 0.3719458714446811, "ebitdaMargin": 0.43547174539531386, "operatingProfitMargin": 0.3678737000375893, "pretaxProfitMargin": 0.3520862047362486, "continuousOperationsProfitMargin": 0.29758175667209624, "netProfitMargin": 0.29726851271770455, "bottomLineProfitMargin": 0.29726851271770455, "receivablesTurnover": 1.5356936694246681, "payablesTurnover": 1.2151610145340552, "inventoryTurnover": 0.6954819768390148, "fixedAssetTurnover": 0.7086033916363313, "assetTurnover": 0.14955915560261226, "currentRatio": 1.383649432753096, "quickRatio": 1.118169221442799, "solvencyRatio": 0.08802176471487307, "cashRatio": 0.37260760370659046, "priceToEarningsRatio": 13.761019494204426, "priceToEarningsGrowthRatio": -0.07663126969521422, "forwardPriceToEarningsGrowthRatio": -0.07663126969521422, "priceToBookRatio": 6.332351015856083, "priceToSalesRatio": 16.362871194085955, "priceToFreeCashFlowRatio": 38.324893617021274, "priceToOperatingCashFlowRatio": 33.84529609952054, "debtToAssetsRatio": 0.3266183814779765, "debtToEquityRatio": 0.8451486204722882, "debtToCapitalRatio": 0.45803823664673804, "longTermDebtToCapitalRatio": 0.45164721210348585, "financialLeverageRatio": 2.5875721282063715, "workingCapitalTurnoverRatio": 2.0672149193809495, "operatingCashFlowRatio": 0.33415605785052394, "operatingCashFlowSalesRatio": 0.4834607192081193, "freeCashFlowOperatingCashFlowRatio": 0.8831152002073345, "debtServiceCoverageRatio": 5.0506644518272426, "interestCoverageRatio": 18.52365930599369, "shortTermOperatingCashFlowCoverageRatio": 8.70011273957159, "operatingCashFlowCoverageRatio": 0.2213775495567859, "capitalExpenditureCoverageRatio": 8.555432372505543, "dividendPaidAndCapexCoverageRatio": 2.799056945955749, "dividendPayoutRatio": 0.3909378292939937, "dividendYield": 0.007102268648384674, "dividendYieldPercentage": 0.7102268648384673, "revenuePerShare": 6.291683090264091, "netIncomePerShare": 1.8703192747339377, "interestDebtPerShare": 13.865195112337407, "cashPerShare": 3.4580212849822627, "bookValuePerShare": 16.27906976744186, "tangibleBookValuePerShare": 0.3618446984627513, "shareholdersEquityPerShare": 16.257784785179346, "operatingCashFlowPerShare": 3.04178163184864, "capexPerShare": 0.3555380370516358, "freeCashFlowPerShare": 2.6862435947970043, "netIncomePerEBT": 0.844306049822064, "ebtPerEbit": 0.9570844686648501, "priceToFairValue": 6.332351015856083, "debtToMarketCap": 0.1334652198458444, "effectiveTaxRate": 0.15480427046263345, "enterpriseValueMultiple": 41.352057257948495, "dividendPerShare": 0.7311785573512022}}
{"date": "2023-06-30", "symbol": "MRK", "type": "ratios_quarter", "result": {"symbol": "MRK", "date": "2023-06-30", "fiscalYear": "2023", "period": "Q2", "reportedCurrency": "USD", "grossProfitMargin": 0.7323578317259727, "ebitMargin": -0.3364150315929498, "ebitdaMargin": -0.27635517126704356, "operatingProfitMargin": -0.3333555038244097, "pretaxProfitMargin": -0.3548387096774194, "continuousOperationsProfitMargin": -0.39720651812437646, "netProfitMargin": -0.39740605254406386, "bottomLineProfitMargin": -0.39740605254406386, "receivablesTurnover": 1.3631006346328196, "payablesTurnover": 1.169087739686229, "inventoryTurnover": 0.67858347386172, "fixedAssetTurnover": 0.6763078583959337, "assetTurnover": 0.14391829155060354, "currentRatio": 1.2813969393861675, "quickRatio": 1.0279131401213986, "solvencyRatio": -0.07716767842743469, "cashRatio": 0.24194237838762075, "priceToEarningsRatio": -12.258376987447699, "priceToEarningsGrowthRatio": 0.03932600709845938, "forwardPriceToEarningsGrowthRatio": 0.03932600709845938, "priceToBookRatio": 7.57178843718502, "priceToSalesRatio": 19.486212836714333, "priceToFreeCashFlowRatio": 106.96429718875503, "priceToOperatingCashFlowRatio": 79.09697894168467, "debtToAssetsRatio": 0.3533201236730513, "debtToEquityRatio": 0.9539451580389218, "debtToCapitalRatio": 0.4882149092640601, "longTermDebtToCapitalRatio": 0.4682470968185254, "financialLeverageRatio": 2.6999457266172175, "workingCapitalTurnoverRatio": 1.7841461967485464, "operatingCashFlowRatio": 0.1583311960331709, "operatingCashFlowSalesRatio": 0.24635849684070502, "freeCashFlowOperatingCashFlowRatio": 0.7394708423326134, "debtServiceCoverageRatio": -1.5378690629011553, "interestCoverageRatio": -18.093862815884478, "shortTermOperatingCashFlowCoverageRatio": 1.3046847481507573, "operatingCashFlowCoverageRatio": 0.10034948931212917, "capitalExpenditureCoverageRatio": 3.838341968911917, "dividendPaidAndCapexCoverageRatio": 1.2996491228070175, "dividendPayoutRatio": -0.31548117154811717, "dividendYield": 0.00643399146296371, "dividendYieldPercentage": 0.6433991462963711, "revenuePerShare": 5.921622686096889, "netIncomePerShare": -2.3532886963371404, "interestDebtPerShare": 14.64671130366286, "cashPerShare": 2.51201260338716, "bookValuePerShare": 15.258763292634896, "tangibleBookValuePerShare": -0.834186687672312, "shareholdersEquityPerShare": 15.239464356045687, "operatingCashFlowPerShare": 1.4588420638046475, "capexPerShare": 0.38007089405277666, "freeCashFlowPerShare": 1.0787711697518707, "netIncomePerEBT": 1.119962511715089, "ebtPerEbit": 1.0644453312051076, "priceToFairValue": 7.57178843718502, "debtToMarketCap": 0.1259867686416199, "effectiveTaxRate": -0.11940018744142455, "enterpriseValueMultiple": -78.03278219013237, "dividendPerShare": 0.7424182749113825}}
{"date": "2023-03-31", "symbol": "MRK", "type": "ratios_quarter", "result": {"symbol": "MRK", "date": "2023-03-31", "fiscalYear": "2023", "period": "Q1", "reportedCurrency": "USD", "grossProfitMargin": 0.7289984123697107, "ebitMargin": 0.26865465589839166, "ebitdaMargin": 0.3370608131428177, "operatingProfitMargin": 0.2627182991647684, "pretaxProfitMargin": 0.25195002415959133, "continuousOperationsProfitMargin": 0.19500241595913578, "netProfitMargin": 0.19472630634361843, "bottomLineProfitMargin": 0.19472630634361843, "receivablesTurnover": 1.3909745559289486, "payablesTurnover": 1.0668478260869565, "inventoryTurnover": 0.6696230598669624, "fixedAssetTurnover": 0.6658240647118301, "assetTurnover": 0.13439274184570857, "currentRatio": 1.4440361419739742, "quickRatio": 1.1905667718645974, "solvencyRatio": 0.0626036688508975, "cashRatio": 0.4196532791491937, "priceToEarningsRatio": 23.92926444523219, "priceToEarningsGrowthRatio": -3.559478086228295, "forwardPriceToEarningsGrowthRatio": -3.559478086228295, "priceToBookRatio": 5.765422983302729, "priceToSalesRatio": 18.638629115758956, "priceToFreeCashFlowRatio": 813.3066867469879, "priceToOperatingCashFlowRatio": 201.65632561613143, "debtToAssetsRatio": 0.28522394151916586, "debtToEquityRatio": 0.6564888756031942, "debtToCapitalRatio": 0.3963134828564063, "longTermDebtToCapitalRatio": 0.37477972980189034, "financialLeverageRatio": 2.3016611863176326, "workingCapitalTurnoverRatio": 1.3318929851981245, "operatingCashFlowRatio": 0.05788768319571138, "operatingCashFlowSalesRatio": 0.0924276937944364, "freeCashFlowOperatingCashFlowRatio": 0.2479462285287528, "debtServiceCoverageRatio": 1.3925875085792725, "interestCoverageRatio": 15.727272727272727, "shortTermOperatingCashFlowCoverageRatio": 0.501122754491018, "operatingCashFlowCoverageRatio": 0.043550380537305665, "capitalExpenditureCoverageRatio": 1.329692154915591, "dividendPaidAndCapexCoverageRatio": 0.4681818181818182, "dividendPayoutRatio": 0.6568592697624955, "dividendYield": 0.006862510037300501, "dividendYieldPercentage": 0.6862510037300501, "revenuePerShare": 5.708037825059102, "netIncomePerShare": 1.11150512214342, "interestDebtPerShare": 12.209613869188336, "cashPerShare": 4.092592592592593, "bookValuePerShare": 18.48108747044917, "tangibleBookValuePerShare": 2.300630417651694, "shareholdersEquityPerShare": 18.45311268715524, "operatingCashFlowPerShare": 0.5275807722616234, "capexPerShare": 0.396769109535067, "freeCashFlowPerShare": 0.13081166272655634, "netIncomePerEBT": 0.7728767123287671, "ebtPerEbit": 0.9590120861797162, "priceToFairValue": 5.765422983302729, "debtToMarketCap": 0.11386655888118792, "effectiveTaxRate": 0.22602739726027396, "enterpriseValueMultiple": 59.60614785992218, "dividendPerShare": 0.7301024428684003}}
{"date": "2022-12-31", "symbol": "MRK", "type": "ratios_quarter", "result": {"symbol": "MRK", "date": "2022-12-31", "fiscalYear": "2022", "period": "Q4", "reportedCurrency": "USD", "grossProfitMargin": 0.7193781634128705, "ebitMargin": 0.2710050614605929, "ebitdaMargin": 0.33550253073029646, "operatingProfitMargin": 0.25213304410701376, "pretaxProfitMargin": 0.2540130151843818, "continuousOperationsProfitMargin": 0.21822125813449023, "netProfitMargin": 0.21814895155459146, "bottomLineProfitMargin": 0.21814895155459146, "receivablesTurnover": 1.4634920634920634, "payablesTurnover": 0.9101782363977486, "inventoryTurnover": 0.6565724919641347, "fixedAssetTurnover": 0.6455979833815704, "assetTurnover": 0.1266947599853426, "currentRatio": 1.473740665869054, "quickRatio": 1.2298774701926647, "solvencyRatio": 0.061947323381192354, "cashRatio": 0.5237014728330377, "priceToEarningsRatio": 23.315313225058006, "priceToEarningsGrowthRatio": -3.3159556586749113, "forwardPriceToEarningsGrowthRatio": -3.3159556586749113, "priceToBookRatio": 6.117918723228457, "priceToSalesRatio": 20.344844540853217, "priceToFreeCashFlowRatio": 85.7571472112161, "priceToOperatingCashFlowRatio": 63.5144920993228, "debtToAssetsRatio": 0.2930102601685599, "debtToEquityRatio": 0.6954621556391468, "debtToCapitalRatio": 0.41019031496870834, "longTermDebtToCapitalRatio": 0.3846205309355598, "financialLeverageRatio": 2.373507860233524, "workingCapitalTurnoverRatio": 1.2546493695001362, "operatingCashFlowRatio": 0.1827633153182887, "operatingCashFlowSalesRatio": 0.3203181489515546, "freeCashFlowOperatingCashFlowRatio": 0.7406320541760723, "debtServiceCoverageRatio": 1.9005043558000918, "interestCoverageRatio": 14.838297872340426, "shortTermOperatingCashFlowCoverageRatio": 2.276464542651593, "operatingCashFlowCoverageRatio": 0.1385024230107863, "capitalExpenditureCoverageRatio": 3.855526544821584, "dividendPaidAndCapexCoverageRatio": 1.5281131424629182, "dividendPayoutRatio": 0.580046403712297, "dividendYield": 0.006219586223367732, "dividendYieldPercentage": 0.6219586223367732, "revenuePerShare": 5.453470031545741, "netIncomePerShare": 1.1896687697160884, "interestDebtPerShare": 12.705047318611987, "cashPerShare": 5.201892744479495, "bookValuePerShare": 18.16167192429022, "tangibleBookValuePerShare": 1.8079652996845426, "shareholdersEquityPerShare": 18.1352523659306, "operatingCashFlowPerShare": 1.746845425867508, "capexPerShare": 0.4530757097791798, "freeCashFlowPerShare": 1.2937697160883281, "netIncomePerEBT": 0.8588101337887846, "ebtPerEbit": 1.007456266131345, "priceToFairValue": 6.117918723228457, "debtToMarketCap": 0.10907732616078804, "effectiveTaxRate": 0.14090520922288644, "enterpriseValueMultiple": 64.79745689655172, "dividendPerShare": 0.6900630914826499}}
{"date": "2022-09-30", "symbol": "MRK", "type": "ratios_quarter", "result": {"symbol": "MRK", "date": "2022-09-30", "fiscalYear": "2022", "period": "Q3", "reportedCurrency": "USD", "grossProfitMargin": 0.7370145063172672, "ebitMargin": 0.2558326091316264, "ebitdaMargin": 0.31994117253827126, "operatingProfitMargin": 0.27448358847516546, "pretaxProfitMargin": 0.23952135837957084, "continuousOperationsProfitMargin": 0.21746106023129888, "netProfitMargin": 0.2171268132896584, "bottomLineProfitMargin": 0.2171268132896584, "receivablesTurnover": 1.5776207551149546, "payablesTurnover": 1.1670127558587957, "inventoryTurnover": 0.7007481296758105, "fixedAssetTurnover": 0.7324226400313357, "assetTurnover": 0.1396979856370411, "currentRatio": 1.4593008087659796, "quickRatio": 1.2151926254456908, "solvencyRatio": 0.0672506673913391, "cashRatio": 0.4846073571614923, "priceToEarningsRatio": 16.790483374384237, "priceToEarningsGrowthRatio": -0.9354697880014073, "forwardPriceToEarningsGrowthRatio": -0.9354697880014073, "priceToBookRatio": 4.90669755724504, "priceToSalesRatio": 14.582656594692159, "priceToFreeCashFlowRatio": 48.735915996425376, "priceToOperatingCashFlowRatio": 38.940014280614065, "debtToAssetsRatio": 0.28406533371933396, "debtToEquityRatio": 0.6841963201223626, "debtToCapitalRatio": 0.4062449917196431, "longTermDebtToCapitalRatio": 0.390485330408555, "financialLeverageRatio": 2.4085878806963876, "workingCapitalTurnoverRatio": 1.5333914202244887, "operatingCashFlowRatio": 0.24358639881728847, "operatingCashFlowSalesRatio": 0.37449027341399826, "freeCashFlowOperatingCashFlowRatio": 0.7990003570153517, "debtServiceCoverageRatio": 2.0440366972477064, "interestCoverageRatio": 16.827868852459016, "shortTermOperatingCashFlowCoverageRatio": 2.893595041322314, "operatingCashFlowCoverageRatio": 0.18416726937997238, "capitalExpenditureCoverageRatio": 4.975133214920071, "dividendPaidAndCapexCoverageRatio": 1.9498781761225201, "dividendPayoutRatio": 0.5378694581280788, "dividendYield": 0.008008546361277765, "dividendYieldPercentage": 0.8008546361277766, "revenuePerShare": 5.905645479668378, "netIncomePerShare": 1.282273983418871, "interestDebtPerShare": 12.10501381760758, "cashPerShare": 4.440584287406238, "bookValuePerShare": 17.57757599684169, "tangibleBookValuePerShare": 0.7879984208448481, "shareholdersEquityPerShare": 17.551519936833795, "operatingCashFlowPerShare": 2.2116067903671537, "capexPerShare": 0.44453217528622185, "freeCashFlowPerShare": 1.7670746150809318, "netIncomePerEBT": 0.9065029305051633, "ebtPerEbit": 0.8726254262055528, "priceToFairValue": 4.90669755724504, "debtToMarketCap": 0.13944130693608878, "effectiveTaxRate": 0.09210159084566007, "enterpriseValueMultiple": 49.6061345591308, "dividendPerShare": 0.6896960126332412}}
{"date": "2022-06-30", "symbol": "MRK", "type": "ratios_quarter", "result": {"symbol": "MRK", "date": "2022-06-30", "fiscalYear": "2022", "period": "Q2", "reportedCurrency": "USD", "grossProfitMargin": 0.7110943603097375, "ebitMargin": 0.32392242856163916, "ebitdaMargin": 0.3881998218323854, "operatingProfitMargin": 0.3472212704721442, "pretaxProfitMargin": 0.30747618721304737, "continuousOperationsProfitMargin": 0.2706091961899541, "netProfitMargin": 0.2702665661618584, "bottomLineProfitMargin": 0.2702665661618584, "receivablesTurnover": 1.5133257285077257, "payablesTurnover": 1.2107983917288914, "inventoryTurnover": 0.7616982836495032, "fixedAssetTurnover": 0.727503863602373, "assetTurnover": 0.13626219711471124, "currentRatio": 1.3862223756906078, "quickRatio": 1.1473152624309393, "solvencyRatio": 0.07654797183937784, "cashRatio": 0.417601864640884, "priceToEarningsRatio": 14.626728575050711, "priceToEarningsGrowthRatio": -1.7761027555418738, "forwardPriceToEarningsGrowthRatio": -1.7761027555418738, "priceToBookRatio": 5.336153134611382, "priceToSalesRatio": 15.812462824641951, "priceToFreeCashFlowRatio": 72.72337535455405, "priceToOperatingCashFlowRatio": 53.638138075313805, "debtToAssetsRatio": 0.2956533918483589, "debtToEquityRatio": 0.7322109936868395, "debtToCapitalRatio": 0.4227031212452941, "longTermDebtToCapitalRatio": 0.3987932209045282, "financialLeverageRatio": 2.4765858057951577, "workingCapitalTurnoverRatio": 1.6381903906600808, "operatingCashFlowRatio": 0.1856871546961326, "operatingCashFlowSalesRatio": 0.29479887617350786, "freeCashFlowOperatingCashFlowRatio": 0.7375639237563923, "debtServiceCoverageRatio": 1.592730661696179, "interestCoverageRatio": 21.1125, "shortTermOperatingCashFlowCoverageRatio": 1.444108761329305, "operatingCashFlowCoverageRatio": 0.13586836370527114, "capitalExpenditureCoverageRatio": 3.8104517271922056, "dividendPaidAndCapexCoverageRatio": 1.4839599862021386, "dividendPayoutRatio": 0.4487829614604463, "dividendYield": 0.007670597002564709, "dividendYieldPercentage": 0.7670597002564709, "revenuePerShare": 5.765705254839984, "netIncomePerShare": 1.5582773607269853, "interestDebtPerShare": 12.604899249308573, "cashPerShare": 4.001580403002766, "bookValuePerShare": 17.114974318451203, "tangibleBookValuePerShare": -0.15487949427103911, "shareholdersEquityPerShare": 17.085341762149348, "operatingCashFlowPerShare": 1.699723429474516, "capexPerShare": 0.4460687475306203, "freeCashFlowPerShare": 1.2536546819438956, "netIncomePerEBT": 0.8789837307778026, "ebtPerEbit": 0.8855338464574699, "priceToFairValue": 5.336153134611382, "debtToMarketCap": 0.13721701293344996, "effectiveTaxRate": 0.11990193893470025, "enterpriseValueMultiple": 44.61416946160635, "dividendPerShare": 0.6993283287238246}}
{"date": "2022-03-31", "symbol": "MRK", "type": "ratios_quarter", "result": {"symbol": "MRK", "date": "2022-03-31", "fiscalYear": "2022", "period": "Q1", "reportedCurrency": "USD", "grossProfitMargin": 0.6616564995912206, "ebitMargin": 0.3209861015030501, "ebitdaMargin": 0.3914219231494874, "operatingProfitMargin": 0.3535626690145274, "pretaxProfitMargin": 0.30570404377083205, "continuousOperationsProfitMargin": 0.27086346770643355, "netProfitMargin": 0.27105213508584364, "bottomLineProfitMargin": 0.27105213508584364, "receivablesTurnover": 1.617928367928368, "payablesTurnover": 1.4481830417227457, "inventoryTurnover": 0.9317630758572913, "fixedAssetTurnover": 0.8052362384159619, "assetTurnover": 0.1490700116248547, "currentRatio": 1.397383043556193, "quickRatio": 1.1386449184441656, "solvencyRatio": 0.08262953663547136, "cashRatio": 0.3834020433769493, "priceToEarningsRatio": 12.031461716937354, "priceToEarningsGrowthRatio": 0.8536608551541272, "forwardPriceToEarningsGrowthRatio": 0.8536608551541272, "priceToBookRatio": 5.073561137881271, "priceToSalesRatio": 13.04461354631784, "priceToFreeCashFlowRatio": 54.91723590150914, "priceToOperatingCashFlowRatio": 43.56698172652804, "debtToAssetsRatio": 0.29806502418719766, "debtToEquityRatio": 0.7776826553824328, "debtToCapitalRatio": 0.43746990106911404, "longTermDebtToCapitalRatio": 0.427961773636122, "financialLeverageRatio": 2.609104028569332, "workingCapitalTurnoverRatio": 2.0837373869741844, "operatingCashFlowRatio": 0.21334468542749596, "operatingCashFlowSalesRatio": 0.29941513112382867, "freeCashFlowOperatingCashFlowRatio": 0.7933207309388783, "debtServiceCoverageRatio": 3.9076498966230186, "interestCoverageRatio": 23.135802469135804, "shortTermOperatingCashFlowCoverageRatio": 3.941225165562914, "operatingCashFlowCoverageRatio": 0.14974523494999056, "capitalExpenditureCoverageRatio": 4.838414634146342, "dividendPaidAndCapexCoverageRatio": 1.7445950897764748, "dividendPayoutRatio": 0.4048723897911833, "dividendYield": 0.0084127847329893, "dividendYieldPercentage": 0.84127847329893, "revenuePerShare": 6.28995253164557, "netIncomePerShare": 1.7049050632911393, "interestDebtPerShare": 12.672863924050633, "cashPerShare": 3.5316455696202533, "bookValuePerShare": 16.199762658227847, "tangibleBookValuePerShare": -1.3160601265822784, "shareholdersEquityPerShare": 16.172072784810126, "operatingCashFlowPerShare": 1.8833069620253164, "capexPerShare": 0.38924050632911394, "freeCashFlowPerShare": 1.4940664556962024, "netIncomePerEBT": 0.8866488376877186, "ebtPerEbit": 0.8646389185343294, "priceToFairValue": 5.073561137881271, "debtToMarketCap": 0.15328141994307268, "effectiveTaxRate": 0.11396831927586916, "enterpriseValueMultiple": 37.05983290488432, "dividendPerShare": 0.6902689873417721}}
{"date": "2021-12-31", "symbol": "MRK", "type": "ratios_quarter", "result": {"symbol": "MRK", "date": "2021-12-31", "fiscalYear": "2021", "period": "Q4", "reportedCurrency": "USD", "grossProfitMargin": 0.7134827305672657, "ebitMargin": 0.3045632719473412, "ebitdaMargin": 0.3663190592411804, "operatingProfitMargin": 0.2772723910953332, "pretaxProfitMargin": 0.2891058353672066, "continuousOperationsProfitMargin": 0.28281931809777383, "netProfitMargin": 0.2779380223356261, "bottomLineProfitMargin": 0.2779380223356261, "receivablesTurnover": 1.4648970747562298, "payablesTurnover": 0.8405293990019527, "inventoryTurnover": 0.6507643205106669, "fixedAssetTurnover": 0.701333056693812, "assetTurnover": 0.12792589929418888, "currentRatio": 1.2678451742627346, "quickRatio": 1.0184735254691688, "solvencyRatio": 0.06810801192223853, "cashRatio": 0.339142091152815, "priceToEarningsRatio": 12.883799893560404, "priceToEarningsGrowthRatio": -0.7287399314795104, "forwardPriceToEarningsGrowthRatio": -0.7287399314795104, "priceToBookRatio": 5.07200083804735, "priceToSalesRatio": 14.323591450336513, "priceToFreeCashFlowRatio": 50.658979858749674, "priceToOperatingCashFlowRatio": 38.49518584774399, "debtToAssetsRatio": 0.32765341457414804, "debtToEquityRatio": 0.9069505552063691, "debtToCapitalRatio": 0.4756025544187324, "longTermDebtToCapitalRatio": 0.44559630629845803, "financialLeverageRatio": 2.768018018018018, "workingCapitalTurnoverRatio": 1.9704167881084231, "operatingCashFlowRatio": 0.2107489946380697, "operatingCashFlowSalesRatio": 0.3720878633237187, "freeCashFlowOperatingCashFlowRatio": 0.7598886901212483, "debtServiceCoverageRatio": 1.8573063716138878, "interestCoverageRatio": 17.9377990430622, "shortTermOperatingCashFlowCoverageRatio": 2.0858208955223883, "operatingCashFlowCoverageRatio": 0.14527446507464412, "capitalExpenditureCoverageRatio": 4.164735099337748, "dividendPaidAndCapexCoverageRatio": 1.7646439845668187, "dividendPayoutRatio": 0.4372006386375732, "dividendYield": 0.00848353440463041, "dividendYieldPercentage": 0.848353440463041, "revenuePerShare": 5.350613375544124, "netIncomePerShare": 1.4871388998812822, "interestDebtPerShare": 13.787099327265532, "cashPerShare": 3.2037989711119903, "bookValuePerShare": 15.139295607439651, "tangibleBookValuePerShare": -2.3506133755441234, "shareholdersEquityPerShare": 15.110407597942224, "operatingCashFlowPerShare": 1.9908982983775227, "capexPerShare": 0.4780371982588049, "freeCashFlowPerShare": 1.5128611001187178, "netIncomePerEBT": 0.961371194678946, "ebtPerEbit": 1.0426780474793278, "priceToFairValue": 5.07200083804735, "debtToMarketCap": 0.17092024093857322, "effectiveTaxRate": 0.02174469173701714, "enterpriseValueMultiple": 44.45876842317787, "dividendPerShare": 0.6501780767708746}}
{"date": "2021-09-30", "symbol": "MRK", "type": "ratios_quarter", "result": {"symbol": "MRK", "date": "2021-09-30", "fiscalYear": "2021", "period": "Q3", "reportedCurrency": "USD", "grossProfitMargin": 0.7377223658202828, "ebitMargin": 0.41523490953322184, "ebitdaMargin": 0.47293598905275963, "operatingProfitMargin": 0.3742587805990573, "pretaxProfitMargin": 0.4003344990117075, "continuousOperationsProfitMargin": 0.3474988596624601, "netProfitMargin": 0.34719476965181695, "bottomLineProfitMargin": 0.34719476965181695, "receivablesTurnover": 1.5347100688367752, "payablesTurnover": 1.0249554367201426, "inventoryTurnover": 0.43254764292878634, "fixedAssetTurnover": 0.7085375706975492, "assetTurnover": 0.1406935204398143, "currentRatio": 1.3089177343223197, "quickRatio": 0.9727747808496291, "solvencyRatio": 0.09241554024743627, "cashRatio": 0.42211732973701954, "priceToEarningsRatio": 10.40224983577841, "priceToEarningsGrowthRatio": 0.05287810333187358, "forwardPriceToEarningsGrowthRatio": 0.05287810333187358, "priceToBookRatio": 5.308942839582053, "priceToSalesRatio": 14.446426942374943, "priceToFreeCashFlowRatio": 52.4216, "priceToOperatingCashFlowRatio": 39.61398790910986, "debtToAssetsRatio": 0.2828095920593835, "debtToEquityRatio": 0.7386992233335196, "debtToCapitalRatio": 0.4248573953563108, "longTermDebtToCapitalRatio": 0.3902318529496942, "financialLeverageRatio": 2.612002011510309, "workingCapitalTurnoverRatio": 1.8672723401235005, "operatingCashFlowRatio": 0.20216621712744437, "operatingCashFlowSalesRatio": 0.3646799452637981, "freeCashFlowOperatingCashFlowRatio": 0.7556806337294142, "debtServiceCoverageRatio": 1.4815013404825736, "interestCoverageRatio": 25.117346938775512, "shortTermOperatingCashFlowCoverageRatio": 1.3573853989813243, "operatingCashFlowCoverageRatio": 0.18142279036345071, "capitalExpenditureCoverageRatio": 4.093003412969283, "dividendPaidAndCapexCoverageRatio": 1.7004608294930876, "dividendPayoutRatio": 0.3610685351434202, "dividendYield": 0.008677654854566398, "dividendYieldPercentage": 0.8677654854566399, "revenuePerShare": 5.199209486166008, "netIncomePerShare": 1.8051383399209486, "interestDebtPerShare": 10.528458498023715, "cashPerShare": 3.958893280632411, "bookValuePerShare": 14.17509881422925, "tangibleBookValuePerShare": 1.4296442687747035, "shareholdersEquityPerShare": 14.147826086956522, "operatingCashFlowPerShare": 1.8960474308300395, "capexPerShare": 0.4632411067193676, "freeCashFlowPerShare": 1.4328063241106719, "netIncomePerEBT": 0.8672616786935055, "ebtPerEbit": 1.0696729636400568, "priceToFairValue": 5.308942839582053, "debtToMarketCap": 0.13914243299550647, "effectiveTaxRate": 0.1319787314849981, "enterpriseValueMultiple": 33.186513422279376, "dividendPerShare": 0.6517786561264822}}
{"date": "2021-06-30", "symbol": "MRK", "type": "ratios_quarter", "result": {"symbol": "MRK", "date": "2021-06-30", "fiscalYear": "2021", "period": "Q2", "reportedCurrency": "USD", "grossProfitMargin": 0.7277670584108051, "ebitMargin": 0.1683038063497632, "ebitdaMargin": 0.23215225399052797, "operatingProfitMargin": 0.14874583406419925, "pretaxProfitMargin": 0.15058761620768285, "continuousOperationsProfitMargin": 0.10647254867567094, "netProfitMargin": 0.13550254341343623, "bottomLineProfitMargin": 0.13550254341343623, "receivablesTurnover": 1.4537804411577202, "payablesTurnover": 0.7965101360020529, "inventoryTurnover": 0.39236506130704085, "fixedAssetTurnover": 0.6312001771479185, "assetTurnover": 0.12572776993648554, "currentRatio": 1.308545603944125, "quickRatio": 0.9474116680361545, "solvencyRatio": 0.03966841186736475, "cashRatio": 0.3914452661371314, "priceToEarningsRatio": 31.875632686084142, "priceToEarningsGrowthRatio": -0.6178968797610157, "forwardPriceToEarningsGrowthRatio": -0.6178968797610157, "priceToBookRatio": 5.916724034360545, "priceToSalesRatio": 17.276917207507456, "priceToFreeCashFlowRatio": 126.60116323907455, "priceToOperatingCashFlowRatio": 79.11301606425702, "debtToAssetsRatio": 0.29244221947776994, "debtToEquityRatio": 0.7965699525440019, "debtToCapitalRatio": 0.44338376661372564, "longTermDebtToCapitalRatio": 0.4192265424669004, "financialLeverageRatio": 2.7238541478945155, "workingCapitalTurnoverRatio": 3.120843027234159, "operatingCashFlowRatio": 0.1136674883593536, "operatingCashFlowSalesRatio": 0.2183827398701982, "freeCashFlowOperatingCashFlowRatio": 0.6248995983935743, "debtServiceCoverageRatio": 0.7970260223048327, "interestCoverageRatio": 8.396039603960396, "shortTermOperatingCashFlowCoverageRatio": 1.0008038585209003, "operatingCashFlowCoverageRatio": 0.09388786244862561, "capitalExpenditureCoverageRatio": 2.6659528907922914, "dividendPaidAndCapexCoverageRatio": 0.9551208285385501, "dividendPayoutRatio": 1.0828478964401294, "dividendYield": 0.008492756105456578, "dividendYieldPercentage": 0.8492756105456578, "revenuePerShare": 4.501381760757995, "netIncomePerShare": 0.6099486774575602, "interestDebtPerShare": 10.5499407816818, "cashPerShare": 3.3853138570864587, "bookValuePerShare": 13.181208053691275, "tangibleBookValuePerShare": 0.35254638768258983, "shareholdersEquityPerShare": 13.144097907619424, "operatingCashFlowPerShare": 0.983024082116068, "capexPerShare": 0.3687327279905251, "freeCashFlowPerShare": 0.6142913541255428, "netIncomePerEBT": 0.8998252766453116, "ebtPerEbit": 1.0123820754716981, "priceToFairValue": 5.916724034360545, "debtToMarketCap": 0.13463023590724083, "effectiveTaxRate": 0.2929528246942341, "enterpriseValueMultiple": 81.20038156403476, "dividendPerShare": 0.6604816423213581}}
{"date": "2021-03-31", "symbol": "MRK", "type": "ratios_quarter", "result": {"symbol": "MRK", "date": "2021-03-31", "fiscalYear": "2021", "period": "Q1", "reportedCurrency": "USD", "grossProfitMargin": 0.6989743107179825, "ebitMargin": 0.29989649007245694, "ebitdaMargin": 0.3838336313164581, "operatingProfitMargin": 0.2662087136539004, "pretaxProfitMargin": 0.28107650324644773, "continuousOperationsProfitMargin": 0.25868071892349676, "netProfitMargin": 0.2991436905994166, "bottomLineProfitMargin": 0.2991436905994166, "receivablesTurnover": 1.290467516697025, "payablesTurnover": 0.7930094199305899, "inventoryTurnover": 0.37297423341494695, "fixedAssetTurnover": 0.5808690899152774, "assetTurnover": 0.11697689521943487, "currentRatio": 1.0207882857251243, "quickRatio": 0.6954212662645575, "solvencyRatio": 0.06380077733199599, "cashRatio": 0.2648230340275407, "priceToEarningsRatio": 14.633228880305914, "priceToEarningsGrowthRatio": -0.05811282282609525, "forwardPriceToEarningsGrowthRatio": -0.05811282282609525, "priceToBookRatio": 6.905776152977175, "priceToSalesRatio": 17.50975237056272, "priceToFreeCashFlowRatio": 283.2209108705784, "priceToOperatingCashFlowRatio": 103.8951080078001, "debtToAssetsRatio": 0.34401796426959613, "debtToEquityRatio": 1.1598812395620708, "debtToCapitalRatio": 0.5370115811539915, "longTermDebtToCapitalRatio": 0.4711170432017587, "financialLeverageRatio": 3.371571720170718, "workingCapitalTurnoverRatio": 21.57766497461929, "operatingCashFlowRatio": 0.06794127688630933, "operatingCashFlowSalesRatio": 0.16853298202691258, "freeCashFlowOperatingCashFlowRatio": 0.36683417085427134, "debtServiceCoverageRatio": 0.5155012749966448, "interestCoverageRatio": 14.145, "shortTermOperatingCashFlowCoverageRatio": 0.2470004137360364, "operatingCashFlowCoverageRatio": 0.05730649857613669, "capitalExpenditureCoverageRatio": 1.5793650793650793, "dividendPaidAndCapexCoverageRatio": 0.644476430370637, "dividendPayoutRatio": 0.5174583202264863, "dividendYield": 0.008840467207529741, "dividendYieldPercentage": 0.8840467207529742, "revenuePerShare": 4.198231844990826, "netIncomePerShare": 1.2558745681025534, "interestDebtPerShare": 12.425612705419821, "cashPerShare": 2.757867367072641, "bookValuePerShare": 10.68184726232304, "tangibleBookValuePerShare": -2.992133997737886, "shareholdersEquityPerShare": 10.644712248355868, "operatingCashFlowPerShare": 0.7075405320766509, "capexPerShare": 0.44799048764652266, "freeCashFlowPerShare": 0.2595500444301282, "netIncomePerEBT": 1.0642785403414798, "ebtPerEbit": 1.0558501237186284, "priceToFairValue": 6.905776152977175, "debtToMarketCap": 0.16795812865466686, "effectiveTaxRate": 0.0796786072982926, "enterpriseValueMultiple": 51.5685556366683, "dividendPerShare": 0.6498627444255113}}
{"date": "2024-12-31", "symbol": "MRK", "type": "ratios_annual", "result": {"symbol": "MRK", "date": "2024-12-31", "fiscalYear": "2024", "period": "FY", "reportedCurrency": "USD", "grossProfitMargin": 0.7632308939035033, "ebitMargin": 0.3304918339359182, "ebitdaMargin": 0.40060466276025436, "operatingProfitMargin": 0.3151259194614138, "pretaxProfitMargin": 0.3106844533100611, "continuousOperationsProfitMargin": 0.2670022441092133, "netProfitMargin": 0.2667528986410672, "bottomLineProfitMargin": 0.2667528986410672, "receivablesTurnover": 6.2432379840435885, "payablesTurnover": 3.7246874233880853, "inventoryTurnover": 2.486986413488296, "fixedAssetTurnover": 2.6985154968669836, "assetTurnover": 0.5479480129113794, "currentRatio": 1.3646023926812103, "quickRatio": 1.1496481351161154, "solvencyRatio": 0.3055956117284474, "cashRatio": 0.46593947923997187, "priceToEarningsRatio": 14.715391715838056, "priceToEarningsGrowthRatio": 0.003112016374950647, "forwardPriceToEarningsGrowthRatio": 0.003112016374950647, "priceToBookRatio": 5.438718286442252, "priceToSalesRatio": 3.925373394838549, "priceToFreeCashFlowRatio": 13.919283819628648, "priceToOperatingCashFlowRatio": 11.73296813862493, "debtToAssetsRatio": 0.3267979437432753, "debtToEquityRatio": 0.8263338587437653, "debtToCapitalRatio": 0.45245498504427606, "longTermDebtToCapitalRatio": 0.4266419065304859, "financialLeverageRatio": 2.5285772893140157, "workingCapitalTurnoverRatio": 7.622713233547161, "operatingCashFlowRatio": 0.7553835327234342, "operatingCashFlowSalesRatio": 0.33455928188505174, "freeCashFlowOperatingCashFlowRatio": 0.8429290106204583, "debtServiceCoverageRatio": 5.842602040816327, "interestCoverageRatio": 15.909520062942565, "shortTermOperatingCashFlowCoverageRatio": 8.10419026047565, "operatingCashFlowCoverageRatio": 0.5609615887117847, "capitalExpenditureCoverageRatio": 6.366548042704626, "dividendPaidAndCapexCoverageRatio": 1.9147342133428469, "dividendPayoutRatio": 0.4580241864812759, "dividendYield": 0.031125517779340407, "dividendYieldPercentage": 3.1125517779340406, "revenuePerShare": 25.342812006319114, "netIncomePerShare": 6.760268562401264, "interestDebtPerShare": 15.61650868878357, "cashPerShare": 5.406398104265403, "bookValuePerShare": 18.31437598736177, "tangibleBookValuePerShare": 3.2914691943127963, "shareholdersEquityPerShare": 18.291074249605057, "operatingCashFlowPerShare": 8.47867298578199, "capexPerShare": 1.3317535545023698, "freeCashFlowPerShare": 7.1469194312796205, "netIncomePerEBT": 0.8585975120385233, "ebtPerEbit": 0.9859057415558083, "priceToFairValue": 5.438718286442252, "debtToMarketCap": 0.14733406764146706, "effectiveTaxRate": 0.14059991974317818, "enterpriseValueMultiple": 10.772246168209756, "dividendPerShare": 3.0963665086887837}}
{"date": "2023-12-31", "symbol": "MRK", "type": "ratios_annual", "result": {"symbol": "MRK", "date": "2023-12-31", "fiscalYear": "2023", "period": "FY", "reportedCurrency": "USD", "grossProfitMargin": 0.731747483989021, "ebitMargin": 0.05048656741245945, "ebitdaMargin": 0.11489644847375863, "operatingProfitMargin": 0.04913914996257174, "pretaxProfitMargin": 0.03142310571404808, "continuousOperationsProfitMargin": 0.006271313316144057, "netProfitMargin": 0.006071695916160692, "bottomLineProfitMargin": 0.006071695916160692, "receivablesTurnover": 5.8087737945695235, "payablesTurnover": 4.1116777154513, "inventoryTurnover": 2.536332179930796, "fixedAssetTurnover": 2.6079128888117653, "assetTurnover": 0.5635340988985236, "currentRatio": 1.251965439402195, "quickRatio": 1.0045146726862302, "solvencyRatio": 0.0613702201622248, "cashRatio": 0.2662489297112166, "priceToEarningsRatio": 778.7143283835617, "priceToEarningsGrowthRatio": -7.982170128153503, "forwardPriceToEarningsGrowthRatio": -7.982170128153503, "priceToBookRatio": 7.563149726191426, "priceToSalesRatio": 4.728116607502288, "priceToFreeCashFlowRatio": 31.087250340150934, "priceToOperatingCashFlowRatio": 21.853815920344456, "debtToAssetsRatio": 0.339985938598547, "debtToEquityRatio": 0.9650621324605518, "debtToCapitalRatio": 0.49111023845955937, "longTermDebtToCapitalRatio": 0.47265098787606646, "financialLeverageRatio": 2.8385354301375694, "workingCapitalTurnoverRatio": 6.695439104527482, "operatingCashFlowRatio": 0.5061882151475052, "operatingCashFlowSalesRatio": 0.216351992015304, "freeCashFlowOperatingCashFlowRatio": 0.7029832385053052, "debtServiceCoverageRatio": 2.142573471008737, "interestCoverageRatio": 2.5776614310645725, "shortTermOperatingCashFlowCoverageRatio": 9.479591836734693, "operatingCashFlowCoverageRatio": 0.35860813940663944, "capitalExpenditureCoverageRatio": 3.3668133574941757, "dividendPaidAndCapexCoverageRatio": 1.1501591793420587, "dividendPayoutRatio": 20.397260273972602, "dividendYield": 0.02619350836437387, "dividendYieldPercentage": 2.6193508364373868, "revenuePerShare": 23.057806955736606, "netIncomePerShare": 0.13999999232876753, "interestDebtPerShare": 14.350574556132901, "cashPerShare": 2.7206025906519127, "bookValuePerShare": 14.435341674775799, "tangibleBookValuePerShare": -0.6033424326935654, "shareholdersEquityPerShare": 14.414629347143597, "operatingCashFlowPerShare": 4.988602466377947, "capexPerShare": 1.4816985489480248, "freeCashFlowPerShare": 3.506903917429922, "netIncomePerEBT": 0.19322392800423505, "ebtPerEbit": 0.6394719025050779, "priceToFairValue": 7.563149726191426, "debtToMarketCap": 0.12333289935703506, "effectiveTaxRate": 0.8004235044997353, "enterpriseValueMultiple": 45.41157229766903, "dividendPerShare": 2.855616281884039}}
{"date": "2022-12-31", "symbol": "MRK", "type": "ratios_annual", "result": {"symbol": "MRK", "date": "2022-12-31", "fiscalYear": "2022", "period": "FY", "reportedCurrency": "USD", "grossProfitMargin": 0.7063070357438052, "ebitMargin": 0.2936086230453924, "ebitdaMargin": 0.35954658165072617, "operatingProfitMargin": 0.3083852031779768, "pretaxProfitMargin": 0.2773813740870064, "continuousOperationsProfitMargin": 0.2450280856231972, "netProfitMargin": 0.24491000792807383, "bottomLineProfitMargin": 0.24491000792807383, "receivablesTurnover": 6.273333333333333, "payablesTurnover": 4.083255159474672, "inventoryTurnover": 2.945525291828794, "fixedAssetTurnover": 2.7673886658575295, "assetTurnover": 0.543083547086845, "currentRatio": 1.473740665869054, "quickRatio": 1.2298774701926647, "solvencyRatio": 0.29203511774587176, "cashRatio": 0.5237014728330377, "priceToEarningsRatio": 19.34881190164612, "priceToEarningsGrowthRatio": 1.751576656359544, "forwardPriceToEarningsGrowthRatio": 1.751576656359544, "priceToBookRatio": 6.1082690091539655, "priceToSalesRatio": 4.73871767623096, "priceToFreeCashFlowRatio": 19.101475487862924, "priceToOperatingCashFlowRatio": 14.71198743126473, "debtToAssetsRatio": 0.2930102601685599, "debtToEquityRatio": 0.6954621556391468, "debtToCapitalRatio": 0.41019031496870834, "longTermDebtToCapitalRatio": 0.3846205309355598, "financialLeverageRatio": 2.373507860233524, "workingCapitalTurnoverRatio": 6.632320859204564, "operatingCashFlowRatio": 0.7877800239283799, "operatingCashFlowSalesRatio": 0.3220990840544507, "freeCashFlowOperatingCashFlowRatio": 0.7702016234616391, "debtServiceCoverageRatio": 6.670220082530949, "interestCoverageRatio": 19.004158004158004, "shortTermOperatingCashFlowCoverageRatio": 9.812435765673175, "operatingCashFlowCoverageRatio": 0.5969985930905112, "capitalExpenditureCoverageRatio": 4.351640838650866, "dividendPaidAndCapexCoverageRatio": 1.675, "dividendPayoutRatio": 0.4829533714443143, "dividendYield": 0.024960363142670618, "dividendYieldPercentage": 2.4960363142670614, "revenuePerShare": 23.41350710900474, "netIncomePerShare": 5.734202211690364, "interestDebtPerShare": 13.012243285939968, "cashPerShare": 5.210110584518167, "bookValuePerShare": 18.190363349131122, "tangibleBookValuePerShare": 1.8108214849921012, "shareholdersEquityPerShare": 18.16390205371248, "operatingCashFlowPerShare": 7.541469194312796, "capexPerShare": 1.7330173775671407, "freeCashFlowPerShare": 5.808451816745656, "netIncomePerEBT": 0.882936025297981, "ebtPerEbit": 0.8994639536155782, "priceToFairValue": 6.1082690091539655, "debtToMarketCap": 0.10924964421159497, "effectiveTaxRate": 0.11663828752128436, "enterpriseValueMultiple": 14.084747830166549, "dividendPerShare": 2.769352290679305}}
{"date": "2021-12-31", "symbol": "MRK", "type": "ratios_annual", "result": {"symbol": "MRK", "date": "2021-12-31", "fiscalYear": "2021", "period": "FY", "reportedCurrency": "USD", "grossProfitMargin": 0.7202283180026281, "ebitMargin": 0.30151527595269384, "ebitdaMargin": 0.36750574901445465, "operatingProfitMargin": 0.2710044349540079, "pretaxProfitMargin": 0.28496632720105125, "continuousOperationsProfitMargin": 0.2537368593955322, "netProfitMargin": 0.26792460578186594, "bottomLineProfitMargin": 0.26792460578186594, "receivablesTurnover": 5.27670639219935, "payablesTurnover": 2.956389672380126, "inventoryTurnover": 2.2889299512850663, "fixedAssetTurnover": 2.5262721095492506, "assetTurnover": 0.4608019376691203, "currentRatio": 1.2678451742627346, "quickRatio": 1.0184735254691688, "solvencyRatio": 0.24115841452021888, "cashRatio": 0.339142091152815, "priceToEarningsRatio": 14.859314890029887, "priceToEarningsGrowthRatio": 0.17492611199655433, "forwardPriceToEarningsGrowthRatio": 0.17492611199655433, "priceToBookRatio": 5.078022208254766, "priceToSalesRatio": 3.9811760840998685, "priceToFreeCashFlowRatio": 20.070303281233826, "priceToOperatingCashFlowRatio": 13.742944220001418, "debtToAssetsRatio": 0.32765341457414804, "debtToEquityRatio": 0.9069505552063691, "debtToCapitalRatio": 0.4756025544187324, "longTermDebtToCapitalRatio": 0.44559630629845803, "financialLeverageRatio": 2.768018018018018, "workingCapitalTurnoverRatio": 14.259698433611478, "operatingCashFlowRatio": 0.5910271447721179, "operatingCashFlowSalesRatio": 0.28968873193166883, "freeCashFlowOperatingCashFlowRatio": 0.6847402367283294, "debtServiceCoverageRatio": 5.089496581727781, "interestCoverageRatio": 16.37593052109181, "shortTermOperatingCashFlowCoverageRatio": 5.849502487562189, "operatingCashFlowCoverageRatio": 0.4074095463601975, "capitalExpenditureCoverageRatio": 3.1719874100719423, "dividendPaidAndCapexCoverageRatio": 1.2759088442756374, "dividendPayoutRatio": 0.5065522262242318, "dividendYield": 0.03408987762713822, "dividendYieldPercentage": 3.4089877627138225, "revenuePerShare": 19.250592885375493, "netIncomePerShare": 5.157707509881423, "interestDebtPerShare": 14.006719367588932, "cashPerShare": 3.2, "bookValuePerShare": 15.121343873517787, "tangibleBookValuePerShare": -2.347826086956522, "shareholdersEquityPerShare": 15.092490118577075, "operatingCashFlowPerShare": 5.576679841897233, "capexPerShare": 1.758102766798419, "freeCashFlowPerShare": 3.818577075098814, "netIncomePerEBT": 0.9401974205634411, "ebtPerEbit": 1.0515190544738238, "priceToFairValue": 5.078022208254766, "debtToMarketCap": 0.1707175687161164, "effectiveTaxRate": 0.1095900281000072, "enterpriseValueMultiple": 12.31544779037935, "dividendPerShare": 2.6126482213438735}}
{"date": "2025-09-30", "symbol": "MRK", "type": "key_metrics_quarter", "result": {"symbol": "MRK", "date": "2025-09-30", "fiscalYear": "2025", "period": "Q3", "reportedCurrency": "USD", "marketCap": 209657140000.00003, "enterpriseValue": 232862140000.00003, "evToSales": 13.47893841166937, "evToOperatingCashFlow": 29.77015341344925, "evToFreeCashFlow": 34.06907681053402, "evToEBITDA": 34.52366790214975, "netDebtToEBITDA": 3.440326167531505, "currentRatio": 1.6612058124912672, "incomeQuality": 1.3516502505616035, "grahamNumber": 32.887047609106745, "grahamNetNet": -11.544035228182546, "taxBurden": 0.8576723498888065, "interestBurden": 1, "workingCapital": 18929000000, "investedCapital": 81468000000, "returnOnAssets": 0.05201730013577549, "operatingReturnOnAssets": 0.06606743144935646, "returnOnTangibleAssets": 0.07784640641610485, "returnOnEquity": 0.1115718418514947, "returnOnInvestedCapital": 0.07718553101780358, "returnOnCapitalEmployed": 0.09149361264152085, "earningsYield": 0.027592668678014014, "freeCashFlowYield": 0.03260084536114534, "capexToOperatingCashFlow": 0.1261825620046024, "capexToDepreciation": 0.8552859618717504, "capexToRevenue": 0.05713128038897893, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.2313614262560778, "stockBasedCompensationToRevenue": 0.0118082889557768, "intangiblesToTotalAssets": 0.3317957433033908, "averageReceivables": 11983000000, "averagePayables": 4019500000, "averageInventory": 6522500000, "daysOfSalesOutstanding": 63.139615651771244, "daysOfPayablesOutstanding": 119.47183098591549, "daysOfInventoryOutstanding": 185.64660691421255, "operatingCycle": 248.7862225659838, "cashConversionCycle": 129.3143915800683, "freeCashFlowToEquity": -16370000000, "freeCashFlowToFirm": -3101000000, "tangibleAssetValue": 14950000000, "netCurrentAssetValue": -11806000000}}
{"date": "2025-06-30", "symbol": "MRK", "type": "key_metrics_quarter", "result": {"symbol": "MRK", "date": "2025-06-30", "fiscalYear": "2025", "period": "Q2", "reportedCurrency": "USD", "marketCap": 198148562400, "enterpriseValue": 225543562400, "evToSales": 14.269490218904213, "evToOperatingCashFlow": 68.49181973883996, "evToFreeCashFlow": 89.18290328192961, "evToEBITDA": 35.11498713996575, "netDebtToEBITDA": 4.2651408998910165, "currentRatio": 1.423551100357184, "incomeQuality": 0.7435086927071574, "grahamNumber": 27.907947449803498, "grahamNetNet": -19.03848765949967, "taxBurden": 0.8855771154230846, "interestBurden": 0.9424962292609351, "workingCapital": 11028000000, "investedCapital": 73048000000, "returnOnAssets": 0.03766922219480442, "operatingReturnOnAssets": 0.04772937307915494, "returnOnTangibleAssets": 0.054830998649970895, "returnOnEquity": 0.09035984732512808, "returnOnInvestedCapital": 0.05292547101757847, "returnOnCapitalEmployed": 0.06068688105283868, "earningsYield": 0.022341822450688647, "freeCashFlowYield": 0.012763150887235506, "capexToOperatingCashFlow": 0.23200728818706348, "capexToDepreciation": 0.6827524575513851, "capexToRevenue": 0.04833607490826269, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.2561052764772871, "stockBasedCompensationToRevenue": 0.013665696570922434, "intangiblesToTotalAssets": 0.3129940522280745, "averageReceivables": 11318000000, "averagePayables": 3838000000, "averageInventory": 6398500000, "daysOfSalesOutstanding": 67.45160065797799, "daysOfPayablesOutstanding": 98.47624402586449, "daysOfInventoryOutstanding": 167.01996064098958, "operatingCycle": 234.47156129896757, "cashConversionCycle": 135.99531727310307, "freeCashFlowToEquity": -24866000000, "freeCashFlowToFirm": 4354162032.406482, "tangibleAssetValue": 12276000000, "netCurrentAssetValue": -31398000000}}
{"date": "2025-03-31", "symbol": "MRK", "type": "key_metrics_quarter", "result": {"symbol": "MRK", "date": "2025-03-31", "fiscalYear": "2025", "period": "Q1", "reportedCurrency": "USD", "marketCap": 225843520320, "enterpriseValue": 252058520320, "evToSales": 16.23147146113723, "evToOperatingCashFlow": 100.823408128, "evToFreeCashFlow": 215.06699686006826, "evToEBITDA": 34.45776080929597, "netDebtToEBITDA": 3.583732057416268, "currentRatio": 1.4103042821959164, "incomeQuality": 0.4916420845624385, "grahamNumber": 29.538363873385897, "grahamNetNet": -18.40301707178065, "taxBurden": 0.8604099610367609, "interestBurden": 0.9496460746460746, "workingCapital": 10329000000, "investedCapital": 72564000000, "returnOnAssets": 0.04411841350914682, "operatingReturnOnAssets": 0.051130785262759014, "returnOnTangibleAssets": 0.06538362512873326, "returnOnEquity": 0.1050791352022344, "returnOnInvestedCapital": 0.056011395467803655, "returnOnCapitalEmployed": 0.06600480277493663, "earningsYield": 0.022489022455917766, "freeCashFlowYield": 0.005189433809477381, "capexToOperatingCashFlow": 0.5312, "capexToDepreciation": 1.2083712465878071, "capexToRevenue": 0.08551741902247408, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.23317663725932128, "stockBasedCompensationToRevenue": 0.012557151136583167, "intangiblesToTotalAssets": 0.3252375740518754, "averageReceivables": 10534000000, "averagePayables": 3931500000, "averageInventory": 6152500000, "daysOfSalesOutstanding": 62.53461266018417, "daysOfPayablesOutstanding": 99.6080725358292, "daysOfInventoryOutstanding": 163.10032173150043, "operatingCycle": 225.6349343916846, "cashConversionCycle": 126.0268618558554, "freeCashFlowToEquity": -25043000000, "freeCashFlowToFirm": 5158626461.121464, "tangibleAssetValue": 10958000000, "netCurrentAssetValue": -31219000000}}
{"date": "2024-12-31", "symbol": "MRK", "type": "key_metrics_quarter", "result": {"symbol": "MRK", "date": "2024-12-31", "fiscalYear": "2024", "period": "Q4", "reportedCurrency": "USD", "marketCap": 252778680000, "enterpriseValue": 277806680000, "evToSales": 17.780765488991296, "evToOperatingCashFlow": 80.52367536231884, "evToFreeCashFlow": 110.54782331874254, "evToEBITDA": 48.780804214223004, "netDebtToEBITDA": 4.3947322212467075, "currentRatio": 1.3646023926812103, "incomeQuality": 0.9214743589743589, "grahamNumber": 24.578080627660942, "grahamNetNet": -18.21408894136167, "taxBurden": 0.8976019184652279, "interestBurden": 0.9270787016451756, "workingCapital": 10362000000, "investedCapital": 72179000000, "returnOnAssets": 0.03196249551688214, "operatingReturnOnAssets": 0.03706134556209992, "returnOnTangibleAssets": 0.04733899934233824, "returnOnEquity": 0.08081964027378921, "returnOnInvestedCapital": 0.04261016871692076, "returnOnCapitalEmployed": 0.0490269039081704, "earningsYield": 0.014807419676374604, "freeCashFlowYield": 0.00994150297802014, "capexToOperatingCashFlow": 0.27159420289855074, "capexToDepreciation": 0.7827903091060986, "capexToRevenue": 0.05997183819764465, "salesGeneralAndAdministrativeToRevenue": 0.018625192012288787, "researchAndDevelopementToRevenue": 0.29339477726574503, "stockBasedCompensationToRevenue": 0.011968766001024065, "intangiblesToTotalAssets": 0.32481683261318806, "averageReceivables": 10829500000, "averagePayables": 3832500000, "averageInventory": 6176500000, "daysOfSalesOutstanding": 59.205069124423964, "daysOfPayablesOutstanding": 95.90125391849529, "daysOfInventoryOutstanding": 143.628526645768, "operatingCycle": 202.83359577019198, "cashConversionCycle": 106.93234185169669, "freeCashFlowToEquity": -22515000000, "freeCashFlowToFirm": 4711492086.330935, "tangibleAssetValue": 8334000000, "netCurrentAssetValue": -31952000000}}
{"date": "2024-09-30", "symbol": "MRK", "type": "key_metrics_quarter", "result": {"symbol": "MRK", "date": "2024-09-30", "fiscalYear": "2024", "period": "Q3", "reportedCurrency": "USD", "marketCap": 288555960000, "enterpriseValue": 312093960000, "evToSales": 18.736504772768207, "evToOperatingCashFlow": 33.59099773974814, "evToFreeCashFlow": 36.68241184767278, "evToEBITDA": 55.6714163396361, "netDebtToEBITDA": 4.1987156617909385, "currentRatio": 1.3641925234908403, "incomeQuality": 2.939259727934198, "grahamNumber": 22.126547258719743, "grahamNetNet": -18.386953955135773, "taxBurden": 0.7718826405867971, "interestBurden": 0.9253393665158371, "workingCapital": 10775000000, "investedCapital": 72928000000, "returnOnAssets": 0.026860769832896574, "operatingReturnOnAssets": 0.03461909437700402, "returnOnTangibleAssets": 0.04005074532191564, "returnOnEquity": 0.07094063188171318, "returnOnInvestedCapital": 0.03380072202224202, "returnOnCapitalEmployed": 0.0453005253223569, "earningsYield": 0.010940685473971843, "freeCashFlowYield": 0.02948474881613951, "capexToOperatingCashFlow": 0.08427510494026477, "capexToDepreciation": 0.6602023608768971, "capexToRevenue": 0.04700726421324368, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.35192411598727263, "stockBasedCompensationToRevenue": 0.011706789938164135, "intangiblesToTotalAssets": 0.329331586291393, "averageReceivables": 11511500000, "averagePayables": 3552500000, "averageInventory": 6356500000, "daysOfSalesOutstanding": 61.49306597826739, "daysOfPayablesOutstanding": 79.10294117647058, "daysOfInventoryOutstanding": 137.73529411764704, "operatingCycle": 199.22836009591444, "cashConversionCycle": 120.12541891944386, "freeCashFlowToEquity": -15030000000, "freeCashFlowToFirm": 5189044009.779951, "tangibleAssetValue": 5853000000, "netCurrentAssetValue": -32611000000}}
{"date": "2024-06-30", "symbol": "MRK", "type": "key_metrics_quarter", "result": {"symbol": "MRK", "date": "2024-06-30", "fiscalYear": "2024", "period": "Q2", "reportedCurrency": "USD", "marketCap": 324098600000, "enterpriseValue": 350582600000, "evToSales": 21.75909880834161, "evToOperatingCashFlow": 62.19311690615576, "evToFreeCashFlow": 72.3447379281882, "evToEBITDA": 47.07070354457573, "netDebtToEBITDA": 3.555853920515575, "currentRatio": 1.466039907904835, "incomeQuality": 1.0322285295733382, "grahamNumber": 28.862610203166867, "grahamNetNet": -18.019731649565905, "taxBurden": 0.9082584082584083, "interestBurden": 0.9509183027232425, "workingCapital": 12145000000, "investedCapital": 73511000000, "returnOnAssets": 0.04843292195684986, "operatingReturnOnAssets": 0.056096924647220096, "returnOnTangibleAssets": 0.07323622205813252, "returnOnEquity": 0.12516635308154742, "returnOnInvestedCapital": 0.06215826913944963, "returnOnCapitalEmployed": 0.07078664664433407, "earningsYield": 0.016831297635966337, "freeCashFlowYield": 0.014952239843060105, "capexToOperatingCashFlow": 0.14032286677310626, "capexToDepreciation": 0.6987632508833922, "capexToRevenue": 0.049093843098311815, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.21722939424031779, "stockBasedCompensationToRevenue": 0.01259930486593843, "intangiblesToTotalAssets": 0.3386753085323626, "averageReceivables": 11504000000, "averagePayables": 3516500000, "averageInventory": 6489500000, "daysOfSalesOutstanding": 65.03103277060576, "daysOfPayablesOutstanding": 84.56875834445928, "daysOfInventoryOutstanding": 155.46328437917222, "operatingCycle": 220.494317149778, "cashConversionCycle": 135.9255588053187, "freeCashFlowToEquity": -21638000000, "freeCashFlowToFirm": 284869796.86979675, "tangibleAssetValue": 5503000000, "netCurrentAssetValue": -30777000000}}
{"date": "2024-03-31", "symbol": "MRK", "type": "key_metrics_quarter", "result": {"symbol": "MRK", "date": "2024-03-31", "fiscalYear": "2024", "period": "Q1", "reportedCurrency": "USD", "marketCap": 331797670000, "enterpriseValue": 360437670000, "evToSales": 22.848663708399368, "evToOperatingCashFlow": 116.64649514563106, "evToFreeCashFlow": 161.7037550471063, "evToEBITDA": 51.809353169469595, "netDebtToEBITDA": 4.11671697570792, "currentRatio": 1.2528387585162755, "incomeQuality": 0.6482064191315292, "grahamNumber": 25.962580943851066, "grahamNetNet": -18.96032372680616, "taxBurden": 0.8398589065255732, "interestBurden": 0.9492717227523857, "workingCapital": 6346000000, "investedCapital": 68144000000, "returnOnAssets": 0.04498861585843985, "operatingReturnOnAssets": 0.054205642656829346, "returnOnTangibleAssets": 0.07097293430308811, "returnOnEquity": 0.11797641462689526, "returnOnInvestedCapital": 0.05776977187143363, "returnOnCapitalEmployed": 0.0713312693498452, "earningsYield": 0.014352120073658142, "freeCashFlowYield": 0.006717949526288114, "capexToOperatingCashFlow": 0.27864077669902915, "capexToDepreciation": 0.875, "capexToRevenue": 0.05458003169572108, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.2530586370839937, "stockBasedCompensationToRevenue": 0.01115689381933439, "intangiblesToTotalAssets": 0.36611588205840395, "averageReceivables": 10857500000, "averagePayables": 3718000000, "averageInventory": 6434000000, "daysOfSalesOutstanding": 64.84564183835182, "daysOfPayablesOutstanding": 89.33898305084745, "daysOfInventoryOutstanding": 165.50847457627117, "operatingCycle": 230.35411641462298, "cashConversionCycle": 141.01513336377553, "freeCashFlowToEquity": -26411000000, "freeCashFlowToFirm": 5272744444.444445, "tangibleAssetValue": 1671000000, "netCurrentAssetValue": -33980000000}}
{"date": "2023-12-31", "symbol": "MRK", "type": "key_metrics_quarter", "result": {"symbol": "MRK", "date": "2023-12-31", "fiscalYear": "2023", "period": "Q4", "reportedCurrency": "USD", "marketCap": 278455250036.33997, "enterpriseValue": 307882250036.33997, "evToSales": 21.044583051014353, "evToOperatingCashFlow": 1251.5538619363413, "evToFreeCashFlow": -414.3771871283176, "evToEBITDA": -398.8112047102849, "netDebtToEBITDA": -38.11787564766839, "currentRatio": 1.251965439402195, "incomeQuality": -0.200652528548124, "grahamNumber": null, "grahamNetNet": -19.96982055204309, "taxBurden": 0.5992179863147605, "interestBurden": 1.1785714285714286, "workingCapital": 6474000000, "investedCapital": 68733000000, "returnOnAssets": -0.011492852120928052, "operatingReturnOnAssets": -0.016054207551944217, "returnOnTangibleAssets": -0.018171846977040627, "returnOnEquity": -0.03262286793858599, "returnOnInvestedCapital": -0.012421167145346993, "returnOnCapitalEmployed": -0.021153109988762797, "earningsYield": -0.004402861859634537, "freeCashFlowYield": -0.0026682923015566573, "capexToOperatingCashFlow": 4.020325203252033, "capexToDepreciation": 1.0259336099585061, "capexToRevenue": 0.06760082023239918, "salesGeneralAndAdministrativeToRevenue": 0.02330827067669173, "researchAndDevelopementToRevenue": 0.6580314422419685, "stockBasedCompensationToRevenue": 0.011414900888585098, "intangiblesToTotalAssets": 0.3675462854464495, "averageReceivables": 10371500000, "averagePayables": 3715500000, "averageInventory": 6244500000, "daysOfSalesOutstanding": 63.664388243335615, "daysOfPayablesOutstanding": 90.23006134969326, "daysOfInventoryOutstanding": 146.27300613496934, "operatingCycle": 209.93739437830496, "cashConversionCycle": 119.7073330286117, "freeCashFlowToEquity": -30170000000, "freeCashFlowToFirm": 1320757575.757576, "tangibleAssetValue": -1573000000, "netCurrentAssetValue": -36872000000}}
{"date": "2023-09-30", "symbol": "MRK", "type": "key_metrics_quarter", "result": {"symbol": "MRK", "date": "2023-09-30", "fiscalYear": "2023", "period": "Q3", "reportedCurrency": "USD", "marketCap": 261184150000, "enterpriseValue": 287438150000, "evToSales": 18.00765254980579, "evToOperatingCashFlow": 37.24739536089154, "evToFreeCashFlow": 42.17727806309611, "evToEBITDA": 41.352057257948495, "netDebtToEBITDA": 3.7770105020860307, "currentRatio": 1.383649432753096, "incomeQuality": 1.6263435194942044, "grahamNumber": 26.156511342004965, "grahamNetNet": -18.050059124950728, "taxBurden": 0.844306049822064, "interestBurden": 0.9466060299814721, "workingCapital": 8860000000, "investedCapital": 71768000000, "returnOnAssets": 0.0444592277493043, "operatingReturnOnAssets": 0.05560711377109415, "returnOnTangibleAssets": 0.07152008440726505, "returnOnEquity": 0.1150414585656791, "returnOnInvestedCapital": 0.058719703310972746, "returnOnCapitalEmployed": 0.07021151937632274, "earningsYield": 0.01816725861810527, "freeCashFlowYield": 0.026092701260777118, "capexToOperatingCashFlow": 0.11688479979266554, "capexToDepreciation": 0.8895463510848126, "capexToRevenue": 0.05650920937225912, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.2071795514346573, "stockBasedCompensationToRevenue": 0.010274401704047111, "intangiblesToTotalAssets": 0.37836723603211936, "averageReceivables": 10712000000, "averagePayables": 3475500000, "averageInventory": 6030500000, "daysOfSalesOutstanding": 58.60543791504824, "daysOfPayablesOutstanding": 74.06425891181989, "daysOfInventoryOutstanding": 129.406660412758, "operatingCycle": 188.01209832780623, "cashConversionCycle": 113.94783941598634, "freeCashFlowToEquity": -19439000000, "freeCashFlowToFirm": 2852927046.263345, "tangibleAssetValue": 918000000, "netCurrentAssetValue": -33473000000}}
{"date": "2023-06-30", "symbol": "MRK", "type": "key_metrics_quarter", "result": {"symbol": "MRK", "date": "2023-06-30", "fiscalYear": "2023", "period": "Q2", "reportedCurrency": "USD", "marketCap": 292975210000, "enterpriseValue": 324226210000, "evToSales": 21.564762886597936, "evToOperatingCashFlow": 87.53407397408208, "evToFreeCashFlow": 118.37393574297188, "evToEBITDA": -78.03278219013237, "netDebtToEBITDA": -7.52129963898917, "currentRatio": 1.2813969393861675, "incomeQuality": -0.6199163179916318, "grahamNumber": null, "grahamNetNet": -18.948995667585663, "taxBurden": 1.119962511715089, "interestBurden": 1.0547647291419533, "workingCapital": 6583000000, "investedCapital": 69674000000, "returnOnAssets": -0.05719400013401105, "operatingReturnOnAssets": -0.04722398888182225, "returnOnTangibleAssets": -0.0939332484396862, "returnOnEquity": -0.15442069624996768, "returnOnInvestedCapital": -0.06685932906852754, "returnOnCapitalEmployed": -0.061819303114400245, "earningsYield": -0.020394216971463215, "freeCashFlowYield": 0.009348913855202971, "capexToOperatingCashFlow": 0.2605291576673866, "capexToDepreciation": 1.0686600221483942, "capexToRevenue": 0.06418357166611241, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.8859993348852677, "stockBasedCompensationToRevenue": 0.011240438975723313, "intangiblesToTotalAssets": 0.3911208109582747, "averageReceivables": 10722500000, "averagePayables": 3561000000, "averageInventory": 5896500000, "daysOfSalesOutstanding": 66.02593947455937, "daysOfPayablesOutstanding": 76.9831013916501, "daysOfInventoryOutstanding": 132.6292246520875, "operatingCycle": 198.65516412664687, "cashConversionCycle": 121.67206273499677, "freeCashFlowToEquity": -28512000000, "freeCashFlowToFirm": -2035926148.0787258, "tangibleAssetValue": -2118000000, "netCurrentAssetValue": -35750000000}}
{"date": "2023-03-31", "symbol": "MRK", "type": "key_metrics_quarter", "result": {"symbol": "MRK", "date": "2023-03-31", "fiscalYear": "2023", "period": "Q1", "reportedCurrency": "USD", "marketCap": 270017820000, "enterpriseValue": 291056820000, "evToSales": 20.09089666597639, "evToOperatingCashFlow": 217.36879761015683, "evToFreeCashFlow": 876.6771686746988, "evToEBITDA": 59.60614785992218, "netDebtToEBITDA": 4.308621748924841, "currentRatio": 1.4440361419739742, "incomeQuality": 0.47465437788018433, "grahamNumber": 21.482351095804493, "grahamNetNet": -15.666371158392435, "taxBurden": 0.7728767123287671, "interestBurden": 0.9378211716341213, "workingCapital": 10271000000, "investedCapital": 73095000000, "returnOnAssets": 0.02616980221900627, "operatingReturnOnAssets": 0.03508545511532292, "returnOnTangibleAssets": 0.04227483890304211, "returnOnEquity": 0.060234018021095785, "returnOnInvestedCapital": 0.03372842811211053, "returnOnCapitalEmployed": 0.04495364081970118, "earningsYield": 0.0104474586158795, "freeCashFlowYield": 0.0012295484794299873, "capexToOperatingCashFlow": 0.7520537714712472, "capexToDepreciation": 1.0161453077699294, "capexToRevenue": 0.06951059570649548, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.29516117898805827, "stockBasedCompensationToRevenue": 0.010008973562504315, "intangiblesToTotalAssets": 0.3809603324798694, "averageReceivables": 9932500000, "averagePayables": 3972000000, "averageInventory": 5887000000, "daysOfSalesOutstanding": 64.70283702629945, "daysOfPayablesOutstanding": 84.36067244014264, "daysOfInventoryOutstanding": 134.40397350993376, "operatingCycle": 199.1068105362332, "cashConversionCycle": 114.74613809609058, "freeCashFlowToEquity": -20707000000, "freeCashFlowToFirm": 4208301369.863014, "tangibleAssetValue": 5839000000, "netCurrentAssetValue": -27489000000}}
{"date": "2022-12-31", "symbol": "MRK", "type": "key_metrics_quarter", "result": {"symbol": "MRK", "date": "2022-12-31", "fiscalYear": "2022", "period": "Q4", "reportedCurrency": "USD", "marketCap": 281369200000, "enterpriseValue": 300660200000, "evToSales": 21.739710773680404, "evToOperatingCashFlow": 67.86911963882619, "evToFreeCashFlow": 91.63675708625419, "evToEBITDA": 64.79745689655172, "netDebtToEBITDA": 4.157543103448276, "currentRatio": 1.473740665869054, "incomeQuality": 1.4678595096090126, "grahamNumber": 22.03261731706012, "grahamNetNet": -15.720425867507887, "taxBurden": 0.8588101337887846, "interestBurden": 0.937299893276414, "workingCapital": 11483000000, "investedCapital": 74378000000, "returnOnAssets": 0.0276383290582631, "operatingReturnOnAssets": 0.03225105322302431, "returnOnTangibleAssets": 0.04457281309557227, "returnOnEquity": 0.06559979126350808, "returnOnInvestedCapital": 0.034374438144762876, "returnOnCapitalEmployed": 0.0410616926319756, "earningsYield": 0.01072256664908597, "freeCashFlowYield": 0.011660835656496874, "capexToOperatingCashFlow": 0.25936794582392775, "capexToDepreciation": 1.2881165919282511, "capexToRevenue": 0.08308026030368763, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.27295733911785974, "stockBasedCompensationToRevenue": 0.010484454085321764, "intangiblesToTotalAssets": 0.37992854525467207, "averageReceivables": 9466000000, "averagePayables": 3817500000, "averageInventory": 5762500000, "daysOfSalesOutstanding": 61.49674620390456, "daysOfPayablesOutstanding": 98.88173151249677, "daysOfInventoryOutstanding": 137.07549600618395, "operatingCycle": 198.57224221008852, "cashConversionCycle": 99.69051069759175, "freeCashFlowToEquity": -16010000000, "freeCashFlowToFirm": 2042887275.8326216, "tangibleAssetValue": 4585000000, "netCurrentAssetValue": -27380000000}}
{"date": "2022-09-30", "symbol": "MRK", "type": "key_metrics_quarter", "result": {"symbol": "MRK", "date": "2022-09-30", "fiscalYear": "2022", "period": "Q3", "reportedCurrency": "USD", "marketCap": 218141960000, "enterpriseValue": 237414960000, "evToSales": 15.871044855939568, "evToOperatingCashFlow": 42.380392716886824, "evToFreeCashFlow": 53.04176943699732, "evToEBITDA": 49.6061345591308, "netDebtToEBITDA": 4.026953614709569, "currentRatio": 1.4593008087659796, "incomeQuality": 1.7226322263222633, "grahamNumber": 22.502928501649315, "grahamNetNet": -16.34050532964864, "taxBurden": 0.9065029305051633, "interestBurden": 0.9362424875881892, "workingCapital": 10563000000, "investedCapital": 73515000000, "returnOnAssets": 0.030332178444355207, "operatingReturnOnAssets": 0.038342297923203345, "returnOnTangibleAssets": 0.050315244837575324, "returnOnEquity": 0.07305771739619416, "returnOnInvestedCapital": 0.043337296039104384, "returnOnCapitalEmployed": 0.0488327010216096, "earningsYield": 0.01488938670946204, "freeCashFlowYield": 0.020518748433359633, "capexToOperatingCashFlow": 0.20099964298464834, "capexToDepreciation": 1.1741397288842543, "capexToRevenue": 0.075272411257437, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.2940704592552978, "stockBasedCompensationToRevenue": 0.009292064977605454, "intangiblesToTotalAssets": 0.39715729214333073, "averageReceivables": 9562500000, "averagePayables": 3426500000, "averageInventory": 5574500000, "daysOfSalesOutstanding": 57.047931011431245, "daysOfPayablesOutstanding": 77.11997966446364, "daysOfInventoryOutstanding": 128.4341637010676, "operatingCycle": 185.48209471249885, "cashConversionCycle": 108.36211504803521, "freeCashFlowToEquity": -14797000000, "freeCashFlowToFirm": 1692527211.8336592, "tangibleAssetValue": 1996000000, "netCurrentAssetValue": -28996000000}}
{"date": "2022-06-30", "symbol": "MRK", "type": "key_metrics_quarter", "result": {"symbol": "MRK", "date": "2022-06-30", "fiscalYear": "2022", "period": "Q2", "reportedCurrency": "USD", "marketCap": 230751270000, "enterpriseValue": 252739270000, "evToSales": 17.319212636195438, "evToOperatingCashFlow": 58.74924918642492, "evToFreeCashFlow": 79.65309486290576, "evToEBITDA": 44.61416946160635, "netDebtToEBITDA": 3.881376875551633, "currentRatio": 1.3862223756906078, "incomeQuality": 1.0893897189161814, "grahamNumber": 24.475156353645918, "grahamNetNet": -17.24585144211774, "taxBurden": 0.8789837307778026, "interestBurden": 0.9492278400676962, "workingCapital": 8948000000, "investedCapital": 72717000000, "returnOnAssets": 0.036827116111863296, "operatingReturnOnAssets": 0.04740764304393183, "returnOnTangibleAssets": 0.06222292340459099, "returnOnEquity": 0.0912055130310108, "returnOnInvestedCapital": 0.05131356724987772, "returnOnCapitalEmployed": 0.06037389636231487, "earningsYield": 0.017091996936788256, "freeCashFlowYield": 0.013750736886518544, "capexToOperatingCashFlow": 0.2624360762436076, "capexToDepreciation": 1.2036247334754797, "capexToRevenue": 0.07736586034400054, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.19173576372233261, "stockBasedCompensationToRevenue": 0.009388062769821147, "intangiblesToTotalAssets": 0.40814230356225784, "averageReceivables": 9735500000, "averagePayables": 3598500000, "averageInventory": 5654500000, "daysOfSalesOutstanding": 59.47166449667649, "daysOfPayablesOutstanding": 74.33111954459203, "daysOfInventoryOutstanding": 118.15702087286526, "operatingCycle": 177.62868536954176, "cashConversionCycle": 103.29756582494973, "freeCashFlowToEquity": -18815000000, "freeCashFlowToFirm": 3889223534.655672, "tangibleAssetValue": -392000000, "netCurrentAssetValue": -31661000000}}
{"date": "2022-03-31", "symbol": "MRK", "type": "key_metrics_quarter", "result": {"symbol": "MRK", "date": "2022-03-31", "fiscalYear": "2022", "period": "Q1", "reportedCurrency": "USD", "marketCap": 207422400000, "enterpriseValue": 230660400000, "evToSales": 14.506031067228475, "evToOperatingCashFlow": 48.4478890989288, "evToFreeCashFlow": 61.06973788721207, "evToEBITDA": 37.05983290488432, "netDebtToEBITDA": 3.733611825192802, "currentRatio": 1.397383043556193, "incomeQuality": 1.1054097980032505, "grahamNumber": 24.907159561691323, "grahamNetNet": -18.405458860759495, "taxBurden": 0.8866488376877186, "interestBurden": 0.9523902821316614, "workingCapital": 8868000000, "investedCapital": 72895000000, "returnOnAssets": 0.040405744928188395, "operatingReturnOnAssets": 0.05294732579275011, "returnOnTangibleAssets": 0.06908379816631403, "returnOnEquity": 0.1054227918694812, "returnOnInvestedCapital": 0.0582196132425323, "returnOnCapitalEmployed": 0.06664927921092564, "earningsYield": 0.020778855128472145, "freeCashFlowYield": 0.01820921944785134, "capexToOperatingCashFlow": 0.2066792690611216, "capexToDepreciation": 0.8785714285714286, "capexToRevenue": 0.0618829004465128, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.16200238978680587, "stockBasedCompensationToRevenue": 0.007546695176404, "intangiblesToTotalAssets": 0.41511981100236245, "averageReceivables": 9529000000, "averagePayables": 4162000000, "averageInventory": 5863500000, "daysOfSalesOutstanding": 55.62669014527388, "daysOfPayablesOutstanding": 62.146840148698885, "daysOfInventoryOutstanding": 96.5910780669145, "operatingCycle": 152.2177682121884, "cashConversionCycle": 90.0709280634895, "freeCashFlowToEquity": -19461000000, "freeCashFlowToFirm": 2184305698.415964, "tangibleAssetValue": -3327000000, "netCurrentAssetValue": -34531000000}}
{"date": "2021-12-31", "symbol": "MRK", "type": "key_metrics_quarter", "result": {"symbol": "MRK", "date": "2021-12-31", "fiscalYear": "2021", "period": "Q4", "reportedCurrency": "USD", "marketCap": 193669280000, "enterpriseValue": 220204280000, "evToSales": 16.286094223800013, "evToOperatingCashFlow": 43.76948519181077, "evToFreeCashFlow": 57.59986398116662, "evToEBITDA": 44.45876842317787, "netDebtToEBITDA": 5.357359176256814, "currentRatio": 1.2678451742627346, "incomeQuality": 1.3156380753138075, "grahamNumber": 22.48563287899932, "grahamNetNet": -19.565492679066086, "taxBurden": 0.961371194678946, "interestBurden": 0.9492472073822243, "workingCapital": 6394000000, "investedCapital": 69870000000, "returnOnAssets": 0.03555547145533332, "operatingReturnOnAssets": 0.03764282988935076, "returnOnTangibleAssets": 0.06110867196773826, "returnOnEquity": 0.09841818562748796, "returnOnInvestedCapital": 0.04338261078660392, "returnOnCapitalEmployed": 0.04581897289237613, "earningsYield": 0.01940421320304387, "freeCashFlowYield": 0.019739836901340263, "capexToOperatingCashFlow": 0.24011130987875173, "capexToDepreciation": 1.4467065868263473, "capexToRevenue": 0.08934250425264403, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.2269062939131721, "stockBasedCompensationToRevenue": 0.008801124177205829, "intangiblesToTotalAssets": 0.41815997123772397, "averageReceivables": 8900500000, "averagePayables": 3987500000, "averageInventory": 6964500000, "daysOfSalesOutstanding": 61.43776347903261, "daysOfPayablesOutstanding": 107.07537429013938, "daysOfInventoryOutstanding": 138.29891584925142, "operatingCycle": 199.73667932828403, "cashConversionCycle": 92.66130503814465, "freeCashFlowToEquity": -22712000000, "freeCashFlowToFirm": 4591455359.426964, "tangibleAssetValue": -5940000000, "netCurrentAssetValue": -37171000000}}
{"date": "2021-09-30", "symbol": "MRK", "type": "key_metrics_quarter", "result": {"symbol": "MRK", "date": "2021-09-30", "fiscalYear": "2021", "period": "Q3", "reportedCurrency": "USD", "marketCap": 190028300000, "enterpriseValue": 206453300000, "evToSales": 15.695096548578379, "evToOperatingCashFlow": 43.038002918490726, "evToFreeCashFlow": 56.95263448275862, "evToEBITDA": 33.186513422279376, "netDebtToEBITDA": 2.6402507635428387, "currentRatio": 1.3089177343223197, "incomeQuality": 1.049442135200175, "grahamNumber": 23.97128749488077, "grahamNetNet": -14.703063241106719, "taxBurden": 0.8672616786935055, "interestBurden": 0.9641157085316734, "workingCapital": 7330000000, "investedCapital": 58141000000, "returnOnAssets": 0.04884805442060453, "operatingReturnOnAssets": 0.05345799263771704, "returnOnTangibleAssets": 0.0745657001044932, "returnOnEquity": 0.12759121640498408, "returnOnInvestedCapital": 0.05829834522372926, "returnOnCapitalEmployed": 0.07056445833213887, "earningsYield": 0.02403326241407201, "freeCashFlowYield": 0.01907610603262777, "capexToOperatingCashFlow": 0.24431936627058579, "capexToDepreciation": 1.5441370223978919, "capexToRevenue": 0.08909837311844306, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.18587501900562567, "stockBasedCompensationToRevenue": 0.008894632811312149, "intangiblesToTotalAssets": 0.3448991379125933, "averageReceivables": 8207000000, "averagePayables": 3631500000, "averageInventory": 7943500000, "daysOfSalesOutstanding": 58.64299832750494, "daysOfPayablesOutstanding": 87.80869565217391, "daysOfInventoryOutstanding": 208.0695652173913, "operatingCycle": 266.7125635448962, "cashConversionCycle": 178.9038678927223, "freeCashFlowToEquity": -12800000000, "freeCashFlowToFirm": 3757132168.6289406, "tangibleAssetValue": 3617000000, "netCurrentAssetValue": -26573000000}}
{"date": "2021-06-30", "symbol": "MRK", "type": "key_metrics_quarter", "result": {"symbol": "MRK", "date": "2021-06-30", "fiscalYear": "2021", "period": "Q2", "reportedCurrency": "USD", "marketCap": 196991410000, "enterpriseValue": 214937410000, "evToSales": 18.85085160498158, "evToOperatingCashFlow": 86.32024497991968, "evToFreeCashFlow": 138.13458226221078, "evToEBITDA": 81.20038156403476, "netDebtToEBITDA": 6.779750661125803, "currentRatio": 1.308545603944125, "incomeQuality": 3.2046332046332044, "grahamNumber": 13.430843813413805, "grahamNetNet": -15.352250296091592, "taxBurden": 0.8998252766453116, "interestBurden": 0.8947368421052632, "workingCapital": 6759000000, "investedCapital": 57318000000, "returnOnAssets": 0.017036432604093155, "operatingReturnOnAssets": 0.018685102046437325, "returnOnTangibleAssets": 0.0265495850016325, "returnOnEquity": 0.0464047576139845, "returnOnInvestedCapital": 0.016825480697608797, "returnOnCapitalEmployed": 0.02465761391061615, "earningsYield": 0.007842981579755178, "freeCashFlowYield": 0.007898821578057642, "capexToOperatingCashFlow": 0.3751004016064257, "capexToDepreciation": 1.3536231884057972, "capexToRevenue": 0.08191545342922295, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.37896860199964916, "stockBasedCompensationToRevenue": 0.011576916330468338, "intangiblesToTotalAssets": 0.35831642554693016, "averageReceivables": 8039000000, "averagePayables": 3965500000, "averageInventory": 8244000000, "daysOfSalesOutstanding": 61.90756007717944, "daysOfPayablesOutstanding": 112.99291237113403, "daysOfInventoryOutstanding": 229.37822164948454, "operatingCycle": 291.28578172666397, "cashConversionCycle": 178.29286935552994, "freeCashFlowToEquity": -16390000000, "freeCashFlowToFirm": -5060176470.588236, "tangibleAssetValue": 893000000, "netCurrentAssetValue": -28635000000}}
{"date": "2021-03-31", "symbol": "MRK", "type": "key_metrics_quarter", "result": {"symbol": "MRK", "date": "2021-03-31", "fiscalYear": "2021", "period": "Q1", "reportedCurrency": "USD", "marketCap": 186076138441.97, "enterpriseValue": 210348138441.97, "evToSales": 19.793745971767198, "evToOperatingCashFlow": 117.44731347960358, "evToFreeCashFlow": 320.1645942800152, "evToEBITDA": 51.5685556366683, "netDebtToEBITDA": 5.950478058347635, "currentRatio": 1.0207882857251243, "incomeQuality": 0.6515096398690433, "grahamNumber": 17.343284765098492, "grahamNetNet": -18.315561715952377, "taxBurden": 1.0642785403414798, "interestBurden": 0.9372450580483213, "workingCapital": 548000000, "investedCapital": 53456000000, "returnOnAssets": 0.034992900150802995, "operatingReturnOnAssets": 0.031013785731904515, "returnOnTangibleAssets": 0.056531635665255896, "returnOnEquity": 0.11798107255520504, "returnOnInvestedCapital": 0.03629353360125361, "returnOnCapitalEmployed": 0.043869987284061655, "earningsYield": 0.01708440440895869, "freeCashFlowYield": 0.00353081273881279, "capexToOperatingCashFlow": 0.6331658291457286, "capexToDepreciation": 1.2713004484304933, "capexToRevenue": 0.10670932530347228, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.2269690411216712, "stockBasedCompensationToRevenue": 0.010445092688435118, "intangiblesToTotalAssets": 0.38100322520281354, "averageReceivables": 7519000000, "averagePayables": 4180500000, "averageInventory": 7065500000, "daysOfSalesOutstanding": 69.74216618048368, "daysOfPayablesOutstanding": 113.4917161613004, "daysOfInventoryOutstanding": 241.30353235386056, "operatingCycle": 311.04569853434424, "cashConversionCycle": 197.55398237304382, "freeCashFlowToEquity": -23615000000, "freeCashFlowToFirm": 2580064278.5403414, "tangibleAssetValue": -7574000000, "netCurrentAssetValue": -36899000000}}
{"date": "2024-12-31", "symbol": "MRK", "type": "key_metrics_annual", "result": {"symbol": "MRK", "date": "2024-12-31", "fiscalYear": "2024", "period": "FY", "reportedCurrency": "USD", "marketCap": 251883360000, "enterpriseValue": 276911360000, "evToSales": 4.315412043386112, "evToOperatingCashFlow": 12.898796348052915, "evToFreeCashFlow": 15.30235190097259, "evToEBITDA": 10.772246168209756, "netDebtToEBITDA": 0.9736248346689489, "currentRatio": 1.3646023926812103, "incomeQuality": 1.2530204867798984, "grahamNumber": 52.746401962583455, "grahamNetNet": -18.278830963665087, "taxBurden": 0.8585975120385233, "interestBurden": 0.9400669590229641, "workingCapital": 10362000000, "investedCapital": 72179000000, "returnOnAssets": 0.1461667207487234, "operatingReturnOnAssets": 0.1807213302291079, "returnOnTangibleAssets": 0.2164845449486518, "returnOnEquity": 0.3695938505387256, "returnOnInvestedCapital": 0.18968017969234086, "returnOnCapitalEmployed": 0.2280066752362267, "earningsYield": 0.06795605712104205, "freeCashFlowYield": 0.07184277675190612, "capexToOperatingCashFlow": 0.15707098937954164, "capexToDepreciation": 0.749499888864192, "capexToRevenue": 0.05254955741179404, "salesGeneralAndAdministrativeToRevenue": 0.11999750654531854, "researchAndDevelopementToRevenue": 0.2795474379753148, "stockBasedCompensationToRevenue": 0.011859493828699663, "intangiblesToTotalAssets": 0.32481683261318806, "averageReceivables": 10313500000, "averagePayables": 4000500000, "averageInventory": 6233500000, "daysOfSalesOutstanding": 58.46325271163197, "daysOfPayablesOutstanding": 97.99480023695122, "daysOfInventoryOutstanding": 146.76397024945697, "operatingCycle": 205.22722296108896, "cashConversionCycle": 107.23242272413773, "freeCashFlowToEquity": -6932000000, "freeCashFlowToFirm": 15464297502.00642, "tangibleAssetValue": 8334000000, "netCurrentAssetValue": -31952000000}}
{"date": "2023-12-31", "symbol": "MRK", "type": "key_metrics_annual", "result": {"symbol": "MRK", "date": "2023-12-31", "fiscalYear": "2023", "period": "FY", "reportedCurrency": "USD", "marketCap": 284230729860, "enterpriseValue": 313657729860, "evToSales": 5.217628376611494, "evToOperatingCashFlow": 24.116387041365524, "evToFreeCashFlow": 34.30577817565351, "evToEBITDA": 45.41157229766903, "netDebtToEBITDA": 4.260460402490227, "currentRatio": 1.251965439402195, "incomeQuality": 35.632876712328766, "grahamNumber": 6.738403368417325, "grahamNetNet": -19.564040023888218, "taxBurden": 0.19322392800423505, "interestBurden": 0.6224052718286656, "workingCapital": 6474000000, "investedCapital": 68733000000, "returnOnAssets": 0.003421607686899461, "operatingReturnOnAssets": 0.027372761600296523, "returnOnTangibleAssets": 0.00541005232187588, "returnOnEquity": 0.009712354647295175, "returnOnInvestedCapital": 0.007134114665260315, "returnOnCapitalEmployed": 0.036477692298193407, "earningsYield": 0.0012841679721956297, "freeCashFlowYield": 0.03216752813639628, "capexToOperatingCashFlow": 0.29701676149469475, "capexToDepreciation": 0.9976756198347108, "capexToRevenue": 0.06426016801131165, "salesGeneralAndAdministrativeToRevenue": 0.1261581967894868, "researchAndDevelopementToRevenue": 0.5078765699076769, "stockBasedCompensationToRevenue": 0.01072943524910588, "intangiblesToTotalAssets": 0.3675462854464495, "averageReceivables": 9899500000, "averagePayables": 4093000000, "averageInventory": 6134500000, "daysOfSalesOutstanding": 62.83598103634699, "daysOfPayablesOutstanding": 88.77154905122163, "daysOfInventoryOutstanding": 143.90859481582538, "operatingCycle": 206.74457585217237, "cashConversionCycle": 117.97302680095075, "freeCashFlowToEquity": -20284000000, "freeCashFlowToFirm": 5623714663.843304, "tangibleAssetValue": -1573000000, "netCurrentAssetValue": -36872000000}}
{"date": "2022-12-31", "symbol": "MRK", "type": "key_metrics_annual", "result": {"symbol": "MRK", "date": "2022-12-31", "fiscalYear": "2022", "period": "FY", "reportedCurrency": "USD", "marketCap": 280925400000, "enterpriseValue": 300216400000, "evToSales": 5.064122935748865, "evToOperatingCashFlow": 15.722251898402723, "evToFreeCashFlow": 20.413163799551235, "evToEBITDA": 14.084747830166549, "netDebtToEBITDA": 0.9050433966690125, "currentRatio": 1.473740665869054, "incomeQuality": 1.3145394465097067, "grahamNumber": 48.40969391464707, "grahamNetNet": -15.745260663507109, "taxBurden": 0.882936025297981, "interestBurden": 0.9447317017120533, "workingCapital": 11483000000, "investedCapital": 74378000000, "returnOnAssets": 0.13300659582264565, "operatingReturnOnAssets": 0.1701806808344271, "returnOnTangibleAssets": 0.21450204618316662, "returnOnEquity": 0.31569220064795284, "returnOnInvestedCapital": 0.18531255826336668, "returnOnCapitalEmployed": 0.21528243897269228, "earningsYield": 0.05168275990707854, "freeCashFlowYield": 0.05235197671695048, "capexToOperatingCashFlow": 0.22979837653836083, "capexToDepreciation": 1.1225377334356612, "capexToRevenue": 0.07401784660020579, "salesGeneralAndAdministrativeToRevenue": 0.1259889006966584, "researchAndDevelopementToRevenue": 0.2285309447902434, "stockBasedCompensationToRevenue": 0.009125719008822092, "intangiblesToTotalAssets": 0.37992854525467207, "averageReceivables": 9340000000, "averagePayables": 4436500000, "averageInventory": 5932000000, "daysOfSalesOutstanding": 58.182784272051, "daysOfPayablesOutstanding": 89.38946642926885, "daysOfInventoryOutstanding": 123.91677675033024, "operatingCycle": 182.09956102238124, "cashConversionCycle": 92.71009459311239, "freeCashFlowToEquity": -4584000000, "freeCashFlowToFirm": 9807793967.404526, "tangibleAssetValue": 4585000000, "netCurrentAssetValue": -27380000000}}
{"date": "2021-12-31", "symbol": "MRK", "type": "key_metrics_annual", "result": {"symbol": "MRK", "date": "2021-12-31", "fiscalYear": "2021", "period": "FY", "reportedCurrency": "USD", "marketCap": 193899200000, "enterpriseValue": 220434200000, "evToSales": 4.525997864651774, "evToOperatingCashFlow": 15.623658657594444, "evToFreeCashFlow": 22.8169133630059, "evToEBITDA": 12.31544779037935, "netDebtToEBITDA": 1.4824850550310074, "currentRatio": 1.2678451742627346, "incomeQuality": 1.1416895937854021, "grahamNumber": 41.85044344587538, "grahamNetNet": -19.542292490118577, "taxBurden": 0.9401974205634411, "interestBurden": 0.9451140619679945, "workingCapital": 6394000000, "investedCapital": 69870000000, "returnOnAssets": 0.12346017749351902, "operatingReturnOnAssets": 0.13380845692967427, "returnOnTangibleAssets": 0.2121892124819097, "returnOnEquity": 0.3417399958097633, "returnOnInvestedCapital": 0.13902057322278746, "returnOnCapitalEmployed": 0.16131358314389774, "earningsYield": 0.06729785373018558, "freeCashFlowYield": 0.049824857451706867, "capexToOperatingCashFlow": 0.31525976327167055, "capexToDepreciation": 1.3839452395768512, "capexToRevenue": 0.09132720105124836, "salesGeneralAndAdministrativeToRevenue": 0.15199983574244416, "researchAndDevelopementToRevenue": 0.2514167214191853, "stockBasedCompensationToRevenue": 0.009834921156373194, "intangiblesToTotalAssets": 0.41815997123772397, "averageReceivables": 8016500000, "averagePayables": 4468000000, "averageInventory": 5753500000, "daysOfSalesOutstanding": 69.17193659658345, "daysOfPayablesOutstanding": 123.46139732863642, "daysOfInventoryOutstanding": 159.46315866725377, "operatingCycle": 228.63509526383723, "cashConversionCycle": 105.1736979352008, "freeCashFlowToEquity": -16874000000, "freeCashFlowToFirm": 5884670437.351395, "tangibleAssetValue": -5940000000, "netCurrentAssetValue": -37171000000}}
{"date": "2025-12-23", "symbol": "MRK", "type": "ratios_ttm", "result": [{"symbol": "MRK", "grossProfitMarginTTM": 0.7831711683661555, "ebitMarginTTM": 0.3543706701953763, "ebitdaMarginTTM": 0.4075348330349498, "operatingProfitMarginTTM": 0.36417840741029034, "pretaxProfitMarginTTM": 0.3396434965361563, "continuousOperationsProfitMarginTTM": 0.2964738849536857, "netProfitMarginTTM": 0.296318206585195, "bottomLineProfitMarginTTM": 0.296318206585195, "receivablesTurnoverTTM": 5.2999174917491745, "payablesTurnoverTTM": 3.358572462020738, "inventoryTurnoverTTM": 2.1613904407200497, "fixedAssetTurnoverTTM": 2.50536292367097, "assetTurnoverTTM": 0.577585354230171, "currentRatioTTM": 1.6612058124912672, "quickRatioTTM": 1.4361114992315216, "solvencyRatioTTM": 0.37816485015919005, "cashRatioTTM": 0.6346583764146989, "priceToEarningsRatioTTM": 13.533348744352212, "priceToEarningsGrowthRatioTTM": 0.8246489141418355, "forwardPriceToEarningsGrowthRatioTTM": -2.0202148266474302, "priceToBookRatioTTM": 4.9680570877531345, "priceToSalesRatioTTM": 4.034586629874679, "priceToFreeCashFlowRatioTTM": 19.860653856234194, "priceToOperatingCashFlowRatioTTM": 15.09485848227366, "debtToAssetsRatioTTM": 0.37202485320960677, "debtToEquityRatioTTM": 0.7979556412729026, "debtToCapitalRatioTTM": 0.4438127520810092, "longTermDebtToCapitalRatioTTM": 0.43530206166479707, "financialLeverageRatioTTM": 2.1448987463837996, "workingCapitalTurnoverRatioTTM": 4.288480154888674, "operatingCashFlowRatioTTM": 0.596094732429789, "operatingCashFlowSalesRatioTTM": 0.2656651358293765, "freeCashFlowOperatingCashFlowRatioTTM": 0.7646645180193379, "debtServiceCoverageRatioTTM": 9.040169949787563, "interestCoverageRatioTTM": 19.75760135135135, "shortTermOperatingCashFlowCoverageRatioTTM": 12.145907473309608, "operatingCashFlowCoverageRatioTTM": 0.41245709866099484, "capitalExpenditureCoverageRatioTTM": 4.249252988047809, "dividendPaidAndCapexCoverageRatioTTM": 1.407422680412371, "dividendPayoutRatioTTM": 0.426027109383209, "dividendYieldTTM": 0.0318076, "enterpriseValueTTM": 282366672170, "revenuePerShareTTM": 25.71457165732586, "netIncomePerShareTTM": 7.619695756605284, "interestDebtPerShareTTM": 17.036829463570857, "cashPerShareTTM": 7.291433146517214, "bookValuePerShareTTM": 20.756605284227383, "tangibleBookValuePerShareTTM": 5.984787830264211, "shareholdersEquityPerShareTTM": 20.756605284227383, "operatingCashFlowPerShareTTM": 6.83146517213771, "capexPerShareTTM": 1.6076861489191354, "freeCashFlowPerShareTTM": 5.223779023218575, "netIncomePerEBTTTM": 0.8724389237750378, "ebtPerEbitTTM": 0.9326294190569828, "priceToFairValueTTM": 4.9680570877531345, "debtToMarketCapTTM": 0.1596455203177585, "effectiveTaxRateTTM": 0.12710271806389511, "enterpriseValueMultipleTTM": 10.786411191458477, "dividendPerShareTTM": 3.28}]}
{"date": "2025-12-23", "symbol": "MRK", "type": "key_metrics_ttm", "result": [{"symbol": "MRK", "marketCap": 259161672170, "enterpriseValueTTM": 282366672170, "evToSalesTTM": 4.395838283957343, "evToOperatingCashFlowTTM": 16.546538070319365, "evToFreeCashFlowTTM": 21.638951043758144, "evToEBITDATTM": 10.786411191458477, "netDebtToEBITDATTM": 0.8864313545725419, "currentRatioTTM": 1.6612058124912672, "incomeQualityTTM": 0.8960357049094251, "grahamNumberTTM": 59.65381703738294, "grahamNetNetTTM": -11.544035228182546, "taxBurdenTTM": 0.8724389237750378, "interestBurdenTTM": 0.9584413302288802, "workingCapitalTTM": 18929000000, "investedCapitalTTM": 81468000000, "returnOnAssetsTTM": 0.17114905631535882, "operatingReturnOnAssetsTTM": 0.2045414801343033, "returnOnTangibleAssetsTTM": 0.256132843513248, "returnOnEquityTTM": 0.38946038436552066, "returnOnInvestedCapitalTTM": 0.24312044429493157, "returnOnCapitalEmployedTTM": 0.28325967185324213, "earningsYieldTTM": 0.07389154147212261, "freeCashFlowYieldTTM": 0.05035080955736527, "capexToOperatingCashFlowTTM": 0.23533548198066218, "capexToDepreciationTTM": 0.8789669511928212, "capexToRevenueTTM": 0.0625204327858644, "salesGeneralAndAdministrativeToRevenueTTM": 0.004530240523079318, "researchAndDevelopementToRevenueTTM": 0.2529773487973846, "stockBasedCompensationToRevenueTTM": 0.012485405152953996, "intangiblesToTotalAssetsTTM": 0.3317957433033908, "averageReceivablesTTM": 11983000000, "averagePayablesTTM": 4019500000, "averageInventoryTTM": 6522500000, "daysOfSalesOutstandingTTM": 68.86899665291509, "daysOfPayablesOutstandingTTM": 108.67712521539346, "daysOfInventoryOutstandingTTM": 168.87277426766227, "operatingCycleTTM": 237.74177092057735, "cashConversionCycleTTM": 129.0646457051839, "freeCashFlowToEquityTTM": -10156000000, "freeCashFlowToFirmTTM": 11367760828.711555, "tangibleAssetValueTTM": 14950000000, "netCurrentAssetValueTTM": -11806000000}]}
{"date": "2025-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2025-09-30", "stockPrice": 83.93, "numberOfShares": 2498000000, "marketCapitalization": 209657140000, "minusCashAndCashEquivalents": 18169000000, "addTotalDebt": 41374000000, "enterpriseValue": 232862140000}}
{"date": "2025-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2025-06-30", "stockPrice": 79.16, "numberOfShares": 2503140000, "marketCapitalization": 198148562400, "minusCashAndCashEquivalents": 8007000000, "addTotalDebt": 35402000000, "enterpriseValue": 225543562400}}
{"date": "2025-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2025-03-31", "stockPrice": 89.76, "numberOfShares": 2516082000, "marketCapitalization": 225843520320, "minusCashAndCashEquivalents": 8629000000, "addTotalDebt": 34844000000, "enterpriseValue": 252058520320}}
{"date": "2024-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2024-12-31", "stockPrice": 99.48, "numberOfShares": 2541000000, "marketCapitalization": 252778680000, "minusCashAndCashEquivalents": 13242000000, "addTotalDebt": 38270000000, "enterpriseValue": 277806680000}}
{"date": "2024-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2024-09-30", "stockPrice": 113.56, "numberOfShares": 2541000000, "marketCapitalization": 288555960000, "minusCashAndCashEquivalents": 14593000000, "addTotalDebt": 38131000000, "enterpriseValue": 312093960000}}
{"date": "2024-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2024-06-30", "stockPrice": 127.9, "numberOfShares": 2534000000, "marketCapitalization": 324098600000, "minusCashAndCashEquivalents": 11304000000, "addTotalDebt": 37788000000, "enterpriseValue": 350582600000}}
{"date": "2024-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2024-03-31", "stockPrice": 130.99, "numberOfShares": 2533000000, "marketCapitalization": 331797670000, "minusCashAndCashEquivalents": 5579000000, "addTotalDebt": 34219000000, "enterpriseValue": 360437670000}}
{"date": "2023-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2023-12-31", "stockPrice": 109.02, "numberOfShares": 2554166667, "marketCapitalization": 278455250036, "minusCashAndCashEquivalents": 6841000000, "addTotalDebt": 36268000000, "enterpriseValue": 307882250036}}
{"date": "2023-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2023-09-30", "stockPrice": 102.95, "numberOfShares": 2537000000, "marketCapitalization": 261184150000, "minusCashAndCashEquivalents": 8605000000, "addTotalDebt": 34859000000, "enterpriseValue": 287438150000}}
{"date": "2023-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2023-06-30", "stockPrice": 115.39, "numberOfShares": 2539000000, "marketCapitalization": 292975210000, "minusCashAndCashEquivalents": 5660000000, "addTotalDebt": 36911000000, "enterpriseValue": 324226210000}}
{"date": "2023-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2023-03-31", "stockPrice": 106.39, "numberOfShares": 2538000000, "marketCapitalization": 270017820000, "minusCashAndCashEquivalents": 9707000000, "addTotalDebt": 30746000000, "enterpriseValue": 291056820000}}
{"date": "2022-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2022-12-31", "stockPrice": 110.95, "numberOfShares": 2536000000, "marketCapitalization": 281369200000, "minusCashAndCashEquivalents": 12694000000, "addTotalDebt": 31985000000, "enterpriseValue": 300660200000}}
{"date": "2022-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2022-09-30", "stockPrice": 86.12, "numberOfShares": 2533000000, "marketCapitalization": 218141960000, "minusCashAndCashEquivalents": 11145000000, "addTotalDebt": 30418000000, "enterpriseValue": 237414960000}}
{"date": "2022-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2022-06-30", "stockPrice": 91.17, "numberOfShares": 2531000000, "marketCapitalization": 230751270000, "minusCashAndCashEquivalents": 9675000000, "addTotalDebt": 31663000000, "enterpriseValue": 252739270000}}
{"date": "2022-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2022-03-31", "stockPrice": 82.05, "numberOfShares": 2528000000, "marketCapitalization": 207422400000, "minusCashAndCashEquivalents": 8556000000, "addTotalDebt": 31794000000, "enterpriseValue": 230660400000}}
{"date": "2021-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2021-12-31", "stockPrice": 76.64, "numberOfShares": 2527000000, "marketCapitalization": 193669280000, "minusCashAndCashEquivalents": 8096000000, "addTotalDebt": 34631000000, "enterpriseValue": 220204280000}}
{"date": "2021-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2021-09-30", "stockPrice": 75.11, "numberOfShares": 2530000000, "marketCapitalization": 190028300000, "minusCashAndCashEquivalents": 10016000000, "addTotalDebt": 26441000000, "enterpriseValue": 206453300000}}
{"date": "2021-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2021-06-30", "stockPrice": 77.77, "numberOfShares": 2533000000, "marketCapitalization": 196991410000, "minusCashAndCashEquivalents": 8575000000, "addTotalDebt": 26521000000, "enterpriseValue": 214937410000}}
{"date": "2021-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2021-03-31", "stockPrice": 73.51, "numberOfShares": 2531303747, "marketCapitalization": 186076138441, "minusCashAndCashEquivalents": 6981000000, "addTotalDebt": 31253000000, "enterpriseValue": 210348138441}}
{"date": "2020-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2020-12-31", "stockPrice": 78, "numberOfShares": 2530225827, "marketCapitalization": 197357614506, "minusCashAndCashEquivalents": 8050000000, "addTotalDebt": 33417000000, "enterpriseValue": 222724614506}}
{"date": "2020-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2020-09-30", "stockPrice": 79.09, "numberOfShares": 2529760132, "marketCapitalization": 200078728839, "minusCashAndCashEquivalents": 7356000000, "addTotalDebt": 28741000000, "enterpriseValue": 221463728839}}
{"date": "2020-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2020-06-30", "stockPrice": 73.74, "numberOfShares": 2529168427, "marketCapitalization": 186500879806, "minusCashAndCashEquivalents": 11103000000, "addTotalDebt": 30874000000, "enterpriseValue": 206271879806}}
{"date": "2020-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2020-03-31", "stockPrice": 73.36, "numberOfShares": 2524013328, "marketCapitalization": 185161617742, "minusCashAndCashEquivalents": 7425000000, "addTotalDebt": 27998000000, "enterpriseValue": 205734617742}}
{"date": "2019-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2019-12-31", "stockPrice": 86.72, "numberOfShares": 2539016026, "marketCapitalization": 220183469774, "minusCashAndCashEquivalents": 9676000000, "addTotalDebt": 27351000000, "enterpriseValue": 237858469774}}
{"date": "2019-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2019-09-30", "stockPrice": 80.27, "numberOfShares": 2550888630, "marketCapitalization": 204759830330, "minusCashAndCashEquivalents": 7869000000, "addTotalDebt": 27111000000, "enterpriseValue": 224001830330}}
{"date": "2019-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2019-06-30", "stockPrice": 80.81, "numberOfShares": 2566795022, "marketCapitalization": 207422705727, "minusCashAndCashEquivalents": 6659000000, "addTotalDebt": 27588000000, "enterpriseValue": 228351705727}}
{"date": "2019-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2019-03-31", "stockPrice": 79.43, "numberOfShares": 2583071214, "marketCapitalization": 205173346528, "minusCashAndCashEquivalents": 8076000000, "addTotalDebt": 26969000000, "enterpriseValue": 224066346528}}
{"date": "2018-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2018-12-31", "stockPrice": 72.86, "numberOfShares": 2592559543, "marketCapitalization": 188893888302, "minusCashAndCashEquivalents": 7965000000, "addTotalDebt": 25114000000, "enterpriseValue": 206042888302}}
{"date": "2018-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2018-09-30", "stockPrice": 68.21, "numberOfShares": 2658739396, "marketCapitalization": 181352614201, "minusCashAndCashEquivalents": 7826000000, "addTotalDebt": 23592000000, "enterpriseValue": 197118614201}}
{"date": "2018-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2018-06-30", "stockPrice": 57.88, "numberOfShares": 2670041946, "marketCapitalization": 154542027834, "minusCashAndCashEquivalents": 5310000000, "addTotalDebt": 23338000000, "enterpriseValue": 172570027834}}
{"date": "2018-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2018-03-31", "stockPrice": 51.94, "numberOfShares": 2692481383, "marketCapitalization": 139847483033, "minusCashAndCashEquivalents": 4483000000, "addTotalDebt": 23556000000, "enterpriseValue": 158920483033}}
{"date": "2017-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2017-12-31", "stockPrice": 53.65, "numberOfShares": 2696611608, "marketCapitalization": 144673212769, "minusCashAndCashEquivalents": 6092000000, "addTotalDebt": 24410000000, "enterpriseValue": 162991212769}}
{"date": "2017-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2017-09-30", "stockPrice": 61.05, "numberOfShares": 2727000000, "marketCapitalization": 166483350000, "minusCashAndCashEquivalents": 7901000000, "addTotalDebt": 26995000000, "enterpriseValue": 185577350000}}
{"date": "2017-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2017-06-30", "stockPrice": 61.11, "numberOfShares": 2727128779, "marketCapitalization": 166654839684, "minusCashAndCashEquivalents": 7786000000, "addTotalDebt": 24887000000, "enterpriseValue": 183755839684}}
{"date": "2017-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2017-03-31", "stockPrice": 60.59, "numberOfShares": 2740435881, "marketCapitalization": 166043010029, "minusCashAndCashEquivalents": 11708000000, "addTotalDebt": 28474000000, "enterpriseValue": 182809010029}}
{"date": "2016-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2016-12-31", "stockPrice": 56.13, "numberOfShares": 2748731322, "marketCapitalization": 154286289103, "minusCashAndCashEquivalents": 6515000000, "addTotalDebt": 24842000000, "enterpriseValue": 172613289103}}
{"date": "2016-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2016-09-30", "stockPrice": 59.51, "numberOfShares": 2761661188, "marketCapitalization": 164346457297, "minusCashAndCashEquivalents": 7907000000, "addTotalDebt": 25143000000, "enterpriseValue": 181582457297}}
{"date": "2016-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2016-06-30", "stockPrice": 54.93, "numberOfShares": 2765627486, "marketCapitalization": 151915917805, "minusCashAndCashEquivalents": 6608000000, "addTotalDebt": 24286000000, "enterpriseValue": 169593917805}}
{"date": "2016-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2016-03-31", "stockPrice": 50.45, "numberOfShares": 2769552710, "marketCapitalization": 139723934219, "minusCashAndCashEquivalents": 9716000000, "addTotalDebt": 25769000000, "enterpriseValue": 155776934219}}
{"date": "2015-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2015-12-31", "stockPrice": 50.37, "numberOfShares": 2781128073, "marketCapitalization": 140085421037, "minusCashAndCashEquivalents": 8524000000, "addTotalDebt": 26412000000, "enterpriseValue": 157973421037}}
{"date": "2015-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2015-09-30", "stockPrice": 47.09, "numberOfShares": 2802234464, "marketCapitalization": 131957220909, "minusCashAndCashEquivalents": 7548000000, "addTotalDebt": 26667000000, "enterpriseValue": 151076220909}}
{"date": "2015-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2015-06-30", "stockPrice": 54.28, "numberOfShares": 2823955757, "marketCapitalization": 153284318489, "minusCashAndCashEquivalents": 6922000000, "addTotalDebt": 26552000000, "enterpriseValue": 172914318489}}
{"date": "2015-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2015-03-31", "stockPrice": 54.81, "numberOfShares": 2828388471, "marketCapitalization": 155023972095, "minusCashAndCashEquivalents": 7980000000, "addTotalDebt": 30234000000, "enterpriseValue": 177277972095}}
{"date": "2014-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2014-12-31", "stockPrice": 54.15, "numberOfShares": 2838140196, "marketCapitalization": 153685291613, "minusCashAndCashEquivalents": 7441000000, "addTotalDebt": 21403000000, "enterpriseValue": 167647291613}}
{"date": "2014-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2014-09-30", "stockPrice": 56.52, "numberOfShares": 2860842886, "marketCapitalization": 161694839916, "minusCashAndCashEquivalents": 11370000000, "addTotalDebt": 27841000000, "enterpriseValue": 178165839916}}
{"date": "2014-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2014-06-30", "stockPrice": 55.16, "numberOfShares": 2899710364, "marketCapitalization": 159948023678, "minusCashAndCashEquivalents": 9743000000, "addTotalDebt": 23067000000, "enterpriseValue": 173272023678}}
{"date": "2014-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2014-03-31", "stockPrice": 54.13, "numberOfShares": 2929538434, "marketCapitalization": 158575915432, "minusCashAndCashEquivalents": 15828000000, "addTotalDebt": 28148000000, "enterpriseValue": 170895915432}}
{"date": "2013-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2013-12-31", "stockPrice": 47.72, "numberOfShares": 2927526714, "marketCapitalization": 139701574792, "minusCashAndCashEquivalents": 15621000000, "addTotalDebt": 25060000000, "enterpriseValue": 149140574792}}
{"date": "2013-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2013-09-30", "stockPrice": 45.4, "numberOfShares": 2927000000, "marketCapitalization": 132885800000, "minusCashAndCashEquivalents": 14090000000, "addTotalDebt": 26623000000, "enterpriseValue": 145418800000}}
{"date": "2013-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2013-06-30", "stockPrice": 44.17, "numberOfShares": 2926472850, "marketCapitalization": 129262305784, "minusCashAndCashEquivalents": 15090000000, "addTotalDebt": 28108000000, "enterpriseValue": 142280305784}}
{"date": "2013-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2013-03-31", "stockPrice": 42.29, "numberOfShares": 3017375569, "marketCapitalization": 127604812813, "minusCashAndCashEquivalents": 13024000000, "addTotalDebt": 20825000000, "enterpriseValue": 135405812813}}
{"date": "2012-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2012-12-31", "stockPrice": 39.04, "numberOfShares": 3026635301, "marketCapitalization": 118159842151, "minusCashAndCashEquivalents": 13451000000, "addTotalDebt": 20569000000, "enterpriseValue": 125277842151}}
{"date": "2012-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2012-09-30", "stockPrice": 43.11, "numberOfShares": 3044404255, "marketCapitalization": 131244267433, "minusCashAndCashEquivalents": 17360000000, "addTotalDebt": 19600000000, "enterpriseValue": 133484267433}}
{"date": "2012-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2012-06-30", "stockPrice": 39.81, "numberOfShares": 3038908996, "marketCapitalization": 120978967130, "minusCashAndCashEquivalents": 16752000000, "addTotalDebt": 18979000000, "enterpriseValue": 123205967130}}
{"date": "2012-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2012-03-31", "stockPrice": 36.62, "numberOfShares": 3041984306, "marketCapitalization": 111397465285, "minusCashAndCashEquivalents": 14656000000, "addTotalDebt": 18158000000, "enterpriseValue": 114899465285}}
{"date": "2011-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2011-12-31", "stockPrice": 35.95, "numberOfShares": 3040838643, "marketCapitalization": 109318149215, "minusCashAndCashEquivalents": 13531000000, "addTotalDebt": 17515000000, "enterpriseValue": 113302149215}}
{"date": "2011-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2011-09-30", "stockPrice": 31.18, "numberOfShares": 3070000000, "marketCapitalization": 95722600000, "minusCashAndCashEquivalents": 14253000000, "addTotalDebt": 18147000000, "enterpriseValue": 99616600000}}
{"date": "2011-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2011-06-30", "stockPrice": 33.65, "numberOfShares": 3083012450, "marketCapitalization": 103743368942, "minusCashAndCashEquivalents": 12342000000, "addTotalDebt": 18306000000, "enterpriseValue": 109707368942}}
{"date": "2011-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2011-03-31", "stockPrice": 31.48, "numberOfShares": 3085291294, "marketCapitalization": 97124969935, "minusCashAndCashEquivalents": 11695000000, "addTotalDebt": 17846000000, "enterpriseValue": 103275969935}}
{"date": "2010-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2010-12-31", "stockPrice": 34.37, "numberOfShares": 3079918606, "marketCapitalization": 105856802488, "minusCashAndCashEquivalents": 10900000000, "addTotalDebt": 17882000000, "enterpriseValue": 112838802488}}
{"date": "2010-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2010-09-30", "stockPrice": 35.1, "numberOfShares": 3079918606, "marketCapitalization": 108105143070, "minusCashAndCashEquivalents": 9874000000, "addTotalDebt": 18148000000, "enterpriseValue": 116379143070}}
{"date": "2010-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2010-06-30", "stockPrice": 33.34, "numberOfShares": 3114300000, "marketCapitalization": 103830762000, "minusCashAndCashEquivalents": 8665600000, "addTotalDebt": 17982600000, "enterpriseValue": 113147762000}}
{"date": "2010-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2010-03-31", "stockPrice": 35.61, "numberOfShares": 3117641862, "marketCapitalization": 111019226705, "minusCashAndCashEquivalents": 8236000000, "addTotalDebt": 19103500000, "enterpriseValue": 121886726705}}
{"date": "2009-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2009-12-31", "stockPrice": 34.84, "numberOfShares": 2109100000, "marketCapitalization": 73481044000, "minusCashAndCashEquivalents": 9311000000, "addTotalDebt": 17474000000, "enterpriseValue": 81644044000}}
{"date": "2009-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2009-09-30", "stockPrice": 30.16, "numberOfShares": 2109100000, "marketCapitalization": 63610456000, "minusCashAndCashEquivalents": 21816900000, "addTotalDebt": 9071500000, "enterpriseValue": 50865056000}}
{"date": "2009-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2009-06-30", "stockPrice": 26.66, "numberOfShares": 2110000000, "marketCapitalization": 56252600000, "minusCashAndCashEquivalents": 12457600000, "addTotalDebt": 10682900000, "enterpriseValue": 54477900000}}
{"date": "2009-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2009-03-31", "stockPrice": 25.51, "numberOfShares": 2108669357, "marketCapitalization": 53792155297, "minusCashAndCashEquivalents": 6017100000, "addTotalDebt": 6738000000, "enterpriseValue": 54513055297}}
{"date": "2008-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2008-12-31", "stockPrice": 28.99, "numberOfShares": 2110800000, "marketCapitalization": 61192092000, "minusCashAndCashEquivalents": 4368300000, "addTotalDebt": 6240400000, "enterpriseValue": 63064192000}}
{"date": "2008-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2008-09-30", "stockPrice": 30.09, "numberOfShares": 2128500000, "marketCapitalization": 64046565000, "minusCashAndCashEquivalents": 5720100000, "addTotalDebt": 6933000000, "enterpriseValue": 65259465000}}
{"date": "2008-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2008-06-30", "stockPrice": 35.94, "numberOfShares": 2144500000, "marketCapitalization": 77073330000, "minusCashAndCashEquivalents": 7345200000, "addTotalDebt": 5113700000, "enterpriseValue": 74841830000}}
{"date": "2008-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2008-03-31", "stockPrice": 36.19, "numberOfShares": 2160300000, "marketCapitalization": 78181257000, "minusCashAndCashEquivalents": 6289400000, "addTotalDebt": 4386500000, "enterpriseValue": 76278357000}}
{"date": "2007-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2007-12-31", "stockPrice": 55.41, "numberOfShares": 2169212389, "marketCapitalization": 120196058474, "minusCashAndCashEquivalents": 5336100000, "addTotalDebt": 5739400000, "enterpriseValue": 120599358474}}
{"date": "2007-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2007-09-30", "stockPrice": 49.99, "numberOfShares": 2179285714, "marketCapitalization": 108942492842, "minusCashAndCashEquivalents": 5208300000, "addTotalDebt": 5846700000, "enterpriseValue": 109580892842}}
{"date": "2007-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2007-06-30", "stockPrice": 47.49, "numberOfShares": 2177142857, "marketCapitalization": 103392514278, "minusCashAndCashEquivalents": 3469500000, "addTotalDebt": 6302800000, "enterpriseValue": 106225814278}}
{"date": "2007-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2007-03-31", "stockPrice": 42.12, "numberOfShares": 2157341772, "marketCapitalization": 90867235436, "minusCashAndCashEquivalents": 2101900000, "addTotalDebt": 6476000000, "enterpriseValue": 95241335436}}
{"date": "2006-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2006-12-31", "stockPrice": 41.57, "numberOfShares": 2170100000, "marketCapitalization": 90211057000, "minusCashAndCashEquivalents": 5914700000, "addTotalDebt": 6836100000, "enterpriseValue": 91132457000}}
{"date": "2006-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2006-09-30", "stockPrice": 39.95, "numberOfShares": 2175200000, "marketCapitalization": 86899240000, "minusCashAndCashEquivalents": 6222100000, "addTotalDebt": 5985300000, "enterpriseValue": 86662440000}}
{"date": "2006-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2006-06-30", "stockPrice": 34.74, "numberOfShares": 2172898551, "marketCapitalization": 75486495661, "minusCashAndCashEquivalents": 8213300000, "addTotalDebt": 6461700000, "enterpriseValue": 73734895661}}
{"date": "2006-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2006-03-31", "stockPrice": 33.59, "numberOfShares": 2184300000, "marketCapitalization": 73370637000, "minusCashAndCashEquivalents": 10187200000, "addTotalDebt": 6714600000, "enterpriseValue": 69898037000}}
{"date": "2005-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2005-12-31", "stockPrice": 30.33, "numberOfShares": 2185300000, "marketCapitalization": 66280149000, "minusCashAndCashEquivalents": 9585300000, "addTotalDebt": 8097600000, "enterpriseValue": 64792449000}}
{"date": "2005-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2005-09-30", "stockPrice": 25.95, "numberOfShares": 2194000000, "marketCapitalization": 56934300000, "minusCashAndCashEquivalents": 2918000000, "addTotalDebt": 7317200000, "enterpriseValue": 61333500000}}
{"date": "2005-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2005-06-30", "stockPrice": 29.37, "numberOfShares": 2201800000, "marketCapitalization": 64666866000, "minusCashAndCashEquivalents": 1917600000, "addTotalDebt": 7166800000, "enterpriseValue": 69916066000}}
{"date": "2005-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2005-03-31", "stockPrice": 30.87, "numberOfShares": 2207200000, "marketCapitalization": 68136264000, "minusCashAndCashEquivalents": 2389600000, "addTotalDebt": 7270400000, "enterpriseValue": 73017064000}}
{"date": "2004-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2004-12-31", "stockPrice": 30.65, "numberOfShares": 2213900000, "marketCapitalization": 67856035000, "minusCashAndCashEquivalents": 2878800000, "addTotalDebt": 6872700000, "enterpriseValue": 71849935000}}
{"date": "2004-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2004-09-30", "stockPrice": 31.47, "numberOfShares": 2218500000, "marketCapitalization": 69816195000, "minusCashAndCashEquivalents": 2666900000, "addTotalDebt": 6586600000, "enterpriseValue": 73735895000}}
{"date": "2004-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2004-06-30", "stockPrice": 45.29, "numberOfShares": 2221400000, "marketCapitalization": 100607206000, "minusCashAndCashEquivalents": 1599800000, "addTotalDebt": 6605000000, "enterpriseValue": 105612406000}}
{"date": "2004-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2004-03-31", "stockPrice": 42.14, "numberOfShares": 2222600000, "marketCapitalization": 93660364000, "minusCashAndCashEquivalents": 1762100000, "addTotalDebt": 6876800000, "enterpriseValue": 98775064000}}
{"date": "2003-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2003-12-31", "stockPrice": 44.05, "numberOfShares": 2224700000, "marketCapitalization": 97998035000, "minusCashAndCashEquivalents": 1201000000, "addTotalDebt": 6796000000, "enterpriseValue": 103593035000}}
{"date": "2003-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2003-09-30", "stockPrice": 48.27, "numberOfShares": 2237000000, "marketCapitalization": 107979990000, "minusCashAndCashEquivalents": 2173800000, "addTotalDebt": 9672400000, "enterpriseValue": 115478590000}}
{"date": "2003-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2003-06-30", "stockPrice": 57.74, "numberOfShares": 2241400000, "marketCapitalization": 129418436000, "minusCashAndCashEquivalents": 1664700000, "addTotalDebt": 10163200000, "enterpriseValue": 137916936000}}
{"date": "2003-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2003-03-31", "stockPrice": 52.23, "numberOfShares": 2244300000, "marketCapitalization": 117219789000, "minusCashAndCashEquivalents": 2216900000, "addTotalDebt": 9810800000, "enterpriseValue": 124813689000}}
{"date": "2002-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2002-12-31", "stockPrice": 53.98, "numberOfShares": 2246700000, "marketCapitalization": 121276866000, "minusCashAndCashEquivalents": 2243000000, "addTotalDebt": 8548800000, "enterpriseValue": 127582666000}}
{"date": "2002-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2002-09-30", "stockPrice": 43.59, "numberOfShares": 2249900000, "marketCapitalization": 98073141000, "minusCashAndCashEquivalents": 1496600000, "addTotalDebt": 9712500000, "enterpriseValue": 106289041000}}
{"date": "2002-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2002-06-30", "stockPrice": 46.48, "numberOfShares": 2262700000, "marketCapitalization": 105170296000, "minusCashAndCashEquivalents": 1318900000, "addTotalDebt": 9711800000, "enterpriseValue": 113563196000}}
{"date": "2002-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2002-03-31", "stockPrice": 54.92, "numberOfShares": 2271300000, "marketCapitalization": 124739796000, "minusCashAndCashEquivalents": 2943100000, "addTotalDebt": 9935600000, "enterpriseValue": 131732296000}}
{"date": "2001-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2001-12-31", "stockPrice": 56.07, "numberOfShares": 2271300000, "marketCapitalization": 127351791000, "minusCashAndCashEquivalents": 2144000000, "addTotalDebt": 8865300000, "enterpriseValue": 134073091000}}
{"date": "2001-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2001-09-30", "stockPrice": 65.14, "numberOfShares": 2282900000, "marketCapitalization": 148708106000, "minusCashAndCashEquivalents": 1633600000, "addTotalDebt": 9454500000, "enterpriseValue": 156529006000}}
{"date": "2001-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2001-06-30", "stockPrice": 60.94, "numberOfShares": 2290800000, "marketCapitalization": 139601352000, "minusCashAndCashEquivalents": 2108400000, "addTotalDebt": 9420800000, "enterpriseValue": 146913752000}}
{"date": "2001-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2001-03-31", "stockPrice": 72.37, "numberOfShares": 2303700000, "marketCapitalization": 166718769000, "minusCashAndCashEquivalents": 2158500000, "addTotalDebt": 7401300000, "enterpriseValue": 171961569000}}
{"date": "2000-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2000-12-31", "stockPrice": 89.27, "numberOfShares": 2303700000, "marketCapitalization": 205651299000, "minusCashAndCashEquivalents": 2536800000, "addTotalDebt": 6920000000, "enterpriseValue": 210034499000}}
{"date": "2000-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2000-09-30", "stockPrice": 70.98, "numberOfShares": 2299400000, "marketCapitalization": 163211412000, "minusCashAndCashEquivalents": 1535100000, "addTotalDebt": 6612100000, "enterpriseValue": 168288412000}}
{"date": "2000-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2000-06-30", "stockPrice": 73.06, "numberOfShares": 2300200000, "marketCapitalization": 168052612000, "minusCashAndCashEquivalents": 2806000000, "addTotalDebt": 7223400000, "enterpriseValue": 172470012000}}
{"date": "2000-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "2000-03-31", "stockPrice": 59.24, "numberOfShares": 2317500000, "marketCapitalization": 137288700000, "minusCashAndCashEquivalents": 2222700000, "addTotalDebt": 5799000000, "enterpriseValue": 140865000000}}
{"date": "1999-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1999-12-31", "stockPrice": 64.06, "numberOfShares": 2317500000, "marketCapitalization": 148459050000, "minusCashAndCashEquivalents": 2021900000, "addTotalDebt": 6002900000, "enterpriseValue": 152440050000}}
{"date": "1999-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1999-09-30", "stockPrice": 61.8, "numberOfShares": 2368615385, "marketCapitalization": 146380430793, "minusCashAndCashEquivalents": 2103400000, "addTotalDebt": 4814400000, "enterpriseValue": 149091430793}}
{"date": "1999-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1999-06-30", "stockPrice": 70.2, "numberOfShares": 2357600000, "marketCapitalization": 165503520000, "minusCashAndCashEquivalents": 2267900000, "addTotalDebt": 3825200000, "enterpriseValue": 167060820000}}
{"date": "1999-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1999-03-31", "stockPrice": 76.4, "numberOfShares": 2361900000, "marketCapitalization": 180449160000, "minusCashAndCashEquivalents": 1792600000, "addTotalDebt": 3848100000, "enterpriseValue": 182504660000}}
{"date": "1998-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1998-12-31", "stockPrice": 70.5, "numberOfShares": 2329749867, "marketCapitalization": 164247365623, "minusCashAndCashEquivalents": 2606200000, "addTotalDebt": 3845000000, "enterpriseValue": 165486165623}}
{"date": "1998-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1998-09-30", "stockPrice": 61.77, "numberOfShares": 2398245614, "marketCapitalization": 148139631576, "minusCashAndCashEquivalents": 2429300000, "addTotalDebt": 3593900000, "enterpriseValue": 149304231576}}
{"date": "1998-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1998-06-30", "stockPrice": 63.77, "numberOfShares": 2350178571, "marketCapitalization": 149870887472, "minusCashAndCashEquivalents": 1424900000, "addTotalDebt": 2894800000, "enterpriseValue": 151340787472}}
{"date": "1998-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1998-03-31", "stockPrice": 61.11, "numberOfShares": 2376326531, "marketCapitalization": 145217314309, "minusCashAndCashEquivalents": 1596600000, "addTotalDebt": 2502800000, "enterpriseValue": 146123514309}}
{"date": "1997-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1997-12-31", "stockPrice": 50.54, "numberOfShares": 2376326531, "marketCapitalization": 120099542876, "minusCashAndCashEquivalents": 1125100000, "addTotalDebt": 2249000000, "enterpriseValue": 121223442876}}
{"date": "1997-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1997-09-30", "stockPrice": 47.68, "numberOfShares": 2394400000, "marketCapitalization": 114164992000, "minusCashAndCashEquivalents": 1281800000, "addTotalDebt": 2276400000, "enterpriseValue": 115159592000}}
{"date": "1997-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1997-06-30", "stockPrice": 48.81, "numberOfShares": 2405000000, "marketCapitalization": 117388050000, "minusCashAndCashEquivalents": 1587000000, "addTotalDebt": 2223600000, "enterpriseValue": 118024650000}}
{"date": "1997-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1997-03-31", "stockPrice": 40.2, "numberOfShares": 2429285714, "marketCapitalization": 97657285702, "minusCashAndCashEquivalents": 1736600000, "addTotalDebt": 1709800000, "enterpriseValue": 97630485702}}
{"date": "1996-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1996-12-31", "stockPrice": 37.96, "numberOfShares": 2426839744, "marketCapitalization": 92122836682, "minusCashAndCashEquivalents": 1352400000, "addTotalDebt": 1762000000, "enterpriseValue": 92532436682}}
{"date": "1996-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1996-09-30", "stockPrice": 33.55, "numberOfShares": 2385476190, "marketCapitalization": 80032726174, "minusCashAndCashEquivalents": 1344200000, "addTotalDebt": 2179500000, "enterpriseValue": 80868026174}}
{"date": "1996-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1996-06-30", "stockPrice": 31.53, "numberOfShares": 2430250000, "marketCapitalization": 76625782500, "minusCashAndCashEquivalents": 1686800000, "addTotalDebt": 1839300000, "enterpriseValue": 76778282500}}
{"date": "1996-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1996-03-31", "stockPrice": 30.21, "numberOfShares": 2468000000, "marketCapitalization": 74558280000, "minusCashAndCashEquivalents": 1753400000, "addTotalDebt": 2089900000, "enterpriseValue": 74894780000}}
{"date": "1995-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1995-12-31", "stockPrice": 31.29, "numberOfShares": 2456600000, "marketCapitalization": 76867014000, "minusCashAndCashEquivalents": 1847400000, "addTotalDebt": 1795900000, "enterpriseValue": 76815514000}}
{"date": "1995-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1995-09-30", "stockPrice": 26.7, "numberOfShares": 2462571429, "marketCapitalization": 65750657154, "minusCashAndCashEquivalents": 1906100000, "addTotalDebt": 1728800000, "enterpriseValue": 65573357154}}
{"date": "1995-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1995-06-30", "stockPrice": 23.42, "numberOfShares": 2451714286, "marketCapitalization": 57419148578, "minusCashAndCashEquivalents": 1664100000, "addTotalDebt": 1274200000, "enterpriseValue": 57029248578}}
{"date": "1995-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1995-03-31", "stockPrice": 20.32, "numberOfShares": 2443225806, "marketCapitalization": 49646348377, "minusCashAndCashEquivalents": 2221100000, "addTotalDebt": 1298800000, "enterpriseValue": 48724048377}}
{"date": "1994-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1994-12-31", "stockPrice": 18.18, "numberOfShares": 2443225806, "marketCapitalization": 44417845153, "minusCashAndCashEquivalents": 1604000000, "addTotalDebt": 1292600000, "enterpriseValue": 44106445153}}
{"date": "1994-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1994-09-30", "stockPrice": 16.98, "numberOfShares": 2531612903, "marketCapitalization": 42986787092, "minusCashAndCashEquivalents": 1213000000, "addTotalDebt": 2065400000, "enterpriseValue": 43839187092}}
{"date": "1994-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1994-06-30", "stockPrice": 14.18, "numberOfShares": 2464838710, "marketCapitalization": 34951412907, "minusCashAndCashEquivalents": 1219700000, "addTotalDebt": 2527800000, "enterpriseValue": 36259512907}}
{"date": "1994-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1994-03-31", "stockPrice": 14.18, "numberOfShares": 2500740741, "marketCapitalization": 35460503707, "minusCashAndCashEquivalents": 917000000, "addTotalDebt": 2530200000, "enterpriseValue": 37073703707}}
{"date": "1993-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1993-12-31", "stockPrice": 16.4, "numberOfShares": 2276451613, "marketCapitalization": 37333806453, "minusCashAndCashEquivalents": 829400000, "addTotalDebt": 2856800000, "enterpriseValue": 39361206453}}
{"date": "1993-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1993-09-30", "stockPrice": 14.66, "numberOfShares": 2276451613, "marketCapitalization": 33372780646, "minusCashAndCashEquivalents": 1197400000, "addTotalDebt": 1154000000, "enterpriseValue": 33329380646}}
{"date": "1993-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1993-06-30", "stockPrice": 17.22, "numberOfShares": 2157500000, "marketCapitalization": 37152150000, "minusCashAndCashEquivalents": 847800000, "addTotalDebt": 1918700000, "enterpriseValue": 38223050000}}
{"date": "1993-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1993-03-31", "stockPrice": 16.87, "numberOfShares": 2273333333, "marketCapitalization": 38351133327, "minusCashAndCashEquivalents": 702500000, "addTotalDebt": 1465900000, "enterpriseValue": 39114533327}}
{"date": "1992-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1992-12-31", "stockPrice": 20.68, "numberOfShares": 2289390000, "marketCapitalization": 47344585200, "minusCashAndCashEquivalents": 575100000, "addTotalDebt": 1320900000, "enterpriseValue": 48090385200}}
{"date": "1992-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1992-09-30", "stockPrice": 21.22, "numberOfShares": 2301785714, "marketCapitalization": 48843892851, "minusCashAndCashEquivalents": 868800000, "addTotalDebt": 1443400000, "enterpriseValue": 49418492851}}
{"date": "1992-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1992-06-30", "stockPrice": 23.24, "numberOfShares": 2253103448, "marketCapitalization": 52362124131, "minusCashAndCashEquivalents": 715900000, "addTotalDebt": 1122300000, "enterpriseValue": 52768524131}}
{"date": "1992-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1992-03-31", "stockPrice": 23.38, "numberOfShares": 2274800000, "marketCapitalization": 53184824000, "minusCashAndCashEquivalents": 694800000, "addTotalDebt": 807700000, "enterpriseValue": 53297724000}}
{"date": "1991-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1991-12-31", "stockPrice": 26.46, "numberOfShares": 2301666667, "marketCapitalization": 60902100008, "minusCashAndCashEquivalents": 797900000, "addTotalDebt": 832100000, "enterpriseValue": 60936300008}}
{"date": "1991-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1991-09-30", "stockPrice": 20.68, "numberOfShares": 2301666667, "marketCapitalization": 47598466673, "minusCashAndCashEquivalents": 920300000, "addTotalDebt": 1063000000, "enterpriseValue": 47741166673}}
{"date": "1991-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1991-06-30", "stockPrice": 18.44, "numberOfShares": 2316666667, "marketCapitalization": 42719333339, "minusCashAndCashEquivalents": 718200000, "addTotalDebt": 982100000, "enterpriseValue": 42983233339}}
{"date": "1991-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1991-03-31", "stockPrice": 16.76, "numberOfShares": 2302380952, "marketCapitalization": 38587904755, "minusCashAndCashEquivalents": 779200000, "addTotalDebt": 866300000, "enterpriseValue": 38675004755}}
{"date": "1990-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1990-12-31", "stockPrice": 14.27, "numberOfShares": 2325000000, "marketCapitalization": 33177750000, "minusCashAndCashEquivalents": 806400000, "addTotalDebt": 917100000, "enterpriseValue": 33288450000}}
{"date": "1990-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1990-09-30", "stockPrice": 12.75, "numberOfShares": 2325000000, "marketCapitalization": 29643750000, "minusCashAndCashEquivalents": 647600000, "addTotalDebt": 839600000, "enterpriseValue": 29835750000}}
{"date": "1990-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1990-06-30", "stockPrice": 13.78, "numberOfShares": 2351000000, "marketCapitalization": 32396780000, "minusCashAndCashEquivalents": 560800000, "addTotalDebt": 742400000, "enterpriseValue": 32578380000}}
{"date": "1990-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1990-03-31", "stockPrice": 11.04, "numberOfShares": 2375294118, "marketCapitalization": 26223247062, "minusCashAndCashEquivalents": 508700000, "addTotalDebt": 558800000, "enterpriseValue": 26273347062}}
{"date": "1989-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1989-12-31", "stockPrice": 12.49, "numberOfShares": 2297058824, "marketCapitalization": 28690264711, "minusCashAndCashEquivalents": 685100000, "addTotalDebt": 445100000, "enterpriseValue": 28450264711}}
{"date": "1989-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1989-09-30", "stockPrice": 12.04, "numberOfShares": 2297058824, "marketCapitalization": 27656588240, "minusCashAndCashEquivalents": 623800000, "addTotalDebt": 102000000, "enterpriseValue": 27134788240}}
{"date": "1989-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1989-06-30", "stockPrice": 10.63, "numberOfShares": 2385724000, "marketCapitalization": 25360246120, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 25360246120}}
{"date": "1989-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1989-03-31", "stockPrice": 10.33, "numberOfShares": 2382822000, "marketCapitalization": 24614551260, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 24614551260}}
{"date": "1988-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1988-12-31", "stockPrice": 9.18, "numberOfShares": 2366342000, "marketCapitalization": 21723019560, "minusCashAndCashEquivalents": 1550000000, "addTotalDebt": 601600000, "enterpriseValue": 20774619560}}
{"date": "1988-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1988-09-30", "stockPrice": 9.18, "numberOfShares": 2366342000, "marketCapitalization": 21723019560, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 21723019560}}
{"date": "1988-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1988-06-30", "stockPrice": 8.94, "numberOfShares": 2366342000, "marketCapitalization": 21155097480, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 21155097480}}
{"date": "1988-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1988-03-31", "stockPrice": 8.32, "numberOfShares": 2465280000, "marketCapitalization": 20511129600, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 20511129600}}
{"date": "1987-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1987-12-31", "stockPrice": 8.4, "numberOfShares": 2368708000, "marketCapitalization": 19897147200, "minusCashAndCashEquivalents": 1148200000, "addTotalDebt": 1018200000, "enterpriseValue": 19767147200}}
{"date": "1987-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1987-09-30", "stockPrice": 10.96, "numberOfShares": 2465280000, "marketCapitalization": 27019468800, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 27019468800}}
{"date": "1987-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1987-06-30", "stockPrice": 9.03, "numberOfShares": 2465280000, "marketCapitalization": 22261478400, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 22261478400}}
{"date": "1987-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1987-03-31", "stockPrice": 8.19, "numberOfShares": 2460138000, "marketCapitalization": 20148530220, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 20148530220}}
{"date": "1986-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1986-12-31", "stockPrice": 6.56, "numberOfShares": 2460138000, "marketCapitalization": 16138505279, "minusCashAndCashEquivalents": 965800000, "addTotalDebt": 540400000, "enterpriseValue": 15713105279}}
{"date": "1986-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1986-09-30", "stockPrice": 5.22, "numberOfShares": 2539586000, "marketCapitalization": 13256638920, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 13256638920}}
{"date": "1986-06-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1986-06-30", "stockPrice": 5.54, "numberOfShares": 2539586000, "marketCapitalization": 14069306440, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 14069306440}}
{"date": "1986-03-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1986-03-31", "stockPrice": 4.62, "numberOfShares": 2531292000, "marketCapitalization": 11694569040, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 11694569040}}
{"date": "1985-12-31", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1985-12-31", "stockPrice": 3.63, "numberOfShares": 2531292000, "marketCapitalization": 9188589960, "minusCashAndCashEquivalents": 842000000, "addTotalDebt": 500800000, "enterpriseValue": 8847389960}}
{"date": "1985-09-30", "symbol": "MRK", "type": "enterprise_values", "result": {"symbol": "MRK", "date": "1985-09-30", "stockPrice": 2.87, "numberOfShares": 2591748000, "marketCapitalization": 7438316760, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 7438316760}}
{"date": "2029-12-31", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2029-12-31", "revenueLow": 71238511097, "revenueHigh": 73769993343, "revenueAvg": 72751299487, "ebitdaLow": 21196994715, "ebitdaHigh": 21950236395, "ebitdaAvg": 21647124385, "ebitLow": 16204390079, "ebitHigh": 16780218029, "ebitAvg": 16548499084, "netIncomeLow": 25251441609, "netIncomeHigh": 26425434430, "netIncomeAvg": 25953011710, "sgaExpenseLow": 12600285883, "sgaExpenseHigh": 13048040889, "sgaExpenseAvg": 12867859782, "epsAvg": 10.2137, "epsHigh": 10.39962, "epsLow": 9.9376, "numAnalystsRevenue": 11, "numAnalystsEps": 4}}
{"date": "2028-12-31", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2028-12-31", "revenueLow": 72567300138, "revenueHigh": 75146001308, "revenueAvg": 74108306084, "ebitdaLow": 21592375441, "ebitdaHigh": 22359667096, "ebitdaAvg": 22050901236, "ebitLow": 16506645357, "ebitHigh": 17093214040, "ebitAvg": 16857172917, "netIncomeLow": 26479938880, "netIncomeHigh": 27711053380, "netIncomeAvg": 27215634610, "sgaExpenseLow": 12835314964, "sgaExpenseHigh": 13291421800, "sgaExpenseAvg": 13107879833, "epsAvg": 10.7106, "epsHigh": 10.90557, "epsLow": 10.42107, "numAnalystsRevenue": 8, "numAnalystsEps": 3}}
{"date": "2027-12-31", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2027-12-31", "revenueLow": 71396459886, "revenueHigh": 71623071882, "revenueAvg": 71509765884, "ebitdaLow": 21243992323, "ebitdaHigh": 21311420645, "ebitdaAvg": 21277706484, "ebitLow": 16240318171, "ebitHigh": 16291864858, "ebitAvg": 16266091515, "netIncomeLow": 23862810519, "netIncomeHigh": 27644199670, "netIncomeAvg": 24510298240, "sgaExpenseLow": 12628223018, "sgaExpenseHigh": 12668304932, "sgaExpenseAvg": 12648263975, "epsAvg": 10.18749, "epsHigh": 10.87926, "epsLow": 9.39111, "numAnalystsRevenue": 18, "numAnalystsEps": 6}}
{"date": "2026-12-31", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2026-12-31", "revenueLow": 66549397858, "revenueHigh": 68952121871, "revenueAvg": 68023337799, "ebitdaLow": 19801750667, "ebitdaHigh": 20516680379, "ebitdaAvg": 20240320995, "ebitLow": 15137772896, "ebitHigh": 15684312633, "ebitAvg": 15473045172, "netIncomeLow": 13831196615, "netIncomeHigh": 24490107189, "netIncomeAvg": 17715811790, "sgaExpenseLow": 11770900675, "sgaExpenseHigh": 12195881615, "sgaExpenseAvg": 12031603268, "epsAvg": 8.36956, "epsHigh": 9.63798, "epsLow": 5.44321, "numAnalystsRevenue": 15, "numAnalystsEps": 12}}
{"date": "2025-12-31", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2025-12-31", "revenueLow": 64644757496, "revenueHigh": 65104649059, "revenueAvg": 64794722137, "ebitdaLow": 19235025576, "ebitdaHigh": 19371866154, "ebitdaAvg": 19279647504, "ebitLow": 14704530610, "ebitHigh": 14809140633, "ebitAvg": 14738642574, "netIncomeLow": 22590938378, "netIncomeHigh": 23149373949, "netIncomeAvg": 22870156163.5, "sgaExpenseLow": 11434018099, "sgaExpenseHigh": 11515361253, "sgaExpenseAvg": 11460543041, "epsAvg": 8.97049, "epsHigh": 9.11034, "epsLow": 8.89057, "numAnalystsRevenue": 15, "numAnalystsEps": 11}}
{"date": "2024-12-31", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2024-12-31", "revenueLow": 63745494573, "revenueHigh": 64284864160, "revenueAvg": 63985214390, "ebitdaLow": 18967450200, "ebitdaHigh": 19127939437, "ebitdaAvg": 19038778750, "ebitLow": 14499978227, "ebitHigh": 14622666855, "ebitAvg": 14554506507, "netIncomeLow": 18878384917, "netIncomeHigh": 19480906837, "netIncomeAvg": 19179645877, "sgaExpenseLow": 11274961295, "sgaExpenseHigh": 11370362096, "sgaExpenseAvg": 11317361651, "epsAvg": 7.52831, "epsHigh": 7.66663, "epsLow": 7.42951, "numAnalystsRevenue": 15, "numAnalystsEps": 16}}
{"date": "2023-12-31", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2023-12-31", "revenueLow": 59384151558, "revenueHigh": 60827199426, "revenueAvg": 59970798190, "ebitdaLow": 17238572698, "ebitdaHigh": 25857859047, "ebitdaAvg": 21548215873, "ebitLow": 15261526626, "ebitHigh": 22892289942, "ebitAvg": 19076908284, "netIncomeLow": 10988799999, "netIncomeHigh": 16483199999, "netIncomeAvg": 13736000000, "sgaExpenseLow": 7912935451, "sgaExpenseHigh": 11869403179, "sgaExpenseAvg": 9891169315, "epsAvg": 1.37699, "epsHigh": 1.40206, "epsLow": 1.33977, "numAnalystsRevenue": 24, "numAnalystsEps": 23}}
{"date": "2022-12-30", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2022-12-30", "revenueLow": 57915378784, "revenueHigh": 59923222327, "revenueAvg": 59123781378, "ebitdaLow": 15671429727, "ebitdaHigh": 23507144590, "ebitdaAvg": 19589287159, "ebitLow": 13874115116, "ebitHigh": 20811172676, "ebitAvg": 17342643896, "netIncomeLow": 11927421788, "netIncomeHigh": 17891132682, "netIncomeAvg": 14909277235, "sgaExpenseLow": 7193577684, "sgaExpenseHigh": 10790366527, "sgaExpenseAvg": 8991972106, "epsAvg": 7.394, "epsHigh": 7.52397, "epsLow": 7.19754, "numAnalystsRevenue": 6, "numAnalystsEps": 15}}
{"date": "2021-12-30", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2021-12-30", "revenueLow": 47527206508, "revenueHigh": 49174906942, "revenueAvg": 48518860208, "ebitdaLow": 14124454722, "ebitdaHigh": 21186682082, "ebitdaAvg": 17655568402, "ebitLow": 10300821710, "ebitHigh": 15451232566, "ebitAvg": 12876027139, "netIncomeLow": 9814669471, "netIncomeHigh": 14722004208, "netIncomeAvg": 12268336840, "sgaExpenseLow": 7747997790, "sgaExpenseHigh": 11621996686, "sgaExpenseAvg": 9684997238, "epsAvg": 5.79192, "epsHigh": 5.89373, "epsLow": 5.63803, "numAnalystsRevenue": 7, "numAnalystsEps": 14}}
{"date": "2020-12-30", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2020-12-30", "revenueLow": 47202858511, "revenueHigh": 48839314262, "revenueAvg": 48187744700, "ebitdaLow": 7764098072, "ebitdaHigh": 12569625370, "ebitdaAvg": 10166861721, "ebitLow": 4175220801, "ebitHigh": 8287179028, "ebitAvg": 6231199915, "netIncomeLow": 3147848438, "netIncomeHigh": 6906816134, "netIncomeAvg": 5027332287, "sgaExpenseLow": 7225665156, "sgaExpenseHigh": 10838497737, "sgaExpenseAvg": 9032081447, "epsAvg": 5.71976, "epsHigh": 5.8203, "epsLow": 5.56779, "numAnalystsRevenue": 11, "numAnalystsEps": 14}}
{"date": "2019-12-30", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2019-12-30", "revenueLow": 45945279739, "revenueHigh": 47538137028, "revenueAvg": 46903926585, "ebitdaLow": 11292534922, "ebitdaHigh": 16938802384, "ebitdaAvg": 14115668653, "ebitLow": 8573636211, "ebitHigh": 12860454318, "ebitAvg": 10717045265, "netIncomeLow": 6916275394, "netIncomeHigh": 10374413092, "netIncomeAvg": 8645344243, "sgaExpenseLow": 7466237045, "sgaExpenseHigh": 11199355569, "sgaExpenseAvg": 9332796308, "epsAvg": 4.9267, "epsHigh": 5.0133, "epsLow": 4.7958, "numAnalystsRevenue": 6, "numAnalystsEps": 15}}
{"date": "2018-12-30", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2018-12-30", "revenueLow": 41372628057, "revenueHigh": 42806958037, "revenueAvg": 42235866667, "ebitdaLow": 10858626317, "ebitdaHigh": 16287939478, "ebitdaAvg": 13573282898, "ebitLow": 6930414858, "ebitHigh": 10395622288, "ebitAvg": 8663018573, "netIncomeLow": 4824173897, "netIncomeHigh": 7236260848, "netIncomeAvg": 6030217373, "sgaExpenseLow": 7816593710, "sgaExpenseHigh": 11724890565, "sgaExpenseAvg": 9770742138, "epsAvg": 4.12853, "epsHigh": 4.2011, "epsLow": 4.01883, "numAnalystsRevenue": 9, "numAnalystsEps": 8}}
{"date": "2017-12-30", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2017-12-30", "revenueLow": 39383042453, "revenueHigh": 40748396340, "revenueAvg": 40204768421, "ebitdaLow": 8656739720, "ebitdaHigh": 12985109580, "ebitdaAvg": 10820924651, "ebitLow": 5307414096, "ebitHigh": 7961121144, "ebitAvg": 6634267621, "netIncomeLow": 1208565655, "netIncomeHigh": 2865988330, "netIncomeAvg": 2037276993, "sgaExpenseLow": 7196165661, "sgaExpenseHigh": 10794248493, "sgaExpenseAvg": 8995207077, "epsAvg": 3.75886, "epsHigh": 3.82493, "epsLow": 3.65899, "numAnalystsRevenue": 14, "numAnalystsEps": 13}}
{"date": "2016-12-30", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2016-12-30", "revenueLow": 39159307260, "revenueHigh": 40516904567, "revenueAvg": 39976365000, "ebitdaLow": 8149848836, "ebitdaHigh": 12253773258, "ebitdaAvg": 10201811048, "ebitLow": 4347229522, "ebitHigh": 6979844283, "ebitAvg": 5663536903, "netIncomeLow": 2692472365, "netIncomeHigh": 4633708549, "netIncomeAvg": 3663090457, "sgaExpenseLow": 7524417544, "sgaExpenseHigh": 11286626317, "sgaExpenseAvg": 9405521931, "epsAvg": 3.6048, "epsHigh": 3.66816, "epsLow": 3.50902, "numAnalystsRevenue": 8, "numAnalystsEps": 9}}
{"date": "2015-12-30", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2015-12-30", "revenueLow": 38777544569, "revenueHigh": 40121906708, "revenueAvg": 39586636842, "ebitdaLow": 9290710362, "ebitdaHigh": 13936065545, "ebitdaAvg": 11613387954, "ebitLow": 5674190037, "ebitHigh": 8511285057, "ebitAvg": 7092737547, "netIncomeLow": 3338129674, "netIncomeHigh": 5007194512, "netIncomeAvg": 4172662093, "sgaExpenseLow": 7710619122, "sgaExpenseHigh": 11565928682, "sgaExpenseAvg": 9638273902, "epsAvg": 3.40563, "epsHigh": 3.46549, "epsLow": 3.31514, "numAnalystsRevenue": 9, "numAnalystsEps": 8}}
{"date": "2014-12-30", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2014-12-30", "revenueLow": 32254119032, "revenueHigh": 48381178549, "revenueAvg": 40317648791, "ebitdaLow": 19052210021, "ebitdaHigh": 28578315032, "ebitdaAvg": 23815262527, "ebitLow": 5057929334, "ebitHigh": 7586894000, "ebitAvg": 6322411668, "netIncomeLow": 9217108681, "netIncomeHigh": 13825663023, "netIncomeAvg": 11521385853, "sgaExpenseLow": 8837673251, "sgaExpenseHigh": 13256509878, "sgaExpenseAvg": 11047091565, "epsAvg": 3.18, "epsHigh": 3.81, "epsLow": 2.55, "numAnalystsRevenue": 19, "numAnalystsEps": 19}}
{"date": "2013-12-30", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2013-12-30", "revenueLow": 34238132559, "revenueHigh": 51357198841, "revenueAvg": 42797665700, "ebitdaLow": 10248068605, "ebitdaHigh": 15372102907, "ebitdaAvg": 12810085757, "ebitLow": 5933832318, "ebitHigh": 8900748478, "ebitAvg": 7417290398, "netIncomeLow": 3383825091, "netIncomeHigh": 5075737639, "netIncomeAvg": 4229781365, "sgaExpenseLow": 9242723552, "sgaExpenseHigh": 13864085328, "sgaExpenseAvg": 11553404440, "epsAvg": 3.29, "epsHigh": 3.95, "epsLow": 2.63, "numAnalystsRevenue": 9, "numAnalystsEps": 9}}
{"date": "2011-12-30", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2011-12-30", "revenueLow": 37122302472, "revenueHigh": 55683453707, "revenueAvg": 46402878090, "ebitdaLow": 11850881263, "ebitdaHigh": 17776321896, "ebitdaAvg": 14813601580, "ebitLow": 6916993405, "ebitHigh": 10375490108, "ebitAvg": 8646241757, "netIncomeLow": 4867243893, "netIncomeHigh": 7300865840, "netIncomeAvg": 6084054867, "sgaExpenseLow": 10594862262, "sgaExpenseHigh": 15892293393, "sgaExpenseAvg": 13243577828, "epsAvg": 3.52, "epsHigh": 4.23, "epsLow": 2.81, "numAnalystsRevenue": 11, "numAnalystsEps": 11}}
{"date": "2010-12-30", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2010-12-30", "revenueLow": 34728539832, "revenueHigh": 52092809749, "revenueAvg": 43410674791, "ebitdaLow": 7260169109, "ebitdaHigh": 10890253665, "ebitdaAvg": 9075211387, "ebitLow": 2377017748, "ebitHigh": 3980524212, "ebitAvg": 3178770981, "netIncomeLow": 457692643, "netIncomeHigh": 1186208845, "netIncomeAvg": 821950744, "sgaExpenseLow": 9939794975, "sgaExpenseHigh": 14909692463, "sgaExpenseAvg": 12424743719, "epsAvg": 3.04, "epsHigh": 3.65, "epsLow": 2.43, "numAnalystsRevenue": 18, "numAnalystsEps": 18}}
{"date": "2009-12-30", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2009-12-30", "revenueLow": 21345895209, "revenueHigh": 32018842813, "revenueAvg": 26682369011, "ebitdaLow": 14040549304, "ebitdaHigh": 21060823958, "ebitdaAvg": 17550686631, "ebitLow": 2944038453, "ebitHigh": 4650157680, "ebitAvg": 3797098067, "netIncomeLow": 10001177040, "netIncomeHigh": 15001765561, "netIncomeAvg": 12501471301, "sgaExpenseLow": 6642889425, "sgaExpenseHigh": 9964334138, "sgaExpenseAvg": 8303611782, "epsAvg": 3.04, "epsHigh": 3.65, "epsLow": 2.43, "numAnalystsRevenue": 7, "numAnalystsEps": 7}}
{"date": "2008-12-30", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2008-12-30", "revenueLow": 17973718625, "revenueHigh": 26960577937, "revenueAvg": 22467148281, "ebitdaLow": 8591081363, "ebitdaHigh": 12886622046, "ebitdaAvg": 10738851705, "ebitLow": 4576844007, "ebitHigh": 6865266011, "ebitAvg": 5721055009, "netIncomeLow": 5861196452, "netIncomeHigh": 8791794680, "netIncomeAvg": 7326495566, "sgaExpenseLow": 5514747776, "sgaExpenseHigh": 8272121666, "sgaExpenseAvg": 6893434721, "epsAvg": 3.02, "epsHigh": 3.63, "epsLow": 2.41, "numAnalystsRevenue": 17, "numAnalystsEps": 17}}
{"date": "2007-12-30", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2007-12-30", "revenueLow": 17998689453, "revenueHigh": 26998034180, "revenueAvg": 22498361817, "ebitdaLow": 2994212944, "ebitdaHigh": 6955400497, "ebitdaAvg": 4974806721, "ebitLow": 4149110642, "ebitHigh": 6223665964, "ebitAvg": 5186388303, "netIncomeLow": 1834173756, "netIncomeHigh": 4249925500, "netIncomeAvg": 3042049628, "sgaExpenseLow": 5566473075, "sgaExpenseHigh": 8349709615, "sgaExpenseAvg": 6958091345, "epsAvg": 2.77, "epsHigh": 3.33, "epsLow": 2.21, "numAnalystsRevenue": 15, "numAnalystsEps": 15}}
{"date": "2006-12-30", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2006-12-30", "revenueLow": 17185008155, "revenueHigh": 25777512233, "revenueAvg": 21481260194, "ebitdaLow": 6329586706, "ebitdaHigh": 9494380061, "ebitdaAvg": 7911983384, "ebitLow": 2706653148, "ebitHigh": 4059979722, "ebitAvg": 3383316435, "netIncomeLow": 3283033681, "netIncomeHigh": 4924550522, "netIncomeAvg": 4103792102, "sgaExpenseLow": 6209324758, "sgaExpenseHigh": 9313987137, "sgaExpenseAvg": 7761655948, "epsAvg": 2.22, "epsHigh": 2.66, "epsLow": 1.78, "numAnalystsRevenue": 8, "numAnalystsEps": 8}}
{"date": "2005-12-30", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2005-12-30", "revenueLow": 17341693789, "revenueHigh": 26012540684, "revenueAvg": 21677117237, "ebitdaLow": 7018006144, "ebitdaHigh": 10527009217, "ebitdaAvg": 8772507681, "ebitLow": 4533733142, "ebitHigh": 6800599714, "ebitAvg": 5667166428, "netIncomeLow": 3565409053, "netIncomeHigh": 5348113580, "netIncomeAvg": 4456761317, "sgaExpenseLow": 5538580687, "sgaExpenseHigh": 8307871030, "sgaExpenseAvg": 6923225859, "epsAvg": 2.37, "epsHigh": 2.84, "epsLow": 1.9, "numAnalystsRevenue": 16, "numAnalystsEps": 16}}
{"date": "2004-12-30", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2004-12-30", "revenueLow": 18975504995, "revenueHigh": 28463257494, "revenueAvg": 23719381245, "ebitdaLow": 7778448183, "ebitdaHigh": 11667672276, "ebitdaAvg": 9723060230, "ebitLow": 5455428419, "ebitHigh": 8183142627, "ebitAvg": 6819285524, "netIncomeLow": 4797035273, "netIncomeHigh": 7195552910, "netIncomeAvg": 5996294092, "sgaExpenseLow": 6076396400, "sgaExpenseHigh": 9114594600, "sgaExpenseAvg": 7595495500, "epsAvg": 2.82, "epsHigh": 3.38, "epsLow": 2.26, "numAnalystsRevenue": 18, "numAnalystsEps": 18}}
{"date": "2003-12-30", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2003-12-30", "revenueLow": 30686046264, "revenueHigh": 46029069397, "revenueAvg": 38357557831, "ebitdaLow": 8668234778, "ebitdaHigh": 13002352167, "ebitdaAvg": 10835293473, "ebitLow": 7122529780, "ebitHigh": 10683794671, "ebitAvg": 8903162226, "netIncomeLow": 5517480716, "netIncomeHigh": 8276221074, "netIncomeAvg": 6896850896, "sgaExpenseLow": 5409149164, "sgaExpenseHigh": 8113723747, "sgaExpenseAvg": 6761436456, "epsAvg": 3.1, "epsHigh": 3.71, "epsLow": 2.49, "numAnalystsRevenue": 19, "numAnalystsEps": 19}}
{"date": "2002-12-30", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2002-12-30", "revenueLow": 41432240000, "revenueHigh": 62148360000, "revenueAvg": 51790300000, "ebitdaLow": 9361520000, "ebitdaHigh": 14042280000, "ebitdaAvg": 11701900000, "ebitLow": 7734320000, "ebitHigh": 11601480000, "ebitAvg": 9667900000, "netIncomeLow": 5719600000, "netIncomeHigh": 8579400000, "netIncomeAvg": 7149500000, "sgaExpenseLow": 4949440000, "sgaExpenseHigh": 7424160000, "sgaExpenseAvg": 6186800000, "epsAvg": 3.14, "epsHigh": 3.77, "epsLow": 2.51, "numAnalystsRevenue": 17, "numAnalystsEps": 17}}
{"date": "2001-12-30", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2001-12-30", "revenueLow": 37933461000, "revenueHigh": 56900191500, "revenueAvg": 47416826250, "ebitdaLow": 9432441132, "ebitdaHigh": 14148661698, "ebitdaAvg": 11790551415, "ebitLow": 7731634313, "ebitHigh": 11597451469, "ebitAvg": 9664542891, "netIncomeLow": 5788053168, "netIncomeHigh": 8682079753, "netIncomeAvg": 7235066461, "sgaExpenseLow": 4949184313, "sgaExpenseHigh": 7423776469, "sgaExpenseAvg": 6186480391, "epsAvg": 3.1, "epsHigh": 3.72, "epsLow": 2.48, "numAnalystsRevenue": 16, "numAnalystsEps": 16}}
{"date": "2000-12-30", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "2000-12-30", "revenueLow": 31220883671, "revenueHigh": 46831325507, "revenueAvg": 39026104589, "ebitdaLow": 8556490862, "ebitdaHigh": 12834736293, "ebitdaAvg": 10695613578, "ebitLow": 7006769698, "ebitHigh": 10510154547, "ebitAvg": 8758462123, "netIncomeLow": 5257486104, "netIncomeHigh": 7886229157, "netIncomeAvg": 6571857631, "sgaExpenseLow": 4765183295, "sgaExpenseHigh": 7147774942, "sgaExpenseAvg": 5956479119, "epsAvg": 2.69, "epsHigh": 3.23, "epsLow": 2.15, "numAnalystsRevenue": 15, "numAnalystsEps": 15}}
{"date": "1999-12-30", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "1999-12-30", "revenueLow": 26061575272, "revenueHigh": 39092362909, "revenueAvg": 32576969091, "ebitdaLow": 7779918518, "ebitdaHigh": 11669877777, "ebitdaAvg": 9724898148, "ebitLow": 6050048888, "ebitHigh": 9075073333, "ebitAvg": 7562561111, "netIncomeLow": 4693146666, "netIncomeHigh": 7039719999, "netIncomeAvg": 5866433333, "sgaExpenseLow": 4142899259, "sgaExpenseHigh": 6214348888, "sgaExpenseAvg": 5178624074, "epsAvg": 2.44, "epsHigh": 2.93, "epsLow": 1.95, "numAnalystsRevenue": 10, "numAnalystsEps": 10}}
{"date": "1998-12-30", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "1998-12-30", "revenueLow": 21333691428, "revenueHigh": 32000537142, "revenueAvg": 26667114285, "ebitdaLow": 7263025185, "ebitdaHigh": 10894537777, "ebitdaAvg": 9078781481, "ebitLow": 5055202962, "ebitHigh": 7582804444, "ebitAvg": 6319003703, "netIncomeLow": 4159564444, "netIncomeHigh": 6239346666, "netIncomeAvg": 5199455555, "sgaExpenseLow": 3577668148, "sgaExpenseHigh": 5366502222, "sgaExpenseAvg": 4472085185, "epsAvg": 2.14, "epsHigh": 2.57, "epsLow": 1.71, "numAnalystsRevenue": 12, "numAnalystsEps": 12}}
{"date": "1997-12-30", "symbol": "MRK", "type": "analyst_estimates_annual", "result": {"symbol": "MRK", "date": "1997-12-30", "revenueLow": 18811761568, "revenueHigh": 28217642352, "revenueAvg": 23514701960, "ebitdaLow": 5957101176, "ebitdaHigh": 8935651764, "ebitdaAvg": 7446376470, "ebitLow": 4510127058, "ebitHigh": 6765190588, "ebitAvg": 5637658823, "netIncomeLow": 3671794509, "netIncomeHigh": 5507691764, "netIncomeAvg": 4589743137, "sgaExpenseLow": 3421463529, "sgaExpenseHigh": 5132195294, "sgaExpenseAvg": 4276829412, "epsAvg": 1.9, "epsHigh": 2.28, "epsLow": 1.52, "numAnalystsRevenue": 12, "numAnalystsEps": 12}}
{"date": "2025-12-19", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-12-19 00:00:00", "acceptedDate": "2025-12-19 16:06:10", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312525326810/0001193125-25-326810-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312525326810/d31841dsctota.htm"}}
{"date": "2025-12-17", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-12-17 00:00:00", "acceptedDate": "2025-12-17 17:15:56", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312525322941/0001193125-25-322941-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312525322941/d87372dsctota.htm"}}
{"date": "2025-12-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-12-05 00:00:00", "acceptedDate": "2025-12-05 17:08:05", "formType": "SC TO-T", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312525309877/0001193125-25-309877-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312525309877/d78449dsctot.htm"}}
{"date": "2025-12-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-12-04 00:00:00", "acceptedDate": "2025-12-04 16:36:38", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828025055388/0001628280-25-055388-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828025055388/mrk-20251204.htm"}}
{"date": "2025-12-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-12-03 00:00:00", "acceptedDate": "2025-12-03 16:22:15", "formType": "424B5", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828025055041/0001628280-25-055041-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828025055041/merck-finalprospectussuppl.htm"}}
{"date": "2025-12-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-12-02 00:00:00", "acceptedDate": "2025-12-01 20:19:38", "formType": "FWP", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828025054565/0001628280-25-054565-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828025054565/merck-fwp.htm"}}
{"date": "2025-12-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-12-01 00:00:00", "acceptedDate": "2025-12-01 08:13:38", "formType": "424B5", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828025054305/0001628280-25-054305-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828025054305/merck-preliminaryprospectu.htm"}}
{"date": "2025-11-12", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-11-12 00:00:00", "acceptedDate": "2025-11-12 16:11:52", "formType": "13F-HR", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000063/0000310158-25-000063-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000063/form13fhrinfotable93025.xml"}}
{"date": "2025-11-12", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-11-12 00:00:00", "acceptedDate": "2025-11-12 16:01:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000061/0000310158-25-000061-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000061/xslF345X05/form4.xml"}}
{"date": "2025-11-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-11-05 00:00:00", "acceptedDate": "2025-11-05 16:08:41", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/mrk-20250930.htm"}}
{"date": "2025-11-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-11-04 00:00:00", "acceptedDate": "2025-11-04 16:02:03", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000056/0000310158-25-000056-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000056/xslF345X05/form4.xml"}}
{"date": "2025-10-30", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-10-30 00:00:00", "acceptedDate": "2025-10-30 06:40:38", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465925103974/0001104659-25-103974-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465925103974/tm2529620d1_8k.htm"}}
{"date": "2025-10-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-10-02 00:00:00", "acceptedDate": "2025-10-02 09:31:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000053/0000310158-25-000053-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000053/xslF345X05/form4.xml"}}
{"date": "2025-10-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-10-02 00:00:00", "acceptedDate": "2025-10-02 09:29:34", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000051/0000310158-25-000051-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000051/xslF345X05/form4.xml"}}
{"date": "2025-10-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-10-02 00:00:00", "acceptedDate": "2025-10-02 09:28:01", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000049/0000310158-25-000049-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000049/xslF345X05/form4.xml"}}
{"date": "2025-09-09", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-09-09 00:00:00", "acceptedDate": "2025-09-09 16:33:09", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000047/0000310158-25-000047-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000047/mrk-20250909.htm"}}
{"date": "2025-09-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-09-04 00:00:00", "acceptedDate": "2025-09-04 16:15:44", "formType": "424B5", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000041/0000310158-25-000041-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000041/merckco-424bfinal.htm"}}
{"date": "2025-09-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-09-03 00:00:00", "acceptedDate": "2025-09-02 18:37:32", "formType": "FWP", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000031/0000310158-25-000031-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000031/merck-pricingtermsheet.htm"}}
{"date": "2025-09-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-09-02 00:00:00", "acceptedDate": "2025-09-02 08:15:19", "formType": "424B5", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000027/0000310158-25-000027-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000027/merckco-424bprelim.htm"}}
{"date": "2025-08-13", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-08-13 00:00:00", "acceptedDate": "2025-08-13 17:05:55", "formType": "13F-HR", "link": "https://www.sec.gov/Archives/edgar/data/310158/000169130425000005/0001691304-25-000005-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000169130425000005/form13finfotableq22025.xml"}}
{"date": "2025-08-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-08-05 00:00:00", "acceptedDate": "2025-08-05 16:13:52", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000014/0000310158-25-000014-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000014/mrk-20250630.htm"}}
{"date": "2025-08-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-08-05 00:00:00", "acceptedDate": "2025-08-05 08:46:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000012/0000310158-25-000012-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000012/xslF345X05/form4.xml"}}
{"date": "2025-08-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-08-05 00:00:00", "acceptedDate": "2025-08-05 08:43:24", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000010/0000310158-25-000010-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000010/xslF345X05/form4.xml"}}
{"date": "2025-07-29", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-07-29 00:00:00", "acceptedDate": "2025-07-29 06:42:43", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465925071380/0001104659-25-071380-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465925071380/tm2521736d1_ex99-1.htm"}}
{"date": "2025-07-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-07-02 00:00:00", "acceptedDate": "2025-07-02 12:08:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225018465/0001127602-25-018465-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225018465/xslF345X05/form4.xml"}}
{"date": "2025-07-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-07-02 00:00:00", "acceptedDate": "2025-07-02 12:06:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225018463/0001127602-25-018463-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225018463/xslF345X05/form4.xml"}}
{"date": "2025-07-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-07-02 00:00:00", "acceptedDate": "2025-07-02 12:04:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225018460/0001127602-25-018460-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225018460/xslF345X05/form4.xml"}}
{"date": "2025-06-27", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-06-27 00:00:00", "acceptedDate": "2025-06-27 14:16:51", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828025033262/0001628280-25-033262-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828025033262/a11-k_msdpuertoricosavings.htm"}}
{"date": "2025-06-27", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-06-27 00:00:00", "acceptedDate": "2025-06-27 14:12:30", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828025033255/0001628280-25-033255-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828025033255/a11-k_merckussavingsplanye.htm"}}
{"date": "2025-06-27", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-06-27 00:00:00", "acceptedDate": "2025-06-27 14:08:51", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828025033252/0001628280-25-033252-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828025033252/a11-k_msdemployeestockpurc.htm"}}
{"date": "2025-06-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-06-03 00:00:00", "acceptedDate": "2025-06-03 13:45:50", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225016390/0001127602-25-016390-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225016390/xslF345X05/form4.xml"}}
{"date": "2025-06-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-06-03 00:00:00", "acceptedDate": "2025-06-03 13:25:24", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225016373/0001127602-25-016373-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225016373/xslF345X05/form4.xml"}}
{"date": "2025-06-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-06-03 00:00:00", "acceptedDate": "2025-06-03 13:22:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225016370/0001127602-25-016370-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225016370/xslF345X05/form4.xml"}}
{"date": "2025-06-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-06-03 00:00:00", "acceptedDate": "2025-06-03 13:21:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225016367/0001127602-25-016367-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225016367/xslF345X05/form4.xml"}}
{"date": "2025-06-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-06-03 00:00:00", "acceptedDate": "2025-06-03 13:18:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225016365/0001127602-25-016365-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225016365/xslF345X05/form4.xml"}}
{"date": "2025-06-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-06-03 00:00:00", "acceptedDate": "2025-06-03 13:14:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225016360/0001127602-25-016360-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225016360/xslF345X05/form4.xml"}}
{"date": "2025-06-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-06-03 00:00:00", "acceptedDate": "2025-06-03 13:05:40", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225016354/0001127602-25-016354-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225016354/xslF345X05/form4.xml"}}
{"date": "2025-06-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-06-03 00:00:00", "acceptedDate": "2025-06-03 12:58:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225016350/0001127602-25-016350-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225016350/xslF345X05/form4.xml"}}
{"date": "2025-06-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-06-03 00:00:00", "acceptedDate": "2025-06-03 12:55:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225016347/0001127602-25-016347-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225016347/xslF345X05/form4.xml"}}
{"date": "2025-06-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-06-03 00:00:00", "acceptedDate": "2025-06-03 12:53:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225016345/0001127602-25-016345-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225016345/xslF345X05/form4.xml"}}
{"date": "2025-06-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-06-03 00:00:00", "acceptedDate": "2025-06-03 12:51:42", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225016343/0001127602-25-016343-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225016343/xslF345X05/form4.xml"}}
{"date": "2025-06-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-06-03 00:00:00", "acceptedDate": "2025-06-03 12:49:42", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225016340/0001127602-25-016340-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225016340/xslF345X05/form4.xml"}}
{"date": "2025-05-30", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-05-30 00:00:00", "acceptedDate": "2025-05-30 09:56:39", "formType": "SD", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465925054621/0001104659-25-054621-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465925054621/tm2515985d1_sd.htm"}}
{"date": "2025-05-29", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-05-29 00:00:00", "acceptedDate": "2025-05-29 13:46:56", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465925054131/0001104659-25-054131-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465925054131/tm2516491d1_8k.htm"}}
{"date": "2025-05-14", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-05-14 00:00:00", "acceptedDate": "2025-05-14 16:02:08", "formType": "13F-HR", "link": "https://www.sec.gov/Archives/edgar/data/310158/000006497825000005/0000064978-25-000005-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000006497825000005/13fhrinfotable033125.xml"}}
{"date": "2025-05-07", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-05-07 00:00:00", "acceptedDate": "2025-05-06 18:19:37", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/310158/000109690625000695/0001096906-25-000695-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000109690625000695/nlpc_px14a6g.htm"}}
{"date": "2025-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-05-05 00:00:00", "acceptedDate": "2025-05-05 16:23:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013348/0001127602-25-013348-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013348/xslF345X05/form4.xml"}}
{"date": "2025-05-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-05-02 00:00:00", "acceptedDate": "2025-05-02 16:18:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013190/0001127602-25-013190-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013190/xslF345X05/form4.xml"}}
{"date": "2025-05-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-05-02 00:00:00", "acceptedDate": "2025-05-02 16:14:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013182/0001127602-25-013182-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013182/xslF345X05/form4.xml"}}
{"date": "2025-05-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-05-02 00:00:00", "acceptedDate": "2025-05-02 16:12:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013174/0001127602-25-013174-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013174/xslF345X05/form4.xml"}}
{"date": "2025-05-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-05-02 00:00:00", "acceptedDate": "2025-05-02 16:10:24", "formType": "4/A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013170/0001127602-25-013170-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013170/xslF345X05/form4a.xml"}}
{"date": "2025-05-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-05-02 00:00:00", "acceptedDate": "2025-05-02 16:10:22", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828025021834/0001628280-25-021834-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828025021834/mrk-20250331.htm"}}
{"date": "2025-05-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-05-02 00:00:00", "acceptedDate": "2025-05-02 16:07:21", "formType": "4/A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013165/0001127602-25-013165-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013165/xslF345X05/form4a.xml"}}
{"date": "2025-05-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-05-01 00:00:00", "acceptedDate": "2025-05-01 18:19:37", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013057/0001127602-25-013057-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013057/xslF345X05/form4.xml"}}
{"date": "2025-05-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-05-01 00:00:00", "acceptedDate": "2025-05-01 18:15:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013055/0001127602-25-013055-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013055/xslF345X05/form4.xml"}}
{"date": "2025-05-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-05-01 00:00:00", "acceptedDate": "2025-05-01 18:13:51", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013053/0001127602-25-013053-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013053/xslF345X05/form4.xml"}}
{"date": "2025-05-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-05-01 00:00:00", "acceptedDate": "2025-05-01 18:12:34", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013051/0001127602-25-013051-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013051/xslF345X05/form4.xml"}}
{"date": "2025-05-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-05-01 00:00:00", "acceptedDate": "2025-05-01 18:10:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013049/0001127602-25-013049-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013049/xslF345X05/form4.xml"}}
{"date": "2025-05-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-05-01 00:00:00", "acceptedDate": "2025-05-01 18:07:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013046/0001127602-25-013046-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013046/xslF345X05/form4.xml"}}
{"date": "2025-05-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-05-01 00:00:00", "acceptedDate": "2025-05-01 18:06:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013043/0001127602-25-013043-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013043/xslF345X05/form4.xml"}}
{"date": "2025-05-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-05-01 00:00:00", "acceptedDate": "2025-05-01 18:04:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013039/0001127602-25-013039-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013039/xslF345X05/form4.xml"}}
{"date": "2025-05-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-05-01 00:00:00", "acceptedDate": "2025-05-01 18:03:00", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013037/0001127602-25-013037-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013037/xslF345X05/form4.xml"}}
{"date": "2025-05-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-05-01 00:00:00", "acceptedDate": "2025-05-01 18:00:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013034/0001127602-25-013034-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013034/xslF345X05/form4.xml"}}
{"date": "2025-05-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-05-01 00:00:00", "acceptedDate": "2025-05-01 17:58:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013031/0001127602-25-013031-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013031/xslF345X05/form4.xml"}}
{"date": "2025-05-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-05-01 00:00:00", "acceptedDate": "2025-05-01 17:45:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013018/0001127602-25-013018-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013018/xslF345X05/form4.xml"}}
{"date": "2025-05-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-05-01 00:00:00", "acceptedDate": "2025-05-01 17:43:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013014/0001127602-25-013014-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225013014/xslF345X05/form4.xml"}}
{"date": "2025-04-29", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-04-29 00:00:00", "acceptedDate": "2025-04-29 16:04:40", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225012727/0001127602-25-012727-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225012727/xslF345X05/form4.xml"}}
{"date": "2025-04-24", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-04-24 00:00:00", "acceptedDate": "2025-04-24 06:45:16", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465925038301/0001104659-25-038301-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465925038301/tm2512885d1_ex99-1.htm"}}
{"date": "2025-04-24", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-04-24 00:00:00", "acceptedDate": "2025-04-23 19:08:53", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/310158/000121465925006301/0001214659-25-006301-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000121465925006301/p423257px14a6g.htm"}}
{"date": "2025-04-15", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-04-15 00:00:00", "acceptedDate": "2025-04-15 16:35:50", "formType": "ARS", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828025017867/0001628280-25-017867-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828025017867/formars202410-k.pdf"}}
{"date": "2025-04-14", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-04-14 00:00:00", "acceptedDate": "2025-04-14 12:28:19", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/310158/000121465925005819/0001214659-25-005819-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000121465925005819/e414251px14a6g.htm"}}
{"date": "2025-04-09", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-04-09 00:00:00", "acceptedDate": "2025-04-09 16:22:47", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312525076870/0001193125-25-076870-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312525076870/d949921ddefa14a.htm"}}
{"date": "2025-04-09", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-04-09 00:00:00", "acceptedDate": "2025-04-09 16:16:20", "formType": "DEF 14A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312525076859/0001193125-25-076859-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312525076859/d151723ddef14a.htm"}}
{"date": "2025-04-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-04-02 00:00:00", "acceptedDate": "2025-04-02 09:57:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225010926/0001127602-25-010926-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225010926/xslF345X05/form4.xml"}}
{"date": "2025-04-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-04-02 00:00:00", "acceptedDate": "2025-04-02 09:53:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225010922/0001127602-25-010922-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225010922/xslF345X05/form4.xml"}}
{"date": "2025-04-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-04-02 00:00:00", "acceptedDate": "2025-04-02 09:50:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225010918/0001127602-25-010918-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225010918/xslF345X05/form4.xml"}}
{"date": "2025-03-06", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-03-06 00:00:00", "acceptedDate": "2025-03-06 14:08:52", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000093247125000355/0000932471-25-000355-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/102909/000093247125000355/xslSCHEDULE_13G_X01/primary_doc.xml"}}
{"date": "2025-02-25", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-02-25 00:00:00", "acceptedDate": "2025-02-25 16:19:11", "formType": "10-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/mrk-20241231.htm"}}
{"date": "2025-02-20", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-02-20 00:00:00", "acceptedDate": "2025-02-20 16:01:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225005928/0001127602-25-005928-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225005928/xslF345X05/form4.xml"}}
{"date": "2025-02-14", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-02-14 00:00:00", "acceptedDate": "2025-02-14 11:14:05", "formType": "13F-HR", "link": "https://www.sec.gov/Archives/edgar/data/310158/000089534525000055/0000895345-25-000055-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000089534525000055/informationtable.xml"}}
{"date": "2025-02-13", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-02-13 00:00:00", "acceptedDate": "2025-02-13 16:01:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225004615/0001127602-25-004615-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225004615/xslF345X05/form4.xml"}}
{"date": "2025-02-11", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-02-11 00:00:00", "acceptedDate": "2025-02-11 14:59:22", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225004103/0001127602-25-004103-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225004103/xslF345X05/form4.xml"}}
{"date": "2025-02-07", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-02-07 00:00:00", "acceptedDate": "2025-02-07 16:09:51", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225003559/0001127602-25-003559-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225003559/xslF345X05/form4.xml"}}
{"date": "2025-02-07", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-02-07 00:00:00", "acceptedDate": "2025-02-07 16:07:43", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225003552/0001127602-25-003552-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225003552/xslF345X05/form4.xml"}}
{"date": "2025-02-07", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-02-07 00:00:00", "acceptedDate": "2025-02-07 16:04:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225003547/0001127602-25-003547-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225003547/xslF345X05/form4.xml"}}
{"date": "2025-02-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-02-04 00:00:00", "acceptedDate": "2025-02-04 06:45:47", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465925008863/0001104659-25-008863-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465925008863/tm255059d1_ex99-1.htm"}}
{"date": "2025-02-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-02-03 00:00:00", "acceptedDate": "2025-02-03 16:15:22", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465925008629/0001104659-25-008629-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465925008629/xslSCHEDULE_13G_X01/primary_doc.xml"}}
{"date": "2025-01-29", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-01-29 00:00:00", "acceptedDate": "2025-01-29 18:29:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225002357/0001127602-25-002357-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225002357/xslF345X05/form4.xml"}}
{"date": "2025-01-29", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-01-29 00:00:00", "acceptedDate": "2025-01-29 18:27:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225002355/0001127602-25-002355-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225002355/xslF345X05/form4.xml"}}
{"date": "2025-01-29", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-01-29 00:00:00", "acceptedDate": "2025-01-29 18:25:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225002353/0001127602-25-002353-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225002353/xslF345X05/form4.xml"}}
{"date": "2025-01-29", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-01-29 00:00:00", "acceptedDate": "2025-01-29 18:23:37", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225002351/0001127602-25-002351-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225002351/xslF345X05/form4.xml"}}
{"date": "2025-01-29", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-01-29 00:00:00", "acceptedDate": "2025-01-29 18:21:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225002349/0001127602-25-002349-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225002349/xslF345X05/form4.xml"}}
{"date": "2025-01-29", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-01-29 00:00:00", "acceptedDate": "2025-01-29 18:19:34", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225002346/0001127602-25-002346-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225002346/xslF345X05/form4.xml"}}
{"date": "2025-01-29", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-01-29 00:00:00", "acceptedDate": "2025-01-29 18:17:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225002344/0001127602-25-002344-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225002344/xslF345X05/form4.xml"}}
{"date": "2025-01-29", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-01-29 00:00:00", "acceptedDate": "2025-01-29 18:14:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225002341/0001127602-25-002341-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225002341/xslF345X05/form4.xml"}}
{"date": "2025-01-29", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-01-29 00:00:00", "acceptedDate": "2025-01-29 18:12:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225002338/0001127602-25-002338-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225002338/xslF345X05/form4.xml"}}
{"date": "2025-01-29", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-01-29 00:00:00", "acceptedDate": "2025-01-29 18:09:19", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225002336/0001127602-25-002336-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225002336/xslF345X05/form4.xml"}}
{"date": "2025-01-29", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-01-29 00:00:00", "acceptedDate": "2025-01-29 18:07:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225002334/0001127602-25-002334-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225002334/xslF345X05/form4.xml"}}
{"date": "2025-01-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-01-03 00:00:00", "acceptedDate": "2025-01-03 13:57:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225000275/0001127602-25-000275-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225000275/xslF345X05/form4.xml"}}
{"date": "2025-01-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-01-03 00:00:00", "acceptedDate": "2025-01-03 13:55:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225000271/0001127602-25-000271-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225000271/xslF345X05/form4.xml"}}
{"date": "2025-01-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-01-03 00:00:00", "acceptedDate": "2025-01-03 13:53:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225000267/0001127602-25-000267-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225000267/xslF345X05/form4.xml"}}
{"date": "2025-01-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-01-03 00:00:00", "acceptedDate": "2025-01-03 12:59:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225000246/0001127602-25-000246-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225000246/xslF345X05/form4.xml"}}
{"date": "2025-01-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2025-01-03 00:00:00", "acceptedDate": "2025-01-03 12:55:09", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760225000242/0001127602-25-000242-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760225000242/xslF345X02/form3.xml"}}
{"date": "2024-12-23", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-12-23 00:00:00", "acceptedDate": "2024-12-23 07:32:39", "formType": "SC 13G", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465924131061/0001104659-24-131061-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465924131061/xslSCHEDULE_13G_X01/primary_doc.xml"}}
{"date": "2024-12-23", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-12-23 00:00:00", "acceptedDate": "2024-12-23 06:00:18", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465924130971/0001104659-24-130971-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/64978/000110465924130971/xslF345X02/tm2431704-2_3seq1.xml"}}
{"date": "2024-11-22", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-11-22 00:00:00", "acceptedDate": "2024-11-22 14:28:06", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465924122027/0001104659-24-122027-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465924122027/tm2429161d1_ex3-1.htm"}}
{"date": "2024-11-06", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-11-06 00:00:00", "acceptedDate": "2024-11-06 16:09:57", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000089534524000536/0000895345-24-000536-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000089534524000536/ff4087100_13ga1-evaxion.htm"}}
{"date": "2024-11-06", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-11-06 00:00:00", "acceptedDate": "2024-11-06 16:05:36", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/0001628280-24-045689-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/mrk-20240930.htm"}}
{"date": "2024-11-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-11-04 00:00:00", "acceptedDate": "2024-11-04 10:05:27", "formType": "25-NSE", "link": "https://www.sec.gov/Archives/edgar/data/310158/000087666124001036/0000876661-24-001036-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000087666124001036/xslF25X02/primary_doc.xml"}}
{"date": "2024-10-31", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-10-31 00:00:00", "acceptedDate": "2024-10-31 06:44:02", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465924112841/0001104659-24-112841-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465924112841/tm2426878d1_ex99-1.htm"}}
{"date": "2024-10-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-10-01 00:00:00", "acceptedDate": "2024-10-01 14:16:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224024643/0001127602-24-024643-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224024643/xslF345X05/form4.xml"}}
{"date": "2024-10-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-10-01 00:00:00", "acceptedDate": "2024-10-01 14:10:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224024641/0001127602-24-024641-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224024641/xslF345X05/form4.xml"}}
{"date": "2024-10-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-10-01 00:00:00", "acceptedDate": "2024-10-01 14:06:03", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224024639/0001127602-24-024639-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224024639/xslF345X05/form4.xml"}}
{"date": "2024-08-06", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-08-06 00:00:00", "acceptedDate": "2024-08-06 12:20:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224021690/0001127602-24-021690-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224021690/xslF345X05/form4.xml"}}
{"date": "2024-08-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-08-05 00:00:00", "acceptedDate": "2024-08-05 16:02:11", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828024034715/0001628280-24-034715-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828024034715/mrk-20240630.htm"}}
{"date": "2024-07-30", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-07-30 00:00:00", "acceptedDate": "2024-07-30 06:41:50", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465924083722/0001104659-24-083722-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465924083722/tm2420272d1_ex99-1.htm"}}
{"date": "2024-07-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-07-02 00:00:00", "acceptedDate": "2024-07-02 13:25:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224019749/0001127602-24-019749-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224019749/xslF345X05/form4.xml"}}
{"date": "2024-07-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-07-02 00:00:00", "acceptedDate": "2024-07-02 13:23:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224019747/0001127602-24-019747-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224019747/xslF345X05/form4.xml"}}
{"date": "2024-07-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-07-02 00:00:00", "acceptedDate": "2024-07-02 13:20:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224019745/0001127602-24-019745-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224019745/xslF345X05/form4.xml"}}
{"date": "2024-06-25", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-06-25 00:00:00", "acceptedDate": "2024-06-25 13:38:29", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828024029764/0001628280-24-029764-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828024029764/a11-k_msdemployeestockpurc.htm"}}
{"date": "2024-06-25", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-06-25 00:00:00", "acceptedDate": "2024-06-25 13:37:56", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828024029763/0001628280-24-029763-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828024029763/a11-k_msdpuertoricosavings.htm"}}
{"date": "2024-06-25", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-06-25 00:00:00", "acceptedDate": "2024-06-25 13:37:27", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828024029762/0001628280-24-029762-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828024029762/a11-k_merckussavingsplanye.htm"}}
{"date": "2024-06-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-06-04 00:00:00", "acceptedDate": "2024-06-04 15:02:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224017600/0001127602-24-017600-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224017600/xslF345X05/form4.xml"}}
{"date": "2024-06-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-06-04 00:00:00", "acceptedDate": "2024-06-04 15:00:43", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224017597/0001127602-24-017597-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224017597/xslF345X05/form4.xml"}}
{"date": "2024-06-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-06-04 00:00:00", "acceptedDate": "2024-06-04 14:59:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224017595/0001127602-24-017595-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224017595/xslF345X05/form4.xml"}}
{"date": "2024-06-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-06-04 00:00:00", "acceptedDate": "2024-06-04 14:55:30", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224017592/0001127602-24-017592-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224017592/xslF345X05/form4.xml"}}
{"date": "2024-06-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-06-04 00:00:00", "acceptedDate": "2024-06-04 14:44:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224017586/0001127602-24-017586-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224017586/xslF345X05/form4.xml"}}
{"date": "2024-06-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-06-04 00:00:00", "acceptedDate": "2024-06-04 14:44:03", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224017585/0001127602-24-017585-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224017585/xslF345X05/form4.xml"}}
{"date": "2024-06-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-06-04 00:00:00", "acceptedDate": "2024-06-04 14:41:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224017580/0001127602-24-017580-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224017580/xslF345X05/form4.xml"}}
{"date": "2024-06-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-06-04 00:00:00", "acceptedDate": "2024-06-04 14:38:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224017578/0001127602-24-017578-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224017578/xslF345X05/form4.xml"}}
{"date": "2024-06-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-06-04 00:00:00", "acceptedDate": "2024-06-04 14:34:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224017576/0001127602-24-017576-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224017576/xslF345X05/form4.xml"}}
{"date": "2024-06-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-06-04 00:00:00", "acceptedDate": "2024-06-04 14:32:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224017574/0001127602-24-017574-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224017574/xslF345X05/form4.xml"}}
{"date": "2024-06-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-06-04 00:00:00", "acceptedDate": "2024-06-04 14:15:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224017571/0001127602-24-017571-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224017571/xslF345X05/form4.xml"}}
{"date": "2024-05-30", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-30 00:00:00", "acceptedDate": "2024-05-30 16:39:33", "formType": "CERT", "link": "https://www.sec.gov/Archives/edgar/data/310158/000087666124000434/0000876661-24-000434-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000087666124000434/MRKNotes053024.pdf"}}
{"date": "2024-05-30", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-30 00:00:00", "acceptedDate": "2024-05-30 16:28:13", "formType": "8-A12B", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828024025816/0001628280-24-025816-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828024025816/merck-form8xa.htm"}}
{"date": "2024-05-30", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-30 00:00:00", "acceptedDate": "2024-05-30 16:14:21", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828024025800/0001628280-24-025800-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828024025800/exhibit41-8xk.htm"}}
{"date": "2024-05-28", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-28 00:00:00", "acceptedDate": "2024-05-28 16:31:44", "formType": "SD", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465924065620/0001104659-24-065620-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465924065620/tm2414280d1_sd.htm"}}
{"date": "2024-05-20", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-20 00:00:00", "acceptedDate": "2024-05-20 06:28:28", "formType": "424B5", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828024024209/0001628280-24-024209-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828024024209/merckco-424b5final.htm"}}
{"date": "2024-05-16", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-16 00:00:00", "acceptedDate": "2024-05-16 16:15:53", "formType": "FWP", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828024023789/0001628280-24-023789-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828024023789/msd-fwp.htm"}}
{"date": "2024-05-15", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-15 00:00:00", "acceptedDate": "2024-05-15 16:07:34", "formType": "424B5", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828024023547/0001628280-24-023547-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828024023547/merckco-424bprelim.htm"}}
{"date": "2024-05-15", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-15 00:00:00", "acceptedDate": "2024-05-15 11:31:53", "formType": "POSASR", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828024023433/0001628280-24-023433-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828024023433/merckco-posasr.htm"}}
{"date": "2024-05-06", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-06 00:00:00", "acceptedDate": "2024-05-06 16:10:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224014271/0001127602-24-014271-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224014271/xslF345X05/form4.xml"}}
{"date": "2024-05-06", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-06 00:00:00", "acceptedDate": "2024-05-06 16:08:55", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224014269/0001127602-24-014269-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224014269/xslF345X05/form4.xml"}}
{"date": "2024-05-06", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-06 00:00:00", "acceptedDate": "2024-05-06 16:06:55", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224014265/0001127602-24-014265-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224014265/xslF345X05/form4.xml"}}
{"date": "2024-05-06", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-06 00:00:00", "acceptedDate": "2024-05-06 16:01:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224014263/0001127602-24-014263-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224014263/xslF345X05/form4.xml"}}
{"date": "2024-05-06", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-06 00:00:00", "acceptedDate": "2024-05-06 09:29:56", "formType": "144", "link": "https://www.sec.gov/Archives/edgar/data/310158/000195004724003402/0001950047-24-003402-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000195004724003402/xsl144X01/primary_doc.xml"}}
{"date": "2024-05-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-03 00:00:00", "acceptedDate": "2024-05-03 16:10:43", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828024020283/0001628280-24-020283-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828024020283/mrk-20240331.htm"}}
{"date": "2024-05-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-02 00:00:00", "acceptedDate": "2024-05-02 16:29:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013994/0001127602-24-013994-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013994/xslF345X05/form4.xml"}}
{"date": "2024-05-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-02 00:00:00", "acceptedDate": "2024-05-02 16:25:48", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013989/0001127602-24-013989-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013989/xslF345X05/form4.xml"}}
{"date": "2024-05-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-02 00:00:00", "acceptedDate": "2024-05-02 16:23:48", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013981/0001127602-24-013981-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013981/xslF345X05/form4.xml"}}
{"date": "2024-05-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-02 00:00:00", "acceptedDate": "2024-05-02 16:22:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013976/0001127602-24-013976-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013976/xslF345X05/form4.xml"}}
{"date": "2024-05-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-02 00:00:00", "acceptedDate": "2024-05-02 16:20:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013970/0001127602-24-013970-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013970/xslF345X05/form4.xml"}}
{"date": "2024-05-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-02 00:00:00", "acceptedDate": "2024-05-02 16:19:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013964/0001127602-24-013964-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013964/xslF345X05/form4.xml"}}
{"date": "2024-05-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-02 00:00:00", "acceptedDate": "2024-05-02 16:17:40", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013958/0001127602-24-013958-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013958/xslF345X05/form4.xml"}}
{"date": "2024-05-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-02 00:00:00", "acceptedDate": "2024-05-02 16:15:55", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013953/0001127602-24-013953-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013953/xslF345X05/form4.xml"}}
{"date": "2024-05-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-02 00:00:00", "acceptedDate": "2024-05-02 16:14:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013947/0001127602-24-013947-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013947/xslF345X05/form4.xml"}}
{"date": "2024-05-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-02 00:00:00", "acceptedDate": "2024-05-02 16:13:01", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013943/0001127602-24-013943-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013943/xslF345X05/form4.xml"}}
{"date": "2024-05-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-02 00:00:00", "acceptedDate": "2024-05-02 16:11:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013937/0001127602-24-013937-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013937/xslF345X05/form4.xml"}}
{"date": "2024-05-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-02 00:00:00", "acceptedDate": "2024-05-02 16:09:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013930/0001127602-24-013930-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013930/xslF345X05/form4.xml"}}
{"date": "2024-05-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-02 00:00:00", "acceptedDate": "2024-05-02 16:07:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013922/0001127602-24-013922-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013922/xslF345X05/form4.xml"}}
{"date": "2024-05-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-05-02 00:00:00", "acceptedDate": "2024-05-02 16:05:55", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013916/0001127602-24-013916-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224013916/xslF345X05/form4.xml"}}
{"date": "2024-04-25", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-04-25 00:00:00", "acceptedDate": "2024-04-25 06:41:15", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465924051517/0001104659-24-051517-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465924051517/tm2412490d1_ex99-1.htm"}}
{"date": "2024-04-11", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-04-11 00:00:00", "acceptedDate": "2024-04-11 16:12:25", "formType": "ARS", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828024015812/0001628280-24-015812-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828024015812/merck_10-kxarsx4.pdf"}}
{"date": "2024-04-11", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-04-11 00:00:00", "acceptedDate": "2024-04-11 16:10:56", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312524093221/0001193125-24-093221-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312524093221/d500367ddefa14a.htm"}}
{"date": "2024-04-11", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-04-11 00:00:00", "acceptedDate": "2024-04-11 16:08:27", "formType": "DEF 14A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312524093204/0001193125-24-093204-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312524093204/d500367ddef14a.htm"}}
{"date": "2024-04-11", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-04-11 00:00:00", "acceptedDate": "2024-04-11 16:05:38", "formType": "10-K/A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312524093194/0001193125-24-093194-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312524093194/d807955d10ka.htm"}}
{"date": "2024-04-08", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-04-08 00:00:00", "acceptedDate": "2024-04-08 13:56:05", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224012645/0001127602-24-012645-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224012645/xslF345X02/form3.xml"}}
{"date": "2024-04-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-04-01 00:00:00", "acceptedDate": "2024-04-01 17:16:09", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/310158/000109690624000709/0001096906-24-000709-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000109690624000709/insp_px14a6g.htm"}}
{"date": "2024-03-29", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-03-29 00:00:00", "acceptedDate": "2024-03-29 16:18:48", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224011450/0001127602-24-011450-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224011450/xslF345X05/form4.xml"}}
{"date": "2024-03-29", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-03-29 00:00:00", "acceptedDate": "2024-03-29 16:16:43", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224011448/0001127602-24-011448-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224011448/xslF345X05/form4.xml"}}
{"date": "2024-03-29", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-03-29 00:00:00", "acceptedDate": "2024-03-29 16:14:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224011446/0001127602-24-011446-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224011446/xslF345X05/form4.xml"}}
{"date": "2024-03-29", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-03-29 00:00:00", "acceptedDate": "2024-03-29 16:12:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224011444/0001127602-24-011444-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224011444/xslF345X05/form4.xml"}}
{"date": "2024-03-28", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-03-28 00:00:00", "acceptedDate": "2024-03-27 20:57:27", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/310158/000109690624000638/0001096906-24-000638-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000109690624000638/bowy_px14a6g.htm"}}
{"date": "2024-03-19", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-03-19 00:00:00", "acceptedDate": "2024-03-19 16:28:12", "formType": "S-3ASR", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312524071348/0001193125-24-071348-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312524071348/d809857ds3asr.htm"}}
{"date": "2024-03-19", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-03-19 00:00:00", "acceptedDate": "2024-03-19 16:26:41", "formType": "S-3ASR", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312524071343/0001193125-24-071343-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312524071343/d774797ds3asr.htm"}}
{"date": "2024-03-11", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-03-11 00:00:00", "acceptedDate": "2024-03-11 15:27:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000095017024029165/0000950170-24-029165-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/64978/000095017024029165/xslF345X05/ownership.xml"}}
{"date": "2024-02-26", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-02-26 00:00:00", "acceptedDate": "2024-02-26 09:06:55", "formType": "10-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828024006850/0001628280-24-006850-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828024006850/mrk-20231231.htm"}}
{"date": "2024-02-20", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 16:14:41", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465924025524/0001104659-24-025524-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465924025524/0001104659-24-025524.txt"}}
{"date": "2024-02-15", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-02-15 00:00:00", "acceptedDate": "2024-02-15 16:03:47", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224005196/0001127602-24-005196-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224005196/xslF345X05/form4.xml"}}
{"date": "2024-02-15", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-02-15 00:00:00", "acceptedDate": "2024-02-15 16:01:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224005191/0001127602-24-005191-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224005191/xslF345X05/form4.xml"}}
{"date": "2024-02-14", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 16:03:40", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224004993/0001127602-24-004993-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224004993/xslF345X05/form4.xml"}}
{"date": "2024-02-14", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 09:40:23", "formType": "144", "link": "https://www.sec.gov/Archives/edgar/data/310158/000195004724000931/0001950047-24-000931-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000195004724000931/xsl144X01/primary_doc.xml"}}
{"date": "2024-02-14", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 09:30:41", "formType": "144", "link": "https://www.sec.gov/Archives/edgar/data/310158/000195004724000927/0001950047-24-000927-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000195004724000927/xsl144X01/primary_doc.xml"}}
{"date": "2024-02-14", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 09:24:35", "formType": "144", "link": "https://www.sec.gov/Archives/edgar/data/310158/000195004724000923/0001950047-24-000923-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000195004724000923/xsl144X01/primary_doc.xml"}}
{"date": "2024-02-13", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-02-13 00:00:00", "acceptedDate": "2024-02-13 16:55:49", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465924020082/0001104659-24-020082-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/102909/000110465924020082/tv0090-merckcoinc.htm"}}
{"date": "2024-02-13", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-02-13 00:00:00", "acceptedDate": "2024-02-13 09:50:19", "formType": "144", "link": "https://www.sec.gov/Archives/edgar/data/310158/000195004724000906/0001950047-24-000906-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000195004724000906/xsl144X01/primary_doc.xml"}}
{"date": "2024-02-13", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-02-13 00:00:00", "acceptedDate": "2024-02-13 09:48:55", "formType": "144", "link": "https://www.sec.gov/Archives/edgar/data/310158/000195004724000905/0001950047-24-000905-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000195004724000905/xsl144X01/primary_doc.xml"}}
{"date": "2024-02-12", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-02-12 00:00:00", "acceptedDate": "2024-02-12 16:03:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224004438/0001127602-24-004438-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224004438/xslF345X05/form4.xml"}}
{"date": "2024-02-09", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-02-09 00:00:00", "acceptedDate": "2024-02-09 09:06:44", "formType": "144", "link": "https://www.sec.gov/Archives/edgar/data/310158/000195004724000784/0001950047-24-000784-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000195004724000784/xsl144X01/primary_doc.xml"}}
{"date": "2024-02-08", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-02-08 00:00:00", "acceptedDate": "2024-02-08 16:04:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224003969/0001127602-24-003969-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224003969/xslF345X05/form4.xml"}}
{"date": "2024-02-07", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-02-07 00:00:00", "acceptedDate": "2024-02-07 09:09:01", "formType": "144", "link": "https://www.sec.gov/Archives/edgar/data/310158/000195004724000712/0001950047-24-000712-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000195004724000712/xsl144X01/primary_doc.xml"}}
{"date": "2024-02-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-02-05 00:00:00", "acceptedDate": "2024-02-05 16:01:30", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224003352/0001127602-24-003352-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224003352/xslF345X05/form4.xml"}}
{"date": "2024-02-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-02-02 00:00:00", "acceptedDate": "2024-02-02 16:07:51", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224003099/0001127602-24-003099-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224003099/xslF345X05/form4.xml"}}
{"date": "2024-02-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-02-02 00:00:00", "acceptedDate": "2024-02-02 16:05:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224003093/0001127602-24-003093-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224003093/xslF345X05/form4.xml"}}
{"date": "2024-02-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-02-02 00:00:00", "acceptedDate": "2024-02-02 09:35:50", "formType": "144", "link": "https://www.sec.gov/Archives/edgar/data/310158/000195004724000626/0001950047-24-000626-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000195004724000626/xsl144X01/primary_doc.xml"}}
{"date": "2024-02-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-02-02 00:00:00", "acceptedDate": "2024-02-02 09:09:01", "formType": "144", "link": "https://www.sec.gov/Archives/edgar/data/310158/000195004724000610/0001950047-24-000610-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000195004724000610/xsl144X01/primary_doc.xml"}}
{"date": "2024-02-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-02-02 00:00:00", "acceptedDate": "2024-02-02 09:08:32", "formType": "144", "link": "https://www.sec.gov/Archives/edgar/data/310158/000195004724000609/0001950047-24-000609-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000195004724000609/xsl144X01/primary_doc.xml"}}
{"date": "2024-02-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-02-01 00:00:00", "acceptedDate": "2024-02-01 06:39:01", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465924009109/0001104659-24-009109-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465924009109/tm244517d1_ex99-1.htm"}}
{"date": "2024-01-26", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-01-26 00:00:00", "acceptedDate": "2024-01-26 11:49:42", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000108636424004323/0001086364-24-004323-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000108636424004323/us58933y1055_012624.txt"}}
{"date": "2024-01-24", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-01-24 00:00:00", "acceptedDate": "2024-01-24 16:17:50", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224002036/0001127602-24-002036-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224002036/xslF345X05/form4.xml"}}
{"date": "2024-01-24", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-01-24 00:00:00", "acceptedDate": "2024-01-24 16:16:20", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224002034/0001127602-24-002034-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224002034/xslF345X05/form4.xml"}}
{"date": "2024-01-24", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-01-24 00:00:00", "acceptedDate": "2024-01-24 16:14:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224002032/0001127602-24-002032-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224002032/xslF345X05/form4.xml"}}
{"date": "2024-01-24", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-01-24 00:00:00", "acceptedDate": "2024-01-24 16:13:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224002029/0001127602-24-002029-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224002029/xslF345X05/form4.xml"}}
{"date": "2024-01-24", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-01-24 00:00:00", "acceptedDate": "2024-01-24 16:11:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224002026/0001127602-24-002026-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224002026/xslF345X05/form4.xml"}}
{"date": "2024-01-24", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-01-24 00:00:00", "acceptedDate": "2024-01-24 16:10:00", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224002024/0001127602-24-002024-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224002024/xslF345X05/form4.xml"}}
{"date": "2024-01-24", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-01-24 00:00:00", "acceptedDate": "2024-01-24 16:08:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224002022/0001127602-24-002022-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224002022/xslF345X05/form4.xml"}}
{"date": "2024-01-24", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-01-24 00:00:00", "acceptedDate": "2024-01-24 16:06:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224002019/0001127602-24-002019-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224002019/xslF345X05/form4.xml"}}
{"date": "2024-01-24", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-01-24 00:00:00", "acceptedDate": "2024-01-24 16:05:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224002015/0001127602-24-002015-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224002015/xslF345X05/form4.xml"}}
{"date": "2024-01-24", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-01-24 00:00:00", "acceptedDate": "2024-01-24 16:03:40", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224002011/0001127602-24-002011-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224002011/xslF345X05/form4.xml"}}
{"date": "2024-01-24", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-01-24 00:00:00", "acceptedDate": "2024-01-24 16:01:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224002008/0001127602-24-002008-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224002008/xslF345X05/form4.xml"}}
{"date": "2024-01-23", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-01-23 00:00:00", "acceptedDate": "2024-01-23 15:29:11", "formType": "SC 13G", "link": "https://www.sec.gov/Archives/edgar/data/310158/000089534524000014/0000895345-24-000014-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000089534524000014/ff2943026_13g-evaxion.htm"}}
{"date": "2024-01-17", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-01-17 00:00:00", "acceptedDate": "2024-01-17 17:52:40", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/310158/000095017024005090/0000950170-24-005090-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/64978/000095017024005090/xslF345X02/ownership.xml"}}
{"date": "2024-01-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-01-02 00:00:00", "acceptedDate": "2024-01-02 16:27:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224000142/0001127602-24-000142-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224000142/xslF345X05/form4.xml"}}
{"date": "2024-01-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-01-02 00:00:00", "acceptedDate": "2024-01-02 16:22:34", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224000138/0001127602-24-000138-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224000138/xslF345X05/form4.xml"}}
{"date": "2024-01-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-01-02 00:00:00", "acceptedDate": "2024-01-02 16:20:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224000133/0001127602-24-000133-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224000133/xslF345X05/form4.xml"}}
{"date": "2024-01-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2024-01-02 00:00:00", "acceptedDate": "2024-01-02 16:18:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760224000129/0001127602-24-000129-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760224000129/xslF345X05/form4.xml"}}
{"date": "2023-12-13", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-12-13 00:00:00", "acceptedDate": "2023-12-13 17:27:54", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223029602/0001127602-23-029602-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223029602/xslF345X02/form3.xml"}}
{"date": "2023-11-28", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-11-28 00:00:00", "acceptedDate": "2023-11-28 16:51:48", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465923121671/0001104659-23-121671-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465923121671/0001104659-23-121671.txt"}}
{"date": "2023-11-13", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-11-13 00:00:00", "acceptedDate": "2023-11-13 07:36:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223027135/0001127602-23-027135-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223027135/xslF345X05/form4.xml"}}
{"date": "2023-11-09", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-11-09 00:00:00", "acceptedDate": "2023-11-09 10:05:52", "formType": "144", "link": "https://www.sec.gov/Archives/edgar/data/310158/000195004723004857/0001950047-23-004857-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000195004723004857/xsl144X01/primary_doc.xml"}}
{"date": "2023-11-09", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-11-09 00:00:00", "acceptedDate": "2023-11-09 09:04:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223027077/0001127602-23-027077-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223027077/xslF345X05/form4.xml"}}
{"date": "2023-11-08", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-11-08 00:00:00", "acceptedDate": "2023-11-08 09:38:43", "formType": "144", "link": "https://www.sec.gov/Archives/edgar/data/310158/000195004723004829/0001950047-23-004829-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000195004723004829/xsl144X01/primary_doc.xml"}}
{"date": "2023-11-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-11-03 00:00:00", "acceptedDate": "2023-11-03 16:10:43", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828023036717/0001628280-23-036717-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828023036717/mrk-20230930.htm"}}
{"date": "2023-11-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-11-01 00:00:00", "acceptedDate": "2023-11-01 15:49:48", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223026457/0001127602-23-026457-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223026457/xslF345X05/form4.xml"}}
{"date": "2023-10-31", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-10-31 00:00:00", "acceptedDate": "2023-10-31 11:08:20", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223026390/0001127602-23-026390-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223026390/xslF345X05/form4.xml"}}
{"date": "2023-10-26", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-10-26 00:00:00", "acceptedDate": "2023-10-26 06:38:04", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465923111585/0001104659-23-111585-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465923111585/tm2328962d1_ex99-1.htm"}}
{"date": "2023-10-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-10-03 00:00:00", "acceptedDate": "2023-10-03 15:45:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223025134/0001127602-23-025134-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223025134/xslF345X05/form4.xml"}}
{"date": "2023-10-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-10-03 00:00:00", "acceptedDate": "2023-10-03 15:33:01", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223025114/0001127602-23-025114-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223025114/xslF345X05/form4.xml"}}
{"date": "2023-10-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-10-03 00:00:00", "acceptedDate": "2023-10-03 15:20:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223025095/0001127602-23-025095-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223025095/xslF345X05/form4.xml"}}
{"date": "2023-10-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-10-03 00:00:00", "acceptedDate": "2023-10-03 15:04:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223025088/0001127602-23-025088-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223025088/xslF345X05/form4.xml"}}
{"date": "2023-08-15", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-08-15 00:00:00", "acceptedDate": "2023-08-15 16:08:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223022547/0001127602-23-022547-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223022547/xslF345X05/form4.xml"}}
{"date": "2023-08-14", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-08-14 00:00:00", "acceptedDate": "2023-08-14 09:13:30", "formType": "144", "link": "https://www.sec.gov/Archives/edgar/data/310158/000195004723003024/0001950047-23-003024-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000195004723003024/xsl144X01/primary_doc.xml"}}
{"date": "2023-08-07", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-08-07 00:00:00", "acceptedDate": "2023-08-07 16:09:00", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828023027770/0001628280-23-027770-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828023027770/mrk-20230630.htm"}}
{"date": "2023-08-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-08-04 00:00:00", "acceptedDate": "2023-08-04 16:17:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223022015/0001127602-23-022015-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223022015/xslF345X05/form4.xml"}}
{"date": "2023-08-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-08-04 00:00:00", "acceptedDate": "2023-08-04 16:06:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223022002/0001127602-23-022002-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223022002/xslF345X05/form4.xml"}}
{"date": "2023-08-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-08-03 00:00:00", "acceptedDate": "2023-08-03 16:08:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223021936/0001127602-23-021936-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223021936/xslF345X05/form4.xml"}}
{"date": "2023-08-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-08-03 00:00:00", "acceptedDate": "2023-08-03 09:12:17", "formType": "144", "link": "https://www.sec.gov/Archives/edgar/data/310158/000195004723002744/0001950047-23-002744-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000195004723002744/xsl144X01/primary_doc.xml"}}
{"date": "2023-08-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-08-01 00:00:00", "acceptedDate": "2023-08-01 06:46:06", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465923086030/0001104659-23-086030-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465923086030/tm2322190d1_ex99-1.htm"}}
{"date": "2023-07-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-07-05 00:00:00", "acceptedDate": "2023-07-05 16:53:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223020143/0001127602-23-020143-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223020143/xslF345X04/form4.xml"}}
{"date": "2023-07-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-07-05 00:00:00", "acceptedDate": "2023-07-05 16:48:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223020136/0001127602-23-020136-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223020136/xslF345X04/form4.xml"}}
{"date": "2023-07-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-07-05 00:00:00", "acceptedDate": "2023-07-05 16:36:51", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223020098/0001127602-23-020098-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223020098/xslF345X04/form4.xml"}}
{"date": "2023-07-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-07-05 00:00:00", "acceptedDate": "2023-07-05 16:21:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223020050/0001127602-23-020050-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223020050/xslF345X04/form4.xml"}}
{"date": "2023-06-30", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-06-30 00:00:00", "acceptedDate": "2023-06-30 16:04:51", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223019612/0001127602-23-019612-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223019612/xslF345X04/form4.xml"}}
{"date": "2023-06-27", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-06-27 00:00:00", "acceptedDate": "2023-06-27 14:11:17", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828023023562/0001628280-23-023562-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828023023562/a11-k_merckussavingsplanye.htm"}}
{"date": "2023-06-27", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-06-27 00:00:00", "acceptedDate": "2023-06-27 14:10:46", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828023023561/0001628280-23-023561-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828023023561/a11-k_msdpuertoricosavings.htm"}}
{"date": "2023-06-27", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-06-27 00:00:00", "acceptedDate": "2023-06-27 14:09:56", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828023023559/0001628280-23-023559-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828023023559/a11-k_msdemployeestockpurc.htm"}}
{"date": "2023-05-31", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-31 00:00:00", "acceptedDate": "2023-05-31 16:20:02", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223017227/0001127602-23-017227-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223017227/xslF345X04/form4.xml"}}
{"date": "2023-05-31", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-31 00:00:00", "acceptedDate": "2023-05-31 16:01:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223017218/0001127602-23-017218-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223017218/xslF345X04/form4.xml"}}
{"date": "2023-05-31", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-31 00:00:00", "acceptedDate": "2023-05-31 15:11:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223017206/0001127602-23-017206-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223017206/xslF345X04/form4.xml"}}
{"date": "2023-05-31", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-31 00:00:00", "acceptedDate": "2023-05-31 15:08:42", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223017202/0001127602-23-017202-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223017202/xslF345X04/form4.xml"}}
{"date": "2023-05-31", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-31 00:00:00", "acceptedDate": "2023-05-31 14:55:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223017190/0001127602-23-017190-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223017190/xslF345X04/form4.xml"}}
{"date": "2023-05-31", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-31 00:00:00", "acceptedDate": "2023-05-31 14:53:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223017186/0001127602-23-017186-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223017186/xslF345X04/form4.xml"}}
{"date": "2023-05-31", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-31 00:00:00", "acceptedDate": "2023-05-31 14:50:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223017183/0001127602-23-017183-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223017183/xslF345X04/form4.xml"}}
{"date": "2023-05-31", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-31 00:00:00", "acceptedDate": "2023-05-31 14:39:48", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223017171/0001127602-23-017171-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223017171/xslF345X04/form4.xml"}}
{"date": "2023-05-31", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-31 00:00:00", "acceptedDate": "2023-05-31 14:24:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223017153/0001127602-23-017153-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223017153/xslF345X04/form4.xml"}}
{"date": "2023-05-31", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-31 00:00:00", "acceptedDate": "2023-05-31 14:19:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223017149/0001127602-23-017149-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223017149/xslF345X04/form4.xml"}}
{"date": "2023-05-31", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-31 00:00:00", "acceptedDate": "2023-05-31 14:14:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223017145/0001127602-23-017145-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223017145/xslF345X04/form4.xml"}}
{"date": "2023-05-31", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-31 00:00:00", "acceptedDate": "2023-05-31 14:07:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223017140/0001127602-23-017140-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223017140/xslF345X04/form4.xml"}}
{"date": "2023-05-26", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-26 00:00:00", "acceptedDate": "2023-05-26 09:00:25", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000114036123026845/0001140361-23-026845-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000114036123026845/0001140361-23-026845.txt"}}
{"date": "2023-05-22", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-22 00:00:00", "acceptedDate": "2023-05-22 16:58:48", "formType": "SD", "link": "https://www.sec.gov/Archives/edgar/data/310158/000114036123026037/0001140361-23-026037-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000114036123026037/brhc20053129_sd.htm"}}
{"date": "2023-05-18", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-18 00:00:00", "acceptedDate": "2023-05-18 16:46:30", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/310158/000121465923007447/0001214659-23-007447-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000121465923007447/o517232px14a6g.htm"}}
{"date": "2023-05-17", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-17 00:00:00", "acceptedDate": "2023-05-17 16:31:09", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312523147049/0001193125-23-147049-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312523147049/d436124dex41.htm"}}
{"date": "2023-05-10", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-10 00:00:00", "acceptedDate": "2023-05-10 16:27:15", "formType": "424B5", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312523140766/0001193125-23-140766-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312523140766/d358973d424b5.htm"}}
{"date": "2023-05-09", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-09 00:00:00", "acceptedDate": "2023-05-08 20:58:26", "formType": "FWP", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312523138605/0001193125-23-138605-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312523138605/d434115dfwp.htm"}}
{"date": "2023-05-08", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-08 00:00:00", "acceptedDate": "2023-05-08 08:17:38", "formType": "424B5", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312523137713/0001193125-23-137713-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312523137713/d358973d424b5.htm"}}
{"date": "2023-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-05 00:00:00", "acceptedDate": "2023-05-05 17:19:27", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014764/0001127602-23-014764-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014764/xslF345X04/form4.xml"}}
{"date": "2023-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-05 00:00:00", "acceptedDate": "2023-05-05 17:13:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014759/0001127602-23-014759-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014759/xslF345X04/form4.xml"}}
{"date": "2023-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-05 00:00:00", "acceptedDate": "2023-05-05 17:09:36", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014755/0001127602-23-014755-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014755/xslF345X04/form4.xml"}}
{"date": "2023-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-05 00:00:00", "acceptedDate": "2023-05-05 17:06:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014751/0001127602-23-014751-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014751/xslF345X04/form4.xml"}}
{"date": "2023-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-05 00:00:00", "acceptedDate": "2023-05-05 17:01:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014745/0001127602-23-014745-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014745/xslF345X04/form4.xml"}}
{"date": "2023-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-05 00:00:00", "acceptedDate": "2023-05-05 16:54:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014739/0001127602-23-014739-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014739/xslF345X04/form4.xml"}}
{"date": "2023-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-05 00:00:00", "acceptedDate": "2023-05-05 07:39:41", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828023015990/0001628280-23-015990-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828023015990/mrk-20230331.htm"}}
{"date": "2023-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-04 00:00:00", "acceptedDate": "2023-05-04 18:37:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014583/0001127602-23-014583-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014583/xslF345X04/form4.xml"}}
{"date": "2023-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-04 00:00:00", "acceptedDate": "2023-05-04 18:33:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014578/0001127602-23-014578-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014578/xslF345X04/form4.xml"}}
{"date": "2023-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-04 00:00:00", "acceptedDate": "2023-05-04 18:29:24", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014574/0001127602-23-014574-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014574/xslF345X04/form4.xml"}}
{"date": "2023-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-04 00:00:00", "acceptedDate": "2023-05-04 18:26:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014571/0001127602-23-014571-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014571/xslF345X04/form4.xml"}}
{"date": "2023-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-04 00:00:00", "acceptedDate": "2023-05-04 18:22:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014569/0001127602-23-014569-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014569/xslF345X04/form4.xml"}}
{"date": "2023-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-04 00:00:00", "acceptedDate": "2023-05-04 18:18:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014567/0001127602-23-014567-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014567/xslF345X04/form4.xml"}}
{"date": "2023-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-04 00:00:00", "acceptedDate": "2023-05-04 18:14:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014564/0001127602-23-014564-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014564/xslF345X04/form4.xml"}}
{"date": "2023-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-04 00:00:00", "acceptedDate": "2023-05-04 18:11:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014561/0001127602-23-014561-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014561/xslF345X04/form4.xml"}}
{"date": "2023-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-04 00:00:00", "acceptedDate": "2023-05-04 18:01:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014557/0001127602-23-014557-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014557/xslF345X04/form4.xml"}}
{"date": "2023-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-04 00:00:00", "acceptedDate": "2023-05-04 17:56:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014553/0001127602-23-014553-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014553/xslF345X04/form4.xml"}}
{"date": "2023-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-04 00:00:00", "acceptedDate": "2023-05-04 17:50:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014547/0001127602-23-014547-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014547/xslF345X04/form4.xml"}}
{"date": "2023-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-04 00:00:00", "acceptedDate": "2023-05-04 17:47:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014543/0001127602-23-014543-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014543/xslF345X04/form4.xml"}}
{"date": "2023-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-04 00:00:00", "acceptedDate": "2023-05-04 17:43:51", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014541/0001127602-23-014541-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014541/xslF345X04/form4.xml"}}
{"date": "2023-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-04 00:00:00", "acceptedDate": "2023-05-04 17:40:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014539/0001127602-23-014539-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014539/xslF345X04/form4.xml"}}
{"date": "2023-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-04 00:00:00", "acceptedDate": "2023-05-04 17:34:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014537/0001127602-23-014537-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014537/xslF345X04/form4.xml"}}
{"date": "2023-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-04 00:00:00", "acceptedDate": "2023-05-04 09:30:17", "formType": "144", "link": "https://www.sec.gov/Archives/edgar/data/310158/000195004723000395/0001950047-23-000395-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000195004723000395/xsl144X01/primary_doc.xml"}}
{"date": "2023-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-04 00:00:00", "acceptedDate": "2023-05-04 09:08:54", "formType": "144", "link": "https://www.sec.gov/Archives/edgar/data/310158/000195004723000386/0001950047-23-000386-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000195004723000386/xsl144X01/primary_doc.xml"}}
{"date": "2023-05-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-03 00:00:00", "acceptedDate": "2023-05-03 16:29:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014278/0001127602-23-014278-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014278/xslF345X04/form4.xml"}}
{"date": "2023-05-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-03 00:00:00", "acceptedDate": "2023-05-03 16:24:55", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014272/0001127602-23-014272-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014272/xslF345X04/form4.xml"}}
{"date": "2023-05-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-03 00:00:00", "acceptedDate": "2023-05-03 16:10:55", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014248/0001127602-23-014248-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014248/xslF345X04/form4.xml"}}
{"date": "2023-05-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-03 00:00:00", "acceptedDate": "2023-05-03 16:07:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014238/0001127602-23-014238-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014238/xslF345X04/form4.xml"}}
{"date": "2023-05-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-03 00:00:00", "acceptedDate": "2023-05-03 15:54:43", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014222/0001127602-23-014222-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014222/xslF345X04/form4.xml"}}
{"date": "2023-05-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-03 00:00:00", "acceptedDate": "2023-05-03 15:11:30", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014206/0001127602-23-014206-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014206/xslF345X04/form4.xml"}}
{"date": "2023-05-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-03 00:00:00", "acceptedDate": "2023-05-03 15:00:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014204/0001127602-23-014204-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014204/xslF345X04/form4.xml"}}
{"date": "2023-05-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-03 00:00:00", "acceptedDate": "2023-05-03 09:28:27", "formType": "144", "link": "https://www.sec.gov/Archives/edgar/data/310158/000195004723000354/0001950047-23-000354-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000195004723000354/xsl144X01/primary_doc.xml"}}
{"date": "2023-05-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-03 00:00:00", "acceptedDate": "2023-05-03 09:15:39", "formType": "144", "link": "https://www.sec.gov/Archives/edgar/data/310158/000195004723000346/0001950047-23-000346-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000195004723000346/xsl144X01/primary_doc.xml"}}
{"date": "2023-05-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-02 00:00:00", "acceptedDate": "2023-05-02 11:37:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014025/0001127602-23-014025-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223014025/xslF345X04/form4.xml"}}
{"date": "2023-05-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-02 00:00:00", "acceptedDate": "2023-05-02 09:09:29", "formType": "144", "link": "https://www.sec.gov/Archives/edgar/data/310158/000195004723000311/0001950047-23-000311-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000195004723000311/xsl144X01/primary_doc.xml"}}
{"date": "2023-05-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-05-01 00:00:00", "acceptedDate": "2023-05-01 09:30:17", "formType": "144", "link": "https://www.sec.gov/Archives/edgar/data/310158/000195004723000281/0001950047-23-000281-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000195004723000281/xsl144X01/primary_doc.xml"}}
{"date": "2023-04-28", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-04-28 00:00:00", "acceptedDate": "2023-04-28 17:15:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223013808/0001127602-23-013808-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223013808/xslF345X04/form4.xml"}}
{"date": "2023-04-28", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-04-28 00:00:00", "acceptedDate": "2023-04-28 16:18:59", "formType": "3/A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223013779/0001127602-23-013779-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223013779/xslF345X02/form3a.xml"}}
{"date": "2023-04-28", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-04-28 00:00:00", "acceptedDate": "2023-04-28 09:42:02", "formType": "144", "link": "https://www.sec.gov/Archives/edgar/data/310158/000195004723000258/0001950047-23-000258-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000195004723000258/xsl144X01/primary_doc.xml"}}
{"date": "2023-04-28", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-04-28 00:00:00", "acceptedDate": "2023-04-28 09:28:05", "formType": "144", "link": "https://www.sec.gov/Archives/edgar/data/310158/000195004723000256/0001950047-23-000256-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000195004723000256/xsl144X01/primary_doc.xml"}}
{"date": "2023-04-27", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-04-27 00:00:00", "acceptedDate": "2023-04-27 06:43:09", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465923050654/0001104659-23-050654-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465923050654/tm2313695d1_ex99-1.htm"}}
{"date": "2023-04-24", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-04-24 00:00:00", "acceptedDate": "2023-04-21 19:39:04", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/310158/000121465923005792/0001214659-23-005792-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000121465923005792/b421233px14a6g.htm"}}
{"date": "2023-04-19", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-04-19 00:00:00", "acceptedDate": "2023-04-19 16:04:17", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/310158/000121465923005649/0001214659-23-005649-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000121465923005649/o419233px14a6g.htm"}}
{"date": "2023-04-14", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-04-14 00:00:00", "acceptedDate": "2023-04-14 16:34:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223012932/0001127602-23-012932-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223012932/xslF345X04/form4.xml"}}
{"date": "2023-04-13", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-04-13 00:00:00", "acceptedDate": "2023-04-13 10:47:36", "formType": "144", "link": "https://www.sec.gov/Archives/edgar/data/310158/000195004723000109/0001950047-23-000109-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000195004723000109/xsl144X01/primary_doc.xml"}}
{"date": "2023-04-12", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-04-12 00:00:00", "acceptedDate": "2023-04-12 08:58:01", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/310158/000121465923005236/0001214659-23-005236-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000121465923005236/o411232px14a6g.htm"}}
{"date": "2023-04-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-04-03 00:00:00", "acceptedDate": "2023-04-03 16:51:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223011952/0001127602-23-011952-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223011952/xslF345X04/form4.xml"}}
{"date": "2023-04-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-04-03 00:00:00", "acceptedDate": "2023-04-03 16:45:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223011949/0001127602-23-011949-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223011949/xslF345X04/form4.xml"}}
{"date": "2023-04-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-04-03 00:00:00", "acceptedDate": "2023-04-03 16:42:34", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223011944/0001127602-23-011944-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223011944/xslF345X04/form4.xml"}}
{"date": "2023-04-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-04-03 00:00:00", "acceptedDate": "2023-04-03 16:38:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223011940/0001127602-23-011940-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223011940/xslF345X04/form4.xml"}}
{"date": "2023-04-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-04-03 00:00:00", "acceptedDate": "2023-04-03 16:21:03", "formType": "ARS", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828023010404/0001628280-23-010404-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828023010404/a10kformars3.pdf"}}
{"date": "2023-04-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-04-03 00:00:00", "acceptedDate": "2023-04-03 16:10:50", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312523089540/0001193125-23-089540-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312523089540/d277629ddefa14a.htm"}}
{"date": "2023-04-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-04-03 00:00:00", "acceptedDate": "2023-04-03 16:06:23", "formType": "DEF 14A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312523089525/0001193125-23-089525-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312523089525/d277607ddef14a.htm"}}
{"date": "2023-02-24", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-02-24 00:00:00", "acceptedDate": "2023-02-24 16:22:30", "formType": "10-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000162828023005061/0001628280-23-005061-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000162828023005061/mrk-20221231.htm"}}
{"date": "2023-02-16", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-02-16 00:00:00", "acceptedDate": "2023-02-16 11:58:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223005484/0001127602-23-005484-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223005484/xslF345X03/form4.xml"}}
{"date": "2023-02-14", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 10:03:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223005037/0001127602-23-005037-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223005037/xslF345X03/form4.xml"}}
{"date": "2023-02-13", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-02-13 00:00:00", "acceptedDate": "2023-02-13 16:17:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223004855/0001127602-23-004855-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223004855/xslF345X03/form4.xml"}}
{"date": "2023-02-10", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-02-10 00:00:00", "acceptedDate": "2023-02-10 11:28:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223004321/0001127602-23-004321-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223004321/xslF345X03/form4.xml"}}
{"date": "2023-02-09", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-02-09 00:00:00", "acceptedDate": "2023-02-09 10:54:48", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465923015120/0001104659-23-015120-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/102909/000110465923015120/tv0082-merckcoinc.htm"}}
{"date": "2023-02-08", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-02-08 00:00:00", "acceptedDate": "2023-02-08 10:27:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223003923/0001127602-23-003923-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223003923/xslF345X03/form4.xml"}}
{"date": "2023-02-06", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-02-06 00:00:00", "acceptedDate": "2023-02-06 16:21:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223003562/0001127602-23-003562-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223003562/xslF345X03/form4.xml"}}
{"date": "2023-02-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-02-03 00:00:00", "acceptedDate": "2023-02-03 16:27:51", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000130655023007637/0001306550-23-007637-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000130655023007637/us58933y1055_020323.txt"}}
{"date": "2023-02-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-02-02 00:00:00", "acceptedDate": "2023-02-02 06:42:34", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465923009552/0001104659-23-009552-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465923009552/tm235007d1_ex99-1.htm"}}
{"date": "2023-01-25", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-01-25 00:00:00", "acceptedDate": "2023-01-25 17:38:19", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223002257/0001127602-23-002257-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223002257/xslF345X03/form4.xml"}}
{"date": "2023-01-25", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-01-25 00:00:00", "acceptedDate": "2023-01-25 17:33:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223002251/0001127602-23-002251-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223002251/xslF345X03/form4.xml"}}
{"date": "2023-01-25", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-01-25 00:00:00", "acceptedDate": "2023-01-25 17:26:36", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223002247/0001127602-23-002247-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223002247/xslF345X03/form4.xml"}}
{"date": "2023-01-25", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-01-25 00:00:00", "acceptedDate": "2023-01-25 17:14:40", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223002241/0001127602-23-002241-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223002241/xslF345X03/form4.xml"}}
{"date": "2023-01-25", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-01-25 00:00:00", "acceptedDate": "2023-01-25 17:03:30", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223002228/0001127602-23-002228-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223002228/xslF345X03/form4.xml"}}
{"date": "2023-01-25", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-01-25 00:00:00", "acceptedDate": "2023-01-25 16:59:46", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223002223/0001127602-23-002223-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223002223/xslF345X03/form4.xml"}}
{"date": "2023-01-25", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-01-25 00:00:00", "acceptedDate": "2023-01-25 16:56:55", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223002217/0001127602-23-002217-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223002217/xslF345X03/form4.xml"}}
{"date": "2023-01-25", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-01-25 00:00:00", "acceptedDate": "2023-01-25 16:52:20", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223002213/0001127602-23-002213-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223002213/xslF345X03/form4.xml"}}
{"date": "2023-01-25", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-01-25 00:00:00", "acceptedDate": "2023-01-25 16:48:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223002204/0001127602-23-002204-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223002204/xslF345X03/form4.xml"}}
{"date": "2023-01-25", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-01-25 00:00:00", "acceptedDate": "2023-01-25 16:41:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223002197/0001127602-23-002197-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223002197/xslF345X03/form4.xml"}}
{"date": "2023-01-25", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-01-25 00:00:00", "acceptedDate": "2023-01-25 16:35:47", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223002193/0001127602-23-002193-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223002193/xslF345X03/form4.xml"}}
{"date": "2023-01-11", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-01-11 00:00:00", "acceptedDate": "2023-01-11 16:22:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223001274/0001127602-23-001274-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223001274/xslF345X03/form4.xml"}}
{"date": "2023-01-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-01-03 00:00:00", "acceptedDate": "2023-01-03 16:42:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223000159/0001127602-23-000159-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223000159/xslF345X03/form4.xml"}}
{"date": "2023-01-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-01-03 00:00:00", "acceptedDate": "2023-01-03 16:35:40", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223000152/0001127602-23-000152-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223000152/xslF345X03/form4.xml"}}
{"date": "2023-01-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-01-03 00:00:00", "acceptedDate": "2023-01-03 16:30:02", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223000147/0001127602-23-000147-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223000147/xslF345X03/form4.xml"}}
{"date": "2023-01-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2023-01-03 00:00:00", "acceptedDate": "2023-01-03 16:21:27", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760223000135/0001127602-23-000135-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760223000135/xslF345X03/form4.xml"}}
{"date": "2022-11-10", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-11-10 00:00:00", "acceptedDate": "2022-11-10 17:01:36", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222025313/0001127602-22-025313-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222025313/xslF345X03/form4.xml"}}
{"date": "2022-11-10", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-11-10 00:00:00", "acceptedDate": "2022-11-10 16:44:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222025307/0001127602-22-025307-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222025307/xslF345X03/form4.xml"}}
{"date": "2022-11-10", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-11-10 00:00:00", "acceptedDate": "2022-11-10 16:42:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222025304/0001127602-22-025304-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222025304/xslF345X03/form4.xml"}}
{"date": "2022-11-08", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-11-08 00:00:00", "acceptedDate": "2022-11-08 16:56:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222025118/0001127602-22-025118-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222025118/xslF345X03/form4.xml"}}
{"date": "2022-11-07", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-11-07 00:00:00", "acceptedDate": "2022-11-07 16:09:20", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222025022/0001127602-22-025022-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222025022/xslF345X03/form4.xml"}}
{"date": "2022-11-07", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-11-07 00:00:00", "acceptedDate": "2022-11-07 16:06:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222025018/0001127602-22-025018-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222025018/xslF345X03/form4.xml"}}
{"date": "2022-11-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-11-03 00:00:00", "acceptedDate": "2022-11-03 16:28:44", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015822000034/0000310158-22-000034-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015822000034/mrk-20220930.htm"}}
{"date": "2022-11-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-11-03 00:00:00", "acceptedDate": "2022-11-03 16:06:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222024871/0001127602-22-024871-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222024871/xslF345X03/form4.xml"}}
{"date": "2022-11-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-11-01 00:00:00", "acceptedDate": "2022-11-01 17:07:48", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222024629/0001127602-22-024629-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222024629/xslF345X03/form4.xml"}}
{"date": "2022-11-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-11-01 00:00:00", "acceptedDate": "2022-11-01 17:04:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222024626/0001127602-22-024626-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222024626/xslF345X03/form4.xml"}}
{"date": "2022-11-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-11-01 00:00:00", "acceptedDate": "2022-11-01 16:38:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222024610/0001127602-22-024610-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222024610/xslF345X03/form4.xml"}}
{"date": "2022-11-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-11-01 00:00:00", "acceptedDate": "2022-11-01 16:36:48", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222024608/0001127602-22-024608-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222024608/xslF345X03/form4.xml"}}
{"date": "2022-11-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-11-01 00:00:00", "acceptedDate": "2022-11-01 16:33:03", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222024602/0001127602-22-024602-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222024602/xslF345X03/form4.xml"}}
{"date": "2022-11-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-11-01 00:00:00", "acceptedDate": "2022-11-01 16:30:40", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222024599/0001127602-22-024599-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222024599/xslF345X03/form4.xml"}}
{"date": "2022-11-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-11-01 00:00:00", "acceptedDate": "2022-11-01 16:28:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222024595/0001127602-22-024595-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222024595/xslF345X03/form4.xml"}}
{"date": "2022-10-27", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-10-27 00:00:00", "acceptedDate": "2022-10-27 06:38:10", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465922111729/0001104659-22-111729-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465922111729/tm2227726d1_ex99-1.htm"}}
{"date": "2022-10-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-10-04 00:00:00", "acceptedDate": "2022-10-04 11:52:40", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222023387/0001127602-22-023387-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222023387/xslF345X03/form4.xml"}}
{"date": "2022-10-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-10-04 00:00:00", "acceptedDate": "2022-10-04 11:50:55", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222023383/0001127602-22-023383-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222023383/xslF345X03/form4.xml"}}
{"date": "2022-10-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-10-04 00:00:00", "acceptedDate": "2022-10-04 11:49:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222023381/0001127602-22-023381-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222023381/xslF345X03/form4.xml"}}
{"date": "2022-10-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-10-04 00:00:00", "acceptedDate": "2022-10-04 11:47:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222023378/0001127602-22-023378-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222023378/xslF345X03/form4.xml"}}
{"date": "2022-08-19", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-08-19 00:00:00", "acceptedDate": "2022-08-19 15:19:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222021362/0001127602-22-021362-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222021362/xslF345X03/form4.xml"}}
{"date": "2022-08-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-08-05 00:00:00", "acceptedDate": "2022-08-04 17:35:47", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015822000030/0000310158-22-000030-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015822000030/mrk-20220630.htm"}}
{"date": "2022-08-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-08-04 00:00:00", "acceptedDate": "2022-08-04 16:04:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222020472/0001127602-22-020472-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222020472/xslF345X03/form4.xml"}}
{"date": "2022-08-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-08-04 00:00:00", "acceptedDate": "2022-08-04 15:59:37", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222020468/0001127602-22-020468-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222020468/xslF345X03/form4.xml"}}
{"date": "2022-07-28", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-07-28 00:00:00", "acceptedDate": "2022-07-28 06:36:26", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465922083410/0001104659-22-083410-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465922083410/tm2221828d1_8k.htm"}}
{"date": "2022-07-26", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-07-26 00:00:00", "acceptedDate": "2022-07-26 15:57:24", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222019781/0001127602-22-019781-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222019781/xslF345X02/form3.xml"}}
{"date": "2022-07-08", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-07-08 00:00:00", "acceptedDate": "2022-07-08 11:48:47", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222019084/0001127602-22-019084-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222019084/xslF345X02/form3.xml"}}
{"date": "2022-07-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-07-05 00:00:00", "acceptedDate": "2022-07-05 14:09:30", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222018676/0001127602-22-018676-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222018676/xslF345X03/form4.xml"}}
{"date": "2022-07-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-07-05 00:00:00", "acceptedDate": "2022-07-05 14:07:37", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222018673/0001127602-22-018673-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222018673/xslF345X03/form4.xml"}}
{"date": "2022-07-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-07-05 00:00:00", "acceptedDate": "2022-07-05 14:05:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222018671/0001127602-22-018671-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222018671/xslF345X03/form4.xml"}}
{"date": "2022-07-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-07-05 00:00:00", "acceptedDate": "2022-07-05 14:03:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222018669/0001127602-22-018669-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222018669/xslF345X03/form4.xml"}}
{"date": "2022-06-15", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-06-15 00:00:00", "acceptedDate": "2022-06-15 14:22:00", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015822000025/0000310158-22-000025-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015822000025/a11-k_merckussavingsplanye.htm"}}
{"date": "2022-06-15", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-06-15 00:00:00", "acceptedDate": "2022-06-15 14:19:22", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015822000023/0000310158-22-000023-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015822000023/a11-k_msdpuertoricosavings.htm"}}
{"date": "2022-06-15", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-06-15 00:00:00", "acceptedDate": "2022-06-15 14:07:03", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015822000021/0000310158-22-000021-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015822000021/a11-k_msdemployeestockpurc.htm"}}
{"date": "2022-06-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-06-01 00:00:00", "acceptedDate": "2022-06-01 16:29:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016186/0001127602-22-016186-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016186/xslF345X03/form4.xml"}}
{"date": "2022-06-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-06-01 00:00:00", "acceptedDate": "2022-06-01 16:27:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016184/0001127602-22-016184-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016184/xslF345X03/form4.xml"}}
{"date": "2022-06-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-06-01 00:00:00", "acceptedDate": "2022-06-01 16:25:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016182/0001127602-22-016182-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016182/xslF345X03/form4.xml"}}
{"date": "2022-06-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-06-01 00:00:00", "acceptedDate": "2022-06-01 16:24:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016178/0001127602-22-016178-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016178/xslF345X03/form4.xml"}}
{"date": "2022-06-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-06-01 00:00:00", "acceptedDate": "2022-06-01 16:22:37", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016173/0001127602-22-016173-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016173/xslF345X03/form4.xml"}}
{"date": "2022-06-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-06-01 00:00:00", "acceptedDate": "2022-06-01 16:21:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016169/0001127602-22-016169-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016169/xslF345X03/form4.xml"}}
{"date": "2022-06-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-06-01 00:00:00", "acceptedDate": "2022-06-01 16:19:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016164/0001127602-22-016164-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016164/xslF345X03/form4.xml"}}
{"date": "2022-06-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-06-01 00:00:00", "acceptedDate": "2022-06-01 16:17:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016158/0001127602-22-016158-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016158/xslF345X03/form4.xml"}}
{"date": "2022-06-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-06-01 00:00:00", "acceptedDate": "2022-06-01 16:15:48", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016153/0001127602-22-016153-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016153/xslF345X03/form4.xml"}}
{"date": "2022-06-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-06-01 00:00:00", "acceptedDate": "2022-06-01 16:13:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016149/0001127602-22-016149-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016149/xslF345X03/form4.xml"}}
{"date": "2022-06-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-06-01 00:00:00", "acceptedDate": "2022-06-01 16:11:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016144/0001127602-22-016144-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016144/xslF345X03/form4.xml"}}
{"date": "2022-06-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-06-01 00:00:00", "acceptedDate": "2022-06-01 16:09:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016138/0001127602-22-016138-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016138/xslF345X03/form4.xml"}}
{"date": "2022-06-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-06-01 00:00:00", "acceptedDate": "2022-06-01 16:08:03", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016135/0001127602-22-016135-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222016135/xslF345X02/form3.xml"}}
{"date": "2022-05-26", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-26 00:00:00", "acceptedDate": "2022-05-26 16:06:45", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015822000015/0000310158-22-000015-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015822000015/mrk-20220524.htm"}}
{"date": "2022-05-20", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-20 00:00:00", "acceptedDate": "2022-05-20 16:06:23", "formType": "SD", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015822000013/0000310158-22-000013-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015822000013/formsd-merckxreportingperi.htm"}}
{"date": "2022-05-13", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-13 00:00:00", "acceptedDate": "2022-05-13 14:32:47", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/310158/000121465922006794/0001214659-22-006794-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000121465922006794/j513222px14a6g.htm"}}
{"date": "2022-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-05 00:00:00", "acceptedDate": "2022-05-05 17:27:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013549/0001127602-22-013549-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013549/xslF345X03/form4.xml"}}
{"date": "2022-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-05 00:00:00", "acceptedDate": "2022-05-05 17:24:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013544/0001127602-22-013544-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013544/xslF345X03/form4.xml"}}
{"date": "2022-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-05 00:00:00", "acceptedDate": "2022-05-05 17:21:30", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013539/0001127602-22-013539-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013539/xslF345X03/form4.xml"}}
{"date": "2022-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-05 00:00:00", "acceptedDate": "2022-05-05 17:19:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013535/0001127602-22-013535-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013535/xslF345X03/form4.xml"}}
{"date": "2022-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-05 00:00:00", "acceptedDate": "2022-05-05 17:17:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013533/0001127602-22-013533-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013533/xslF345X03/form4.xml"}}
{"date": "2022-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-05 00:00:00", "acceptedDate": "2022-05-05 17:13:42", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013530/0001127602-22-013530-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013530/xslF345X03/form4.xml"}}
{"date": "2022-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-05 00:00:00", "acceptedDate": "2022-05-05 17:11:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013527/0001127602-22-013527-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013527/xslF345X03/form4.xml"}}
{"date": "2022-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-05 00:00:00", "acceptedDate": "2022-05-05 17:09:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013524/0001127602-22-013524-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013524/xslF345X03/form4.xml"}}
{"date": "2022-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-05 00:00:00", "acceptedDate": "2022-05-05 17:07:00", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013522/0001127602-22-013522-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013522/xslF345X03/form4.xml"}}
{"date": "2022-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-05 00:00:00", "acceptedDate": "2022-05-05 17:04:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013519/0001127602-22-013519-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013519/xslF345X03/form4.xml"}}
{"date": "2022-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-05 00:00:00", "acceptedDate": "2022-05-05 17:01:37", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013516/0001127602-22-013516-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013516/xslF345X03/form4.xml"}}
{"date": "2022-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-05 00:00:00", "acceptedDate": "2022-05-05 16:59:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013514/0001127602-22-013514-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013514/xslF345X03/form4.xml"}}
{"date": "2022-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-05 00:00:00", "acceptedDate": "2022-05-05 16:57:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013512/0001127602-22-013512-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013512/xslF345X03/form4.xml"}}
{"date": "2022-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-05 00:00:00", "acceptedDate": "2022-05-05 16:55:50", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013510/0001127602-22-013510-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013510/xslF345X03/form4.xml"}}
{"date": "2022-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-05 00:00:00", "acceptedDate": "2022-05-05 16:53:42", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013508/0001127602-22-013508-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013508/xslF345X03/form4.xml"}}
{"date": "2022-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-05 00:00:00", "acceptedDate": "2022-05-05 16:28:37", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015822000011/0000310158-22-000011-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015822000011/mrk-20220331.htm"}}
{"date": "2022-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-04 00:00:00", "acceptedDate": "2022-05-04 17:58:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013291/0001127602-22-013291-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013291/xslF345X03/form4.xml"}}
{"date": "2022-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-04 00:00:00", "acceptedDate": "2022-05-04 17:54:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013286/0001127602-22-013286-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013286/xslF345X03/form4.xml"}}
{"date": "2022-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-04 00:00:00", "acceptedDate": "2022-05-04 17:50:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013279/0001127602-22-013279-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013279/xslF345X03/form4.xml"}}
{"date": "2022-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-04 00:00:00", "acceptedDate": "2022-05-04 17:44:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013267/0001127602-22-013267-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013267/xslF345X03/form4.xml"}}
{"date": "2022-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-04 00:00:00", "acceptedDate": "2022-05-04 17:37:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013254/0001127602-22-013254-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013254/xslF345X03/form4.xml"}}
{"date": "2022-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-04 00:00:00", "acceptedDate": "2022-05-04 17:30:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013244/0001127602-22-013244-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013244/xslF345X03/form4.xml"}}
{"date": "2022-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-04 00:00:00", "acceptedDate": "2022-05-04 16:53:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013216/0001127602-22-013216-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013216/xslF345X03/form4.xml"}}
{"date": "2022-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-04 00:00:00", "acceptedDate": "2022-05-04 16:44:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013210/0001127602-22-013210-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013210/xslF345X03/form4.xml"}}
{"date": "2022-05-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-03 00:00:00", "acceptedDate": "2022-05-03 16:25:00", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013032/0001127602-22-013032-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013032/xslF345X03/form4.xml"}}
{"date": "2022-05-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-03 00:00:00", "acceptedDate": "2022-05-03 16:22:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013030/0001127602-22-013030-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013030/xslF345X03/form4.xml"}}
{"date": "2022-05-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-03 00:00:00", "acceptedDate": "2022-05-03 16:21:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013028/0001127602-22-013028-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013028/xslF345X03/form4.xml"}}
{"date": "2022-05-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-03 00:00:00", "acceptedDate": "2022-05-03 16:19:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013026/0001127602-22-013026-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013026/xslF345X03/form4.xml"}}
{"date": "2022-05-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-03 00:00:00", "acceptedDate": "2022-05-03 16:17:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013024/0001127602-22-013024-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013024/xslF345X03/form4.xml"}}
{"date": "2022-05-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-03 00:00:00", "acceptedDate": "2022-05-03 16:16:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013022/0001127602-22-013022-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013022/xslF345X03/form4.xml"}}
{"date": "2022-05-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-03 00:00:00", "acceptedDate": "2022-05-03 16:13:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013019/0001127602-22-013019-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013019/xslF345X03/form4.xml"}}
{"date": "2022-05-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-05-03 00:00:00", "acceptedDate": "2022-05-03 16:11:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013015/0001127602-22-013015-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222013015/xslF345X03/form4.xml"}}
{"date": "2022-04-28", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-04-28 00:00:00", "acceptedDate": "2022-04-28 06:35:40", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465922051588/0001104659-22-051588-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465922051588/tm2213615d1_8k.htm"}}
{"date": "2022-04-21", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-04-21 00:00:00", "acceptedDate": "2022-04-20 18:45:29", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465922047977/0001104659-22-047977-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465922047977/tm2212593d1_8k.htm"}}
{"date": "2022-04-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-04-04 00:00:00", "acceptedDate": "2022-04-04 16:37:56", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312522095142/0001193125-22-095142-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312522095142/d19917ddefa14a.htm"}}
{"date": "2022-04-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-04-04 00:00:00", "acceptedDate": "2022-04-04 16:34:55", "formType": "DEF 14A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312522095134/0001193125-22-095134-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312522095134/d154286ddef14a.htm"}}
{"date": "2022-04-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-04-01 00:00:00", "acceptedDate": "2022-04-01 13:41:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222010797/0001127602-22-010797-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222010797/xslF345X03/form4.xml"}}
{"date": "2022-04-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-04-01 00:00:00", "acceptedDate": "2022-04-01 13:39:36", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222010795/0001127602-22-010795-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222010795/xslF345X03/form4.xml"}}
{"date": "2022-04-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-04-01 00:00:00", "acceptedDate": "2022-04-01 13:38:00", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222010793/0001127602-22-010793-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222010793/xslF345X03/form4.xml"}}
{"date": "2022-04-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-04-01 00:00:00", "acceptedDate": "2022-04-01 13:35:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222010791/0001127602-22-010791-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222010791/xslF345X03/form4.xml"}}
{"date": "2022-03-25", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-03-25 00:00:00", "acceptedDate": "2022-03-25 16:14:51", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015822000006/0000310158-22-000006-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015822000006/mrk-20220322.htm"}}
{"date": "2022-03-10", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-03-10 00:00:00", "acceptedDate": "2022-03-10 19:17:42", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222008932/0001127602-22-008932-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222008932/xslF345X02/form3.xml"}}
{"date": "2022-03-10", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-03-10 00:00:00", "acceptedDate": "2022-03-10 19:15:38", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222008930/0001127602-22-008930-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222008930/xslF345X02/form3.xml"}}
{"date": "2022-02-28", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-02-28 00:00:00", "acceptedDate": "2022-02-28 16:35:47", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222007033/0001127602-22-007033-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222007033/xslF345X03/form4.xml"}}
{"date": "2022-02-28", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-02-28 00:00:00", "acceptedDate": "2022-02-28 16:32:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222007028/0001127602-22-007028-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222007028/xslF345X03/form4.xml"}}
{"date": "2022-02-28", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-02-28 00:00:00", "acceptedDate": "2022-02-28 16:29:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222007025/0001127602-22-007025-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222007025/xslF345X03/form4.xml"}}
{"date": "2022-02-28", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-02-28 00:00:00", "acceptedDate": "2022-02-28 16:27:00", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222007023/0001127602-22-007023-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222007023/xslF345X03/form4.xml"}}
{"date": "2022-02-28", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-02-28 00:00:00", "acceptedDate": "2022-02-28 16:24:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222007019/0001127602-22-007019-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222007019/xslF345X03/form4.xml"}}
{"date": "2022-02-28", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-02-28 00:00:00", "acceptedDate": "2022-02-28 16:22:01", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222007016/0001127602-22-007016-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222007016/xslF345X03/form4.xml"}}
{"date": "2022-02-28", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-02-28 00:00:00", "acceptedDate": "2022-02-28 16:19:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222007013/0001127602-22-007013-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222007013/xslF345X03/form4.xml"}}
{"date": "2022-02-28", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-02-28 00:00:00", "acceptedDate": "2022-02-28 16:17:42", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222007008/0001127602-22-007008-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222007008/xslF345X03/form4.xml"}}
{"date": "2022-02-28", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-02-28 00:00:00", "acceptedDate": "2022-02-28 16:15:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222007005/0001127602-22-007005-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222007005/xslF345X03/form4.xml"}}
{"date": "2022-02-28", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-02-28 00:00:00", "acceptedDate": "2022-02-28 16:12:19", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222007002/0001127602-22-007002-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222007002/xslF345X03/form4.xml"}}
{"date": "2022-02-28", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-02-28 00:00:00", "acceptedDate": "2022-02-28 16:09:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222007000/0001127602-22-007000-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222007000/xslF345X03/form4.xml"}}
{"date": "2022-02-28", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-02-28 00:00:00", "acceptedDate": "2022-02-28 16:06:46", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222006996/0001127602-22-006996-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222006996/xslF345X03/form4.xml"}}
{"date": "2022-02-25", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-02-25 00:00:00", "acceptedDate": "2022-02-25 16:44:28", "formType": "10-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015822000003/0000310158-22-000003-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015822000003/mrk-20211231.htm"}}
{"date": "2022-02-14", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-02-14 00:00:00", "acceptedDate": "2022-02-14 11:13:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222004674/0001127602-22-004674-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222004674/xslF345X03/form4.xml"}}
{"date": "2022-02-11", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-02-11 00:00:00", "acceptedDate": "2022-02-11 16:11:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222004553/0001127602-22-004553-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222004553/xslF345X03/form4.xml"}}
{"date": "2022-02-09", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-02-09 00:00:00", "acceptedDate": "2022-02-09 15:15:54", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465922016283/0001104659-22-016283-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/102909/000110465922016283/tv0070-merckcoinc.htm"}}
{"date": "2022-02-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-02-03 00:00:00", "acceptedDate": "2022-02-03 06:39:53", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465922011130/0001104659-22-011130-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465922011130/tm222755d1_8k.htm"}}
{"date": "2022-02-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-02-02 00:00:00", "acceptedDate": "2022-02-02 17:21:49", "formType": "SC 13G", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465922010933/0001104659-22-010933-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465922010933/tm225267d1_sc13g.htm"}}
{"date": "2022-02-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-02-01 00:00:00", "acceptedDate": "2022-01-31 17:59:30", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000083423722004085/0000834237-22-004085-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000083423722004085/us58933y1055_012822.txt"}}
{"date": "2022-01-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-01-04 00:00:00", "acceptedDate": "2022-01-04 16:13:27", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222000447/0001127602-22-000447-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222000447/xslF345X03/form4.xml"}}
{"date": "2022-01-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-01-04 00:00:00", "acceptedDate": "2022-01-04 16:11:20", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222000437/0001127602-22-000437-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222000437/xslF345X03/form4.xml"}}
{"date": "2022-01-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-01-04 00:00:00", "acceptedDate": "2022-01-04 16:09:40", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222000431/0001127602-22-000431-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222000431/xslF345X03/form4.xml"}}
{"date": "2022-01-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2022-01-04 00:00:00", "acceptedDate": "2022-01-04 16:07:43", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760222000424/0001127602-22-000424-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760222000424/xslF345X03/form4.xml"}}
{"date": "2021-12-10", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-12-10 00:00:00", "acceptedDate": "2021-12-10 17:25:07", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312521354132/0001193125-21-354132-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312521354132/d124536d8k.htm"}}
{"date": "2021-12-09", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-12-09 00:00:00", "acceptedDate": "2021-12-09 16:37:22", "formType": "424B5", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312521352723/0001193125-21-352723-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312521352723/d128376d424b5.htm"}}
{"date": "2021-12-08", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-12-08 00:00:00", "acceptedDate": "2021-12-07 18:41:59", "formType": "FWP", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312521350497/0001193125-21-350497-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312521350497/d253432dfwp.htm"}}
{"date": "2021-12-07", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-12-07 00:00:00", "acceptedDate": "2021-12-07 08:13:05", "formType": "424B5", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312521349678/0001193125-21-349678-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312521349678/d128376d424b5.htm"}}
{"date": "2021-11-10", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-11-10 00:00:00", "acceptedDate": "2021-11-10 16:06:19", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221028802/0001127602-21-028802-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221028802/xslF345X03/form4.xml"}}
{"date": "2021-11-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-11-05 00:00:00", "acceptedDate": "2021-11-05 16:24:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221028469/0001127602-21-028469-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221028469/xslF345X03/form4.xml"}}
{"date": "2021-11-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-11-05 00:00:00", "acceptedDate": "2021-11-05 16:22:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221028467/0001127602-21-028467-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221028467/xslF345X03/form4.xml"}}
{"date": "2021-11-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-11-05 00:00:00", "acceptedDate": "2021-11-05 16:09:58", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015821000032/0000310158-21-000032-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015821000032/mrk-20210930.htm"}}
{"date": "2021-11-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-11-04 00:00:00", "acceptedDate": "2021-11-04 16:24:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221028391/0001127602-21-028391-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221028391/xslF345X03/form4.xml"}}
{"date": "2021-11-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-11-04 00:00:00", "acceptedDate": "2021-11-04 16:21:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221028389/0001127602-21-028389-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221028389/xslF345X03/form4.xml"}}
{"date": "2021-11-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-11-04 00:00:00", "acceptedDate": "2021-11-04 16:19:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221028387/0001127602-21-028387-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221028387/xslF345X03/form4.xml"}}
{"date": "2021-11-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-11-03 00:00:00", "acceptedDate": "2021-11-03 16:11:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221028263/0001127602-21-028263-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221028263/xslF345X03/form4.xml"}}
{"date": "2021-11-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-11-02 00:00:00", "acceptedDate": "2021-11-02 18:16:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221028169/0001127602-21-028169-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221028169/xslF345X03/form4.xml"}}
{"date": "2021-11-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-11-02 00:00:00", "acceptedDate": "2021-11-02 18:14:22", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221028167/0001127602-21-028167-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221028167/xslF345X03/form4.xml"}}
{"date": "2021-11-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-11-02 00:00:00", "acceptedDate": "2021-11-02 18:12:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221028165/0001127602-21-028165-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221028165/xslF345X03/form4.xml"}}
{"date": "2021-11-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-11-02 00:00:00", "acceptedDate": "2021-11-02 18:11:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221028163/0001127602-21-028163-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221028163/xslF345X03/form4.xml"}}
{"date": "2021-10-28", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-10-28 00:00:00", "acceptedDate": "2021-10-28 06:40:29", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465921130675/0001104659-21-130675-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465921130675/tm2131077d1_8k.htm"}}
{"date": "2021-10-15", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-10-15 00:00:00", "acceptedDate": "2021-10-15 10:14:09", "formType": "25-NSE", "link": "https://www.sec.gov/Archives/edgar/data/310158/000087666121001491/0000876661-21-001491-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000087666121001491/xslF25X02/primary_doc.xml"}}
{"date": "2021-10-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-10-01 00:00:00", "acceptedDate": "2021-10-01 11:38:03", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221026168/0001127602-21-026168-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221026168/xslF345X03/form4.xml"}}
{"date": "2021-10-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-10-01 00:00:00", "acceptedDate": "2021-10-01 11:35:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221026166/0001127602-21-026166-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221026166/xslF345X03/form4.xml"}}
{"date": "2021-10-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-10-01 00:00:00", "acceptedDate": "2021-10-01 11:33:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221026163/0001127602-21-026163-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221026163/xslF345X03/form4.xml"}}
{"date": "2021-10-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-10-01 00:00:00", "acceptedDate": "2021-10-01 11:31:22", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221026161/0001127602-21-026161-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221026161/xslF345X03/form4.xml"}}
{"date": "2021-08-25", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-08-25 00:00:00", "acceptedDate": "2021-08-25 10:46:21", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221024278/0001127602-21-024278-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221024278/xslF345X02/form3.xml"}}
{"date": "2021-08-20", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-08-20 00:00:00", "acceptedDate": "2021-08-20 16:55:58", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000114036121029043/0001140361-21-029043-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000114036121029043/brhc10028249_8k.htm"}}
{"date": "2021-08-09", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-08-09 00:00:00", "acceptedDate": "2021-08-09 07:07:53", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015821000028/0000310158-21-000028-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015821000028/mrk-20210630.htm"}}
{"date": "2021-07-29", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-07-29 00:00:00", "acceptedDate": "2021-07-29 07:01:02", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465921097239/0001104659-21-097239-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465921097239/tm2123400d1_8k.htm"}}
{"date": "2021-07-15", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-07-15 00:00:00", "acceptedDate": "2021-07-15 11:02:50", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221021957/0001127602-21-021957-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221021957/xslF345X02/form3.xml"}}
{"date": "2021-07-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-07-02 00:00:00", "acceptedDate": "2021-07-02 09:40:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221021120/0001127602-21-021120-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221021120/xslF345X03/form4.xml"}}
{"date": "2021-07-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-07-02 00:00:00", "acceptedDate": "2021-07-02 09:38:37", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221021118/0001127602-21-021118-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221021118/xslF345X03/form4.xml"}}
{"date": "2021-07-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-07-02 00:00:00", "acceptedDate": "2021-07-02 09:36:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221021116/0001127602-21-021116-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221021116/xslF345X03/form4.xml"}}
{"date": "2021-07-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-07-02 00:00:00", "acceptedDate": "2021-07-02 09:34:46", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221021114/0001127602-21-021114-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221021114/xslF345X03/form4.xml"}}
{"date": "2021-06-21", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-06-21 00:00:00", "acceptedDate": "2021-06-21 16:34:35", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465921083528/0001104659-21-083528-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465921083528/tm2120148-1_8k.htm"}}
{"date": "2021-06-16", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-06-16 00:00:00", "acceptedDate": "2021-06-16 14:11:49", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015821000024/0000310158-21-000024-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015821000024/a11-k_msdemployeestockpurc.htm"}}
{"date": "2021-06-16", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-06-16 00:00:00", "acceptedDate": "2021-06-16 14:07:41", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015821000022/0000310158-21-000022-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015821000022/a11-k_msdpuertoricosavings.htm"}}
{"date": "2021-06-16", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-06-16 00:00:00", "acceptedDate": "2021-06-16 14:04:52", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015821000020/0000310158-21-000020-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015821000020/a11-k_merckussavingsplanye.htm"}}
{"date": "2021-06-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-06-04 00:00:00", "acceptedDate": "2021-06-04 16:46:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000089924321022060/0000899243-21-022060-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000089924321022060/xslF345X03/doc4.xml"}}
{"date": "2021-06-03", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-06-03 00:00:00", "acceptedDate": "2021-06-03 08:06:05", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312521180657/0001193125-21-180657-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312521180657/d190548d8k.htm"}}
{"date": "2021-06-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-06-02 00:00:00", "acceptedDate": "2021-06-02 16:48:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221018726/0001127602-21-018726-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221018726/xslF345X03/form4.xml"}}
{"date": "2021-06-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-06-02 00:00:00", "acceptedDate": "2021-06-02 14:11:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221018671/0001127602-21-018671-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221018671/xslF345X03/form4.xml"}}
{"date": "2021-06-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-06-02 00:00:00", "acceptedDate": "2021-06-02 14:08:30", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221018669/0001127602-21-018669-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221018669/xslF345X03/form4.xml"}}
{"date": "2021-06-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-06-02 00:00:00", "acceptedDate": "2021-06-02 14:05:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221018667/0001127602-21-018667-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221018667/xslF345X03/form4.xml"}}
{"date": "2021-06-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-06-02 00:00:00", "acceptedDate": "2021-06-02 14:02:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221018665/0001127602-21-018665-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221018665/xslF345X03/form4.xml"}}
{"date": "2021-06-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-06-02 00:00:00", "acceptedDate": "2021-06-02 13:56:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221018661/0001127602-21-018661-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221018661/xslF345X03/form4.xml"}}
{"date": "2021-06-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-06-02 00:00:00", "acceptedDate": "2021-06-02 13:52:40", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221018658/0001127602-21-018658-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221018658/xslF345X03/form4.xml"}}
{"date": "2021-06-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-06-02 00:00:00", "acceptedDate": "2021-06-02 13:50:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221018656/0001127602-21-018656-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221018656/xslF345X03/form4.xml"}}
{"date": "2021-06-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-06-02 00:00:00", "acceptedDate": "2021-06-02 13:49:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221018654/0001127602-21-018654-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221018654/xslF345X03/form4.xml"}}
{"date": "2021-06-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-06-02 00:00:00", "acceptedDate": "2021-06-02 13:47:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221018652/0001127602-21-018652-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221018652/xslF345X03/form4.xml"}}
{"date": "2021-06-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-06-02 00:00:00", "acceptedDate": "2021-06-02 13:45:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221018650/0001127602-21-018650-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221018650/xslF345X03/form4.xml"}}
{"date": "2021-06-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-06-02 00:00:00", "acceptedDate": "2021-06-02 13:42:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221018647/0001127602-21-018647-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221018647/xslF345X03/form4.xml"}}
{"date": "2021-05-27", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-05-27 00:00:00", "acceptedDate": "2021-05-27 10:13:32", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015821000015/0000310158-21-000015-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015821000015/0000310158-21-000015.txt"}}
{"date": "2021-05-21", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-05-21 00:00:00", "acceptedDate": "2021-05-21 09:41:21", "formType": "SD", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015821000012/0000310158-21-000012-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015821000012/formsd-calendaryear2020_fi.htm"}}
{"date": "2021-05-11", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-05-11 00:00:00", "acceptedDate": "2021-05-11 14:41:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221016201/0001127602-21-016201-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221016201/xslF345X03/form4.xml"}}
{"date": "2021-05-07", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-05-07 00:00:00", "acceptedDate": "2021-05-07 17:02:45", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/310158/000089924321018701/0000899243-21-018701-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000089924321018701/xslF345X02/doc3.xml"}}
{"date": "2021-05-06", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-05-06 00:00:00", "acceptedDate": "2021-05-06 17:04:47", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015770/0001127602-21-015770-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015770/xslF345X03/form4.xml"}}
{"date": "2021-05-06", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-05-06 00:00:00", "acceptedDate": "2021-05-06 17:02:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015768/0001127602-21-015768-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015768/xslF345X03/form4.xml"}}
{"date": "2021-05-06", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-05-06 00:00:00", "acceptedDate": "2021-05-06 17:01:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015766/0001127602-21-015766-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015766/xslF345X03/form4.xml"}}
{"date": "2021-05-06", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-05-06 00:00:00", "acceptedDate": "2021-05-06 16:55:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015763/0001127602-21-015763-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015763/xslF345X03/form4.xml"}}
{"date": "2021-05-06", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-05-06 00:00:00", "acceptedDate": "2021-05-06 16:53:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015760/0001127602-21-015760-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015760/xslF345X03/form4.xml"}}
{"date": "2021-05-06", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-05-06 00:00:00", "acceptedDate": "2021-05-06 16:50:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015758/0001127602-21-015758-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015758/xslF345X03/form4.xml"}}
{"date": "2021-05-06", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-05-06 00:00:00", "acceptedDate": "2021-05-06 16:48:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015754/0001127602-21-015754-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015754/xslF345X03/form4.xml"}}
{"date": "2021-05-06", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-05-06 00:00:00", "acceptedDate": "2021-05-06 16:46:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015752/0001127602-21-015752-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015752/xslF345X03/form4.xml"}}
{"date": "2021-05-06", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-05-06 00:00:00", "acceptedDate": "2021-05-06 16:43:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015749/0001127602-21-015749-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015749/xslF345X03/form4.xml"}}
{"date": "2021-05-06", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-05-06 00:00:00", "acceptedDate": "2021-05-06 16:42:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015747/0001127602-21-015747-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015747/xslF345X03/form4.xml"}}
{"date": "2021-05-06", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-05-06 00:00:00", "acceptedDate": "2021-05-06 16:40:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015744/0001127602-21-015744-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015744/xslF345X03/form4.xml"}}
{"date": "2021-05-06", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-05-06 00:00:00", "acceptedDate": "2021-05-06 16:36:50", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015739/0001127602-21-015739-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015739/xslF345X03/form4.xml"}}
{"date": "2021-05-06", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-05-06 00:00:00", "acceptedDate": "2021-05-06 16:34:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015734/0001127602-21-015734-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015734/xslF345X03/form4.xml"}}
{"date": "2021-05-06", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-05-06 00:00:00", "acceptedDate": "2021-05-06 15:11:34", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/310158/000121465921004979/0001214659-21-004979-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000121465921004979/m56210px14a6g.htm"}}
{"date": "2021-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-05-05 00:00:00", "acceptedDate": "2021-05-05 16:31:16", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312521151781/0001193125-21-151781-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312521151781/d915811dex991.htm"}}
{"date": "2021-05-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-05-05 00:00:00", "acceptedDate": "2021-05-05 16:26:12", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015821000009/0000310158-21-000009-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015821000009/mrk-20210331.htm"}}
{"date": "2021-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-05-04 00:00:00", "acceptedDate": "2021-05-04 17:04:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015279/0001127602-21-015279-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015279/xslF345X03/form4.xml"}}
{"date": "2021-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-05-04 00:00:00", "acceptedDate": "2021-05-04 17:01:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015269/0001127602-21-015269-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015269/xslF345X03/form4.xml"}}
{"date": "2021-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-05-04 00:00:00", "acceptedDate": "2021-05-04 16:57:46", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015262/0001127602-21-015262-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015262/xslF345X03/form4.xml"}}
{"date": "2021-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-05-04 00:00:00", "acceptedDate": "2021-05-04 16:55:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015251/0001127602-21-015251-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015251/xslF345X03/form4.xml"}}
{"date": "2021-05-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-05-04 00:00:00", "acceptedDate": "2021-05-04 16:50:02", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015234/0001127602-21-015234-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221015234/xslF345X03/form4.xml"}}
{"date": "2021-04-29", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-04-29 00:00:00", "acceptedDate": "2021-04-29 06:38:30", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465921056877/0001104659-21-056877-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465921056877/tm2114316d1_ex99-1.htm"}}
{"date": "2021-04-07", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-04-07 00:00:00", "acceptedDate": "2021-04-07 11:20:43", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221013368/0001127602-21-013368-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221013368/xslF345X02/form3.xml"}}
{"date": "2021-04-07", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-04-07 00:00:00", "acceptedDate": "2021-04-07 10:56:56", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221013352/0001127602-21-013352-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221013352/xslF345X02/form3.xml"}}
{"date": "2021-04-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-04-05 00:00:00", "acceptedDate": "2021-04-05 16:07:02", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312521106323/0001193125-21-106323-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312521106323/d165789ddefa14a.htm"}}
{"date": "2021-04-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-04-05 00:00:00", "acceptedDate": "2021-04-05 16:05:51", "formType": "DEF 14A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312521106317/0001193125-21-106317-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312521106317/d50486ddef14a.htm"}}
{"date": "2021-04-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-04-01 00:00:00", "acceptedDate": "2021-04-01 15:03:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221012554/0001127602-21-012554-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221012554/xslF345X03/form4.xml"}}
{"date": "2021-04-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-04-01 00:00:00", "acceptedDate": "2021-04-01 14:55:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221012552/0001127602-21-012552-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221012552/xslF345X03/form4.xml"}}
{"date": "2021-04-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-04-01 00:00:00", "acceptedDate": "2021-04-01 14:51:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221012550/0001127602-21-012550-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221012550/xslF345X03/form4.xml"}}
{"date": "2021-03-26", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-03-26 00:00:00", "acceptedDate": "2021-03-26 16:19:29", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465921042458/0001104659-21-042458-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465921042458/tm2110937d1_8k.htm"}}
{"date": "2021-03-25", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-03-25 00:00:00", "acceptedDate": "2021-03-25 16:46:22", "formType": "S-3ASR", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312521094554/0001193125-21-094554-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312521094554/d126908ds3asr.htm"}}
{"date": "2021-03-25", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-03-25 00:00:00", "acceptedDate": "2021-03-25 16:42:21", "formType": "S-3ASR", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312521094529/0001193125-21-094529-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312521094529/d136878ds3asr.htm"}}
{"date": "2021-03-24", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-03-24 00:00:00", "acceptedDate": "2021-03-24 16:58:59", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312521092736/0001193125-21-092736-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312521092736/d106859d8k.htm"}}
{"date": "2021-03-17", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-03-17 00:00:00", "acceptedDate": "2021-03-17 09:47:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221010907/0001127602-21-010907-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221010907/xslF345X03/form4.xml"}}
{"date": "2021-03-17", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-03-17 00:00:00", "acceptedDate": "2021-03-17 09:44:28", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221010905/0001127602-21-010905-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221010905/xslF345X02/form3.xml"}}
{"date": "2021-03-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-03-04 00:00:00", "acceptedDate": "2021-03-04 06:06:59", "formType": "SC 13D", "link": "https://www.sec.gov/Archives/edgar/data/310158/000119312521068374/0001193125-21-068374-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000119312521068374/d112314dsc13d.htm"}}
{"date": "2021-03-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-03-04 00:00:00", "acceptedDate": "2021-03-04 06:06:29", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/310158/000089924321009725/0000899243-21-009725-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000089924321009725/xslF345X02/doc3.xml"}}
{"date": "2021-03-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-03-02 00:00:00", "acceptedDate": "2021-03-02 12:00:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008587/0001127602-21-008587-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008587/xslF345X03/form4.xml"}}
{"date": "2021-03-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-03-02 00:00:00", "acceptedDate": "2021-03-02 11:57:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008585/0001127602-21-008585-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008585/xslF345X03/form4.xml"}}
{"date": "2021-03-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-03-02 00:00:00", "acceptedDate": "2021-03-02 11:56:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008583/0001127602-21-008583-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008583/xslF345X03/form4.xml"}}
{"date": "2021-03-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-03-02 00:00:00", "acceptedDate": "2021-03-02 11:54:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008581/0001127602-21-008581-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008581/xslF345X03/form4.xml"}}
{"date": "2021-03-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-03-02 00:00:00", "acceptedDate": "2021-03-02 11:51:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008579/0001127602-21-008579-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008579/xslF345X03/form4.xml"}}
{"date": "2021-03-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-03-02 00:00:00", "acceptedDate": "2021-03-02 11:50:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008577/0001127602-21-008577-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008577/xslF345X03/form4.xml"}}
{"date": "2021-03-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-03-02 00:00:00", "acceptedDate": "2021-03-02 11:48:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008575/0001127602-21-008575-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008575/xslF345X03/form4.xml"}}
{"date": "2021-03-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-03-02 00:00:00", "acceptedDate": "2021-03-02 11:46:03", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008573/0001127602-21-008573-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008573/xslF345X03/form4.xml"}}
{"date": "2021-03-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-03-02 00:00:00", "acceptedDate": "2021-03-02 11:44:02", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008571/0001127602-21-008571-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008571/xslF345X03/form4.xml"}}
{"date": "2021-03-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-03-02 00:00:00", "acceptedDate": "2021-03-02 11:41:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008569/0001127602-21-008569-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008569/xslF345X03/form4.xml"}}
{"date": "2021-03-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-03-02 00:00:00", "acceptedDate": "2021-03-02 11:39:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008567/0001127602-21-008567-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008567/xslF345X03/form4.xml"}}
{"date": "2021-03-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-03-02 00:00:00", "acceptedDate": "2021-03-02 11:35:47", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008565/0001127602-21-008565-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008565/xslF345X03/form4.xml"}}
{"date": "2021-03-02", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-03-02 00:00:00", "acceptedDate": "2021-03-02 11:14:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008561/0001127602-21-008561-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221008561/xslF345X03/form4.xml"}}
{"date": "2021-02-25", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-02-25 00:00:00", "acceptedDate": "2021-02-25 16:34:56", "formType": "10-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000031015821000004/0000310158-21-000004-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000031015821000004/mrk-20201231.htm"}}
{"date": "2021-02-10", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 10:02:34", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465921017241/0001104659-21-017241-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/102909/000110465921017241/tv0052-merckcoinc.htm"}}
{"date": "2021-02-09", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-02-09 00:00:00", "acceptedDate": "2021-02-09 16:27:34", "formType": "5", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221004702/0001127602-21-004702-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221004702/xslF345X03/form5.xml"}}
{"date": "2021-02-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-02-05 00:00:00", "acceptedDate": "2021-02-05 08:03:25", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/310158/000083423721007520/0000834237-21-007520-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000083423721007520/us58933y1055_020421.txt"}}
{"date": "2021-02-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-02-04 00:00:00", "acceptedDate": "2021-02-04 11:16:01", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000114036121003357/0001140361-21-003357-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000114036121003357/brhc10019731_ex99-1.htm"}}
{"date": "2021-02-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-02-04 00:00:00", "acceptedDate": "2021-02-04 06:50:38", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465921011912/0001104659-21-011912-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465921011912/tm213179d2_ex99-1.htm"}}
{"date": "2021-02-01", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-02-01 00:00:00", "acceptedDate": "2021-02-01 07:04:12", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465921009673/0001104659-21-009673-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465921009673/tm213179d1_ex99-1.htm"}}
{"date": "2021-01-07", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-01-07 00:00:00", "acceptedDate": "2021-01-07 16:56:15", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221001210/0001127602-21-001210-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221001210/xslF345X02/form3.xml"}}
{"date": "2021-01-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-01-05 00:00:00", "acceptedDate": "2021-01-05 16:27:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221000550/0001127602-21-000550-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221000550/xslF345X03/form4.xml"}}
{"date": "2021-01-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-01-05 00:00:00", "acceptedDate": "2021-01-05 16:24:50", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221000543/0001127602-21-000543-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221000543/xslF345X03/form4.xml"}}
{"date": "2021-01-05", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-01-05 00:00:00", "acceptedDate": "2021-01-05 16:23:27", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/310158/000112760221000534/0001127602-21-000534-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000112760221000534/xslF345X03/form4.xml"}}
{"date": "2021-01-04", "symbol": "MRK", "type": "sec_filings", "result": {"symbol": "MRK", "cik": "0000310158", "filingDate": "2021-01-04 00:00:00", "acceptedDate": "2021-01-04 14:28:32", "formType": "SC 13G", "link": "https://www.sec.gov/Archives/edgar/data/310158/000110465921000228/0001104659-21-000228-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/310158/000110465921000228/tm211463d1_sc13g.htm"}}
{"date": "2025-12-22", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-22 09:31:13", "publisher": "Zacks Investment Research", "title": "Drug Sector on a High as 9 Drugmakers Strike Drug Pricing Deals", "image": "https://images.financialmodelingprep.com/news/drug-sector-on-a-high-as-9-drugmakers-strike-20251222.jpg", "site": "zacks.com", "text": "Amgen and eight other pharma giants struck deals with the Trump administration to cut U.S. drug prices while gaining tariff relief and manufacturing incentives.", "url": "https://www.zacks.com/stock/news/2807163/drug-sector-on-a-high-as-9-drugmakers-strike-drug-pricing-deals?cid=CS-STOCKNEWSAPI-FT-analyst_blog|industry_focus-2807163"}}
{"date": "2025-12-22", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-22 05:40:53", "publisher": "Defense World", "title": "Brighton Jones LLC Buys 20,086 Shares of Merck & Co., Inc. $MRK", "image": "https://images.financialmodelingprep.com/news/brighton-jones-llc-buys-20086-shares-of-merck-co-20251222.gif", "site": "defenseworld.net", "text": "Brighton Jones LLC lifted its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 38.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 72,969 shares of the company's stock after acquiring an additional 20,086 shares during the quarter.", "url": "https://www.defenseworld.net/2025/12/22/brighton-jones-llc-buys-20086-shares-of-merck-co-inc-mrk.html"}}
{"date": "2025-12-20", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-20 19:09:01", "publisher": "Fool - Investing News", "title": "Dividend ETF Matchup: SCHD Offers Higher Yield While VIG Leads in Growth", "image": "https://images.financialmodelingprep.com/news/dividend-etf-matchup-schd-offers-higher-yield-while-vig-20251220.jpeg", "site": "fool.com", "text": "Yield, sector focus, and risk profiles set these two dividend ETFs apart-see how their distinct strategies may fit different investor goals.", "url": "https://www.fool.com/coverage/etfs/2025/12/20/dividend-etf-matchup-schd-offers-higher-yield-while-vig-leads-in-growth/"}}
{"date": "2025-12-20", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-20 01:38:01", "publisher": "Benzinga", "title": "Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal", "image": "https://images.financialmodelingprep.com/news/trump-secures-drug-price-cuts-from-9-major-pharma-20251220.jpeg", "site": "feeds.benzinga.com", "text": "Trump and nine major pharmaceutical companies struck deals to lower drug prices for cash payers and Medicaid, with over $150 billion pledged for U.S. R&D and manufacturing.", "url": "https://www.benzinga.com/news/health-care/25/12/49525415/trump-secures-drug-price-cuts-from-9-major-pharma-firms-including-bristol-myers-gilead-merck-in-"}}
{"date": "2025-12-19", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-19 17:35:00", "publisher": "GuruFocus", "title": "Market Today: Oracle-TikTok JV, Tesla Pay Reinstated, Nike Sinks", "image": "https://images.financialmodelingprep.com/news/market-today-oracletiktok-jv-tesla-pay-reinstated-nike-sinks-20251219.png", "site": "gurufocus.com", "text": "Guru Stock PicksVanguard Health Care Fund has made the following transactions:Reduce in ARGX by 14.38%Sold out in PACSAdd in CLDX by 3.64%New position in PTGXCI", "url": "https://www.gurufocus.com/news/4078691/market-today-oracletiktok-jv-tesla-pay-reinstated-nike-sinks"}}
{"date": "2025-12-19", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-19 16:09:00", "publisher": "WSJ", "title": "Nine pharmaceutical companies including Bristol-Myers Squibb, GSK and Merck agreed to lower the prices that certain federal government programs and patients pay", "image": "https://images.financialmodelingprep.com/news/nine-pharmaceutical-companies-including-bristolmyers-squibb-gsk-and-merck-20251219.jpg", "site": "wsj.com", "text": "The companies, including Bristol-Myers Squibb, GSK and Merck, would avoid potential U.S. tariffs in return.", "url": "https://www.wsj.com/health/pharma/more-drugmakers-reach-deals-with-white-house-to-lower-prices-4d9fa55c"}}
{"date": "2025-12-19", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-19 16:03:59", "publisher": "Reuters", "title": "US FDA grants priority vouchers to Merck's cholesterol pill, cancer therapy", "image": "https://images.financialmodelingprep.com/news/us-fda-grants-priority-vouchers-to-mercks-cholesterol-pill-20251219.jpg", "site": "reuters.com", "text": "The U.S. Food and Drug Administration said on Friday it has granted national priority vouchers to Merck's cholesterol pill and its cancer therapy, making them the latest additions to the fast-track program.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-grants-priority-vouchers-mercks-cholesterol-pill-cancer-therapy-2025-12-19/"}}
{"date": "2025-12-19", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-19 16:01:00", "publisher": "GuruFocus", "title": "Vanguard Health Care Fund's Strategic Moves: Spotlight on AbbVie Inc", "image": "https://images.financialmodelingprep.com/news/vanguard-health-care-funds-strategic-moves-spotlight-on-abbvie-20251219.png", "site": "gurufocus.com", "text": "Exploring the Fund's Recent Portfolio Adjustments Vanguard Health Care Fund (Trades, Portfolio) recently submitted its N-PORT filing for the third quarter of 2", "url": "https://www.gurufocus.com/news/4078525/vanguard-health-care-funds-strategic-moves-spotlight-on-abbvie-inc"}}
{"date": "2025-12-19", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-19 15:14:21", "publisher": "The Guardian", "title": "Trump strikes deal with US drugmakers to cut Medicaid medicine costs", "image": "https://images.financialmodelingprep.com/news/trump-strikes-deal-with-us-drugmakers-to-cut-medicaid-20251219.jpg", "site": "theguardian.com", "text": "Officials pledge massive savings' as companies agree to offer drugs at prices paid in other wealthy countries", "url": "https://www.theguardian.com/business/2025/dec/19/trump-drugs-costs-medicaid"}}
{"date": "2025-12-19", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-19 15:00:00", "publisher": "The Motley Fool", "title": "Better Buy in 2026: Pfizer or Merck?", "image": "https://images.financialmodelingprep.com/news/better-buy-in-2026-pfizer-or-merck-20251219.jpg", "site": "fool.com", "text": "Pfizer has at least two key candidates in the pipeline that look like future winners. Merck has launched several products in preparation for a massive upcoming patent cliff.", "url": "https://www.fool.com/investing/2025/12/19/better-buy-in-2026-pfizer-or-merck/"}}
{"date": "2025-12-19", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-19 14:39:00", "publisher": "Business Wire", "title": "Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans", "image": "https://images.financialmodelingprep.com/news/merck-reaches-agreement-with-us-government-to-expand-access-20251219.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans.", "url": "https://www.businesswire.com/news/home/20251219167722/en/Merck-Reaches-Agreement-With-U.S.-Government-to-Expand-Access-to-Medicines-and-Lower-Costs-for-Americans/"}}
{"date": "2025-12-19", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-19 14:34:16", "publisher": "CNBC", "title": "Nine of the largest pharma companies ink deals with Trump to lower drug prices", "image": "https://images.financialmodelingprep.com/news/nine-of-the-largest-pharma-companies-ink-deals-with-20251219.jpg", "site": "cnbc.com", "text": "Several of the largest U.S. and European-based drugmakers inked deals with President Donald Trump to voluntarily sell their medications for less, as his administration pushes to link the nation's drug prices to cheaper ones abroad. Pfizer, AstraZeneca, Eli Lilly, and Novo Nordisk have already struck deals with the Trump administration to cut prices.", "url": "https://www.cnbc.com/2025/12/19/nine-pharma-companies-ink-deals-with-trump-to-lower-drug-prices.html"}}
{"date": "2025-12-19", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-19 12:43:03", "publisher": "Benzinga", "title": "Evaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out", "image": "https://images.financialmodelingprep.com/news/evaxion-seeks-new-partner-for-gonorrhea-vaccine-after-merck-20251219.jpg", "site": "benzinga.com", "text": "Merck & Co. Inc. (NYSE: MRK) will not exercise its option for Evaxion A/S (NASDAQ: EVAX) Gonorrhea vaccine candidate EVX-B2.", "url": "https://www.benzinga.com/news/contracts/25/12/49514660/evaxion-seeks-new-partner-for-gonorrhea-vaccine-after-merck-opts-out"}}
{"date": "2025-12-19", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-19 11:36:12", "publisher": "Zacks Investment Research", "title": "Can Merck Successfully Steer Through the Upcoming Headwinds?", "image": "https://images.financialmodelingprep.com/news/can-merck-successfully-steer-through-the-upcoming-headwinds-20251219.jpg", "site": "zacks.com", "text": "MRK faces looming Keytruda LOE, falling Gardasil sales and pricing pressure, but new products, pipeline and planned cost savings aim to offset the headwinds.", "url": "https://www.zacks.com/stock/news/2806853/can-merck-successfully-steer-through-the-upcoming-headwinds?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2806853"}}
{"date": "2025-12-19", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-19 10:46:12", "publisher": "Zacks Investment Research", "title": "Here's Why Merck (MRK) is a Strong Growth Stock", "image": "https://images.financialmodelingprep.com/news/heres-why-merck-mrk-is-a-strong-growth-stock-20251219.jpg", "site": "zacks.com", "text": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.", "url": "https://www.zacks.com/stock/news/2806779/here-s-why-merck-mrk-is-a-strong-growth-stock?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|zacks_education_growth_score-2806779"}}
{"date": "2025-12-19", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-19 10:45:00", "publisher": "Market Watch", "title": "Trump to announce new drug-pricing deals later today", "image": "https://images.financialmodelingprep.com/news/trump-to-announce-new-drugpricing-deals-later-today-20251219.jpg", "site": "marketwatch.com", "text": "The White House is getting ready to announce more deals with drugmakers aimed at lowering drug prices.", "url": "https://www.marketwatch.com/story/trump-to-announce-new-drug-pricing-deals-later-today-8261bdfe"}}
{"date": "2025-12-19", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-19 07:37:00", "publisher": "GuruFocus", "title": "First Look: Oracle leads TikTok JV, CPI cools, Nike drops", "image": "https://images.financialmodelingprep.com/news/first-look-oracle-leads-tiktok-jv-cpi-cools-nike-20251219.png", "site": "gurufocus.com", "text": "Stock News TikTok inks U.S. spinoff deal: Oracle (ORCL) and partners Silver Lake and MGX will take major stakes in a new TikTok U.S. venture, with U.S. data hos", "url": "https://www.gurufocus.com/news/4077544/first-look-oracle-leads-tiktok-jv-cpi-cools-nike-drops"}}
{"date": "2025-12-19", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-19 03:22:57", "publisher": "Defense World", "title": "Addenda Capital Inc. Purchases 20,625 Shares of Merck & Co., Inc. $MRK", "image": "https://images.financialmodelingprep.com/news/addenda-capital-inc-purchases-20625-shares-of-merck-co-20251219.gif", "site": "defenseworld.net", "text": "Addenda Capital Inc. increased its position in Merck and Co., Inc. (NYSE: MRK) by 26.9% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 97,395 shares of the company's stock after buying an additional 20,625 shares during the", "url": "https://www.defenseworld.net/2025/12/19/addenda-capital-inc-purchases-20625-shares-of-merck-co-inc-mrk.html"}}
{"date": "2025-12-19", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-19 01:32:52", "publisher": "Defense World", "title": "Merck & Co., Inc. (NYSE:MRK) Trading Up 1.6% Following Analyst Upgrade", "image": "https://images.financialmodelingprep.com/news/merck-co-inc-nysemrk-trading-up-16-following-analyst-20251219.gif", "site": "defenseworld.net", "text": "Merck and Co., Inc. (NYSE: MRK - Get Free Report)'s stock price traded up 1.6% on Thursday after BMO Capital Markets upgraded the stock from a market perform rating to an outperform rating. BMO Capital Markets now has a $130.00 price target on the stock, up from their previous price target of $82.00. Merck and Co.,", "url": "https://www.defenseworld.net/2025/12/19/merck-co-inc-nysemrk-trading-up-1-6-following-analyst-upgrade.html"}}
{"date": "2025-12-18", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-18 22:47:02", "publisher": "Seeking Alpha", "title": "Merck's Deep Pipeline And Cash Flow Strength Support The Bull Case", "image": "https://images.financialmodelingprep.com/news/mercks-deep-pipeline-and-cash-flow-strength-support-the-20251218.jpg", "site": "seekingalpha.com", "text": "Merck is reiterated as a buy, with the price target raised to $114, reflecting robust Q3 results and strong technical momentum. Q3 saw non-GAAP EPS of $2.58 (vs. $2.35 consensus) and revenue of $17.3B, driven by Keytruda, Gardasil, and disciplined cost management. Pipeline strength, including 80 Phase III trials and the Verona Pharma acquisition, positions MRK for growth beyond Keytruda's patent cliff.", "url": "https://seekingalpha.com/article/4854575-mercks-deep-pipeline-and-cash-flow-strength-support-the-bull-case-raising-my-target"}}
{"date": "2025-12-18", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-18 18:51:10", "publisher": "Zacks Investment Research", "title": "Merck (MRK) Rises Higher Than Market: Key Facts", "image": "https://images.financialmodelingprep.com/news/merck-mrk-rises-higher-than-market-key-facts-20251218.jpg", "site": "zacks.com", "text": "In the latest trading session, Merck (MRK) closed at $100.69, marking a +1.52% move from the previous day.", "url": "https://www.zacks.com/stock/news/2806456/merck-mrk-rises-higher-than-market-key-facts?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6v1-2806456"}}
{"date": "2025-12-18", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-18 17:35:00", "publisher": "GuruFocus", "title": "Market Today: CPI Cools; Micron Lifts AI Stocks (MU)", "image": "https://images.financialmodelingprep.com/news/market-today-cpi-cools-micron-lifts-ai-stocks-mu-20251218.png", "site": "gurufocus.com", "text": "Guru Stock PicksCI Select Canadian Equity Fund has made the following transactions:Reduce in TSX: ABX by 9.95%Sold out in TSX:DOLAdd in TSX: KEY by 27.62%New posi", "url": "https://www.gurufocus.com/news/4077010/market-today-cpi-cools-micron-lifts-ai-stocks-mu"}}
{"date": "2025-12-18", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-18 11:55:51", "publisher": "Benzinga", "title": "Merck Cholesterol, Cancer Drugs May Enter FDA Fast-Track Program: Report", "image": "https://images.financialmodelingprep.com/news/merck-cholesterol-cancer-drugs-may-enter-fda-fasttrack-program-20251218.jpg", "site": "benzinga.com", "text": "The U.S. Food and Drug Administration (FDA) is preparing to fast-track reviews of two experimental Merck & Co. Inc. (NYSE: MRK) drugs with potential blockbuster sales.", "url": "https://www.benzinga.com/news/health-care/25/12/49485635/merck-cholesterol-cancer-drugs-may-enter-fda-fast-track-program-report"}}
{"date": "2025-12-18", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-18 07:50:59", "publisher": "247 Wallst", "title": "Here Are Thursdays Top Wall Street Analyst Research Calls: Digital Realty, GE Vernova, Micron Technology, Merck & Co., Rivian, United Airlines, and More", "image": "https://images.financialmodelingprep.com/news/here-are-thursdays-top-wall-street-analyst-research-calls-20251218.jpg", "site": "247wallst.com", "text": "Pre-Market Stock Futures: Futures are trading higher on Thursday as we grind closer to the Christmas holiday, which is just a week off now. The song remains the same for the AI/Datacenter trade, and participants are finding it's going to be a bit tougher here at the end of the year than in the last... Here Are Thursday's Top Wall Street Analyst Research Calls: Digital Realty, GE Vernova, Micron Technology, Merck and Co., Rivian, United Airlines, and More.", "url": "https://247wallst.com/investing/2025/12/18/here-are-thursdays-top-wall-street-analyst-research-calls-digital-realty-ge-vernova-micron-technology-merck-co-rivian-united-airlines-and-more/"}}
{"date": "2025-12-18", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-18 02:06:44", "publisher": "Defense World", "title": "Merck & Co., Inc. (NYSE:MRK) Shares Acquired Rep. Gilbert Ray Cisneros, Jr.", "image": "https://images.financialmodelingprep.com/news/merck-co-inc-nysemrk-shares-acquired-rep-gilbert-ray-20251218.gif", "site": "defenseworld.net", "text": "Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Merck and Co., Inc. (NYSE: MRK). In a filing disclosed on December 15th, the Representative disclosed that they had bought between $1,001 and $15,000 in Merck and Co., Inc. stock on November 18th. The trade occurred in the Representative's \"150 MAIN STREET TRUST > BANK OF", "url": "https://www.defenseworld.net/2025/12/18/merck-co-inc-nysemrk-shares-acquired-rep-gilbert-ray-cisneros-jr.html"}}
{"date": "2025-12-17", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-17 15:37:38", "publisher": "Reuters", "title": "Exclusive: US FDA taps Merck drugs with blockbuster sales potential for national priority vouchers", "image": "https://images.financialmodelingprep.com/news/exclusive-us-fda-taps-merck-drugs-with-blockbuster-sales-20251217.jpg", "site": "reuters.com", "text": "The U.S. Food and Drug Administration is moving to fast-track reviews of two experimental Merck drugs with multibillion-dollar potential, according to internal documents seen by Reuters.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-taps-merck-drugs-with-blockbuster-sales-potential-national-priority-2025-12-17/"}}
{"date": "2025-12-17", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-17 12:45:06", "publisher": "Benzinga", "title": "Merck's Keytruda-Padcev Combo Boosts Survival In Pivotal Bladder Cancer Trial", "image": "https://images.financialmodelingprep.com/news/mercks-keytrudapadcev-combo-boosts-survival-in-pivotal-bladder-cancer-20251217.jpg", "site": "benzinga.com", "text": "Merck & Co. Inc. (NYSE: MRK) on Wednesday shared topline results from the Phase 3 KEYNOTE-B15 trial (also known as EV-304) in patients with muscle-invasive bladder cancer (MIBC) who are eligible for cisplatin-based chemotherapy.", "url": "https://www.benzinga.com/markets/large-cap/25/12/49457425/mercks-keytruda-padcev-combo-boosts-survival-in-pivotal-bladder-cancer-trial"}}
{"date": "2025-12-17", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-17 10:14:31", "publisher": "Benzinga", "title": "Pfizer, Merck Are Boring Again  And That's Exactly Why 2026 Investors Are Circling Back", "image": "https://images.financialmodelingprep.com/news/pfizer-merck-are-boring-again-and-thats-exactly-why-20251217.jpg", "site": "benzinga.com", "text": "Pfizer Inc (NYSE: PFE) and Merck & Co Inc (NYSE: MRK) aren't exciting stocks anymore  and after a bruising reset, that's starting to look intentional. Pfizer's stock has been back in focus this month after the company laid out a cautious 2026 outlook, acknowledging that the post-COVID reset isn't over yet.", "url": "https://www.benzinga.com/markets/biotech/25/12/49451490/pfizer-merck-are-boring-again-and-thats-exactly-why-2026-investors-are-circling-back"}}
{"date": "2025-12-17", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-17 08:15:00", "publisher": "The Motley Fool", "title": "The Ultimate High-Yield Drug Stock to Buy With $1,000 Right Now", "image": "https://images.financialmodelingprep.com/news/the-ultimate-highyield-drug-stock-to-buy-with-1000-20251217.jpg", "site": "fool.com", "text": "Pfizer has a substantial 6.6% dividend yield but a payout ratio exceeding 100%. Eli Lilly has a payout ratio of roughly 30%, but its dividend yield is a tiny 0.6%.", "url": "https://www.fool.com/investing/2025/12/17/the-ultimate-high-yield-drug-stock-to-buy-with-100/"}}
{"date": "2025-12-17", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-17 06:45:00", "publisher": "Business Wire", "title": "KEYTRUDA (pembrolizumab) Plus Padcev (enfortumab vedotin-ejfv) Significantly Improved Event-Free Survival, Overall Survival and Pathologic Complete Response Rates for Cisplatin-Eligible Patients with MIBC When Given Before and After Surgery", "image": "https://images.financialmodelingprep.com/news/keytruda-pembrolizumab-plus-padcev-enfortumab-vedotinejfv-significantly-improved-eventfree-20251217.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive topline results from the Phase 3 KEYNOTE-B15 trial (also known as EV-304) in patients with muscle-invasive bladder cancer (MIBC) who are eligible for cisplatin-based chemotherapy. The trial showed KEYTRUDA (pembrolizumab) plus Padcev  (enfortumab vedotin-ejfv), given as neoadjuvant and adjuvant treatment (before and after surgery), demonstrated a statistically signific.", "url": "https://www.businesswire.com/news/home/20251216027641/en/KEYTRUDA%C2%AE-pembrolizumab-Plus-Padcev%C2%AE-enfortumab-vedotin-ejfv-Significantly-Improved-Event-Free-Survival-Overall-Survival-and-Pathologic-Complete-Response-Rates-for-Cisplatin-Eligible-Patients-with-MIBC-When-Given-Before-and-After-Surgery/"}}
{"date": "2025-12-17", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-17 04:50:55", "publisher": "Defense World", "title": "Cullen Investment Group LTD. Purchases 8,890 Shares of Merck & Co., Inc. $MRK", "image": "https://images.financialmodelingprep.com/news/cullen-investment-group-ltd-purchases-8890-shares-of-merck-20251217.gif", "site": "defenseworld.net", "text": "Cullen Investment Group LTD. lifted its position in Merck and Co., Inc. (NYSE: MRK) by 7.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 129,316 shares of the company's stock after purchasing an additional 8,890 shares during the quarter.", "url": "https://www.defenseworld.net/2025/12/17/cullen-investment-group-ltd-purchases-8890-shares-of-merck-co-inc-mrk.html"}}
{"date": "2025-12-17", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-17 03:58:42", "publisher": "Defense World", "title": "Assenagon Asset Management S.A. Buys 3,618,532 Shares of Merck & Co., Inc. $MRK", "image": "https://images.financialmodelingprep.com/news/assenagon-asset-management-sa-buys-3618532-shares-of-merck-20251217.gif", "site": "defenseworld.net", "text": "Assenagon Asset Management S.A. increased its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 192.7% during the undefined quarter, according to the company in its most recent filing with the SEC. The fund owned 5,496,664 shares of the company's stock after purchasing an additional 3,618,532 shares during the quarter. Merck", "url": "https://www.defenseworld.net/2025/12/17/assenagon-asset-management-s-a-buys-3618532-shares-of-merck-co-inc-mrk.html"}}
{"date": "2025-12-17", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-17 03:58:42", "publisher": "Defense World", "title": "ARS Wealth Advisors Group LLC Raises Stock Holdings in Merck & Co., Inc. $MRK", "image": "https://images.financialmodelingprep.com/news/ars-wealth-advisors-group-llc-raises-stock-holdings-in-20251217.gif", "site": "defenseworld.net", "text": "ARS Wealth Advisors Group LLC increased its stake in Merck and Co., Inc. (NYSE: MRK) by 5.0% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 171,472 shares of the company's stock after purchasing an additional 8,233 shares during the", "url": "https://www.defenseworld.net/2025/12/17/ars-wealth-advisors-group-llc-raises-stock-holdings-in-merck-co-inc-mrk.html"}}
{"date": "2025-12-16", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-16 12:07:00", "publisher": "The Motley Fool", "title": "Should You Buy the 5 Highest-Paying Dividend Stocks in the Dow Jones Before 2026?", "image": "https://images.financialmodelingprep.com/news/should-you-buy-the-5-highestpaying-dividend-stocks-in-20251216.jpg", "site": "fool.com", "text": "The Dow Jones tracks 30 of the largest American companies across different sectors. Verizon, Chevron, and Merck hold the highest dividend yields in the Dow Jones.", "url": "https://www.fool.com/investing/2025/12/16/should-you-buy-the-5-highest-paying-dividend-stock/"}}
{"date": "2025-12-16", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-16 10:46:23", "publisher": "Zacks Investment Research", "title": "Eli Lilly or Merck: Where Should Investors Put Their Money?", "image": "https://images.financialmodelingprep.com/news/eli-lilly-or-merck-where-should-investors-put-their-20251216.jpg", "site": "zacks.com", "text": "LLY's explosive GLP-1 growth, deep obesity pipeline and strong estimate momentum give it the edge over MRK despite a richer valuation.", "url": "https://www.zacks.com/stock/news/2804999/eli-lilly-or-merck-where-should-investors-put-their-money?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2804999"}}
{"date": "2025-12-16", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-16 07:08:42", "publisher": "Defense World", "title": "Cardinal Capital Management Inc. Buys 24,204 Shares of Merck & Co., Inc. $MRK", "image": "https://images.financialmodelingprep.com/news/cardinal-capital-management-inc-buys-24204-shares-of-merck-20251216.gif", "site": "defenseworld.net", "text": "Cardinal Capital Management Inc. raised its stake in Merck and Co., Inc. (NYSE: MRK) by 9.0% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 293,875 shares of the company's stock after acquiring an additional 24,204 shares during the", "url": "https://www.defenseworld.net/2025/12/16/cardinal-capital-management-inc-buys-24204-shares-of-merck-co-inc-mrk.html"}}
{"date": "2025-12-16", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-16 05:44:54", "publisher": "Defense World", "title": "GAMMA Investing LLC Has $5.78 Million Stake in Merck & Co., Inc. $MRK", "image": "https://images.financialmodelingprep.com/news/gamma-investing-llc-has-578-million-stake-in-merck-20251216.gif", "site": "defenseworld.net", "text": "GAMMA Investing LLC raised its position in shares of Merck and Co., Inc. (NYSE: MRK) by 19.1% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 68,811 shares of the company's stock after purchasing an additional 11,047 shares during", "url": "https://www.defenseworld.net/2025/12/16/gamma-investing-llc-has-5-78-million-stake-in-merck-co-inc-mrk.html"}}
{"date": "2025-12-15", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-15 10:51:30", "publisher": "Zacks Investment Research", "title": "MRK Gets Positive CHMP Opinion for Expanded Use of Winrevair in PAH", "image": "https://images.financialmodelingprep.com/news/mrk-gets-positive-chmp-opinion-for-expanded-use-of-20251215.jpg", "site": "zacks.com", "text": "Merck secures a positive CHMP opinion to expand Winrevair's PAH use, potentially broadening treatment to adult patients across WHO FC II-IV.", "url": "https://www.zacks.com/stock/news/2804440/mrk-gets-positive-chmp-opinion-for-expanded-use-of-winrevair-in-pah?cid=CS-STOCKNEWSAPI-FT-analyst_blog|company_news_medical_sector-2804440"}}
{"date": "2025-12-15", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-15 08:04:46", "publisher": "Defense World", "title": "Merck & Co., Inc. $MRK Shares Bought by Corient Private Wealth LLC", "image": "https://images.financialmodelingprep.com/news/merck-co-inc-mrk-shares-bought-by-corient-private-20251215.gif", "site": "defenseworld.net", "text": "Corient Private Wealth LLC increased its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 85.6% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 4,937,948 shares of the company's stock after purchasing an additional 2,277,088 shares during", "url": "https://www.defenseworld.net/2025/12/15/merck-co-inc-mrk-shares-bought-by-corient-private-wealth-llc.html"}}
{"date": "2025-12-15", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-15 06:46:42", "publisher": "Defense World", "title": "Caxton Associates LLP Increases Stake in Merck & Co., Inc. $MRK", "image": "https://images.financialmodelingprep.com/news/caxton-associates-llp-increases-stake-in-merck-co-inc-20251215.gif", "site": "defenseworld.net", "text": "Caxton Associates LLP grew its holdings in Merck and Co., Inc. (NYSE: MRK) by 23.3% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 39,421 shares of the company's stock after acquiring an additional 7,458 shares during the period. Caxton Associates", "url": "https://www.defenseworld.net/2025/12/15/caxton-associates-llp-increases-stake-in-merck-co-inc-mrk.html"}}
{"date": "2025-12-15", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-15 06:46:42", "publisher": "Defense World", "title": "Cullen Capital Management LLC Grows Holdings in Merck & Co., Inc. $MRK", "image": "https://images.financialmodelingprep.com/news/cullen-capital-management-llc-grows-holdings-in-merck-co-20251215.gif", "site": "defenseworld.net", "text": "Cullen Capital Management LLC grew its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 1.8% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,276,476 shares of the company's stock after purchasing an additional 39,800 shares during the quarter. Merck", "url": "https://www.defenseworld.net/2025/12/15/cullen-capital-management-llc-grows-holdings-in-merck-co-inc-mrk.html"}}
{"date": "2025-12-15", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-15 06:12:42", "publisher": "Defense World", "title": "Rep. Julie Johnson Sells Off Shares of Merck & Co., Inc. (NYSE:MRK)", "image": "https://images.financialmodelingprep.com/news/rep-julie-johnson-sells-off-shares-of-merck-co-20251215.gif", "site": "defenseworld.net", "text": "Representative Julie Johnson (D-Texas) recently sold shares of Merck and Co., Inc. (NYSE: MRK). In a filing disclosed on December 11th, the Representative disclosed that they had sold between $1,001 and $15,000 in Merck and Co., Inc. stock on November 13th. The trade occurred in the Representative's \"CHASE BROKERAGE ACCOUNT (3935)\" account. Representative Julie Johnson also", "url": "https://www.defenseworld.net/2025/12/15/rep-julie-johnson-sells-off-shares-of-merck-co-inc-nysemrk.html"}}
{"date": "2025-12-15", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-15 03:53:00", "publisher": "Defense World", "title": "Caldwell Trust Co Purchases Shares of 48,103 Merck & Co., Inc. $MRK", "image": "https://images.financialmodelingprep.com/news/caldwell-trust-co-purchases-shares-of-48103-merck-co-20251215.gif", "site": "defenseworld.net", "text": "Caldwell Trust Co acquired a new stake in Merck and Co., Inc. (NYSE: MRK) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 48,103 shares of the company's stock, valued at approximately $3,808,000. A number of other hedge funds have also recently made", "url": "https://www.defenseworld.net/2025/12/15/caldwell-trust-co-purchases-shares-of-48103-merck-co-inc-mrk.html"}}
{"date": "2025-12-14", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-14 15:27:00", "publisher": "The Motley Fool", "title": "Should You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead?", "image": "https://images.financialmodelingprep.com/news/should-you-forget-teva-pharmaceutical-and-buy-these-unstoppable-20251214.jpg", "site": "fool.com", "text": "Shares of Teva -- a generic-drug maker with a history of losses and high leverage -- have rallied strongly. Pfizer and Merck, which make branded drugs, are financially strong and are rebuilding their drug pipelines.", "url": "https://www.fool.com/investing/2025/12/14/should-you-forget-teva-and-buy-these-stock-instead/"}}
{"date": "2025-12-13", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-13 10:10:04", "publisher": "247 Wallst", "title": "Why Ditching Schwab U.S. Dividend Equity ETF In the AI Era Is a Mistake", "image": "https://images.financialmodelingprep.com/news/why-ditching-schwab-us-dividend-equity-etf-in-the-20251213.jpg", "site": "247wallst.com", "text": "The rapid rise of artificial intelligence (AI) has transformed the stock market in recent years, powering massive gains in technology giants and growth-oriented investments. At the same time, dividend-focused funds like the Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) have faced scrutiny for lagging behind broader indices dominated by AI-driven companies. Schwab U.S. Dividend Equity ETF... Why Ditching Schwab U.S. Dividend Equity ETF In the AI Era Is a Mistake.", "url": "https://247wallst.com/investing/2025/12/13/why-ditching-schwab-u-s-dividend-equity-etf-in-the-ai-era-is-a-mistake/"}}
{"date": "2025-12-13", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-13 06:36:43", "publisher": "Defense World", "title": "AQR Capital Management LLC Buys 1,029,454 Shares of Merck & Co., Inc. $MRK", "image": "https://images.financialmodelingprep.com/news/aqr-capital-management-llc-buys-1029454-shares-of-merck-20251213.gif", "site": "defenseworld.net", "text": "AQR Capital Management LLC lifted its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 13.3% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 8,787,272 shares of the company's stock after buying an additional 1,029,454 shares during the period. Merck", "url": "https://www.defenseworld.net/2025/12/13/aqr-capital-management-llc-buys-1029454-shares-of-merck-co-inc-mrk.html"}}
{"date": "2025-12-12", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-12 12:23:00", "publisher": "The Motley Fool", "title": "Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026", "image": "https://images.financialmodelingprep.com/news/here-are-2-affordable-healthcare-stocks-to-buy-heading-20251212.jpeg", "site": "fool.com", "text": "One of these pharmaceutical leaders overcame a major obstacle and has a strong outlook. The other is actively pushing greater innovation to get around a rapidly approaching patent cliff.", "url": "https://www.fool.com/investing/2025/12/12/2-affordable-healthcare-stocks-to-buy-into-2026/"}}
{"date": "2025-12-12", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-12 11:05:27", "publisher": "Zacks Investment Research", "title": "Can MRK's New Drugs & Pipeline Help Navigate the Looming Keytruda LOE?", "image": "https://images.financialmodelingprep.com/news/can-mrks-new-drugs-pipeline-help-navigate-the-looming-20251212.jpg", "site": "zacks.com", "text": "Merck leans on a fast-growing pipeline and new product launches to aid long-term growth as Keytruda's 2028 LOE nears.", "url": "https://www.zacks.com/stock/news/2803770/can-mrk-s-new-drugs-pipeline-help-navigate-the-looming-keytruda-loe?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2803770"}}
{"date": "2025-12-12", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-12 08:45:00", "publisher": "Business Wire", "title": "Merck Receives Positive EU CHMP Opinion for Expanded Use of WINREVAIR (sotatercept) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension)", "image": "https://images.financialmodelingprep.com/news/merck-receives-positive-eu-chmp-opinion-for-expanded-use-20251212.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) recommended the approval of an expanded indication for WINREVAIR (sotatercept), in combination with other pulmonary arterial hypertension (PAH) therapies, for the treatment of PAH in adult patients with WHO Functional Class (FC) II, III, and IV based on the Phase 3 ZENITH study. The cur.", "url": "https://www.businesswire.com/news/home/20251211664046/en/Merck-Receives-Positive-EU-CHMP-Opinion-for-Expanded-Use-of-WINREVAIR%E2%84%A2-sotatercept-in-Adults-with-Pulmonary-Arterial-Hypertension-PAH-WHO*-Group-1-Pulmonary-Hypertension/"}}
{"date": "2025-12-11", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-11 18:46:20", "publisher": "Zacks Investment Research", "title": "Merck (MRK) Laps the Stock Market: Here's Why", "image": "https://images.financialmodelingprep.com/news/merck-mrk-laps-the-stock-market-heres-why-20251211.jpg", "site": "zacks.com", "text": "Merck (MRK) closed at $99.01 in the latest trading session, marking a +1.42% move from the prior day.", "url": "https://www.zacks.com/stock/news/2803291/merck-mrk-laps-the-stock-market-here-s-why?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6-2803291"}}
{"date": "2025-12-10", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-10 14:45:21", "publisher": "MarketBeat", "title": "Dividend Stocks for 2026: Where to Invest as the Market Cools", "image": "https://images.financialmodelingprep.com/news/dividend-stocks-for-2026-where-to-invest-as-the-20251210.jpg", "site": "marketbeat.com", "text": "As we enter the final stretch of 2025, it's clear that this has been a strong year for equities. However, with valuations across the tech sector stretched and talk of an AI-fueled bubble growing louder, many investors are beginning to look for more stable, income-generating opportunities.", "url": "https://www.marketbeat.com/originals/dividend-stocks-for-2026-where-to-invest-as-the-market-cools/"}}
{"date": "2025-12-10", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-10 10:00:00", "publisher": "The Motley Fool", "title": "2 Pharmaceutical Stocks to Buy at a Discount", "image": "https://images.financialmodelingprep.com/news/2-pharmaceutical-stocks-to-buy-at-a-discount-20251210.jpg", "site": "fool.com", "text": "Weight loss drugs are the big story in the pharmaceutical industry today, but other opportunities exist, too. Bristol Myers Squibb isn't focused on weight loss, has an attractive yield, and continues to cover its dividend.", "url": "https://www.fool.com/investing/2025/12/10/2-pharmaceutical-stocks-to-buy-at-a-discount/"}}
{"date": "2025-12-09", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-09 12:06:04", "publisher": "Zacks Investment Research", "title": "MRK Stock Trading Above 200- & 50-Day SMA for 2 Months: Time to Buy?", "image": "https://images.financialmodelingprep.com/news/mrk-stock-trading-above-200-50day-sma-for-2-20251209.jpg", "site": "zacks.com", "text": "Merck holds bullish momentum as pipeline advances and major deals offset vaccine weakness and Keytruda risks.", "url": "https://www.zacks.com/stock/news/2801725/mrk-stock-trading-above-200-50-day-sma-for-2-months-time-to-buy?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2801725"}}
{"date": "2025-12-09", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-09 11:51:21", "publisher": "CNBC", "title": "FDA approves Merck drug for decimated U.S. cattle herds to stop screwworm", "image": "https://images.financialmodelingprep.com/news/fda-approves-merck-drug-for-decimated-us-cattle-herds-20251209.jpg", "site": "cnbc.com", "text": "The U.S. Food and Drug Administrationgranted conditional approval for a Merck Animal Health pour-on treatment for the prevention and treatment of New World Screwworm, with farmers able to receive doses by December 20. U.S. cattle herds are at historic lows, pressuring beef prices, with the parasite from Mexico among multiple reasons for the decline in ranchers' livestock.", "url": "https://www.cnbc.com/2025/12/09/fda-merck-screwworm-treatment-cattle-herd-decline.html"}}
{"date": "2025-12-09", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-09 11:15:00", "publisher": "The Motley Fool", "title": "Here's 1 Major Catalyst Behind Merck Stock's Recent 3.8% Bump", "image": "https://images.financialmodelingprep.com/news/heres-1-major-catalyst-behind-merck-stocks-recent-38-20251209.jpg", "site": "fool.com", "text": "Merck spent a small fortune on the acquisition of Acceleron Pharma, and so far, it's paying off. Recent phase 2 data suggests the pharmaceutical giant could get even more bang for its buck.", "url": "https://www.fool.com/investing/2025/12/09/heres-1-major-catalyst-behind-merck-stocks-recent/"}}
{"date": "2025-12-09", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-09 10:55:17", "publisher": "The Motley Fool", "title": "1 Major Factor Behind the Healthcare Sector's Recent Surge", "image": "https://images.financialmodelingprep.com/news/1-major-factor-behind-the-healthcare-sectors-recent-surge-20251209.jpg", "site": "fool.com", "text": "Eli Lilly's GLP-1 drug became the world's best-selling drug in Q3. Merck, Johnson & Johnson, AbbVie, and other companies are soaring on new drugs or the growth of existing ones.", "url": "https://www.fool.com/investing/2025/12/09/major-factor-behind-healthcare-sector-surge/"}}
{"date": "2025-12-09", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-09 08:00:00", "publisher": "Business Wire", "title": "BenchSci Extends ASCEND Agreement with Merck to Support Preclinical Disease Biology Research", "image": "https://images.financialmodelingprep.com/news/benchsci-extends-ascend-agreement-with-merck-to-support-preclinical-20251209.jpg", "site": "businesswire.com", "text": "TORONTO--(BUSINESS WIRE)--BenchSci, a leading provider of AI software for biopharma research and development, today announced a renewed two-year contract with Merck, known as MSD outside of the United States and Canada. Seeing Merck's teams use ASCEND to unravel disease biology, strengthen hypotheses, and make more evidence-driven decisions underscores the real scientific value AI can deliver. This renewed agreement gives us the opportunity to deepen that impact and continue advancing how comp.", "url": "https://www.businesswire.com/news/home/20251209064752/en/BenchSci-Extends-ASCEND-Agreement-with-Merck-to-Support-Preclinical-Disease-Biology-Research/"}}
{"date": "2025-12-09", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-09 07:18:00", "publisher": "GlobeNewsWire", "title": "Formycon and Zydus partner for exclusive licensing and supply agreement of FYB206, a biosimilar to Keytruda (Pembrolizumab), in the U.S. and Canada", "image": "https://images.financialmodelingprep.com/news/formycon-and-zydus-partner-for-exclusive-licensing-and-supply-20251209.jpg", "site": "globenewswire.com", "text": "PLANEGG-MARTINSRIED, Germany and AHMEDABAD, India, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Formycon AG (FSE: FYB, Formycon) and Zydus Lifesciences Limited (including its subsidiaries and affiliates, Zydus), today jointly announced that they have entered into a strategic partnership for the exclusive licensing and supply of checkpoint inhibitor FYB206, a biosimilar of Keytruda1 (Pembrolizumab), in the U.S. and Canada.", "url": "https://www.globenewswire.com/news-release/2025/12/09/3202239/0/en/Formycon-and-Zydus-partner-for-exclusive-licensing-and-supply-agreement-of-FYB206-a-biosimilar-to-Keytruda-Pembrolizumab-in-the-U-S-and-Canada.html"}}
{"date": "2025-12-08", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-08 09:40:33", "publisher": "Zacks Investment Research", "title": "Watch 5 Bigwigs in December After Double-Digit Returns Past Month", "image": "https://images.financialmodelingprep.com/news/watch-5-bigwigs-in-december-after-doubledigit-returns-past-20251208.jpg", "site": "zacks.com", "text": "Five market giants, CVNA, WMT, AMAT, FCX and MRK, delivered double-digit returns last month with more room to run in December.", "url": "https://www.zacks.com/stock/news/2800824/watch-5-bigwigs-in-december-after-double-digit-returns-past-month?cid=CS-STOCKNEWSAPI-FT-analyst_blog|investment_ideas-2800824"}}
{"date": "2025-12-08", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-08 03:34:58", "publisher": "Defense World", "title": "Bank of Nova Scotia Trims Position in Merck & Co., Inc. $MRK", "image": "https://images.financialmodelingprep.com/news/bank-of-nova-scotia-trims-position-in-merck-co-20251208.gif", "site": "defenseworld.net", "text": "Bank of Nova Scotia trimmed its position in shares of Merck and Co., Inc. (NYSE: MRK) by 46.9% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,430,802 shares of the company's stock after selling 1,262,919 shares during the period. Bank", "url": "https://www.defenseworld.net/2025/12/08/bank-of-nova-scotia-trims-position-in-merck-co-inc-mrk.html"}}
{"date": "2025-12-07", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-07 08:23:00", "publisher": "The Motley Fool", "title": "Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?", "image": "https://images.financialmodelingprep.com/news/should-you-buy-the-3-highestpaying-dividend-stocks-in-20251207.jpg", "site": "fool.com", "text": "Telecom giant Verizon has the highest yield in the Dow at 6.8%. Energy Goliath Chevron currently offers a hefty 4.6% yield.", "url": "https://www.fool.com/investing/2025/12/07/should-you-buy-the-3-highest-paying-dividend-stock/"}}
{"date": "2025-12-07", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-07 07:30:00", "publisher": "Seeking Alpha", "title": "The Generational Shift I See Now - And My 33 Stocks For What's Coming", "image": "https://images.financialmodelingprep.com/news/the-generational-shift-i-see-now-and-my-33-20251207.jpg", "site": "seekingalpha.com", "text": "I see a generational opportunity in quality stocks, defined by high ROE, stable earnings growth, and low debt. Quality stocks have underperformed AI-driven leaders, creating rare relative value and attractive risk/reward for diversified, income-focused investors. My screen highlights 33 U.S. large caps with 25% ROE and 2% yield, many trading at compelling valuations.", "url": "https://seekingalpha.com/article/4850802-the-generational-shift-i-see-now-and-my-33-stocks-for-whats-coming"}}
{"date": "2025-12-07", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-07 07:15:00", "publisher": "The Motley Fool", "title": "Merck's Stock is Suddenly Soaring, but Is the Struggling Healthcare Giant a Buy?", "image": "https://images.financialmodelingprep.com/news/mercks-stock-is-suddenly-soaring-but-is-the-struggling-20251207.jpg", "site": "fool.com", "text": "Merck shares began peeling back in early 2024, mostly on concerns about looming patent expirations for its breadwinning drug. The trading crowd changed its collective mind a couple months ago, sending shares sharply higher.", "url": "https://www.fool.com/investing/2025/12/07/mercks-stock-is-suddenly-soaring-but-is-the-strugg/"}}
{"date": "2025-12-06", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-06 08:00:00", "publisher": "Seeking Alpha", "title": "5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (December 2025)", "image": "https://images.financialmodelingprep.com/news/5-relatively-secure-and-cheap-dividend-stocks-yields-up-20251206.jpg", "site": "seekingalpha.com", "text": "This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields 3.6%, we present two other groups of five DGI stocks each, from moderate to high yields of up to 8%.", "url": "https://seekingalpha.com/article/4849929-5-relatively-secure-and-cheap-dividend-stocks-yields-up-to-8-percent-december-2025"}}
{"date": "2025-12-05", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-05 16:05:00", "publisher": "The Motley Fool", "title": "Do These 3 Healthcare Stocks Need a Checkup?", "image": "https://images.financialmodelingprep.com/news/do-these-3-healthcare-stocks-need-a-checkup-20251205.jpg", "site": "fool.com", "text": "Pfizer has a sizable 6.8% yield and is down nearly 60% from its 2021 highs. Bristol Myers Squibb has a 5% yield and is off its 2023 highs by nearly 40%.", "url": "https://www.fool.com/investing/2025/12/05/do-these-3-healthcare-stocks-need-a-checkup/"}}
{"date": "2025-12-05", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-05 13:35:38", "publisher": "Reuters", "title": "Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newborns", "image": "https://images.financialmodelingprep.com/news/vaccine-makers-raise-concerns-over-us-panels-shift-away-20251205.jpg", "site": "reuters.com", "text": "Vaccine makers expressed concern on Friday's decision by a U.S. advisory panel to scrap its long-standing recommendation that all infants receive a hepatitis B vaccine at birth, a shift that public health experts fear will undermine decades of public health advances.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/vaccine-makers-raise-concerns-over-us-panels-shift-away-hepatitis-b-shots-2025-12-05/"}}
{"date": "2025-12-05", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-05 12:05:00", "publisher": "The Motley Fool", "title": "Is This Pharmaceutical Giant a Buy After a Major Acquisition?", "image": "https://images.financialmodelingprep.com/news/is-this-pharmaceutical-giant-a-buy-after-a-major-20251205.jpg", "site": "fool.com", "text": "Merck's newest acquisition could help it launch a promising flu candidate. Several other ongoing developments are helping paint a bright post-Keytruda picture.", "url": "https://www.fool.com/investing/2025/12/05/is-this-pharmaceutical-giant-a-buy-after-a-major-a/"}}
{"date": "2025-12-05", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-05 04:44:42", "publisher": "Defense World", "title": "Edgestream Partners L.P. Boosts Holdings in Merck & Co., Inc. $MRK", "image": "https://images.financialmodelingprep.com/news/edgestream-partners-lp-boosts-holdings-in-merck-co-inc-20251205.gif", "site": "defenseworld.net", "text": "Edgestream Partners L.P. raised its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 16.7% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 35,207 shares of the company's stock after buying an additional 5,049 shares during the", "url": "https://www.defenseworld.net/2025/12/05/edgestream-partners-l-p-boosts-holdings-in-merck-co-inc-mrk.html"}}
{"date": "2025-12-05", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-05 03:15:00", "publisher": "The Motley Fool", "title": "These Are the 3 Hottest Stocks in the S&P 500 Heading Into the New Year. Should You Invest in Them?", "image": "https://images.financialmodelingprep.com/news/these-are-the-3-hottest-stocks-in-the-sp-20251205.jpg", "site": "fool.com", "text": "New markets are opening up for Albemarle's lithium products. Recent 3M spinoff Solventum is finding its footing.", "url": "https://www.fool.com/investing/2025/12/05/these-3-stocks-are-the-hottest-in-the-sp-500-headi/"}}
{"date": "2025-12-04", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-04 14:22:00", "publisher": "WSJ", "title": "Halozyme Granted Injunction Against Merck & Co. in Germany in Keytruda Patent Case", "image": "https://images.financialmodelingprep.com/news/halozyme-granted-injunction-against-merck-co-in-germany-in-20251204.jpg", "site": "wsj.com", "text": "The Munich Regional Court ruled there was imminent infringement for Merck & Co.'s Keytruda SC in Germany related to Halozyme's MDASE patents in Europe, the San Diego company said.", "url": "https://www.wsj.com/health/pharma/halozyme-granted-injunction-against-merck-co-in-germany-in-keytruda-patent-case-563b13c2"}}
{"date": "2025-12-04", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-04 13:53:57", "publisher": "Benzinga", "title": "Pliant Cancer Drug Boosts Responses When Paired With Merck's Blockbuster Keytruda In Tough-To-Treat Tumors", "image": "https://images.financialmodelingprep.com/news/pliant-cancer-drug-boosts-responses-when-paired-with-mercks-20251204.jpg", "site": "benzinga.com", "text": "Pliant Therapeutics, Inc. (NASDAQ: PLRX) is capturing attention with promising trial results for its cancer therapy, despite a sharp stock decline.", "url": "https://www.benzinga.com/news/health-care/25/12/49217318/pliant-cancer-drug-boosts-responses-when-paired-with-mercks-blockbuster-keytruda-in-tough-to-treat-tumors"}}
{"date": "2025-12-04", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-04 12:21:04", "publisher": "Zacks Investment Research", "title": "Can Merck's New Products Aid Growth as Keytruda LOE Test Looms?", "image": "https://images.financialmodelingprep.com/news/can-mercks-new-products-aid-growth-as-keytruda-loe-20251204.jpg", "site": "zacks.com", "text": "MRK banks on Capvaxive, Winrevair and other new launches to counter Keytruda's looming 2028 LOE and record long-term growth.", "url": "https://www.zacks.com/stock/news/2799683/can-merck-s-new-products-aid-growth-as-keytruda-loe-test-looms?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2799683"}}
{"date": "2025-12-04", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-04 12:05:00", "publisher": "Business Wire", "title": "FDA Conditionally Approves Merck Animal Health's EXZOLT CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis)", "image": "https://images.financialmodelingprep.com/news/fda-conditionally-approves-merck-animal-healths-exzolt-cattleca1-for-20251204.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration (FDA) has granted a conditional approval for EXZOLT CATTLE-CA1 (fluralaner topical solution). This innovative product is in the newest class of parasiticides known as isoxazolines. The pour-on solution is effective for the prevention and treatment of infest.", "url": "https://www.businesswire.com/news/home/20251201522827/en/FDA-Conditionally-Approves-Merck-Animal-Healths-EXZOLT%E2%84%A2-CATTLE-CA1-for-the-Prevention-and-Treatment-of-New-World-Screwworm-Cochliomyia-hominivorax-Larvae-myiasis/"}}
{"date": "2025-12-04", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-04 07:38:00", "publisher": "GuruFocus", "title": "First Look: Insurers, Auto Rules, AI and Fed Jitters", "image": "https://images.financialmodelingprep.com/news/first-look-insurers-auto-rules-ai-and-fed-jitters-20251204.png", "site": "gurufocus.com", "text": "Stock News Insurers under pressure, prior auth pledges stall: UnitedHealth Group (UNH) and peers Cigna (CI), Humana (HUM), CVS Health (CVS) and Elevance Health", "url": "https://www.gurufocus.com/news/3233331/first-look-insurers-auto-rules-ai-and-fed-jitters"}}
{"date": "2025-12-04", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-04 04:43:12", "publisher": "Defense World", "title": "Merck & Co., Inc. $MRK Shares Sold by Groupe la Francaise", "image": "https://images.financialmodelingprep.com/news/merck-co-inc-mrk-shares-sold-by-groupe-la-20251204.gif", "site": "defenseworld.net", "text": "Groupe la Francaise lessened its position in shares of Merck and Co., Inc. (NYSE: MRK) by 34.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 46,461 shares of the company's stock after selling 23,943 shares during the quarter. Groupe la Francaise's holdings", "url": "https://www.defenseworld.net/2025/12/04/merck-co-inc-mrk-shares-sold-by-groupe-la-francaise.html"}}
{"date": "2025-12-04", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-04 01:28:47", "publisher": "Defense World", "title": "Merck & Co., Inc. (NYSE:MRK) Trading 1.3% Higher  After Analyst Upgrade", "image": "https://images.financialmodelingprep.com/news/merck-co-inc-nysemrk-trading-13-higher-after-analyst-20251204.gif", "site": "defenseworld.net", "text": "Shares of Merck and Co., Inc. (NYSE: MRK - Get Free Report) rose 1.3% during mid-day trading on Wednesday after The Goldman Sachs Group raised their price target on the stock from $92.00 to $120.00. The Goldman Sachs Group currently has a buy rating on the stock. Merck and Co., Inc. traded as high as $103.09", "url": "https://www.defenseworld.net/2025/12/04/merck-co-inc-nysemrk-trading-1-3-higher-after-analyst-upgrade.html"}}
{"date": "2025-12-03", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-03 18:22:57", "publisher": "Seeking Alpha", "title": "3 Potential Mid-Cap Biotech Buyout Targets In 2026", "image": "https://images.financialmodelingprep.com/news/3-potential-midcap-biotech-buyout-targets-in-2026-20251203.jpg", "site": "seekingalpha.com", "text": "The biotech sector began December with notable weakness, as both IBB and XBI ETFs declined over two percent during trading on Monday. The sector has bounced back since. However, small biotech stocks have been on a huge run since mid-September, due primarily to a notable uptick in M&A activity across the industry. Numerous small and midcap biotech/biopharma stocks have been purchased for significant buyout premiums in recent months.", "url": "https://seekingalpha.com/article/4850021-3-potential-mid-cap-biotech-buyout-targets-in-2026"}}
{"date": "2025-12-03", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-03 18:03:24", "publisher": "Seeking Alpha", "title": "Merck & Co., Inc. (MRK) Presents at Citi Annual Global Healthcare Conference 2025 Transcript", "image": "https://images.financialmodelingprep.com/news/merck-co-inc-mrk-presents-at-citi-annual-global-20251203.jpg", "site": "seekingalpha.com", "text": "Merck & Co., Inc. (MRK) Presents at Citi Annual Global Healthcare Conference 2025 Transcript", "url": "https://seekingalpha.com/article/4849967-merck-and-co-inc-mrk-presents-at-citi-annual-global-healthcare-conference-2025-transcript"}}
{"date": "2025-12-03", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-03 04:13:25", "publisher": "Seeking Alpha", "title": "Merck & Co., Inc. (MRK) Presents at Evercore 8th Annual Healthcare Conference Transcript", "image": "https://images.financialmodelingprep.com/news/merck-co-inc-mrk-presents-at-evercore-8th-annual-20251203.jpg", "site": "seekingalpha.com", "text": "Merck & Co., Inc. (MRK) Presents at Evercore 8th Annual Healthcare Conference Transcript", "url": "https://seekingalpha.com/article/4849351-merck-and-co-inc-mrk-presents-at-evercore-8th-annual-healthcare-conference-transcript"}}
{"date": "2025-12-02", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-02 12:11:00", "publisher": "Market Watch", "title": "17 dividend-stock bargains from a value manager with a stellar track record", "image": "https://images.financialmodelingprep.com/news/17-dividendstock-bargains-from-a-value-manager-with-a-20251202.jpg", "site": "marketwatch.com", "text": "John Buckingham, editor of the Prudent Speculator, reminds investors to be willing to stomach volatility.", "url": "https://www.marketwatch.com/story/17-dividend-stock-bargains-from-a-value-manager-with-a-stellar-track-record-6df0e310"}}
{"date": "2025-12-02", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-02 10:46:12", "publisher": "Zacks Investment Research", "title": "Why Merck (MRK) is a Top Growth Stock for the Long-Term", "image": "https://images.financialmodelingprep.com/news/why-merck-mrk-is-a-top-growth-stock-for-20251202.jpg", "site": "zacks.com", "text": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.", "url": "https://www.zacks.com/stock/news/2798295/why-merck-mrk-is-a-top-growth-stock-for-the-long-term?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|zacks_education_growth_score-2798295"}}
{"date": "2025-12-02", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-02 08:51:56", "publisher": "24/7 Wall Street", "title": "30% of the S&P 500 Is Mag 7 Tech Stocks, but This ETF Refuses to Own a Single One", "image": "https://images.financialmodelingprep.com/news/30-of-the-sp-500-is-mag-7-tech-20251202.jpg", "site": "247wallst.com", "text": "The Magnificent 7 AI tech stocks have served as the rocket fuel propelling the S&P 500 on its bull run over the past few years.", "url": "https://247wallst.com/investing/2025/12/02/a-perfect-wide-moat-investment-without-any-mag7-exposure/"}}
{"date": "2025-12-02", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-02 05:18:44", "publisher": "Defense World", "title": "Beacon Pointe Advisors LLC Grows Position in Merck & Co., Inc. $MRK", "image": "https://images.financialmodelingprep.com/news/beacon-pointe-advisors-llc-grows-position-in-merck-co-20251202.gif", "site": "defenseworld.net", "text": "Beacon Pointe Advisors LLC increased its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 2.6% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 285,720 shares of the company's stock after acquiring an additional 7,369 shares during the", "url": "https://www.defenseworld.net/2025/12/02/beacon-pointe-advisors-llc-grows-position-in-merck-co-inc-mrk.html"}}
{"date": "2025-12-02", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-02 04:36:47", "publisher": "Defense World", "title": "Merck & Co., Inc. $MRK Stock Position Increased by Brandes Investment Partners LP", "image": "https://images.financialmodelingprep.com/news/merck-co-inc-mrk-stock-position-increased-by-brandes-20251202.gif", "site": "defenseworld.net", "text": "Brandes Investment Partners LP boosted its position in shares of Merck and Co., Inc. (NYSE: MRK) by 5.3% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,912,228 shares of the company's stock after buying an additional 95,978 shares during the quarter.", "url": "https://www.defenseworld.net/2025/12/02/merck-co-inc-mrk-stock-position-increased-by-brandes-investment-partners-lp.html"}}
{"date": "2025-12-02", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-02 04:02:14", "publisher": "Benzinga", "title": "Trump Administration Locks In Zero Tariffs On UK Pharmaceuticals As NHS To Pay More For US Drugs", "image": "https://images.financialmodelingprep.com/news/trump-administration-locks-in-zero-tariffs-on-uk-pharmaceuticals-20251202.jpeg", "site": "feeds.benzinga.com", "text": "The UK and the U.S. have reached a landmark agreement to eliminate tariffs on British pharmaceutical products being exported to America.", "url": "https://www.benzinga.com/news/health-care/25/12/49154128/trump-administration-locks-in-zero-tariffs-on-uk-pharmaceuticals-as-nhs-to-pay-more-for-us-drugs"}}
{"date": "2025-12-01", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-01 14:20:40", "publisher": "Seeking Alpha", "title": "Top 10 High-Yield Dividend Stocks For December 2025", "image": "https://images.financialmodelingprep.com/news/top-10-highyield-dividend-stocks-for-december-2025-20251201.jpg", "site": "seekingalpha.com", "text": "The November 2025 high-yield dividend watchlist delivered a 2.94% gain in last month, outperforming SPY and closely trailing VYM. This watchlist blends quality and value to identify high-yield stocks with attractive valuations, aiming for a 12% long-term CAGR and strong starting yields. Top 10 picks for December include Accenture, EOG Resources, Nike, Paychex, ADP, Penske Automotive, Comcast, Essential Utilities, and Brown Forman.", "url": "https://seekingalpha.com/article/4849026-top-10-high-yield-dividend-stocks-for-december-2025"}}
{"date": "2025-12-01", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-01 10:51:28", "publisher": "Zacks Investment Research", "title": "Here's Why Merck (MRK) is a Strong Momentum Stock", "image": "https://images.financialmodelingprep.com/news/heres-why-merck-mrk-is-a-strong-momentum-stock-20251201.jpg", "site": "zacks.com", "text": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.", "url": "https://www.zacks.com/stock/news/2797776/here-s-why-merck-mrk-is-a-strong-momentum-stock?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|zacks_education_momentum_score-2797776"}}
{"date": "2025-12-01", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-01 06:45:00", "publisher": "Business Wire", "title": "Merck Showcases Data for Alzheimer's Disease Candidates MK-2214 and MK-1167 at CTAD 2025", "image": "https://images.financialmodelingprep.com/news/merck-showcases-data-for-alzheimers-disease-candidates-mk2214-and-20251201.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck Showcases Data for Alzheimer's Disease Candidates MK-2214 and MK-1167 at CTAD 2025.", "url": "https://www.businesswire.com/news/home/20251201813248/en/Merck-Showcases-Data-for-Alzheimers-Disease-Candidates-MK-2214-and-MK-1167-at-CTAD-2025/"}}
{"date": "2025-12-01", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-01 04:16:47", "publisher": "Defense World", "title": "Capital Counsel LLC NY Increases Stock Position in Merck & Co., Inc. $MRK", "image": "https://images.financialmodelingprep.com/news/capital-counsel-llc-ny-increases-stock-position-in-merck-20251201.gif", "site": "defenseworld.net", "text": "Capital Counsel LLC NY lifted its position in shares of Merck and Co., Inc. (NYSE: MRK) by 1.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 63,228 shares of the company's stock after buying an additional 1,120 shares", "url": "https://www.defenseworld.net/2025/12/01/capital-counsel-llc-ny-increases-stock-position-in-merck-co-inc-mrk.html"}}
{"date": "2025-12-01", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-12-01 03:30:54", "publisher": "Defense World", "title": "BLI Banque de Luxembourg Investments Takes Position in Merck & Co., Inc. $MRK", "image": "https://images.financialmodelingprep.com/news/bli-banque-de-luxembourg-investments-takes-position-in-merck-20251201.gif", "site": "defenseworld.net", "text": "BLI Banque de Luxembourg Investments acquired a new stake in shares of Merck and Co., Inc. (NYSE: MRK) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 78,300 shares of the company's stock, valued at approximately $6,192,000. Several other hedge funds", "url": "https://www.defenseworld.net/2025/12/01/bli-banque-de-luxembourg-investments-takes-position-in-merck-co-inc-mrk.html"}}
{"date": "2025-11-30", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-30 04:45:00", "publisher": "The Motley Fool", "title": "These Underrated Companies Could Be \"Training-Wheels\" Stocks for Long-Term Wealth Builders", "image": "https://images.financialmodelingprep.com/news/these-underrated-companies-could-be-trainingwheels-stocks-for-longterm-20251130.jpg", "site": "fool.com", "text": "Merck is a high-yield drug stock with a well-supported dividend payment. Enbridge is a boring energy stock with a hefty yield.", "url": "https://www.fool.com/investing/2025/11/30/these-underrated-companies-could-be-training-wheel/"}}
{"date": "2025-11-29", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-29 18:33:00", "publisher": "The Motley Fool", "title": "Should You Buy This Blue Chip Pharmaceutical Stock That Just Popped 3.8%?", "image": "https://images.financialmodelingprep.com/news/should-you-buy-this-blue-chip-pharmaceutical-stock-that-20251129.jpg", "site": "fool.com", "text": "One of Merck's key assets has just scored a significant phase 2 win, boosting investor confidence. This adds to other recent developments that could help the company overcome its challenges.", "url": "https://www.fool.com/investing/2025/11/29/should-you-buy-this-blue-chip-pharmaceutical-stock/"}}
{"date": "2025-11-28", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-28 10:00:29", "publisher": "Seeking Alpha", "title": "Merck: Excellence Across The Board", "image": "https://images.financialmodelingprep.com/news/merck-excellence-across-the-board-20251128.jpg", "site": "seekingalpha.com", "text": "Merck (MRK) demonstrates excellence across the board through its resilient revenue mix, expanding profitability, and stellar capital allocation. MRK's innovation, highlighted by Keytruda's dominance and diversified revenue streams, supports strong profitability and mitigates concentration risk. MRK's proven investment track record and consistent dividend growth further reinforce its appeal as a long-term investment opportunity.", "url": "https://seekingalpha.com/article/4848455-merck-stock-excellence-across-the-board"}}
{"date": "2025-11-28", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-28 04:18:44", "publisher": "Defense World", "title": "Clarkston Capital Partners LLC Acquires 2,143 Shares of Merck & Co., Inc. $MRK", "image": "https://images.financialmodelingprep.com/news/clarkston-capital-partners-llc-acquires-2143-shares-of-merck-20251128.gif", "site": "defenseworld.net", "text": "Clarkston Capital Partners LLC raised its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 11.8% in the undefined quarter, according to its most recent 13F filing with the SEC. The fund owned 20,250 shares of the company's stock after acquiring an additional 2,143 shares during the period. Clarkston Capital Partners", "url": "https://www.defenseworld.net/2025/11/28/clarkston-capital-partners-llc-acquires-2143-shares-of-merck-co-inc-mrk.html"}}
{"date": "2025-11-27", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-27 10:46:25", "publisher": "Zacks Investment Research", "title": "AstraZeneca or Merck: Which Oncology Giant Has the Edge?", "image": "https://images.financialmodelingprep.com/news/astrazeneca-or-merck-which-oncology-giant-has-the-edge-20251127.jpg", "site": "zacks.com", "text": "AZN and MRK boast major oncology strengths and expanding pipelines amid shifting market dynamics in this pharma matchup.", "url": "https://www.zacks.com/stock/news/2796475/astrazeneca-or-merck-which-oncology-giant-has-the-edge?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2796475"}}
{"date": "2025-11-27", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-27 10:01:12", "publisher": "Zacks Investment Research", "title": "Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know", "image": "https://images.financialmodelingprep.com/news/investors-heavily-search-merck-co-inc-mrk-here-is-20251127.jpg", "site": "zacks.com", "text": "Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.", "url": "https://www.zacks.com/stock/news/2796381/investors-heavily-search-merck-co-inc-mrk-here-is-what-you-need-to-know?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2796381"}}
{"date": "2025-11-27", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-27 03:52:50", "publisher": "Defense World", "title": "Baltimore Washington Financial Advisors Inc. Increases Stake in Merck & Co., Inc. $MRK", "image": "https://images.financialmodelingprep.com/news/baltimore-washington-financial-advisors-inc-increases-stake-in-merck-20251127.gif", "site": "defenseworld.net", "text": "Baltimore Washington Financial Advisors Inc. grew its position in Merck and Co., Inc. (NYSE: MRK) by 22.4% in the undefined quarter, according to its most recent disclosure with the SEC. The fund owned 4,450 shares of the company's stock after buying an additional 815 shares during the period. Baltimore Washington Financial Advisors Inc.'s", "url": "https://www.defenseworld.net/2025/11/27/baltimore-washington-financial-advisors-inc-increases-stake-in-merck-co-inc-mrk.html"}}
{"date": "2025-11-26", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-26 17:35:00", "publisher": "GuruFocus", "title": "Market Today: Stocks Rally, Tesla Robotaxi and Nvidia Scrutiny", "image": "https://images.financialmodelingprep.com/news/market-today-stocks-rally-tesla-robotaxi-and-nvidia-scrutiny-20251126.png", "site": "gurufocus.com", "text": "Stock News Campbell's exec ousted after viral recording: Campbell Soup (CPB) said it terminated IT VP Martin Bally after an internal review concluded he was the", "url": "https://www.gurufocus.com/news/3226287/market-today-stocks-rally-tesla-robotaxi-and-nvidia-scrutiny"}}
{"date": "2025-11-26", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-26 10:51:19", "publisher": "Zacks Investment Research", "title": "Will Soft Gardasil Demand Continue to Dampen Merck's Top Line?", "image": "https://images.financialmodelingprep.com/news/will-soft-gardasil-demand-continue-to-dampen-mercks-top-20251126.jpg", "site": "zacks.com", "text": "MRK faces steep Gardasil declines as China and Japan demand soften, putting pressure on its vaccine portfolio.", "url": "https://www.zacks.com/stock/news/2795962/will-soft-gardasil-demand-continue-to-dampen-merck-s-top-line?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2795962"}}
{"date": "2025-11-26", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-26 08:25:03", "publisher": "Forbes", "title": "Why Is Merck Stock Surging?", "image": "https://images.financialmodelingprep.com/news/why-is-merck-stock-surging-20251126.jpg", "site": "forbes.com", "text": "Merck (MRK)'s stock surged by 41% over the past six months, driven not significantly by revenue, but rather by increased profits and heightened investor confidence. Following crucial Q3 earnings exceeding expectations, the FDA's approval of Keytruda's new formulation, and an excellent upgrade from Wells Fargo, several factors contributed to this boostlet's delve into the main reasons for the rise.", "url": "https://www.forbes.com/sites/greatspeculations/2025/11/26/why-is-merck-stock-surging/"}}
{"date": "2025-11-26", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-26 07:39:00", "publisher": "GuruFocus", "title": "First Look: Campbell Soup fallout, Alphabet AI strength, Nvidia rebuttal", "image": "https://images.financialmodelingprep.com/news/first-look-campbell-soup-fallout-alphabet-ai-strength-nvidia-20251126.png", "site": "gurufocus.com", "text": "Stock News Campbell puts exec on leave: Campbell's Co. (CPB) sidelined a senior IT executive after a lawsuit and leaked audio alleged he disparaged customers an", "url": "https://www.gurufocus.com/news/3225411/first-look-campbell-soup-fallout-alphabet-ai-strength-nvidia-rebuttal"}}
{"date": "2025-11-26", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-26 07:15:00", "publisher": "Business Wire", "title": "Merck to Participate in the Citi 2025 Global Healthcare Conference", "image": "https://images.financialmodelingprep.com/news/merck-to-participate-in-the-citi-2025-global-healthcare-20251126.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck to Participate in the Citi 2025 Global Healthcare Conference.", "url": "https://www.businesswire.com/news/home/20251126929019/en/Merck-to-Participate-in-the-Citi-2025-Global-Healthcare-Conference/"}}
{"date": "2025-11-26", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-26 06:45:00", "publisher": "Business Wire", "title": "Merck to Participate in the 8th Annual Evercore ISI HealthCONx Conference", "image": "https://images.financialmodelingprep.com/news/merck-to-participate-in-the-8th-annual-evercore-isi-20251126.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck to Participate in the 8th Annual Evercore ISI HealthCONx Conference.", "url": "https://www.businesswire.com/news/home/20251126774458/en/Merck-to-Participate-in-the-8th-Annual-Evercore-ISI-HealthCONx-Conference/"}}
{"date": "2025-11-25", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-25 18:00:00", "publisher": "GuruFocus", "title": "Market Today: Stocks Rise on Fed Cut Bets; Alphabet, Apple Hit Records", "image": "https://images.financialmodelingprep.com/news/market-today-stocks-rise-on-fed-cut-bets-alphabet-20251125.png", "site": "gurufocus.com", "text": "Guru Stock PicksJefferies Group has made the following transactions:Reduce in CLDX by 12.28%Sold out in UNFIAdd in SMH by 25.28%New position in XNCRT Rowe Price", "url": "https://www.gurufocus.com/news/3224917/market-today-stocks-rise-on-fed-cut-bets-alphabet-apple-hit-records"}}
{"date": "2025-11-25", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-25 04:34:52", "publisher": "Defense World", "title": "Associated Banc Corp Has $8.35 Million Stock Position in Merck & Co., Inc. $MRK", "image": "https://images.financialmodelingprep.com/news/associated-banc-corp-has-835-million-stock-position-in-20251125.gif", "site": "defenseworld.net", "text": "Associated Banc Corp cut its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 12.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 105,451 shares of the company's stock after selling 14,361 shares during the", "url": "https://www.defenseworld.net/2025/11/25/associated-banc-corp-has-8-35-million-stock-position-in-merck-co-inc-mrk.html"}}
{"date": "2025-11-24", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-24 11:51:05", "publisher": "Zacks Investment Research", "title": "FDA Approves MRK's Keytruda & Keytruda SC Combo in Bladder Cancer", "image": "https://images.financialmodelingprep.com/news/fda-approves-mrks-keytruda-keytruda-sc-combo-in-bladder-20251124.jpg", "site": "zacks.com", "text": "Merck gains FDA nod for Keytruda and Keytruda Qlex with Padcev in MIBC, marking the first PD-1 inhibitor plus ADC regimens for this patient group.", "url": "https://www.zacks.com/stock/news/2794912/fda-approves-mrk-s-keytruda-keytruda-sc-combo-in-bladder-cancer?cid=CS-STOCKNEWSAPI-FT-analyst_blog|company_news_medical_sector-2794912"}}
{"date": "2025-11-24", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-24 11:15:46", "publisher": "Schaeffers Research", "title": "Pharma Stock Pops on Wells Fargo Upgrade", "image": "https://images.financialmodelingprep.com/news/pharma-stock-pops-on-wells-fargo-upgrade-20251124.jpg", "site": "schaeffersresearch.com", "text": "Pharmaceutical stock Merck & Co (NYSE:MRK) is up 4% at $101.64 at last glance, after an upgrade from Wells Fargo to \"overweight\" from \"equal weight,\" with a price-target hike to $125 from $90.", "url": "https://www.schaeffersresearch.com/content/news/2025/11/24/pharma-stock-pops-on-wells-fargo-upgrade"}}
{"date": "2025-11-24", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-24 08:20:45", "publisher": "24/7 Wall Street", "title": "Here are Monday's Top Wall Street Analyst's Research Calls: Baidu, Carvana, Exact Sciences, Ferrari, Marvell Technology, Meta Platforms and More", "image": "https://images.financialmodelingprep.com/news/here-are-mondays-top-wall-street-analysts-research-calls-20251124.jpg", "site": "247wallst.com", "text": "The shortened holiday week is here, and the futures are trading higher this morning.", "url": "https://247wallst.com/investing/2025/11/24/here-are-mondays-top-wall-street-analysts-research-calls-baidu-carvana-exact-sciences-ferrari-marvell-technology-meta-platforms-and-more/"}}
{"date": "2025-11-24", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-24 06:45:00", "publisher": "Business Wire", "title": "Merck Data to be Presented at ASH 2025 Annual Meeting Showcase Continued Advancements in Hematology Pipeline and Novel Therapeutic Approaches", "image": "https://images.financialmodelingprep.com/news/merck-data-to-be-presented-at-ash-2025-annual-20251124.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that new data across multiple hematologic malignancies will be presented at the American Society of Hematology (ASH) Annual Meeting and Exposition in Orlando, Fla. from Dec. 6-9. The data shared at the meeting will highlight the company's ongoing commitment to advancing clinical research in hematology across Merck's expanding and diverse pipeline of investigational candidates,.", "url": "https://www.businesswire.com/news/home/20251124225525/en/Merck-Data-to-be-Presented-at-ASH-2025-Annual-Meeting-Showcase-Continued-Advancements-in-Hematology-Pipeline-and-Novel-Therapeutic-Approaches/"}}
{"date": "2025-11-23", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-23 15:45:00", "publisher": "Seeking Alpha", "title": "Steven Cress' 6 Picks: 3 Dividend Income, 3 AI Growth Stocks", "image": "https://images.financialmodelingprep.com/news/steven-cress-6-picks-3-dividend-income-3-ai-20251123.jpg", "site": "seekingalpha.com", "text": "In volatile markets, Steve Cress recommends a barbell strategy: combining high-yield dividend stocks (MRK, PINE, OMF) with top AI growth stocks (MU, CLS, COMM). Seeking Alpha's quant system outperforms Wall Street by leveraging daily data, sector-relative analysis, and robust risk metrics to identify strong buys.", "url": "https://seekingalpha.com/article/4846958-steven-cress-6-picks-3-dividend-income-3-ai-growth-stocks"}}
{"date": "2025-11-23", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-23 04:16:51", "publisher": "Defense World", "title": "Boston Research & Management Inc. Grows Position in Merck & Co., Inc. $MRK", "image": "https://images.financialmodelingprep.com/news/boston-research-management-inc-grows-position-in-merck-co-20251123.gif", "site": "defenseworld.net", "text": "Boston Research and Management Inc. grew its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 7.1% during the undefined quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 67,359 shares of the company's stock after purchasing an additional 4,473 shares during the period. Boston", "url": "https://www.defenseworld.net/2025/11/23/boston-research-management-inc-grows-position-in-merck-co-inc-mrk.html"}}
{"date": "2025-11-21", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-21 19:30:00", "publisher": "Business Wire", "title": "Merck Recommends Rejection of Tutanota's Mini-Tender Offer", "image": "https://images.financialmodelingprep.com/news/merck-recommends-rejection-of-tutanotas-minitender-offer-20251121.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, has been notified that Tutanota LLC (Tutanota) has commenced an unsolicited mini-tender offer, dated November 10, 2025, to purchase up to 1,000,000 shares of Merck common stock at $65.00 per share. The offer price is approximately 24.66% below the closing price of Merck common stock on November 7, 2025 ($86.28), the last trading day before the date of the offer, and approximately 31.56% below the closing price of Merck common stock on November 20, 2025 ($94.97), the day prior to this release.", "url": "https://www.businesswire.com/news/home/20251121193746/en/Merck-Recommends-Rejection-of-Tutanota%E2%80%99s-%E2%80%9CMini-Tender%E2%80%9D-Offer/"}}
{"date": "2025-11-21", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-21 16:12:00", "publisher": "Business Wire", "title": "FDA Approves KEYTRUDA (pembrolizumab) and KEYTRUDA QLEX (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev (enfortumab vedotin-ejfv), as Perioperative Treatment for Adults with Cisplatin-Ineligible Muscle-Invasive Bladder Cancer", "image": "https://images.financialmodelingprep.com/news/fda-approves-keytruda-pembrolizumab-and-keytruda-qlex-pembrolizumab-and-20251121.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA (pembrolizumab) and KEYTRUDA QLEX (pembrolizumab and berahyaluronidase alfa-pmph) in combination with Padcev (enfortumab vedotin-ejfv), as neoadjuvant treatment and then continued after cystectomy as adjuvant treatment, for the treatment of adult patients with muscle-invasive bladder cancer (MIBC) who ar.", "url": "https://www.businesswire.com/news/home/20251121196103/en/FDA-Approves-KEYTRUDA%C2%AE-pembrolizumab-and-KEYTRUDA-QLEX%E2%84%A2-pembrolizumab-and-berahyaluronidase-alfa-pmph-Each-with-Padcev%C2%AE-enfortumab-vedotin-ejfv-as-Perioperative-Treatment-for-Adults-with-Cisplatin-Ineligible-Muscle-Invasive-Bladder-Cancer/"}}
{"date": "2025-11-21", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-21 08:00:00", "publisher": "Seeking Alpha", "title": "Retirement: 2 Healthcare Giants To Buy At Discounted Prices", "image": "https://images.financialmodelingprep.com/news/retirement-2-healthcare-giants-to-buy-at-discounted-prices-20251121.jpg", "site": "seekingalpha.com", "text": "Merck offers strong dividend growth, a robust drug pipeline, and strategic acquisitions, positioning it well beyond Keytruda's patent expiration. MRK's 3.9% dividend yield, low payout ratio, and A+ credit rating support its 14-year dividend growth streak and future income potential. Elevance Health faces near-term headwinds but boasts a large consumer base, efficiency initiatives, and a 13-year dividend growth record.", "url": "https://seekingalpha.com/article/4846138-retirement-2-healthcare-giants-to-buy-at-discounted-prices"}}
{"date": "2025-11-21", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-21 04:26:49", "publisher": "Defense World", "title": "Merck & Co., Inc. $MRK Shares Sold by Archer Investment Corp", "image": "https://images.financialmodelingprep.com/news/merck-co-inc-mrk-shares-sold-by-archer-investment-20251121.gif", "site": "defenseworld.net", "text": "Archer Investment Corp lessened its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 9.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 24,021 shares of the company's stock after selling 2,379 shares during the period. Archer", "url": "https://www.defenseworld.net/2025/11/21/merck-co-inc-mrk-shares-sold-by-archer-investment-corp.html"}}
{"date": "2025-11-20", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-20 12:13:25", "publisher": "Seeking Alpha", "title": "Merck & Co., Inc. (MRK) Presents at Jefferies London Healthcare Conference 2025 Transcript", "image": "https://images.financialmodelingprep.com/news/merck-co-inc-mrk-presents-at-jefferies-london-healthcare-20251120.jpg", "site": "seekingalpha.com", "text": "Merck & Co., Inc. ( MRK ) Jefferies London Healthcare Conference 2025 November 20, 2025 9:30 AM EST Company Participants Peter Dannenbaum - Vice President of Investor Relations Chirfi Guindo - Senior VP & Chief Marketing Officer of Human Health Marjorie C. Green - Senior VP & Head of Late-Stage Oncology - Global Clinical Development Conference Call Participants Akash Tewari - Jefferies LLC, Research Division Presentation Akash Tewari Jefferies LLC, Research Division Last day.", "url": "https://seekingalpha.com/article/4846188-merck-and-co-inc-mrk-presents-at-jefferies-london-healthcare-conference-2025-transcript"}}
{"date": "2025-11-20", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-20 10:51:17", "publisher": "Zacks Investment Research", "title": "MRK HIV Regimen Meets Goal in New Study, Gains EU Nod for Keytruda SC", "image": "https://images.financialmodelingprep.com/news/mrk-hiv-regimen-meets-goal-in-new-study-gains-20251120.jpg", "site": "zacks.com", "text": "Merck reports strong new HIV study results showing non-inferiority of DOR/ISL to Gilead's Biktarvy and secures an EU approval for its faster-to-administer SC version of Keytruda.", "url": "https://www.zacks.com/stock/news/2793677/mrk-hiv-regimen-meets-goal-in-new-study-gains-eu-nod-for-keytruda-sc?cid=CS-STOCKNEWSAPI-FT-analyst_blog|company_news_medical_sector-2793677"}}
{"date": "2025-11-20", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-20 10:41:00", "publisher": "Zacks Investment Research", "title": "Here's Why Merck (MRK) is a Strong Value Stock", "image": "https://images.financialmodelingprep.com/news/heres-why-merck-mrk-is-a-strong-value-stock-20251120.jpg", "site": "zacks.com", "text": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.", "url": "https://www.zacks.com/stock/news/2793640/here-s-why-merck-mrk-is-a-strong-value-stock?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|zacks_education_value_score-2793640"}}
{"date": "2025-11-20", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-20 09:45:00", "publisher": "Fool - Investing News", "title": "Merck Is Buying Cidara Therapeutics for $9.2 Billion. Is This the Boost the Lagging Drugmaker Needs?", "image": "https://images.financialmodelingprep.com/news/merck-is-buying-cidara-therapeutics-for-92-billion-is-this-20251120.jpeg", "site": "fool.com", "text": "The pharmaceutical giant's post-Keytruda plans continue to take shape.", "url": "https://www.fool.com/investing/2025/11/20/merck-is-buying-cidara-therapeutics-for-92-billion/"}}
{"date": "2025-11-20", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-20 05:40:56", "publisher": "Defense World", "title": "Merck & Co., Inc. $MRK Shares Acquired by 17 Capital Partners LLC", "image": "https://images.financialmodelingprep.com/news/merck-co-inc-mrk-shares-acquired-by-17-capital-partners-20251120.gif", "site": "defenseworld.net", "text": "17 Capital Partners LLC lifted its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 13.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 7,635 shares of the company's stock after buying an additional 930 shares during", "url": "https://www.defenseworld.net/2025/11/20/merck-co-inc-mrk-shares-acquired-by-17-capital-partners-llc.html"}}
{"date": "2025-11-20", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-20 04:26:54", "publisher": "Defense World", "title": "Artisan Partners Limited Partnership Sells 26,500 Shares of Merck & Co., Inc. $MRK", "image": "https://images.financialmodelingprep.com/news/artisan-partners-limited-partnership-sells-26500-shares-of-merck-co-20251120.gif", "site": "defenseworld.net", "text": "Artisan Partners Limited Partnership cut its position in Merck and Co., Inc. (NYSE: MRK) by 2.0% during the undefined quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,300,748 shares of the company's stock after selling 26,500 shares during the period. Artisan Partners Limited Partnership owned", "url": "https://www.defenseworld.net/2025/11/20/artisan-partners-limited-partnership-sells-26500-shares-of-merck-co-inc-mrk.html"}}
{"date": "2025-11-19", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-19 13:23:40", "publisher": "Benzinga", "title": "Merck's Investigational Two-Drug Regime Matches Gilead's Three-Drug Tablet For HIV Treatment", "image": "https://images.financialmodelingprep.com/news/mercks-investigational-twodrug-regime-matches-gileads-threedrug-tablet-for-hiv-20251119.jpg", "site": "benzinga.com", "text": "Merck & Co. Inc. (NYSE: MRK) on Wednesday shared topline results from the Phase 3 trial of an investigational, once-daily, oral, two-drug, single-tablet regimen of doravirine/islatravir (DOR/ISL) in adults with HIV-1 infection who had not previously received antiretroviral treatment (treatment-nave).", "url": "https://www.benzinga.com/news/health-care/25/11/48957826/mercks-investigational-two-drug-regime-matches-gileads-three-drug-tablet-for-hiv-treatment"}}
{"date": "2025-11-19", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-19 13:05:03", "publisher": "Forbes", "title": "Big Pharma Has Spent Nearly $150 Billion On M&A (So Far) In 2025", "image": "https://images.financialmodelingprep.com/news/big-pharma-has-spent-nearly-150-billion-on-ma-20251119.jpg", "site": "forbes.com", "text": "In this week's edition of InnovationRx, we look at the biotech deal frenzy, Recursion's incoming CEO, the infant formula botulism outbreak, and more. To get it in your inbox, subscribe here.", "url": "https://www.forbes.com/sites/innovationrx/2025/11/19/big-pharma-has-spent-nearly-150-billion-on-ma-so-far-in-2025/"}}
{"date": "2025-11-19", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-19 11:56:09", "publisher": "Zacks Investment Research", "title": "Merck Stock Rise as New PAH Drug Winrevair Meets Goal in Another Study", "image": "https://images.financialmodelingprep.com/news/merck-stock-rise-as-new-pah-drug-winrevair-meets-20251119.jpg", "site": "zacks.com", "text": "MRK's Winrevair hits its phase II goal in patients with CpcPH tied to HFpEF, setting up phase III plans and a potential path to broader use. Stock up.", "url": "https://www.zacks.com/stock/news/2793152/merck-stock-rise-as-new-pah-drug-winrevair-meets-goal-in-another-study?cid=CS-STOCKNEWSAPI-FT-analyst_blog|company_news_medical_sector-2793152"}}
{"date": "2025-11-19", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-19 08:25:00", "publisher": "MarketBeat", "title": "Healthcare Rotation Underway: 3 Stocks Leading the Charge", "image": "https://images.financialmodelingprep.com/news/healthcare-rotation-underway-3-stocks-leading-the-charge-20251119.jpg", "site": "marketbeat.com", "text": "Is the artificial intelligence revolution hitting its first roadblock? For the first time since the AI boom began in 2023, the industry is starting to feel the weight of expectations, and many of the tech sector's biggest winners have been struggling amidst a volatile market.", "url": "https://www.marketbeat.com/originals/healthcare-rotation-underway-3-stocks-leading-the-charge/"}}
{"date": "2025-11-19", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-19 06:50:11", "publisher": "Reuters", "title": "Merck's oral HIV treatment meets main goal in late-stage study", "image": "https://images.financialmodelingprep.com/news/mercks-oral-hiv-treatment-meets-main-goal-in-latestage-20251119.jpg", "site": "reuters.com", "text": "Merck said on Wednesday that its experimental oral HIV treatment met the main goal of a late-stage trial.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/mercks-oral-hiv-treatment-meets-main-goal-late-stage-study-2025-11-19/"}}
{"date": "2025-11-19", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-19 06:45:00", "publisher": "Business Wire", "title": "Merck Announces Positive Topline Results from the Pivotal Phase 3 Trial Evaluating Investigational, Once-Daily, Oral, Two-Drug, Single-Tablet Regimen of Doravirine/Islatravir (DOR/ISL) in Treatment-Nave Adults with HIV-1 Infection", "image": "https://images.financialmodelingprep.com/news/merck-announces-positive-topline-results-from-the-pivotal-phase-3-20251119.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from the pivotal double-blind Phase 3 trial of the investigational, once-daily, oral, two-drug, single-tablet regimen of doravirine/islatravir [DOR/ISL (100 mg/0.25 mg)] in adults with HIV-1 infection who had not previously received antiretroviral treatment (treatment-nave) (MK-8591A-053). The success criterion for the primary efficacy hypothesis, as measured.", "url": "https://www.businesswire.com/news/home/20251119717847/en/Merck-Announces-Positive-Topline-Results-from-the-Pivotal-Phase-3-Trial-Evaluating-Investigational-Once-Daily-Oral-Two-Drug-Single-Tablet-Regimen-of-DoravirineIslatravir-DORISL-in-Treatment-Na%C3%AFve-Adults-with-HIV-1-Infection/"}}
{"date": "2025-11-19", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-19 06:30:00", "publisher": "Business Wire", "title": "European Commission Approves Subcutaneous Administration of KEYTRUDA (pembrolizumab) for All Adult Indications Approved in the European Union", "image": "https://images.financialmodelingprep.com/news/european-commission-approves-subcutaneous-administration-of-keytruda-pembrolizumab-for-20251119.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Commission (EC) has approved a new subcutaneous (SC), or under the skin, route of administration and a new pharmaceutical form (solution for injection) of KEYTRUDA (pembrolizumab), Merck's anti-PD-1 therapy. KEYTRUDA SC, as it will be marketed in the European Union (EU), [known as KEYTRUDA QLEXTM (pembrolizumab and berahyaluronidase alfa-pmph) in the U.S.],.", "url": "https://www.businesswire.com/news/home/20251119081276/en/European-Commission-Approves-Subcutaneous-Administration-of-KEYTRUDA%C2%AE-pembrolizumab-for-All-Adult-Indications-Approved-in-the-European-Union/"}}
{"date": "2025-11-18", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-18 16:59:00", "publisher": "MarketBeat", "title": "Merck Writes a $9.2 Billion Check for a Flu Drug That Could Change Everything", "image": "https://images.financialmodelingprep.com/news/merck-writes-a-92-billion-check-for-a-flu-20251118.jpg", "site": "marketbeat.com", "text": "In one of the most decisive strategic moves in thebiotech sector this year, pharmaceutical titan Merck & Co. NYSE: MRK has committed a formidable $9.2 billion in cash to acquireCidara Therapeutics NASDAQ: CDTX.", "url": "https://www.marketbeat.com/originals/merck-writes-a-92-billion-check-for-a-flu-drug-that-could-change-everything/"}}
{"date": "2025-11-18", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-18 14:43:08", "publisher": "Investors Business Daily", "title": "Drug Giant Merck Breaks Out Past New Buy Point; CME, Marathon Eye Entries", "image": "https://images.financialmodelingprep.com/news/drug-giant-merck-breaks-out-past-new-buy-point-20251118.jpg", "site": "investors.com", "text": "Dow Jones drug giant Merck is breaking out past its latest buy point as the stock market volatility continues Tuesday.", "url": "https://www.investors.com/stock-lists/stocks-near-a-buy-zone/dow-jones-merck-stock-mrk-buy-point/"}}
{"date": "2025-11-18", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-18 12:42:18", "publisher": "Benzinga", "title": "Merck's Winrevair Success Extends Beyond Pulmonary Hypertension, Showing Promise In Complex Heart Condition", "image": "https://images.financialmodelingprep.com/news/mercks-winrevair-success-extends-beyond-pulmonary-hypertension-showing-promise-in-20251118.jpg", "site": "benzinga.com", "text": "Merck & Co. Inc. (NYSE: MRK) on Tuesday released topline results from the Phase 2 CADENCE study of Winrevair (sotatercept-csrk) in adults for combined post- and precapillary pulmonary hypertension (CpcPH) due to heart failure with preserved ejection fraction (HFpEF).", "url": "https://www.benzinga.com/news/health-care/25/11/48931416/mercks-winrevair-success-extends-beyond-pulmonary-hypertension-showing-promise-in-complex-heart-condition"}}
{"date": "2025-11-18", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-18 11:30:00", "publisher": "Business Wire", "title": "Merck Announces First-Quarter 2026 Dividend", "image": "https://images.financialmodelingprep.com/news/merck-announces-firstquarter-2026-dividend-20251118.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck Announces First-Quarter 2026 Dividend.", "url": "https://www.businesswire.com/news/home/20251118928676/en/Merck-Announces-First-Quarter-2026-Dividend/"}}
{"date": "2025-11-18", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-18 06:45:00", "publisher": "Business Wire", "title": "Merck's WINREVAIR (sotatercept-csrk) Met Primary Endpoint in Phase 2 CADENCE Study in Adults With Combined Post- and Precapillary Pulmonary Hypertension (CpcPH) due to Heart Failure With Preserved Ejection Fraction (HFpEF)", "image": "https://images.financialmodelingprep.com/news/mercks-winrevair-sotaterceptcsrk-met-primary-endpoint-in-phase-2-20251118.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck's WINREVAIR (sotatercept-csrk) Met Primary Endpoint in Phase 2 CADENCE Study in Adults With CpcPH due to HFpEF.", "url": "https://www.businesswire.com/news/home/20251118918484/en/Merck%E2%80%99s-WINREVAIR%E2%84%A2-sotatercept-csrk-Met-Primary-Endpoint-in-Phase-2-CADENCE-Study-in-Adults-With-Combined-Post--and-Precapillary-Pulmonary-Hypertension-CpcPH-due-to-Heart-Failure-With-Preserved-Ejection-Fraction-HFpEF/"}}
{"date": "2025-11-18", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-18 04:18:36", "publisher": "Seeking Alpha", "title": "Merck Has Many Bullish Attributes (Technical Analysis)", "image": "https://images.financialmodelingprep.com/news/merck-has-many-bullish-attributes-technical-analysis-20251118.jpg", "site": "seekingalpha.com", "text": "Merck presents a bullish investment case with strong valuation, improving grades, and a well-supported, growing dividend. MRK's technical setup is positive: price trades above its 30-week EMA, momentum indicators are bullish, and volume shows institutional accumulation. Since its May low, the company has outperformed the S&P 500, with relative strength now trending higher and above its 30-week EMA.", "url": "https://seekingalpha.com/article/4844918-merck-has-many-bullish-attributes-technical-analysis"}}
{"date": "2025-11-18", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-18 02:34:50", "publisher": "Defense World", "title": "Merck & Co., Inc. (NYSE:MRK) Receives $104.50 Average PT from Brokerages", "image": "https://images.financialmodelingprep.com/news/merck-co-inc-nysemrk-receives-10450-average-pt-from-brokerages-20251118.gif", "site": "defenseworld.net", "text": "Shares of Merck and Co., Inc. (NYSE: MRK - Get Free Report) have received a consensus rating of \"Hold\" from the eighteen brokerages that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, ten have issued a hold recommendation, five have issued a buy recommendation and two have", "url": "https://www.defenseworld.net/2025/11/18/merck-co-inc-nysemrk-receives-104-50-average-pt-from-brokerages.html"}}
{"date": "2025-11-17", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-17 10:27:07", "publisher": "Seeking Alpha", "title": "Merck & Co., Inc. (MRK) M&A Call Transcript", "image": "https://images.financialmodelingprep.com/news/merck-co-inc-mrk-ma-call-transcript-20251117.jpg", "site": "seekingalpha.com", "text": "Merck & Co., Inc. ( MRK ) M&A Call November 17, 2025 8:00 AM EST Company Participants Peter Dannenbaum - Vice President of Investor Relations Robert Davis - Chairman, President & CEO Dean Li - Executive VP & President of Merck Research Laboratories Chirfi Guindo - Senior VP & Chief Marketing Officer of Human Health Caroline Litchfield - Executive VP & CFO Conference Call Participants Carter Gould - Cantor Fitzgerald & Co., Research Division James Shin - Deutsche Bank AG, Research Division Vamil Divan - Guggenheim Securities, LLC, Research Division Daina Graybosch - Leerink Partners LLC, Research Division Alexandria Hammond - Wolfe Research, LLC Steve Scala - TD Cowen, Research Division Evan Seigerman - BMO Capital Markets Equity Research Christopher Schott - JPMorgan Chase & Co, Research Division Geoffrey Meacham - Citigroup Inc., Research Division Courtney Breen - Sanford C. Bernstein & Co., LLC.", "url": "https://seekingalpha.com/article/4844604-merck-and-co-inc-mrk-m-and-a-call-transcript"}}
{"date": "2025-11-17", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-17 09:36:07", "publisher": "Zacks Investment Research", "title": "MRK to Buy Cidara for $9.2B: Focus on Buyout Spree Heading Into 2026", "image": "https://images.financialmodelingprep.com/news/mrk-to-buy-cidara-for-92b-focus-on-buyout-20251117.jpg", "site": "zacks.com", "text": "Merck's $9.2 billion proposed Cidara acquisition will add CD388 to the pipeline, boosting the respiratory portfolio and fueling its ongoing strategic M&A momentum.", "url": "https://www.zacks.com/stock/news/2791705/mrk-to-buy-cidara-for-9-2b-focus-on-buyout-spree-heading-into-2026?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2791705"}}
{"date": "2025-11-17", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-17 09:07:14", "publisher": "Zacks Investment Research", "title": "MRK Up Nearly 10% in a Month: Should You Buy, Sell or Hold the Stock?", "image": "https://images.financialmodelingprep.com/news/mrk-up-nearly-10-in-a-month-should-you-20251117.jpg", "site": "zacks.com", "text": "Merck rebounds on pipeline wins and a $9.2B Cidara deal, but mixed trends and Keytruda risks keep investors weighing next moves.", "url": "https://www.zacks.com/stock/news/2791677/mrk-up-nearly-10-in-a-month-should-you-buy-sell-or-hold-the-stock?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2791677"}}
{"date": "2025-11-17", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-17 08:34:17", "publisher": "Reuters", "title": "Merck expects over $5 billion commercial opportunity from Cidara's flu drug", "image": "https://images.financialmodelingprep.com/news/merck-expects-over-5-billion-commercial-opportunity-from-cidaras-20251117.jpg", "site": "reuters.com", "text": "Merck said on Monday it expects a non-risk adjusted commercial opportunity in excess of $5 billion from Cidara Therapeutics' experimental flu drug.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/merck-expects-over-5-billion-commercial-opportunity-cidaras-flu-drug-2025-11-17/"}}
{"date": "2025-11-17", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-17 04:31:50", "publisher": "Seeking Alpha", "title": "Merck And Royal Gold Among 13 Companies To Announce Annual Increases In Second Half Of November", "image": "https://images.financialmodelingprep.com/news/merck-and-royal-gold-among-13-companies-to-announce-20251117.jpg", "site": "seekingalpha.com", "text": "This is my latest article, where I provide predictions of upcoming dividend increases from companies with long-term dividend growth histories. Dividend growth picked up from companies in the first half of November, with 6 companies announcing 10%+ increases, including ADP, Roper Technologies, Atmos, and Snap-on. Other notable companies expecting dividend hikes include Motorola Solutions, McCormick, and Raymond James, each with robust earnings trends.", "url": "https://seekingalpha.com/article/4844511-merck-and-royal-gold-among-13-companies-to-announce-annual-increases-in-second-half-of-november"}}
{"date": "2025-11-16", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-16 18:49:00", "publisher": "Business Wire", "title": "Cidara Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cidara Therapeutics, Inc. - CDTX", "image": "https://images.financialmodelingprep.com/news/cidara-therapeutics-investor-alert-by-the-former-attorney-general-of-20251116.jpg", "site": "businesswire.com", "text": "NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Cidara Therapeutics, Inc. (NasdaqCM: CDTX) to Merck & Co., Inc. (NYSE: MRK). Under the terms of the proposed transaction, shareholders of Cidara will receive $221.50 in cash for each share of Cidara that they own. KSF is seeking to determine whether this consideration and the process that l.", "url": "https://www.businesswire.com/news/home/20251116665090/en/Cidara-Therapeutics-Investor-Alert-By-The-Former-Attorney-General-Of-Louisiana-Kahn-Swick-Foti-LLC-Investigates-Adequacy-of-Price-and-Process-in-Proposed-Sale-of-Cidara-Therapeutics-Inc.---CDTX/"}}
{"date": "2025-11-14", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-14 18:17:56", "publisher": "CNBC Television", "title": "If M&A continues at this pace you want to be long Biotech into next year, says Mizuho's Jared Holz", "image": "https://images.financialmodelingprep.com/news/if-ma-continues-at-this-pace-you-want-to-be-20251114.jpg", "site": "youtube.com", "text": "Jared Holz, Mizuho, joins 'Fast Money' to talk the uptick in biotech and pharma M&A, what it is signaling, and how to play it.", "url": "https://www.youtube.com/watch?v=60dOgQ7SgcE"}}
{"date": "2025-11-14", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-14 17:01:31", "publisher": "Seeking Alpha", "title": "Merck & Co., Inc. (MRK) Presents at 7th Annual Healthcare Symposium Transcript", "image": "https://images.financialmodelingprep.com/news/merck-co-inc-mrk-presents-at-7th-annual-healthcare-20251114.jpg", "site": "seekingalpha.com", "text": "Merck & Co., Inc. ( MRK ) 7th Annual Healthcare Symposium November 14, 2025 11:55 AM EST Company Participants Michelle Kehily Conference Call Participants Elena Meng Michael Paas Stephen S. Morse Magdalena Sobieszczyk Presentation Unknown Attendee So our final panel of the day is about vaccines.", "url": "https://seekingalpha.com/article/4844051-merck-and-co-inc-mrk-presents-at-7th-annual-healthcare-symposium-transcript"}}
{"date": "2025-11-14", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-14 15:19:12", "publisher": "CNBC Television", "title": "Biopharma companies have confidence in their ability to do deals: BMO's Evan Seigerman", "image": "https://images.financialmodelingprep.com/news/biopharma-companies-have-confidence-in-their-ability-to-do-20251114.jpg", "site": "youtube.com", "text": "Evan Seigerman, BMO Capital Markets head of health care research, joins 'Power Lunch' to discuss what's behind the recent move in health care stocks, the state of play with GLP-1s and much more.", "url": "https://www.youtube.com/watch?v=X24CQW_cpss"}}
{"date": "2025-11-14", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-14 11:20:00", "publisher": "Market Watch", "title": "This is why Merck is buying Cidara Therapeutics for $9.2 billion, and why Wall Street is happy", "image": "https://images.financialmodelingprep.com/news/this-is-why-merck-is-buying-cidara-therapeutics-for-20251114.jpg", "site": "marketwatch.com", "text": "Merck is facing a patent cliff for Keytruda and upheaval in the market for Gardasil.", "url": "https://www.marketwatch.com/story/this-is-why-merck-is-buying-cidara-therapeutics-for-9-2-billion-and-why-wall-street-is-happy-5091d7a2"}}
{"date": "2025-11-14", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-14 10:46:09", "publisher": "Zacks Investment Research", "title": "Here's Why Merck (MRK) is a Strong Growth Stock", "image": "https://images.financialmodelingprep.com/news/heres-why-merck-mrk-is-a-strong-growth-stock-20251114.jpg", "site": "zacks.com", "text": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.", "url": "https://www.zacks.com/stock/news/2791303/here-s-why-merck-mrk-is-a-strong-growth-stock?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|zacks_education_growth_score-2791303"}}
{"date": "2025-11-14", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-14 10:00:46", "publisher": "Schwab Network", "title": "NVDA Price Target Hikes, STUB Shows No Guidance, MRK Buying CDTX", "image": "https://images.financialmodelingprep.com/news/nvda-price-target-hikes-stub-shows-no-guidance-mrk-20251114.jpg", "site": "youtube.com", "text": "Nvidia (NVDA) got bullish momentum from Wells Fargo and Morgan Stanley ahead of next week's earnings. Diane King Hall talks about what analysts expect from Nvidia's long-term prospects.", "url": "https://www.youtube.com/watch?v=MayLDZAvUz4"}}
{"date": "2025-11-14", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-14 09:33:22", "publisher": "Proactive Investors", "title": "Merck to acquire Cidara Therapeutics for $9.2B", "image": "https://images.financialmodelingprep.com/news/merck-to-acquire-cidara-therapeutics-for-92b-20251114.jpg", "site": "proactiveinvestors.com", "text": "Merck & Co Inc (NYSE:MRK, ETR:6MK) announced it has agreed to acquire Cidara Therapeutics Inc (NASDAQ:CDTX)in a $9.2 billion cash deal, paying $221.50 per share, more than double Cidara's stock price prior to the announcement. Shares of Merck slipped 1.5% to about $92 on the news, while Cidara shares surged 105% to $217.", "url": "https://www.proactiveinvestors.com/companies/news/1082537"}}
{"date": "2025-11-14", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-14 07:16:00", "publisher": "WSJ", "title": "Merck to Buy Cidara Therapeutics in $9.2 Billion Deal", "image": "https://images.financialmodelingprep.com/news/merck-to-buy-cidara-therapeutics-in-92-billion-deal-20251114.jpg", "site": "wsj.com", "text": "Merck & Co. has struck a $9.2 billion deal to buy biotechnology company Cidara Therapeutics in a move that bolsters the drugmaker's respiratory portfolio.", "url": "https://www.wsj.com/health/pharma/merck-to-buy-cidara-therapeutics-in-9-2-billion-deal-9fbfdde7"}}
{"date": "2025-11-14", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-14 06:51:56", "publisher": "Reuters", "title": "Merck bets on flu prevention with about $9.2 billion deal for Cidara Therapeutics", "image": "https://images.financialmodelingprep.com/news/merck-bets-on-flu-prevention-with-about-92-billion-deal-20251114.jpg", "site": "reuters.com", "text": "Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, the companies said on Friday, gaining access to an experimental drug for flu prevention.", "url": "https://www.reuters.com/legal/litigation/merck-bets-flu-prevention-with-about-92-billion-deal-cidara-therapeutics-2025-11-14/"}}
{"date": "2025-11-14", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-14 06:45:00", "publisher": "Business Wire", "title": "Merck to Acquire Cidara Therapeutics, Inc., Diversifying Its Portfolio to Include Late-Phase Antiviral Agent", "image": "https://images.financialmodelingprep.com/news/merck-to-acquire-cidara-therapeutics-inc-diversifying-its-portfolio-20251114.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J. & SAN DIEGO, Calif.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Cidara Therapeutics, Inc. (Nasdaq: CDTX) (Cidara), a biotechnology company developing drug-Fc conjugate (DFC) therapeutics, today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Cidara for $221.50 per share in cash, for a total transaction value of approximately $9.2 billion. We continue to.", "url": "https://www.businesswire.com/news/home/20251114185276/en/Merck-to-Acquire-Cidara-Therapeutics-Inc.-Diversifying-Its-Portfolio-to-Include-Late-Phase-Antiviral-Agent/"}}
{"date": "2025-11-14", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-14 06:09:59", "publisher": "Seeking Alpha", "title": "Wall Street Breakfast Podcast: Merck Talks Send Cidara Soaring", "image": "https://images.financialmodelingprep.com/news/wall-street-breakfast-podcast-merck-talks-send-cidara-soaring-20251114.jpg", "site": "seekingalpha.com", "text": "Merck (MRK) is close to acquiring Cidara Therapeutics (CDTX) in a deal potentially exceeding $3.3 billion, with announcement expected soon. CDTX shares surged 85% on news of the potential acquisition, which may include upfront cash and milestone-based payouts.", "url": "https://seekingalpha.com/article/4843776-wall-street-breakfast-podcast-merck-talks-send-cidara-soaring"}}
{"date": "2025-11-14", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-14 04:29:00", "publisher": "Proactive Investors - Finance", "title": "Merck to acquire Cidara Therapeutics for $9.2B", "image": "https://images.financialmodelingprep.com/news/merck-to-acquire-cidara-therapeutics-for-92b-20251114.jpeg", "site": "proactiveinvestors.com", "text": "Merck & Co Inc (NYSE:MRK, ETR:6MK) announced it has agreed to acquire Cidara Therapeutics Inc (NASDAQ:CDTX)in a $9.2 billion cash deal, paying $221.50 per...", "url": "https://www.proactiveinvestors.com/companies/news/1082537/merck-to-acquire-cidara-therapeutics-for-9-2b-1082537.html"}}
{"date": "2025-11-14", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-14 04:13:01", "publisher": "Defense World", "title": "Merck & Co., Inc. $MRK Stake Decreased by Arvest Bank Trust Division", "image": "https://images.financialmodelingprep.com/news/merck-co-inc-mrk-stake-decreased-by-arvest-bank-20251114.gif", "site": "defenseworld.net", "text": "Arvest Bank Trust Division cut its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 43.2% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 14,134 shares of the company's stock after selling 10,755 shares during the period.", "url": "https://www.defenseworld.net/2025/11/14/merck-co-inc-mrk-stake-decreased-by-arvest-bank-trust-division.html"}}
{"date": "2025-11-13", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-13 19:06:06", "publisher": "Zacks Investment Research", "title": "Pulling Back for a Fresh Look at This Recent Pullback", "image": "https://images.financialmodelingprep.com/news/pulling-back-for-a-fresh-look-at-this-recent-20251113.jpg", "site": "zacks.com", "text": "Fed members are openly having second thoughts about further cuts to interest rates, especially with no new data on the jobs or inflation front.", "url": "https://www.zacks.com/stock/news/2790920/pulling-back-for-a-fresh-look-at-this-recent-pullback?cid=CS-STOCKNEWSAPI-FT-ahead_of_wall_street-2790920"}}
{"date": "2025-11-13", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-13 18:53:32", "publisher": "Reuters", "title": "Merck nearing deal for Cidara, FT reports", "image": "https://images.financialmodelingprep.com/news/merck-nearing-deal-for-cidara-ft-reports-20251113.jpg", "site": "reuters.com", "text": "Merck is closing in on a deal to buy Cidara Therapeutics in a deal valuing the biotechnology company at a premium to its $3.3 billion market capitalization, the Financial Times reported on Thursday.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/merck-nearing-deal-cidara-ft-reports-2025-11-13/"}}
{"date": "2025-11-13", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-13 06:45:00", "publisher": "Business Wire", "title": "Merck to Participate in the Jefferies Global Healthcare Conference in London", "image": "https://images.financialmodelingprep.com/news/merck-to-participate-in-the-jefferies-global-healthcare-conference-20251113.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck to Participate in the Jefferies Global Healthcare Conference in London.", "url": "https://www.businesswire.com/news/home/20251113100681/en/Merck-to-Participate-in-the-Jefferies-Global-Healthcare-Conference-in-London/"}}
{"date": "2025-11-13", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-13 04:55:00", "publisher": "The Motley Fool", "title": "Should You Forget Pfizer and Buy This Magnificent Drug Stock Instead?", "image": "https://images.financialmodelingprep.com/news/should-you-forget-pfizer-and-buy-this-magnificent-drug-20251113.jpg", "site": "fool.com", "text": "Pfizer and Merck are two of the largest drug companies on the planet. Both companies are dealing with upcoming patent expirations.", "url": "https://www.fool.com/investing/2025/11/13/forget-pfizer-buy-magnificent-drug-stock/"}}
{"date": "2025-11-12", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-12 10:15:00", "publisher": "The Motley Fool", "title": "2 Strong Healthcare Stock Picks for Value Investors", "image": "https://images.financialmodelingprep.com/news/2-strong-healthcare-stock-picks-for-value-investors-20251112.jpg", "site": "fool.com", "text": "These two tried-and-tested healthcare giants have compelling portfolios and pipelines. Pfizer is moving on from the pandemic era, and a stream of acquisitions has bolstered its pipeline.", "url": "https://www.fool.com/investing/2025/11/12/2-strong-healthcare-stock-picks-for-value-investor/"}}
{"date": "2025-11-12", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-12 04:08:48", "publisher": "Defense World", "title": "Merck & Co., Inc. $MRK Shares Sold by AGF Management Ltd.", "image": "https://images.financialmodelingprep.com/news/merck-co-inc-mrk-shares-sold-by-agf-management-20251112.gif", "site": "defenseworld.net", "text": "AGF Management Ltd. lessened its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 33.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 11,078 shares of the company's stock after selling 5,568 shares during the period.", "url": "https://www.defenseworld.net/2025/11/12/merck-co-inc-mrk-shares-sold-by-agf-management-ltd.html"}}
{"date": "2025-11-11", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-11 17:33:00", "publisher": "GuruFocus", "title": "Market Today: SoftBank exits Nvidia; Ford doubles on EVs", "image": "https://images.financialmodelingprep.com/news/market-today-softbank-exits-nvidia-ford-doubles-on-evs-20251111.png", "site": "gurufocus.com", "text": "Guru Stock PicksJana Partners has made the following transactions:Reduce in MRCY by 16.73%Stock News Airlines caution on lingering flight chaos: United Airlines", "url": "https://www.gurufocus.com/news/3202446/market-today-softbank-exits-nvidia-ford-doubles-on-evs"}}
{"date": "2025-11-11", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-11 05:54:58", "publisher": "Defense World", "title": "49 Wealth Management LLC Sells 3,660 Shares of Merck & Co., Inc. $MRK", "image": "https://images.financialmodelingprep.com/news/49-wealth-management-llc-sells-3660-shares-of-merck-20251111.gif", "site": "defenseworld.net", "text": "49 Wealth Management LLC lowered its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 56.9% during the undefined quarter, according to its most recent filing with the SEC. The firm owned 2,769 shares of the company's stock after selling 3,660 shares during the period. 49 Wealth Management LLC's holdings in", "url": "https://www.defenseworld.net/2025/11/11/49-wealth-management-llc-sells-3660-shares-of-merck-co-inc-mrk.html"}}
{"date": "2025-11-10", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-10 12:21:36", "publisher": "Seeking Alpha", "title": "Merck & Co., Inc. (MRK) Shareholder/Analyst Call Transcript", "image": "https://images.financialmodelingprep.com/news/merck-co-inc-mrk-shareholderanalyst-call-transcript-20251110.jpg", "site": "seekingalpha.com", "text": "Merck & Co., Inc. ( MRK ) Shareholder/Analyst Call November 9, 2025 7:01 PM EST Company Participants Peter Dannenbaum - Vice President of Investor Relations Dean Li - Executive VP & President of Merck Research Laboratories Joerg Koglin - Senior VP & Head of General Medicine - Global Clinical Development Jannie Oosthuizen - Senior VP & President Merck U.S. Human Health Conference Call Participants Taylor Hanley - JPMorgan Chase & Co, Research Division Daina Graybosch - Leerink Partners LLC, Research Division Nick Jennings - Goldman Sachs Group, Inc., Research Division Malcolm Hoffman - BMO Capital Markets Equity Research Vamil Divan - Guggenheim Securities, LLC, Research Division Courtney Breen - Sanford C. Bernstein & Co., LLC.", "url": "https://seekingalpha.com/article/4841115-merck-and-co-inc-mrk-shareholder-analyst-call-transcript"}}
{"date": "2025-11-10", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-10 10:51:35", "publisher": "Zacks Investment Research", "title": "Will Keytruda Aid MRK's Growth in 2026 After a Subdued Q3?", "image": "https://images.financialmodelingprep.com/news/will-keytruda-aid-mrks-growth-in-2026-after-a-20251110.jpg", "site": "zacks.com", "text": "Merck leans on Keytruda's expanding cancer indications and new SC formulation to sustain growth momentum into 2026 after soft sales in Q3.", "url": "https://www.zacks.com/stock/news/2788571/will-keytruda-aid-mrk-s-growth-in-2026-after-a-subdued-q3?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2788571"}}
{"date": "2025-11-09", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-09 17:00:00", "publisher": "Business Wire", "title": "Merck's Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Adults with Heterozygous Familial Hypercholesterolemia (HeFH) in Phase 3 CORALreef HeFH Trial", "image": "https://images.financialmodelingprep.com/news/mercks-enlicitide-decanoate-an-investigational-oral-pcsk9-inhibitor-significantly-20251109.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck's Enlicitide, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Adults with HeFH in Phase 3 CORALreef HeFH Trial.", "url": "https://www.businesswire.com/news/home/20251109011682/en/Merck%E2%80%99s-Enlicitide-Decanoate-an-Investigational-Oral-PCSK9-Inhibitor-Significantly-Reduced-LDL-C-in-Adults-with-Heterozygous-Familial-Hypercholesterolemia-HeFH-in-Phase-3-CORALreef-HeFH-Trial/"}}
{"date": "2025-11-08", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-08 14:30:45", "publisher": "Investors Business Daily", "title": "Merck Takes On Amgen, Regeneron, Lowering Stubbornly High Cholesterol By 60%", "image": "https://images.financialmodelingprep.com/news/merck-takes-on-amgen-regeneron-lowering-stubbornly-high-cholesterol-20251108.jpg", "site": "investors.com", "text": "Merck said Saturday its new pill  a potential rival to Regeneron and Amgen  lowered stubbornly high cholesterol by almost 60%.", "url": "https://www.investors.com/news/technology/merck-amgen-regeneron-pcsk9-pill-cholesterol-treatment/"}}
{"date": "2025-11-08", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-08 14:30:00", "publisher": "Business Wire", "title": "Merck's Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Phase 3 CORALreef Lipids Trial", "image": "https://images.financialmodelingprep.com/news/mercks-enlicitide-decanoate-an-investigational-oral-pcsk9-inhibitor-significantly-reduced-20251108.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck's Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Phase 3 CORALreef Lipids Trial.", "url": "https://www.businesswire.com/news/home/20251108607082/en/Merck%E2%80%99s-Enlicitide-Decanoate-an-Investigational-Oral-PCSK9-Inhibitor-Significantly-Reduced-LDL-C-in-Phase-3-CORALreef-Lipids-Trial/"}}
{"date": "2025-11-07", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-07 10:00:21", "publisher": "Zacks Investment Research", "title": "Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock", "image": "https://images.financialmodelingprep.com/news/here-is-what-to-know-beyond-why-merck-co-20251107.jpg", "site": "zacks.com", "text": "Zacks.com users have recently been watching Merck (MRK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.", "url": "https://www.zacks.com/stock/news/2787675/here-is-what-to-know-beyond-why-merck-co-inc-mrk-is-a-trending-stock?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2787675"}}
{"date": "2025-11-07", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-07 07:15:00", "publisher": "The Motley Fool", "title": "3 Dirt Cheap Stocks to Buy With $1,000 Right Now", "image": "https://images.financialmodelingprep.com/news/3-dirt-cheap-stocks-to-buy-with-1000-right-20251107.jpg", "site": "fool.com", "text": "Pharmaceutical giant Merck has been prepping for the end of exclusivity for its leading drug. Verizon may not offer much in the way of growth, but it more than makes up for it with income.", "url": "https://www.fool.com/investing/2025/11/07/3-dirt-cheap-stocks-to-buy-with-1000-right-now/"}}
{"date": "2025-11-04", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-04 14:46:00", "publisher": "The Motley Fool", "title": "Why Merck Is Sinking This Week", "image": "https://images.financialmodelingprep.com/news/why-merck-is-sinking-this-week-20251104.jpg", "site": "fool.com", "text": "Sales of blockbuster drug Keytruda missed expectations. The drug's patents will begin to expire in 2028.", "url": "https://www.fool.com/investing/2025/11/04/why-merck-is-sinking-this-week/"}}
{"date": "2025-11-04", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-04 10:41:16", "publisher": "Zacks Investment Research", "title": "Why Merck (MRK) is a Top Value Stock for the Long-Term", "image": "https://images.financialmodelingprep.com/news/why-merck-mrk-is-a-top-value-stock-for-20251104.jpg", "site": "zacks.com", "text": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.", "url": "https://www.zacks.com/stock/news/2784585/why-merck-mrk-is-a-top-value-stock-for-the-long-term?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|zacks_education_value_score-2784585"}}
{"date": "2025-11-04", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-04 07:00:58", "publisher": "Reuters", "title": "Merck and Blackstone enter research agreement to develop cancer therapy for $700 million", "image": "https://images.financialmodelingprep.com/news/merck-and-blackstone-enter-research-agreement-to-develop-cancer-20251104.jpg", "site": "reuters.com", "text": "Merck said on Tuesday that it has entered into an agreement to receive funds managed by Blackstone Life Sciences for $700 million to develop an experimental cancer therapy.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/merck-blackstone-enter-research-agreement-develop-cancer-therapy-700-million-2025-11-04/"}}
{"date": "2025-11-04", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-04 06:50:00", "publisher": "Business Wire", "title": "Merck Enters into Research and Development Funding Agreement with Blackstone Life Sciences for Sacituzumab Tirumotecan (sac-TMT)", "image": "https://images.financialmodelingprep.com/news/merck-enters-into-research-and-development-funding-agreement-with-20251104.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the company has entered into an agreement to receive funds managed by Blackstone Life Sciences (Blackstone) for the development of sacituzumab tirumotecan (sac-TMT), an investigational antibody-drug conjugate (ADC) targeting trophoblast cell-surface antigen 2 (TROP2), a protein found on the surface of various cancer cells. Merck is currently evaluating sac-TMT in 15 glo.", "url": "https://www.businesswire.com/news/home/20251104511714/en/Merck-Enters-into-Research-and-Development-Funding-Agreement-with-Blackstone-Life-Sciences-for-Sacituzumab-Tirumotecan-sac-TMT/"}}
{"date": "2025-11-04", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-04 06:45:00", "publisher": "Business Wire", "title": "Merck Signs Agreement with Dr. Falk Pharma GmbH for Certain Development and Commercialization Rights to MK-8690 (PRA-052) an Investigational Anti-CD30 Ligand Monoclonal Antibody", "image": "https://images.financialmodelingprep.com/news/merck-signs-agreement-with-dr-falk-pharma-gmbh-for-20251104.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the company, through a subsidiary (Prometheus BioSciences), has reached an agreement with Dr. Falk Pharma GmbH (Falk) to discontinue an existing contract concerning co-development and co-commercialization rights in certain territories for MK-8690 (formerly PRA-052), and for Merck to assume full responsibility for the development program going forward. MK-8690 is an invest.", "url": "https://www.businesswire.com/news/home/20251104391507/en/Merck-Signs-Agreement-with-Dr.-Falk-Pharma-GmbH-for-Certain-Development-and-Commercialization-Rights-to-MK-8690-PRA-052-an-Investigational-Anti-CD30-Ligand-Monoclonal-Antibody/"}}
{"date": "2025-11-04", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-04 04:30:00", "publisher": "The Motley Fool", "title": "Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?", "image": "https://images.financialmodelingprep.com/news/should-you-buy-the-3-highestpaying-dividend-stocks-in-20251104.jpg", "site": "fool.com", "text": "Verizon has a 7% yield and is a top player in the telecom space. Chevron has a 4.4% yield and is one of the largest integrated energy companies on the planet.", "url": "https://www.fool.com/investing/2025/11/04/should-buy-highest-paying-dividend-stock-dow/"}}
{"date": "2025-11-03", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-03 06:45:00", "publisher": "Business Wire", "title": "Merck Foundation Launches $22 Million Initiative to Improve Cardiovascular Care in the U.S.", "image": "https://images.financialmodelingprep.com/news/merck-foundation-launches-22-million-initiative-to-improve-cardiovascular-20251103.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck Foundation Launches $22 Million Initiative to Improve Cardiovascular Care in the U.S.", "url": "https://www.businesswire.com/news/home/20251103058367/en/Merck-Foundation-Launches-22-Million-Initiative-to-Improve-Cardiovascular-Care-in-the-U.S./"}}
{"date": "2025-11-02", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-02 07:12:34", "publisher": "Seeking Alpha", "title": "Top 10 High-Yield Dividend Stocks For November 2025", "image": "https://images.financialmodelingprep.com/news/top-10-highyield-dividend-stocks-for-november-2025-20251102.jpg", "site": "seekingalpha.com", "text": "The November 2025 high-yield dividend watchlist highlights 10 stocks selected for quality, value, and attractive starting yields, aiming for a 12% CAGR. The watchlist's five-year CAGR is 14.49%, trailing SPY and VYM but offering higher yields, with 81% of stocks delivering positive returns since inception. Recent changes include lowering the minimum yield threshold to 2.5% and expanding the list to test Quality and Value-focused portfolios for broader idea generation.", "url": "https://seekingalpha.com/article/4836745-top-10-high-yield-dividend-stocks-for-november-2025"}}
{"date": "2025-11-01", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-11-01 08:15:00", "publisher": "Seeking Alpha", "title": "5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (Nov. 2025)", "image": "https://images.financialmodelingprep.com/news/5-relatively-secure-and-cheap-dividend-stocks-yields-up-to-20251101.jpg", "site": "seekingalpha.com", "text": "This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields 4%, we present two other groups of five DGI stocks each, from moderate to high yields of up to 8%.", "url": "https://seekingalpha.com/article/4835411-5-relatively-secure-and-cheap-dividend-stocks-yields-up-to-8-percent-nov-2025"}}
{"date": "2025-10-30", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-30 13:45:37", "publisher": "Zacks Investment Research", "title": "MRK Beats Q3 Earnings Estimates, Narrows 2025 Sales View, Stock Down", "image": "https://images.financialmodelingprep.com/news/mrk-beats-q3-earnings-estimates-narrows-2025-sales-view-20251030.jpg", "site": "zacks.com", "text": "Merck tops Q3 earnings and revenue estimates on strong oncology, new drugs and animal health sales, while narrowing its 2025 revenue outlook.", "url": "https://www.zacks.com/stock/news/2781823/mrk-beats-q3-earnings-estimates-narrows-2025-sales-view-stock-down?cid=CS-STOCKNEWSAPI-FT-analyst_blog|earnings_article-2781823"}}
{"date": "2025-10-30", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-30 13:36:24", "publisher": "Seeking Alpha", "title": "Merck & Co., Inc. (MRK) Q3 2025 Earnings Call Transcript", "image": "https://images.financialmodelingprep.com/news/merck-co-inc-mrk-q3-2025-earnings-call-transcript-20251030.jpg", "site": "seekingalpha.com", "text": "Merck & Co., Inc. ( MRK ) Q3 2025 Earnings Call October 30, 2025 9:00 AM EDT Company Participants Peter Dannenbaum - Vice President of Investor Relations Robert Davis - Chairman, President & CEO Caroline Litchfield - Executive VP & CFO Dean Li - Executive VP & President of Merck Research Laboratories Conference Call Participants Asad Haider - Goldman Sachs Group, Inc., Research Division Geoffrey Meacham - Citigroup Inc., Research Division Akash Tewari - Jefferies LLC, Research Division Evan Seigerman - BMO Capital Markets Equity Research Daina Graybosch - Leerink Partners LLC, Research Division Christopher Schott - JPMorgan Chase & Co, Research Division Carter Gould - Cantor Fitzgerald & Co., Research Division Terence Flynn - Morgan Stanley, Research Division Umer Raffat - Evercore ISI Institutional Equities, Research Division Courtney Breen - Sanford C. Bernstein & Co., LLC.", "url": "https://seekingalpha.com/article/4835542-merck-and-co-inc-mrk-q3-2025-earnings-call-transcript"}}
{"date": "2025-10-30", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-30 13:33:37", "publisher": "Seeking Alpha", "title": "My Top 10 High-Yield Picks For November 2025: One Yields 9%+", "image": "https://images.financialmodelingprep.com/news/my-top-10-highyield-picks-for-november-2025-one-20251030.jpg", "site": "seekingalpha.com", "text": "I present a diversified selection of high-yield dividend stocks with strong income and growth potential, including CVX, VZ, MO, ARCC, and others. Each company was selected for sustainable dividends, attractive yields, reasonable payout ratios, and a proven record or potential for dividend growth. CVX and ARCC receive positive Wall Street ratings, while VZ and MO offer high yields and strong free cash flow, supporting portfolio income stability.", "url": "https://seekingalpha.com/article/4835638-my-top-10-high-yield-picks-for-november-2025-one-yields-9-percent-plus"}}
{"date": "2025-10-30", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-30 12:24:17", "publisher": "Benzinga", "title": "Merck Ready For Larger Than $15 Billion Deals, Raises Annual Profit Outlook", "image": "https://images.financialmodelingprep.com/news/merck-ready-for-larger-than-15-billion-deals-raises-20251030.jpg", "site": "benzinga.com", "text": "Merck & Co., Inc. (NYSE:MRK) stock traded in a volatile session on Thursday following its third-quarter earnings report and updated fiscal 2025 outlook.", "url": "https://www.benzinga.com/markets/earnings/25/10/48535333/merck-ready-for-larger-than-15-billion-deals-raises-annual-profit-outlook"}}
{"date": "2025-10-30", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-30 11:22:00", "publisher": "Proactive Investors", "title": "Merck Q3 financial results top estimates, company lowers revenue guidance", "image": "https://images.financialmodelingprep.com/news/merck-q3-financial-results-top-estimates-company-lowers-revenue-20251030.jpg", "site": "proactiveinvestors.com", "text": "Merck & Co Inc (NYSE:MRK, ETR:6MK)on Thursday reported third quarter 2025earnings and revenue that surpassed Wall Street expectations, lifted by strong demand for its cancer immunotherapy Keytruda, butreducedits full-yearsalesoutlookto reflect lower estimated tariff costs, among other factors. The pharmaceutical company's revenue for thequarter rose 4% year over year to$17.28 billion,exceeding the$16.96 billionanalyst consensusestimateprovided by LSEG.", "url": "https://www.proactiveinvestors.com/companies/news/1081463"}}
{"date": "2025-10-30", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-30 10:35:37", "publisher": "Zacks Investment Research", "title": "Merck (MRK) Reports Q3 Earnings: What Key Metrics Have to Say", "image": "https://images.financialmodelingprep.com/news/merck-mrk-reports-q3-earnings-what-key-metrics-have-20251030.jpg", "site": "zacks.com", "text": "The headline numbers for Merck (MRK) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.", "url": "https://www.zacks.com/stock/news/2781329/merck-mrk-reports-q3-earnings-what-key-metrics-have-to-say?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|nfm-2781329"}}
{"date": "2025-10-30", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-30 09:20:41", "publisher": "Seeking Alpha", "title": "Merck: Wall Street Surprised By Q3 Strength, Keytruda Sales Surge", "image": "https://images.financialmodelingprep.com/news/merck-wall-street-surprised-by-q3-strength-keytruda-sales-surge-20251030.jpg", "site": "seekingalpha.com", "text": "Merck published its financial results for Q3 2025 this morning. Strong demand for Winrevair from patients suffering from pulmonary arterial hypertension drove sales to $360 million in the third quarter of 2025, up 141.6% year-on-year. Of MRK's vaccine franchise, its \"gem\" remains Capvaxive, which generated sales of $244 million for the quarter, a sharp 419.1% rise from the same period a year ago.", "url": "https://seekingalpha.com/article/4835377-merck-wall-street-surprised-by-q3-strength-keytruda-sales-surge"}}
{"date": "2025-10-30", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-30 08:46:06", "publisher": "Zacks Investment Research", "title": "Merck (MRK) Q3 Earnings and Revenues Beat Estimates", "image": "https://images.financialmodelingprep.com/news/merck-mrk-q3-earnings-and-revenues-beat-estimates-20251030.jpg", "site": "zacks.com", "text": "Merck (MRK) came out with quarterly earnings of $2.58 per share, beating the Zacks Consensus Estimate of $2.36 per share. This compares to earnings of $1.57 per share a year ago.", "url": "https://www.zacks.com/stock/news/2781068/merck-mrk-q3-earnings-and-revenues-beat-estimates?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_4-2781068"}}
{"date": "2025-10-30", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-30 06:41:00", "publisher": "WSJ", "title": "Merck Profit Rises on Strong Keytruda Demand", "image": "https://images.financialmodelingprep.com/news/merck-profit-rises-on-strong-keytruda-demand-20251030.jpg", "site": "wsj.com", "text": "Merck reported higher third-quarter profit and boosted its full-year outlook, as demand for its flagship Keytruda cancer drug continues to rise.", "url": "https://www.wsj.com/business/earnings/merck-profit-rises-on-strong-keytruda-demand-1905acdb"}}
{"date": "2025-10-30", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-30 06:38:17", "publisher": "CNBC", "title": "Merck tops estimates on Keytruda strength and narrows profit outlook, as it lowers estimated tariff hit", "image": "https://images.financialmodelingprep.com/news/merck-tops-estimates-on-keytruda-strength-and-narrows-profit-20251030.jpeg", "site": "cnbc.com", "text": "Merck reported third-quarter earnings and revenue that topped estimates in part due to strong demand for its cancer immunotherapy Keytruda, and narrowed its full-year profit outlook to reflect lower estimated tariff costs and other items. Sales of Keytruda topped more than $8 billion for the first time in a quarter, up 10% from the same period a year ago.", "url": "https://www.cnbc.com/2025/10/30/merck-mrk-earnings-q3-2025.html"}}
{"date": "2025-10-30", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-30 06:33:26", "publisher": "Reuters", "title": "Merck posts higher third-quarter sales as Keytruda growth offsets drop from Gardasil", "image": "https://images.financialmodelingprep.com/news/merck-posts-higher-thirdquarter-sales-as-keytruda-growth-offsets-20251030.jpg", "site": "reuters.com", "text": "Merck & Co on Thursday posted higher third quarter revenue as growth from its blockbuster cancer drug Keytruda offset falling sales from human papillomavirus vaccine Gardasil in China.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/merck-posts-higher-third-quarter-sales-keytruda-growth-offsets-drop-gardasil-2025-10-30/"}}
{"date": "2025-10-30", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-30 06:30:00", "publisher": "Business Wire", "title": "Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter 2025 Financial Results", "image": "https://images.financialmodelingprep.com/news/merck-co-inc-rahway-nj-usa-announces-thirdquarter-2025-financial-20251030.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter 2025 Financial Results.", "url": "https://www.businesswire.com/news/home/20251030997062/en/Merck-Co.-Inc.-Rahway-N.J.-USA-Announces-Third-Quarter-2025-Financial-Results/"}}
{"date": "2025-10-29", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-29 16:30:00", "publisher": "Barrons", "title": "Merck Reports Earnings Under Shadow of Keytruda Patent Cliff. What to Expect.", "image": "https://images.financialmodelingprep.com/news/merck-reports-earnings-under-shadow-of-keytruda-patent-cliff-what-20251029.jpg", "site": "barrons.com", "text": "Third quarter earnings are coming. The pharmaceutical maker's stock is down 12% this year.", "url": "https://www.barrons.com/articles/merck-reports-earnings-under-shadow-of-keytruda-patent-cliff-what-to-expect-be9e7308"}}
{"date": "2025-10-29", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-29 14:19:35", "publisher": "CNBC Television", "title": "The setup on earnings beyond tech", "image": "https://images.financialmodelingprep.com/news/the-setup-on-earnings-beyond-tech-20251029.jpg", "site": "youtube.com", "text": "The Investment Committee debate some non-mega cap names reporting in the next 24 hours.", "url": "https://www.youtube.com/watch?v=aQH79e2Ewsg"}}
{"date": "2025-10-29", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-29 07:59:01", "publisher": "Reuters", "title": "Merck, Eisai discontinue late-stage study for liver cancer therapy", "image": "https://images.financialmodelingprep.com/news/merck-eisai-discontinue-latestage-study-for-liver-cancer-therapy-20251029.jpg", "site": "reuters.com", "text": "Merck and Japan's Eisai said on Wednesday they will shut down a late-stage study testing an experimental combination therapy to treat a type of liver cancer, after interim results showed the treatment was unlikely to improve overall survival.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/merck-eisai-discontinue-late-stage-study-liver-cancer-therapy-2025-10-29/"}}
{"date": "2025-10-29", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-29 07:00:00", "publisher": "Business Wire", "title": "Merck and Eisai Provide Update on Phase 3 LEAP-012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma", "image": "https://images.financialmodelingprep.com/news/merck-and-eisai-provide-update-on-phase-3-leap012-20251029.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J. & NUTLEY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck and Eisai Provide Update on Phase 3 LEAP-012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma.", "url": "https://www.businesswire.com/news/home/20251029169636/en/Merck-and-Eisai-Provide-Update-on-Phase-3-LEAP-012-Trial-in-Unresectable-Non-Metastatic-Hepatocellular-Carcinoma/"}}
{"date": "2025-10-29", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-29 06:45:00", "publisher": "Business Wire", "title": "European Commission Approves KEYTRUDA (pembrolizumab) as Part of a Treatment Regimen for Adults with Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC) Expressing PD-L1 (CPS >1)", "image": "https://images.financialmodelingprep.com/news/european-commission-approves-keytruda-pembrolizumab-as-part-of-a-20251029.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Commission (EC) has approved KEYTRUDA (pembrolizumab), Merck's anti-PD-1 therapy, as monotherapy for the treatment of resectable locally advanced head and neck squamous cell carcinoma (LA-HNSCC) as neoadjuvant treatment, continued as adjuvant treatment in combination with radiation therapy with or without concomitant cisplatin and then as monotherapy in adul.", "url": "https://www.businesswire.com/news/home/20251029078394/en/European-Commission-Approves-KEYTRUDA%C2%AE-pembrolizumab-as-Part-of-a-Treatment-Regimen-for-Adults-with-Resectable-Locally-Advanced-Head-and-Neck-Squamous-Cell-Carcinoma-LA-HNSCC-Expressing-PD-L1-CPS-1/"}}
{"date": "2025-10-28", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-28 13:40:20", "publisher": "Zacks Investment Research", "title": "Buy, Sell or Hold MRK Stock Ahead of Q3 Earnings? Things to Know", "image": "https://images.financialmodelingprep.com/news/buy-sell-or-hold-mrk-stock-ahead-of-q3-20251028.jpg", "site": "zacks.com", "text": "MRK faces pressure from weak vaccine sales and rising competition, but strong oncology growth and new launches could support a rebound.", "url": "https://www.zacks.com/stock/news/2779328/buy-sell-or-hold-mrk-stock-ahead-of-q3-earnings-things-to-know?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2779328"}}
{"date": "2025-10-28", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-28 10:40:55", "publisher": "CNBC", "title": "Healthy Returns: What to expect from Eli Lilly, Merck, Gilead and AbbVie third-quarter earnings", "image": "https://images.financialmodelingprep.com/news/healthy-returns-what-to-expect-from-eli-lilly-merck-20251028.jpg", "site": "cnbc.com", "text": "Eli Lilly, Merck, Gilead, Bristol Myers Squibb and AbbVie, among other pharmaceutical companies, are slated to report third-quarter earnings this week.", "url": "https://www.cnbc.com/2025/10/28/healthy-returns-eli-lilly-merck-gilead-and-abbvie-earnings-preview.html"}}
{"date": "2025-10-28", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-28 09:16:00", "publisher": "Business Wire", "title": "Merck Partners with Promega to Advance 3-D Cell Drug Discovery Technologies", "image": "https://images.financialmodelingprep.com/news/merck-partners-with-promega-to-advance-3d-cell-drug-20251028.jpg", "site": "businesswire.com", "text": "DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, has entered into a partnership with Promega Corporation, a global life science solutions and service leader based in Madison, Wisconsin in the US, to co-develop novel technologies that advance drug screening and discovery. The agreement unites Merck's strength in organoids and synthetic chemistry with Promega's market leading assay and reporter technologies. Together, the companies aim to develop assays capabl.", "url": "https://www.businesswire.com/news/home/20251028493228/en/Merck-Partners-with-Promega-to-Advance-3-D-Cell-Drug-Discovery-Technologies/"}}
{"date": "2025-10-28", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-28 06:45:00", "publisher": "Business Wire", "title": "Merck Announces KEYTRUDA (pembrolizumab) Plus WELIREG (belzutifan) Met Primary Endpoint of Disease-Free Survival (DFS) in Certain Patients With Clear Cell Renal Cell Carcinoma (RCC) Following Nephrectomy", "image": "https://images.financialmodelingprep.com/news/merck-announces-keytruda-pembrolizumab-plus-welireg-belzutifan-met-primary-20251028.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.,--(BUSINESS WIRE)---- $MRK #MRK--Merck Announces KEYTRUDA Plus WELIREG Met Primary Endpoint of DFS in Certain Patients With Clear Cell Renal Cell Carcinoma (RCC) Following Nephrectomy.", "url": "https://www.businesswire.com/news/home/20251028020827/en/Merck-Announces-KEYTRUDA%C2%AE-pembrolizumab-Plus-WELIREG%C2%AE-belzutifan-Met-Primary-Endpoint-of-Disease-Free-Survival-DFS-in-Certain-Patients-With-Clear-Cell-Renal-Cell-Carcinoma-RCC-Following-Nephrectomy/"}}
{"date": "2025-10-28", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-28 06:43:16", "publisher": "Reuters", "title": "Merck-Eisai's cancer drug combo meets one main goal in late-stage study", "image": "https://images.financialmodelingprep.com/news/merckeisais-cancer-drug-combo-meets-one-main-goal-in-20251028.jpg", "site": "reuters.com", "text": "Merck and Eisai's experimental combination treatment for a type of kidney cancer met one of the main goals in a late-stage study, the drugmakers said on Tuesday.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/merck-eisais-cancer-drug-combo-meets-one-main-goal-late-stage-study-2025-10-28/"}}
{"date": "2025-10-28", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-28 06:30:00", "publisher": "Business Wire", "title": "Merck and Eisai Announce WELIREG (belzutifan) Plus LENVIMA (lenvatinib) Met Primary Endpoint of Progression-Free Survival (PFS) in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma", "image": "https://images.financialmodelingprep.com/news/merck-and-eisai-announce-welireg-belzutifan-plus-lenvima-lenvatinib-20251028.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J. & NUTLEY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck and Eisai Announce WELIREG Plus LENVIMA Met Primary Endpoint of PFS in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma.", "url": "https://www.businesswire.com/news/home/20251028392813/en/Merck-and-Eisai-Announce-WELIREG%C2%AE-belzutifan-Plus-LENVIMA%C2%AE-lenvatinib-Met-Primary-Endpoint-of-Progression-Free-Survival-PFS-in-Certain-Previously-Treated-Patients-With-Advanced-Renal-Cell-Carcinoma/"}}
{"date": "2025-10-27", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-27 14:00:00", "publisher": "The Motley Fool", "title": "3 Dividend-Paying Drug Stocks to Buy at a Discount", "image": "https://images.financialmodelingprep.com/news/3-dividendpaying-drug-stocks-to-buy-at-a-discount-20251027.jpg", "site": "fool.com", "text": "Pfizer currently has a 7% yield, and the company is making important business moves. Bristol Myers Squibb has a 5.6% yield and has been building its drug pipeline with acquisitions.", "url": "https://www.fool.com/investing/2025/10/27/3-dividend-paying-drug-stocks-to-buy-at-a-discount/"}}
{"date": "2025-10-27", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-27 12:45:15", "publisher": "Zacks Investment Research", "title": "Are You Looking for a High-Growth Dividend Stock?", "image": "https://images.financialmodelingprep.com/news/are-you-looking-for-a-highgrowth-dividend-stock-20251027.jpg", "site": "zacks.com", "text": "Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Merck (MRK) have what it takes?", "url": "https://www.zacks.com/stock/news/2778053/are-you-looking-for-a-high-growth-dividend-stock?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_5-2778053"}}
{"date": "2025-10-27", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-27 12:06:06", "publisher": "Zacks Investment Research", "title": "What's in Store for These 5 Pharma Bigwigs This Earnings Season?", "image": "https://images.financialmodelingprep.com/news/whats-in-store-for-these-5-pharma-bigwigs-this-earnings-20251027.jpg", "site": "zacks.com", "text": "As earnings season accelerates, pharma heavyweights LLY, MRK, ABBV, BMY and GILD prepare to reveal their Q3 results amid a strong sector start.", "url": "https://www.zacks.com/stock/news/2777998/what-s-in-store-for-these-5-pharma-bigwigs-this-earnings-season?cid=CS-STOCKNEWSAPI-FT-analyst_blog|earnings_preview_esp-2777998"}}
{"date": "2025-10-27", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-27 10:21:11", "publisher": "Zacks Investment Research", "title": "JNJ vs. MRK: Which Blue-Chip Pharma Stock Should Be in Your Portfolio?", "image": "https://images.financialmodelingprep.com/news/jnj-vs-mrk-which-bluechip-pharma-stock-should-be-in-20251027.jpg", "site": "zacks.com", "text": "J&J's diversified growth, strong pipeline, and robust balance sheet position it as a steadier long-term pick over Merck's Keytruda-dependent outlook.", "url": "https://www.zacks.com/stock/news/2777669/jnj-vs-mrk-which-blue-chip-pharma-stock-should-be-in-your-portfolio?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2777669"}}
{"date": "2025-10-27", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-27 10:16:24", "publisher": "Zacks Investment Research", "title": "Merck (MRK) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates", "image": "https://images.financialmodelingprep.com/news/merck-mrk-q3-earnings-preview-what-you-should-know-beyond-20251027.jpg", "site": "zacks.com", "text": "Get a deeper insight into the potential performance of Merck (MRK) for the quarter ended September 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.", "url": "https://www.zacks.com/stock/news/2777633/merck-mrk-q3-earnings-preview-what-you-should-know-beyond-the-headline-estimates?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|nfm_preview-2777633"}}
{"date": "2025-10-27", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-27 06:45:00", "publisher": "Business Wire", "title": "U.S. FDA Approves Updated Indication for WINREVAIR (sotatercept-csrk) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension) Based on Phase 3 ZENITH Study", "image": "https://images.financialmodelingprep.com/news/us-fda-approves-updated-indication-for-winrevair-sotaterceptcsrk-in-20251027.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an update to the U.S. product label based on the Phase 3 ZENITH trial for WINREVAIR (sotatercept-csrk) for injection, 45mg, 60mg. WINREVAIR, an activin signaling inhibitor, is now FDA-approved for the treatment of adults with pulmonary arterial hypertension (PAH, WHO Group 1 pulmonary hypertension) to improve exercise.", "url": "https://www.businesswire.com/news/home/20251027012612/en/U.S.-FDA-Approves-Updated-Indication-for-WINREVAIR%E2%84%A2-sotatercept-csrk-in-Adults-with-Pulmonary-Arterial-Hypertension-PAH-WHO*-Group-1-Pulmonary-Hypertension-Based-on-Phase-3-ZENITH-Study/"}}
{"date": "2025-10-26", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-26 16:23:00", "publisher": "The Motley Fool", "title": "3 Healthcare Stocks That Are Screaming Deals Right Now", "image": "https://images.financialmodelingprep.com/news/3-healthcare-stocks-that-are-screaming-deals-right-now-20251026.jpg", "site": "fool.com", "text": "DaVita's recession-resistant business is growing internationally, but shares continue to trade at a heavily discounted valuation. Merck could be in for a major move if the pharma can soften the blow of an upcoming patent expiration.", "url": "https://www.fool.com/investing/2025/10/26/3-healthcare-stocks-that-are-screaming-deals-right/"}}
{"date": "2025-10-24", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-24 16:24:00", "publisher": "Seeking Alpha", "title": "Merck Q3 Earnings Preview: Issues That Will Dominate The Agenda", "image": "https://images.financialmodelingprep.com/news/merck-q3-earnings-preview-issues-that-will-dominate-the-20251024.jpg", "site": "seekingalpha.com", "text": "Merck & Co., Inc. faces a pivotal Q3 earnings report as Keytruda's patent expiration looms and pipeline diversification efforts accelerate. MRK's oncology pipeline, including Keytruda Qlex and multiple ADCs, aims to offset future revenue loss, but execution risk remains high. Non-oncology segments face setbacks, with Gardasil sales declining and new launches like Winrevair underperforming expectations.", "url": "https://seekingalpha.com/article/4833285-merck-q3-earnings-preview-issues-that-will-dominate-agenda"}}
{"date": "2025-10-24", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-24 11:06:00", "publisher": "Zacks Investment Research", "title": "Merck's Non-Oncology Drugs Q3 Performance: What to Expect", "image": "https://images.financialmodelingprep.com/news/mercks-nononcology-drugs-q3-performance-what-to-expect-20251024.jpg", "site": "zacks.com", "text": "MRK expects new products like Capvaxive, Winrevair, and the Animal Health business to support its top-line growth in the third quarter.", "url": "https://www.zacks.com/stock/news/2776474/merck-s-non-oncology-drugs-q3-performance-what-to-expect?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2776474"}}
{"date": "2025-10-23", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-23 12:06:06", "publisher": "24/7 Wall Street", "title": "5 Best Dividend Stocks in the S&P 500", "image": "https://images.financialmodelingprep.com/news/5-best-dividend-stocks-in-the-sp-500-20251023.jpg", "site": "247wallst.com", "text": "Income investors rarely chase the loudest headlines.", "url": "https://247wallst.com/investing/2025/10/23/5-best-dividend-stocks-in-the-sp-500/"}}
{"date": "2025-10-23", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-23 11:55:00", "publisher": "PRNewsWire", "title": "eschbach's Shiftconnector Helps Power Merck's Visual Factory to Drive Greater Transparency, Agility, and Supply Chain Resilience", "image": "https://images.financialmodelingprep.com/news/eschbachs-shiftconnector-helps-power-mercks-visual-factory-to-drive-20251023.jpg", "site": "prnewswire.com", "text": "BOSTON , Oct. 23, 2025 /PRNewswire/ --eschbach is pleased to share that Merck (NYSE: MRK), known as MSD outside the United States and Canada, has selected Shiftconnector to improve how it uses digital tools in manufacturing. By integrating Shiftconnector into its established visual factory framework, Merck is enhancing its ability to deliver real-time, actionable insights across global operations.", "url": "https://www.prnewswire.com/news-releases/eschbachs-shiftconnector-helps-power-mercks-visual-factory-to-drive-greater-transparency-agility-and-supply-chain-resilience-302593033.html"}}
{"date": "2025-10-23", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-23 11:06:08", "publisher": "Zacks Investment Research", "title": "Merck (MRK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release", "image": "https://images.financialmodelingprep.com/news/merck-mrk-earnings-expected-to-grow-what-to-know-20251023.jpg", "site": "zacks.com", "text": "Merck (MRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "url": "https://www.zacks.com/stock/news/2775300/merck-mrk-earnings-expected-to-grow-what-to-know-ahead-of-next-week-s-release?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_9-2775300"}}
{"date": "2025-10-23", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-23 06:45:00", "publisher": "Business Wire", "title": "Merck to Present New Data from Its Innovative Cardio-Pulmonary Pipeline and Portfolio at AHA Scientific Sessions 2025", "image": "https://images.financialmodelingprep.com/news/merck-to-present-new-data-from-its-innovative-cardiopulmonary-20251023.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced plans to present new research from the company's cardio-pulmonary portfolio and pipeline at the American Heart Association (AHA) Scientific Sessions 2025 in New Orleans, La., from November 710. Data presented at AHA highlight Merck's continued dedication to advancing research across hypercholesterolemia and pulmonary arterial hypertension (PAH) to help address the global burd.", "url": "https://www.businesswire.com/news/home/20251023391791/en/Merck-to-Present-New-Data-from-Its-Innovative-Cardio-Pulmonary-Pipeline-and-Portfolio-at-AHA-Scientific-Sessions-2025/"}}
{"date": "2025-10-23", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-23 06:00:00", "publisher": "Business Wire", "title": "FDA Grants Priority Review for KEYTRUDA (pembrolizumab) and KEYTRUDA QLEX (pembrolizumab and berahyaluronidase alfa-pmph), Each in Combination with Padcev (enfortumab vedotin-ejfv), for Certain Patients with Muscle-Invasive Bladder Cancer", "image": "https://images.financialmodelingprep.com/news/fda-grants-priority-review-for-keytruda-pembrolizumab-and-keytruda-20251023.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has granted priority review for two supplemental Biologics License Applications (sBLA) for KEYTRUDA (pembrolizumab) and KEYTRUDA QLEX (pembrolizumab and berahyaluronidase alfa-pmph), each in combination with Padcev (enfortumab vedotin-ejfv), for the treatment of patients with muscle-invasive bladder cancer (MIBC) who are inel.", "url": "https://www.businesswire.com/news/home/20251022622711/en/FDA-Grants-Priority-Review-for-KEYTRUDA%C2%AE-pembrolizumab-and-KEYTRUDA-QLEX%E2%84%A2-pembrolizumab-and-berahyaluronidase-alfa-pmph-Each-in-Combination-with-Padcev%C2%AE-enfortumab-vedotin-ejfv-for-Certain-Patients-with-Muscle-Invasive-Bladder-Cancer/"}}
{"date": "2025-10-21", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-21 07:00:00", "publisher": "GlobeNewsWire", "title": "Flare Therapeutics Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate FX-909 in Combination with KEYTRUDA (pembrolizumab) in New Cohort of Ongoing Phase 1 Trial in Metastatic Urothelial Cancer", "image": "https://images.financialmodelingprep.com/news/flare-therapeutics-announces-clinical-trial-collaboration-and-supply-agreement-with-20251021.png", "site": "globenewswire.com", "text": "CAMBRIDGE, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other therapeutic areas, today announced that it has entered into a clinical trial collaboration and supply agreement with Merck (known as MSD outside of the United States and Canada). FX-909, a first-in-class orally available small molecule inhibitor of PPARG, the master regulator of the luminal lineage, will be evaluated in combination with KEYTRUDA  (pembrolizumab), Merck's anti-PD-1 (programmed cell death receptor-1) therapy, in a new cohort within the company's ongoing Phase 1 study in locally-advanced or metastatic urothelial cancer (UC).", "url": "https://www.globenewswire.com/news-release/2025/10/21/3170066/0/en/Flare-Therapeutics-Announces-Clinical-Trial-Collaboration-and-Supply-Agreement-with-Merck-to-Evaluate-FX-909-in-Combination-with-KEYTRUDA-pembrolizumab-in-New-Cohort-of-Ongoing-Pha.html"}}
{"date": "2025-10-21", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-21 06:45:00", "publisher": "Business Wire", "title": "Systematic Review of 15 Studies Focused on Epidemiology and Antimicrobial Resistance of Pneumococcal Serotypes Covered by CAPVAXIVE (Pneumococcal 21-valent Conjugate Vaccine) in U.S. Adults", "image": "https://images.financialmodelingprep.com/news/systematic-review-of-15-studies-focused-on-epidemiology-and-20251021.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Systematic Review of 15 Studies Focused on Epidemiology and Antimicrobial Resistance of Pneumococcal Serotypes Covered by CAPVAXIVE in U.S. Adults.", "url": "https://www.businesswire.com/news/home/20251021711998/en/Systematic-Review-of-15-Studies-Focused-on-Epidemiology-and-Antimicrobial-Resistance-of-Pneumococcal-Serotypes-Covered-by-CAPVAXIVE%C2%AE-Pneumococcal-21-valent-Conjugate-Vaccine-in-U.S.-Adults/"}}
{"date": "2025-10-20", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-20 16:12:30", "publisher": "24/7 Wall Street", "title": "JPMorgan Says Correction Will Be Healthy  5 Safe High-Yield Dividend Stocks", "image": "https://images.financialmodelingprep.com/news/jpmorgan-says-correction-will-be-healthy-5-safe-highyield-20251020.jpg", "site": "247wallst.com", "text": "Jamie Dimon is one of the highest-profile bankers in the world.", "url": "https://247wallst.com/investing/2025/10/20/jpmorgan-says-correction-will-be-healthy-5-safe-high-yield-dividend-stocks/"}}
{"date": "2025-10-20", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-20 11:38:23", "publisher": "Seeking Alpha", "title": "My Top 3 Pharma Stocks", "image": "https://images.financialmodelingprep.com/news/my-top-3-pharma-stocks-20251020.jpg", "site": "seekingalpha.com", "text": "Obesity, type 2 diabetes, and cancer continue to grow across the globe, but pharma stocks remain off the radars of many investors. Many of them consistently beat the Street's consensus estimates and offer dividend yields even higher than IT, as well as oil and gas stocks. In this article, I reveal my top 3 Big Pharma players.", "url": "https://seekingalpha.com/article/4831152-my-top-3-pharma-stocks"}}
{"date": "2025-10-20", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-20 11:16:43", "publisher": "24/7 Wall Street", "title": "Goldman Sachs Reveals Sectors With Top 2026 Payouts: 5 Strong Buys", "image": "https://images.financialmodelingprep.com/news/goldman-sachs-reveals-sectors-with-top-2026-payouts-5-strong-20251020.jpg", "site": "247wallst.com", "text": "Founded in 1869, Goldman Sachs is the world's second-largest investment bank by revenue and is ranked 55th on the Fortune 500 list of the largest United States corporations by total revenue.", "url": "https://247wallst.com/investing/2025/10/20/goldman-sachs-reveals-sectors-with-top-2026-payouts-grab-5-strong-buys-now/"}}
{"date": "2025-10-20", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-20 09:07:00", "publisher": "The Motley Fool", "title": "2 Beaten-Down Stocks to Buy and Hold for the Next Decade", "image": "https://images.financialmodelingprep.com/news/2-beatendown-stocks-to-buy-and-hold-for-the-20251020.jpg", "site": "fool.com", "text": "The market is forward-looking, but investors who earn better-than-average returns often look even further into the future and identify opportunities that are currently being overlooked. That means, among other things, buying shares of companies that are lagging the market but can bounce back over the midterm and beyond.", "url": "https://www.fool.com/investing/2025/10/20/2-beaten-down-stocks-to-buy-and-hold-for-the-next/"}}
{"date": "2025-10-20", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-20 08:45:00", "publisher": "Business Wire", "title": "KEYTRUDA (pembrolizumab) Demonstrates Long-Term Survival Benefit in Certain Patients With Earlier or Advanced Stages of Non-Small Cell Lung Cancer (NSCLC)", "image": "https://images.financialmodelingprep.com/news/keytruda-pembrolizumab-demonstrates-longterm-survival-benefit-in-certain-patients-20251020.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new long-term data highlighting the sustained survival benefits of KEYTRUDA (pembrolizumab), Merck's anti-PD-1 therapy, in treating non-small cell lung cancer (NSCLC). The results are based on the exploratory five-year analyses of KEYNOTE-671 evaluating KEYTRUDA as part of a neoadjuvant followed by adjuvant (perioperative) treatment regimen for patients with resectable NSCLC;.", "url": "https://www.businesswire.com/news/home/20251020515064/en/KEYTRUDA%C2%AE-pembrolizumab-Demonstrates-Long-Term-Survival-Benefit-in-Certain-Patients-With-Earlier-or-Advanced-Stages-of-Non-Small-Cell-Lung-Cancer-NSCLC/"}}
{"date": "2025-10-20", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-20 07:07:49", "publisher": "Reuters", "title": "Merck begins construction of $3 billion manufacturing facility in Virginia", "image": "https://images.financialmodelingprep.com/news/merck-begins-construction-of-3-billion-manufacturing-facility-in-virginia-20251020.jpg", "site": "reuters.com", "text": "Merck said on Monday it has begun construction of a $3 billion pharmaceutical manufacturing facility in Elkton, Virginia as part of its more than $70 billion investment to expand domestic manufacturing and research and development in the U.S.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/merck-begins-construction-3-billion-manufacturing-facility-virginia-2025-10-20/"}}
{"date": "2025-10-20", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-20 06:56:20", "publisher": "Fox Business", "title": "Merck breaks ground on $3B manufacturing plant in Virginia", "image": "https://images.financialmodelingprep.com/news/merck-breaks-ground-on-3b-manufacturing-plant-in-virginia-20251020.jpg", "site": "foxbusiness.com", "text": "Merck is breaking ground on a new 400,000-square-foot manufacturing facility in Elkton, Virginia, as part of its $70 billion U.S. investment strategy.", "url": "https://www.foxbusiness.com/markets/merck-breaks-ground-3b-manufacturing-plant-virginia"}}
{"date": "2025-10-20", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-20 06:45:00", "publisher": "Business Wire", "title": "Merck Breaks Ground on $3 Billion Center of Excellence for Pharmaceutical Manufacturing in Elkton, Virginia", "image": "https://images.financialmodelingprep.com/news/merck-breaks-ground-on-3-billion-center-of-excellence-20251020.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck Breaks Ground on $3 Billion Center of Excellence for Pharmaceutical Manufacturing in Elkton, Virginia.", "url": "https://www.businesswire.com/news/home/20251020913713/en/Merck-Breaks-Ground-on-3-Billion-Center-of-Excellence-for-Pharmaceutical-Manufacturing-in-Elkton-Virginia/"}}
{"date": "2025-10-18", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-18 10:35:00", "publisher": "Business Wire", "title": "KEYTRUDA (pembrolizumab) Plus Chemotherapy With or Without Bevacizumab Reduced Risk of Disease Progression or Death Versus Chemotherapy With or Without Bevacizumab in Certain Patients With Platinum-Resistant Recurrent Ovarian Cancer", "image": "https://images.financialmodelingprep.com/news/keytruda-pembrolizumab-plus-chemotherapy-with-or-without-bevacizumab-reduced-risk-20251018.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the first presentation of results from the pivotal Phase 3 KEYNOTE-B96 trial, also known as ENGOT-ov65, evaluating KEYTRUDA (pembrolizumab), Merck's anti-PD-1 therapy, in combination with chemotherapy (paclitaxel) with or without bevacizumab for the treatment of patients with platinum-resistant recurrent ovarian cancer. These late-breaking data will be presented today during.", "url": "https://www.businesswire.com/news/home/20251018982840/en/KEYTRUDA%C2%AE-pembrolizumab-Plus-Chemotherapy-With-or-Without-Bevacizumab-Reduced-Risk-of-Disease-Progression-or-Death-Versus-Chemotherapy-With-or-Without-Bevacizumab-in-Certain-Patients-With-Platinum-Resistant-Recurrent-Ovarian-Cancer/"}}
{"date": "2025-10-18", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-18 10:30:40", "publisher": "Investors Business Daily", "title": "Pfizer, Merck And Astellas Have An 'Enormous New Hope' For Bladder Cancer Patients", "image": "https://images.financialmodelingprep.com/news/pfizer-merck-and-astellas-have-an-enormous-new-hope-for-20251018.jpg", "site": "investors.com", "text": "Pharma titans Merck, Pfizer and Astellas Pharma are delivering an \"enormous new hope\" for patients with an aggressive form of bladder cancer.", "url": "https://www.investors.com/news/technology/bladder-cancer-padcev-keytruda-merck-pfizer-astellas/"}}
{"date": "2025-10-18", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-18 10:30:00", "publisher": "Business Wire", "title": "KEYTRUDA (pembrolizumab) Plus Padcev (enfortumab vedotin-ejfv) Reduced Risk of Event-Free Survival Events by 60% and Risk of Death by 50% for Certain Patients with Muscle-Invasive Bladder Cancer When Given Before and After Surgery", "image": "https://images.financialmodelingprep.com/news/keytruda-pembrolizumab-plus-padcev-enfortumab-vedotinejfv-reduced-risk-of-20251018.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced landmark results demonstrating KEYTRUDA (pembrolizumab) plus Padcev (enfortumab vedotin-ejfv) reduced the risk of event-free survival (EFS) events by 60% and reduced the risk of death by 50% when given before and after surgery (radical cystectomy) versus surgery alone, the current standard of care, in patients with muscle-invasive bladder cancer (MIBC) who are not eligible f.", "url": "https://www.businesswire.com/news/home/20251017450962/en/KEYTRUDA%C2%AE-pembrolizumab-Plus-Padcev%C2%AE-enfortumab-vedotin-ejfv-Reduced-Risk-of-Event-Free-Survival-Events-by-60-and-Risk-of-Death-by-50-for-Certain-Patients-with-Muscle-Invasive-Bladder-Cancer-When-Given-Before-and-After-Surgery/"}}
{"date": "2025-10-18", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-18 06:00:00", "publisher": "Business Wire", "title": "KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen", "image": "https://images.financialmodelingprep.com/news/keytruda-pembrolizumab-plus-lenvima-lenvatinib-demonstrates-durable-5year-survival-20251018.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J. & NUTLEY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--KEYTRUDA Plus LENVIMA Demonstrates Durable 5-Year Survival Benefit Vs Chemotherapy for Patients With Advanced Endometrial Carcinoma.", "url": "https://www.businesswire.com/news/home/20251018972232/en/KEYTRUDA%C2%AE-pembrolizumab-Plus-LENVIMA%C2%AE-lenvatinib-Demonstrates-Durable-5-Year-Survival-Benefit-Versus-Chemotherapy-for-Patients-With-Advanced-Endometrial-Carcinoma-Following-One-Prior-Platinum-Based-Regimen/"}}
{"date": "2025-10-17", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-17 13:21:10", "publisher": "Zacks Investment Research", "title": "Will Declining Gardasil Sales Ail MRK's Top Line in Q3 Earnings?", "image": "https://images.financialmodelingprep.com/news/will-declining-gardasil-sales-ail-mrks-top-line-in-20251017.jpg", "site": "zacks.com", "text": "Merck faces a sharp Gardasil slowdown as weak demand in China and Japan affects sales of the vaccine.", "url": "https://www.zacks.com/stock/news/2771358/will-declining-gardasil-sales-ail-mrk-s-top-line-in-q3-earnings?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2771358"}}
{"date": "2025-10-17", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-17 03:33:56", "publisher": "Proactive Investors", "title": "Trump strikes deal with Merck to cut IVF drug prices in return for tariff relief", "image": "https://images.financialmodelingprep.com/news/trump-strikes-deal-with-merck-to-cut-ivf-drug-20251017.jpeg", "site": "proactiveinvestors.co.uk", "text": "President Donald Trump has unveiled an agreement with Germany's Merck KGaA to lower the cost of its fertility medicines in the United States in exchange for exemptions from threatened tariffs,part of his drive to make in vitro fertilisation (IVF) more affordable. Under the deal, Merck will sell its full range of IVF drugs through Trump's direct-to-consumer platform, TrumpRX, and expand manufacturing in the US.", "url": "https://www.proactiveinvestors.co.uk/companies/news/1080568"}}
{"date": "2025-10-16", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-16 10:01:15", "publisher": "Zacks Investment Research", "title": "Is Trending Stock Merck & Co., Inc. (MRK) a Buy Now?", "image": "https://images.financialmodelingprep.com/news/is-trending-stock-merck-co-inc-mrk-a-buy-20251016.jpg", "site": "zacks.com", "text": "Zacks.com users have recently been watching Merck (MRK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.", "url": "https://www.zacks.com/stock/news/2769983/is-trending-stock-merck-co-inc-mrk-a-buy-now?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2769983"}}
{"date": "2025-10-16", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-16 08:00:00", "publisher": "Seeking Alpha", "title": "Merck: Earnings Outlook Steady, Keytruda Now Has Some Breathing Room", "image": "https://images.financialmodelingprep.com/news/merck-earnings-outlook-steady-keytruda-now-has-some-breathing-20251016.jpg", "site": "seekingalpha.com", "text": "Merck & Co., Inc. remains the largest U.S. pharma company in 2025, driven by oncology and Keytruda, despite looming patent expiration risks. Keytruda accounts for over half of MRK's pharmaceutical revenue, making its 2028 patent loss a significant challenge for future growth. MRK management is actively working to offset the Keytruda revenue gap, laying a foundation for post-2028 recovery.", "url": "https://seekingalpha.com/article/4830227-merck-earnings-outlook-steady-keytruda-now-has-some-breathing-room"}}
{"date": "2025-10-16", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-16 06:45:00", "publisher": "Business Wire", "title": "Merck Announces Phase 3 KEYNOTE-B96 Trial Met Secondary Endpoint of Overall Survival (OS) in All Comers Population of Patients With Platinum-Resistant Recurrent Ovarian Cancer", "image": "https://images.financialmodelingprep.com/news/merck-announces-phase-3-keynoteb96-trial-met-secondary-endpoint-20251016.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the Phase 3 KEYNOTE-B96 trial, also known as ENGOT-ov65, met its secondary endpoint of overall survival (OS) for the treatment of patients with platinum-resistant recurrent ovarian cancer in all comers. The trial studied KEYTRUDA (pembrolizumab), Merck's anti-PD-1 therapy, in combination with chemotherapy (paclitaxel) with or without bevacizumab for these patients. As pr.", "url": "https://www.businesswire.com/news/home/20251016113482/en/Merck-Announces-Phase-3-KEYNOTE-B96-Trial-Met-Secondary-Endpoint-of-Overall-Survival-OS-in-All-Comers-Population-of-Patients-With-Platinum-Resistant-Recurrent-Ovarian-Cancer/"}}
{"date": "2025-10-16", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-16 02:00:00", "publisher": "WSJ", "title": "Germany's Merck Sets Out Midterm Sales Growth, Profitability Expansion Targets", "image": "https://images.financialmodelingprep.com/news/germanys-merck-sets-out-midterm-sales-growth-profitability-expansion-20251016.jpg", "site": "wsj.com", "text": "The company confirmed its 2025 guidance and is targeting annual organic sales growth in the mid-single-digit percentage range and an expansion in profitability over the medium term.", "url": "https://www.wsj.com/business/retail/germanys-merck-sets-out-midterm-sales-growth-profitability-expansion-targets-df1a7789"}}
{"date": "2025-10-16", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-16 01:04:48", "publisher": "Reuters", "title": "Germany's Merck tweaks mid-term healthcare unit guidance", "image": "https://images.financialmodelingprep.com/news/germanys-merck-tweaks-midterm-healthcare-unit-guidance-20251016.jpg", "site": "reuters.com", "text": "German pharmaceuticals and technology company Merck KGaA slightly improved its mid-term guidance for its healthcare business ahead of its capital markets day on Thursday.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/germanys-merck-tweaks-mid-term-healthcare-unit-guidance-2025-10-16/"}}
{"date": "2025-10-15", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-15 15:43:01", "publisher": "Seeking Alpha", "title": "Merck: A Golden Buying Opportunity", "image": "https://images.financialmodelingprep.com/news/merck-a-golden-buying-opportunity-20251015.jpg", "site": "seekingalpha.com", "text": "Keytruda continues to dominate, driving 50% of revenue, with new approvals and delivery methods strengthening MRK's oncology leadership. The company's long-term outlook is also promising, with a full pipeline of new final-stage drugs, an expanding vaccine portfolio, and breakthroughs in animal health products. Despite patent and regulatory risks, MRK's low valuation, strong balance sheet, and 3.8% dividend yield make it appealing for long-term investors.", "url": "https://seekingalpha.com/article/4830214-merck-a-golden-buying-opportunity"}}
{"date": "2025-10-15", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-15 12:23:05", "publisher": "Benzinga", "title": "Merck's New HIV Treatment Works As Well As Top Drug In Late Trials", "image": "https://images.financialmodelingprep.com/news/mercks-new-hiv-treatment-works-as-well-as-top-20251015.jpeg", "site": "benzinga.com", "text": "The relentless pursuit of innovative treatments in the pharmaceutical industry continues to reshape the landscape of chronic disease management. Merck & Co. Inc. (NYSE:MRK) on Wednesday announced additional data from two Phase 3 studies of a two-drug regimen of doravirine/islatravir (DOR/ISL) in adults with virologically suppressed HIV-1 infection.", "url": "https://www.benzinga.com/news/health-care/25/10/48231084/mercks-new-hiv-treatment-works-as-well-as-top-drug-in-late-trials"}}
{"date": "2025-10-15", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-15 08:00:00", "publisher": "Business Wire", "title": "Merck to Acquire the Chromatography Business of JSR Life Sciences, Expanding Protein A Capabilities and Downstream Portfolio", "image": "https://images.financialmodelingprep.com/news/merck-to-acquire-the-chromatography-business-of-jsr-life-20251015.jpg", "site": "businesswire.com", "text": "DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced the signing of a definitive agreement to acquire the chromatography business of JSR Life Sciences, a leader in contract development and manufacturing, preclinical and translational clinical research, and bioprocessing solutions. The acquisition will expand Merck's downstream processing portfolio with advanced Protein A chromatography capabilities, supporting more efficient and scalable producti.", "url": "https://www.businesswire.com/news/home/20251015543105/en/Merck-to-Acquire-the-Chromatography-Business-of-JSR-Life-Sciences-Expanding-Protein-A-Capabilities-and-Downstream-Portfolio/"}}
{"date": "2025-10-15", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-15 06:45:00", "publisher": "Business Wire", "title": "Merck Announces New Data from Phase 3 Trials Evaluating the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) in Adults with Virologically Suppressed HIV-1 Infection", "image": "https://images.financialmodelingprep.com/news/merck-announces-new-data-from-phase-3-trials-evaluating-20251015.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the presentation of additional data from the Phase 3 studies of the investigational, once-daily, oral, two-drug regimen of doravirine/islatravir [DOR/ISL (100mg/0.25mg)] in adults with HIV-1 infection that was virologically suppressed on bictegravir/emtricitabine/tenofovir alafenamidei [BIC/FTC/TAF (50 mg/200 mg/25 mg)] in trial MK-8591A-052 or antiretroviral therapy [baseline.", "url": "https://www.businesswire.com/news/home/20251015084865/en/Merck-Announces-New-Data-from-Phase-3-Trials-Evaluating-the-Investigational-Once-Daily-Oral-Two-Drug-Regimen-of-DoravirineIslatravir-DORISL-in-Adults-with-Virologically-Suppressed-HIV-1-Infection/"}}
{"date": "2025-10-14", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-14 18:51:18", "publisher": "Zacks Investment Research", "title": "Merck (MRK) Declines More Than Market: Some Information for Investors", "image": "https://images.financialmodelingprep.com/news/merck-mrk-declines-more-than-market-some-information-for-20251014.jpg", "site": "zacks.com", "text": "In the closing of the recent trading day, Merck (MRK) stood at $84.81, denoting a -1.04% move from the preceding trading day.", "url": "https://www.zacks.com/stock/news/2768750/merck-mrk-declines-more-than-market-some-information-for-investors?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6v1-2768750"}}
{"date": "2025-10-14", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-14 06:15:00", "publisher": "The Motley Fool", "title": "Can $10,000 in Merck Stock Turn Into $50,000 by 2030?", "image": "https://images.financialmodelingprep.com/news/can-10000-in-merck-stock-turn-into-50000-by-20251014.jpg", "site": "fool.com", "text": "Turning $10,000 into $50,000 in about five years would require a compound annual growth rate (CAGR) of almost 38%. That's an extremely tough task for any corporation, but can Merck (MRK -0.41%), a leading pharmaceutical company, pull it off?", "url": "https://www.fool.com/investing/2025/10/14/can-10000-in-merck-stock-turn-into-50000-by-2030/"}}
{"date": "2025-10-13", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-13 13:11:24", "publisher": "Zacks Investment Research", "title": "Will Merck (MRK) Beat Estimates Again in Its Next Earnings Report?", "image": "https://images.financialmodelingprep.com/news/will-merck-mrk-beat-estimates-again-in-its-next-20251013.jpg", "site": "zacks.com", "text": "Merck (MRK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.", "url": "https://www.zacks.com/stock/news/2767670/will-merck-mrk-beat-estimates-again-in-its-next-earnings-report?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_7-2767670"}}
{"date": "2025-10-13", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-13 10:51:10", "publisher": "Zacks Investment Research", "title": "Here's Why Merck (MRK) is a Strong Momentum Stock", "image": "https://images.financialmodelingprep.com/news/heres-why-merck-mrk-is-a-strong-momentum-stock-20251013.jpg", "site": "zacks.com", "text": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.", "url": "https://www.zacks.com/stock/news/2767440/here-s-why-merck-mrk-is-a-strong-momentum-stock?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|zacks_education_momentum_score-2767440"}}
{"date": "2025-10-13", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-13 10:00:00", "publisher": "Seeking Alpha", "title": "Merck: An Undervalued Stock In An Expensive Market", "image": "https://images.financialmodelingprep.com/news/merck-an-undervalued-stock-in-an-expensive-market-20251013.jpg", "site": "seekingalpha.com", "text": "Merck has increased its dividend for 14 consecutive years.Its 10-year dividend growth rate of 5.4% is only decent. Merck increased its revenue from $39.5 billion in FY 2015 to $64.2 billion in FY 2024. That's a compound annual growth rate of 5.5%. Merck has a good financial position. The long-term debt/equity ratio is 0.7, while the interest coverage ratio is over 16.", "url": "https://seekingalpha.com/article/4829515-merck-stock-undervalued-expensive-market"}}
{"date": "2025-10-12", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-12 09:19:26", "publisher": "24/7 Wall Street", "title": "5 Bank of America Value 10 Dividend Picks for Q4 Fireworks", "image": "https://images.financialmodelingprep.com/news/5-bank-of-america-value-10-dividend-picks-for-q4-20251012.jpg", "site": "247wallst.com", "text": "A value stock is generally one that trades at a price lower than its fundamental value or what its performance suggests it should be worth.", "url": "https://247wallst.com/investing/2025/10/12/5-bank-of-america-value-10-dividend-picks-for-q4-fireworks/"}}
{"date": "2025-10-10", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-10 13:01:35", "publisher": "Zacks Investment Research", "title": "Will Keytruda Continue to Aid Merck's Top Line in Q3 Earnings?", "image": "https://images.financialmodelingprep.com/news/will-keytruda-continue-to-aid-mercks-top-line-in-20251010.jpg", "site": "zacks.com", "text": "MRK's Keytruda remains its dominant growth engine and is expected to have boosted its top line in the third quarter.", "url": "https://www.zacks.com/stock/news/2766474/will-keytruda-continue-to-aid-merck-s-top-line-in-q3-earnings?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2766474"}}
{"date": "2025-10-10", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-10 09:10:03", "publisher": "Forbes", "title": "High Margins, Lower Price: Is This Merck Stock's Buying Window?", "image": "https://images.financialmodelingprep.com/news/high-margins-lower-price-is-this-merck-stocks-buying-window-20251010.jpg", "site": "forbes.com", "text": "Merck (MRK) stock merits your attention. Why? Because it offers monopoly-like high margins at a discounted price.", "url": "https://www.forbes.com/sites/greatspeculations/2025/10/10/high-margins-lower-price-is-this-merck-stocks-buying-window/"}}
{"date": "2025-10-09", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-09 15:01:26", "publisher": "24/7 Wall Street", "title": "Jamie Dimon Issues Harsh Stock Market Warning  5 of JPMorgan's Safest Dividend Stocks", "image": "https://images.financialmodelingprep.com/news/jamie-dimon-issues-harsh-stock-market-warning-5-of-20251009.jpg", "site": "247wallst.com", "text": "Jamie Dimon is one of the highest-profile bankers in the world. Like Warren Buffett, David Solomon, or other Wall Street titans, when he speaks, people listen.", "url": "https://247wallst.com/investing/2025/10/09/jamie-dimon-issues-stern-stock-market-warning-5-of-jpmorgans-safest-dividend-stocks/"}}
{"date": "2025-10-09", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-09 07:00:00", "publisher": "Business Wire", "title": "Merck to Present New Data from HIV Treatment and Prevention Pipeline at European AIDS Conference 2025", "image": "https://images.financialmodelingprep.com/news/merck-to-present-new-data-from-hiv-treatment-and-20251009.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that it will present new findings from its HIV treatment and prevention pipeline at the 20th European AIDS Conference (EACS 2025) taking place Oct.15-18, 2025, in Paris, France. The company's presentations will include: An oral presentation of weight and body composition at Week 48 from the Phase 3 trial (MK-8591A-052) comparing doravirine/islatravir [DOR/ISL (100mg/0.25mg)] v.", "url": "https://www.businesswire.com/news/home/20251009184957/en/Merck-to-Present-New-Data-from-HIV-Treatment-and-Prevention-Pipeline-at-European-AIDS-Conference-2025/"}}
{"date": "2025-10-09", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-09 06:45:00", "publisher": "Business Wire", "title": "Merck Advances Oncology Innovation, Highlighting Progress in New Tumor Types and Earlier Stages of Disease at ESMO 2025", "image": "https://images.financialmodelingprep.com/news/merck-advances-oncology-innovation-highlighting-progress-in-new-tumor-20251009.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new research from more than 100 abstracts across more than 20 types of cancer and multiple treatment settings from the company's broad and differentiated portfolio and pipeline will be presented at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany, from Oct. 17-21. These data showcase Merck's commitment to rapidly advancing research across multi.", "url": "https://www.businesswire.com/news/home/20251009630802/en/Merck-Advances-Oncology-Innovation-Highlighting-Progress-in-New-Tumor-Types-and-Earlier-Stages-of-Disease-at-ESMO-2025/"}}
{"date": "2025-10-08", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-08 14:59:00", "publisher": "GlobeNewsWire", "title": "MERCK INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Merck & Co., Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm", "image": "https://images.financialmodelingprep.com/news/merck-investigation-alert-bragar-eagel-squire-pc-continues-investigation-20251008.jpeg", "site": "globenewswire.com", "text": "Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Merck (MRK) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Merck between February 3, 2022, to February 3, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directlyat (212) 355-4648.", "url": "https://www.globenewswire.com/news-release/2025/10/08/3163688/0/en/MERCK-INVESTIGATION-ALERT-Bragar-Eagel-Squire-P-C-Continues-Investigation-into-Merck-Co-Inc-on-Behalf-of-Long-Term-Stockholders-and-Encourages-Investors-to-Contact-the-Firm.html"}}
{"date": "2025-10-08", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-08 07:17:49", "publisher": "24/7 Wall Street", "title": "4 Bank of America Strong Buy Growth 10 Stocks That All Pay Dividends", "image": "https://images.financialmodelingprep.com/news/4-bank-of-america-strong-buy-growth-10-stocks-20251008.jpg", "site": "247wallst.com", "text": "BofASecurities is the investment banking and capital markets division of Bank of America, one of the largest financial institutions in the United States.", "url": "https://247wallst.com/investing/2025/10/08/4-bank-of-america-strong-buy-growth-10-stocks-pay-big-dividends/"}}
{"date": "2025-10-07", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-07 18:51:31", "publisher": "Zacks Investment Research", "title": "Merck (MRK) Declines More Than Market: Some Information for Investors", "image": "https://images.financialmodelingprep.com/news/merck-mrk-declines-more-than-market-some-information-for-20251007.jpg", "site": "zacks.com", "text": "Merck (MRK) closed the most recent trading day at $87.61, moving 1.34% from the previous trading session.", "url": "https://www.zacks.com/stock/news/2764025/merck-mrk-declines-more-than-market-some-information-for-investors?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6v1-2764025"}}
{"date": "2025-10-07", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-07 13:01:34", "publisher": "Zacks Investment Research", "title": "MRK Expands Tulisokibart Program in Three New Inflammatory Diseases", "image": "https://images.financialmodelingprep.com/news/mrk-expands-tulisokibart-program-in-three-new-inflammatory-diseases-20251007.jpg", "site": "zacks.com", "text": "Merck broadens its tulisokibart clinical program with three new phase IIb studies, deepening its reach across immune-mediated inflammatory diseases.", "url": "https://www.zacks.com/stock/news/2763790/mrk-expands-tulisokibart-program-in-three-new-inflammatory-diseases?cid=CS-STOCKNEWSAPI-FT-analyst_blog|company_news_medical_sector-2763790"}}
{"date": "2025-10-07", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-07 09:31:16", "publisher": "Zacks Investment Research", "title": "Merck Rises 13% in a Week: Should You Buy, Sell or Hold the Stock?", "image": "https://images.financialmodelingprep.com/news/merck-rises-13-in-a-week-should-you-buy-sell-20251007.jpg", "site": "zacks.com", "text": "MRK's stock witnesses an upside after Pfizer's pricing deal, but Gardasil's slump and Keytruda's looming LOE keep investors cautious.", "url": "https://www.zacks.com/stock/news/2763387/merck-rises-13-in-a-week-should-you-buy-sell-or-hold-the-stock?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2763387"}}
{"date": "2025-10-07", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-07 06:45:00", "publisher": "Business Wire", "title": "Merck Completes Acquisition of Verona Pharma", "image": "https://images.financialmodelingprep.com/news/merck-completes-acquisition-of-verona-pharma-20251007.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck Completes Acquisition of Verona Pharma.", "url": "https://www.businesswire.com/news/home/20251007814715/en/Merck-Completes-Acquisition-of-Verona-Pharma/"}}
{"date": "2025-10-06", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-06 14:24:53", "publisher": "CNBC Television", "title": "How to trade the health care break out", "image": "https://images.financialmodelingprep.com/news/how-to-trade-the-health-care-break-out-20251006.jpg", "site": "youtube.com", "text": "The health care sector up 6.5% in one week. The Investment Committee debate how to trade the space.", "url": "https://www.youtube.com/watch?v=NigWSb4A89I"}}
{"date": "2025-10-06", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-06 13:29:00", "publisher": "Seeking Alpha", "title": "My Top 5 Biotech Stocks Big Pharma Could Buy Next", "image": "https://images.financialmodelingprep.com/news/my-top-5-biotech-stocks-big-pharma-could-buy-20251006.jpg", "site": "seekingalpha.com", "text": "While AI hype reigns on Wall Street, the healthcare sector is still far from the peaks it reached during the COVID-19 pandemic. And what's more important, many of the biotech stocks remain outside of Mr. Market's interest zone. Since the exclusivity of key blockbusters of 'giants', including Merck andPfizer, expires in the next 4 years, there is an urgent need to continue rejuvenating their portfolios of drugs.", "url": "https://seekingalpha.com/article/4828107-my-top-5-biotech-stocks-big-pharma-could-buy-next"}}
{"date": "2025-10-06", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-06 06:45:00", "publisher": "Business Wire", "title": "Merck Expands Tulisokibart Clinical Development Program With Initiation of Phase 2b Trials in Three Additional Immune-Mediated Inflammatory Diseases", "image": "https://images.financialmodelingprep.com/news/merck-expands-tulisokibart-clinical-development-program-with-initiation-of-phase-20251006.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced it has initiated three Phase 2b trials evaluating the safety and efficacy of tulisokibart (MK-7240), an investigational humanized monoclonal antibody targeting tumor necrosis factor (TNF)-like cytokine 1A (TL1A), in patients with three immune-mediated inflammatory diseases: MK-7240-12 (NCT06956235) studying patients with moderate to severe hidradenitis suppurativa (HS) MK-7240-013 (.", "url": "https://www.businesswire.com/news/home/20251006817829/en/Merck-Expands-Tulisokibart-Clinical-Development-Program-With-Initiation-of-Phase-2b-Trials-in-Three-Additional-Immune-Mediated-Inflammatory-Diseases/"}}
{"date": "2025-10-05", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-05 15:41:09", "publisher": "24/7 Wall Street", "title": "The Rotation To Value Is On  5 October Surprise High-Yield Picks", "image": "https://images.financialmodelingprep.com/news/the-rotation-to-value-is-on-5-october-surprise-highyield-20251005.jpg", "site": "247wallst.com", "text": "An October Surprise is usually a significant, late-breaking news event that generally occurs just before a November election and has the potential to influence its outcome.", "url": "https://247wallst.com/investing/2025/10/05/the-rotation-to-value-is-on-5-october-surprise-high-yield-picks/"}}
{"date": "2025-10-04", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-04 12:18:07", "publisher": "Seeking Alpha", "title": "October Dogs Of The Dow Flash One Ideal 'Safer' Dividend Buy", "image": "https://images.financialmodelingprep.com/news/october-dogs-of-the-dow-flash-one-ideal-safer-dividend-20251004.jpg", "site": "seekingalpha.com", "text": "Verizon stands out as the only Dow stock meeting the 'dogcatcher' ideal: annual dividends from $1K invested exceed its share price. Analyst forecasts suggest top-ten Dow Dogs could deliver average net gains of 20% by October 2026, with VZ among the safer high-yield picks. Most Dow Dogs remain overpriced relative to their dividends, but market pullbacks could create fair-value opportunities for income-focused investors.", "url": "https://seekingalpha.com/article/4827877-october-dogs-of-dow-flash-one-ideal-safer-dividend-buy"}}
{"date": "2025-10-04", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-04 08:15:00", "publisher": "Seeking Alpha", "title": "5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (Oct. 2025)", "image": "https://images.financialmodelingprep.com/news/5-relatively-secure-and-cheap-dividend-stocks-yields-up-20251004.jpg", "site": "seekingalpha.com", "text": "This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields 3.56%, we present two other groups of five DGI stocks each, from moderate to high yields of up to 8%.", "url": "https://seekingalpha.com/article/4827004-5-relatively-secure-and-cheap-dividend-stocks-yields-8-percent-oct-2025"}}
{"date": "2025-10-03", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-03 13:21:31", "publisher": "Seeking Alpha", "title": "Merck: A Race Against The Keytruda Clock", "image": "https://images.financialmodelingprep.com/news/merck-a-race-against-the-keytruda-clock-20251003.jpg", "site": "seekingalpha.com", "text": "Merck (MRK) is attractively valued, boasting strong free cash flow, robust margins, and a leading position in oncology with Keytruda. MRK faces a looming patent cliff for Keytruda in 2028, but a strong late-stage pipeline and R&D investments offer long-term growth potential. Recent political developments reduce regulatory risks, and the company's diversified operations and pipeline help buffer near-term uncertainties.", "url": "https://seekingalpha.com/article/4827739-merck-a-race-against-keytruda-clock"}}
{"date": "2025-10-03", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-03 11:11:08", "publisher": "Zacks Investment Research", "title": "MRK Stock Up Nearly 14% So Far This Week: What's Driving It?", "image": "https://images.financialmodelingprep.com/news/mrk-stock-up-nearly-14-so-far-this-week-20251003.jpg", "site": "zacks.com", "text": "Merck shares climb nearly 14% as Pfizer's landmark drug pricing deal with the Trump administration sparked renewed optimism in pharma stocks.", "url": "https://www.zacks.com/stock/news/2761572/mrk-stock-up-nearly-14-so-far-this-week-what-s-driving-it?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2761572"}}
{"date": "2025-10-02", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-02 15:15:08", "publisher": "24/7 Wall Street", "title": "The 5 Highest-Yielding Dogs of the Dow Are Among Our Top Q4 Picks", "image": "https://images.financialmodelingprep.com/news/the-5-highestyielding-dogs-of-the-dow-are-among-our-20251002.jpg", "site": "247wallst.com", "text": "The Dogs of the Dow is a well-known strategy first published in 1991 by Michael O'Higgins.", "url": "https://247wallst.com/investing/2025/10/02/the-5-highest-yielding-dogs-of-the-dow-are-among-our-top-q4-picks/"}}
{"date": "2025-10-02", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-02 11:37:00", "publisher": "The Motley Fool", "title": "Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?", "image": "https://images.financialmodelingprep.com/news/should-you-buy-the-3-highestpaying-dividend-stocks-in-the-20251002.jpg", "site": "fool.com", "text": "Verizon (VZ -1.25%) is currently the highest-yielding stock in the Dow Jones Industrial Average (DJINDICES: ^DJI), and it isn't even close. The wireless carrier is shelling out 6.3% of its market cap a year to its shareholders, 200 basis points higher than any of the 29 other stocks in the iconic index.", "url": "https://www.fool.com/investing/2025/10/02/should-you-buy-the-3-highest-paying-dividend-stock/"}}
{"date": "2025-10-02", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-02 10:31:08", "publisher": "Zacks Investment Research", "title": "Is It Worth Investing in Merck (MRK) Based on Wall Street's Bullish Views?", "image": "https://images.financialmodelingprep.com/news/is-it-worth-investing-in-merck-mrk-based-on-20251002.jpg", "site": "zacks.com", "text": "When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?", "url": "https://www.zacks.com/stock/news/2760748/is-it-worth-investing-in-merck-mrk-based-on-wall-street-s-bullish-views?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|average_broker_rating-2760748"}}
{"date": "2025-10-02", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-02 10:01:08", "publisher": "Zacks Investment Research", "title": "Is Most-Watched Stock Merck & Co., Inc. (MRK) Worth Betting on Now?", "image": "https://images.financialmodelingprep.com/news/is-mostwatched-stock-merck-co-inc-mrk-worth-betting-20251002.jpg", "site": "zacks.com", "text": "Zacks.com users have recently been watching Merck (MRK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.", "url": "https://www.zacks.com/stock/news/2760676/is-most-watched-stock-merck-co-inc-mrk-worth-betting-on-now?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2760676"}}
{"date": "2025-10-02", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-02 08:20:03", "publisher": "Forbes", "title": "ABBV Stock vs. Eli Lilly & Merck", "image": "https://images.financialmodelingprep.com/news/abbv-stock-vs-eli-lilly-merck-20251002.jpg", "site": "forbes.com", "text": "AbbVie stock (NYSE: ABBV) rallied 11% in a week, largely driven by a key development that boosted the entire sector: Pfizer's agreement to lower its drug prices for Medicaid and a White House decision to grant a three-year exemption from 100% import tariffs. Since the market sees this event as broadly positive for pharmaceutical companies, ABBV's stock has risen significantly.", "url": "https://www.forbes.com/sites/greatspeculations/2025/10/02/abbv-stock-vs-eli-lilly--merck/"}}
{"date": "2025-10-01", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-01 14:23:22", "publisher": "Seeking Alpha", "title": "Top 10 High-Yield Dividend Stocks For October 2025", "image": "https://images.financialmodelingprep.com/news/top-10-highyield-dividend-stocks-for-october-2025-20251001.jpg", "site": "seekingalpha.com", "text": "The October 2025 high-yield dividend watchlist highlights 10 stocks with an average forward yield of 3.95% and a projected 19.02% return. This month's selection process lowered the yield threshold to 2.5%, expanding the pool to 69 companies and increasing diversification opportunities. The watchlist has delivered a 15.01% CAGR since inception, outperforming its 12% target and offering higher starting yields than SPY and VYM.", "url": "https://seekingalpha.com/article/4827280-top-10-high-yield-dividend-stocks-for-october-2025"}}
{"date": "2025-10-01", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-10-01 06:45:00", "publisher": "Business Wire", "title": "Merck to Hold Third-Quarter 2025 Sales and Earnings Conference Call Oct. 30", "image": "https://images.financialmodelingprep.com/news/merck-to-hold-thirdquarter-2025-sales-and-earnings-conference-20251001.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck to Hold Third-Quarter 2025 Sales and Earnings Conference Call Oct. 30.", "url": "https://www.businesswire.com/news/home/20251001942767/en/Merck-to-Hold-Third-Quarter-2025-Sales-and-Earnings-Conference-Call-Oct.-30/"}}
{"date": "2025-09-30", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-09-30 16:55:43", "publisher": "Investopedia", "title": "S&P 500 Gains and Losses Today: Pfizer and Merck Jump; Payments Stocks Decline", "image": "https://images.financialmodelingprep.com/news/sp-500-gains-and-losses-today-pfizer-and-merck-20250930.jpg", "site": "investopedia.com", "text": "An agreement with the U.S. government and a favorable regulatory decision in Europe helped lift shares of large drugmakers. Meanwhile, the announcement of a collaboration that will integrate shopping functions into a popular chatbot dragged on several financial technology firms.", "url": "https://www.investopedia.com/s-and-p-500-gains-and-losses-today-pfizer-and-merck-jump-payments-stocks-decline-11821787"}}
{"date": "2025-09-30", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-09-30 15:19:11", "publisher": "Schaeffers Research", "title": "3 Pharma Stocks Getting an Intraday Trump Bump", "image": "https://images.financialmodelingprep.com/news/3-pharma-stocks-getting-an-intraday-trump-bump-20250930.jpg", "site": "schaeffersresearch.com", "text": "Pharmaceutical stocks are enjoying tailwinds today, after President Donald Trump announced the launch of a direct-to-consumer website dubbed \"TrumpRX.", "url": "https://www.schaeffersresearch.com/content/news/2025/09/30/3-pharma-stocks-getting-an-intraday-trump-bump"}}
{"date": "2025-09-30", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-09-30 12:16:04", "publisher": "Seeking Alpha", "title": "7 Ideal \"Safer\" Dividend Buys From 61 September Graham Value All-Stars (GVAS)", "image": "https://images.financialmodelingprep.com/news/7-ideal-safer-dividend-buys-from-61-september-graham-20250930.jpg", "site": "seekingalpha.com", "text": "The article analyzes Large Cap Value (GASV) stocks using YCharts' Value Score and the Ben Graham Formula to identify fair-priced, high-yield dividend opportunities. Seven of fourteen 'safer' lowest-priced GASV DogsET, MPLX, YRD, VZ, BMY, BBVA, and MFCare highlighted as buyable for September 2025. Top ten GASV stocks are projected by analysts to deliver average net gains of 26.84% by September 2026, with Energy Transfer (ET) leading at 35.43%.", "url": "https://seekingalpha.com/article/4826955-7-ideal-safer-dividend-buys-from-61-september-graham-value-all-stars-gvas"}}
{"date": "2025-09-30", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-09-30 09:53:14", "publisher": "Seeking Alpha", "title": "Merck: Initiating \"Strong Buy\" On Shift To Qlex SC Injection For Solid Tumors", "image": "https://images.financialmodelingprep.com/news/merck-initiating-strong-buy-on-shift-to-qlex-sc-injection-20250930.jpg", "site": "seekingalpha.com", "text": "Merck earns a \"Strong Buy\" rating due to strategic moves, including FDA approval of QLEX, the first subcutaneous immune checkpoint inhibitor. QLEX extends Keytruda's patent life, offering rapid, flexible dosing and broader treatment settings, countering the upcoming IV Keytruda patent cliff in 2028. MRK's acquisition of Verona Pharma adds Ohtuvayre for COPD, expanding its cardiopulmonary portfolio and future growth opportunities.", "url": "https://seekingalpha.com/article/4826896-merck-initiating-strong-buy-on-shift-to-qlex-sc-injection-for-solid-tumors"}}
{"date": "2025-09-30", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-09-30 03:39:00", "publisher": "Business Wire", "title": "WINREVAIR (sotatercept-csrk) Reduced the Risk of Clinical Worsening Events by 76% Compared to Placebo in Patients Recently Diagnosed With PAH on Background Therapy in Phase 3 HYPERION Trial", "image": "https://images.financialmodelingprep.com/news/winrevair-sotaterceptcsrk-reduced-the-risk-of-clinical-worsening-events-20250930.jpg", "site": "businesswire.com", "text": "RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive results from the Phase 3 HYPERION trial evaluating WINREVAIR (sotatercept-csrk) versus placebo (both in combination with background therapy) in recently diagnosed adults with pulmonary arterial hypertension (PAH, WHO* Group 1) functional class (FC) II or III at intermediate or high risk of disease progression. In the study, WINREVAIR reduced the risk of clinical worseni.", "url": "https://www.businesswire.com/news/home/20250930429500/en/WINREVAIR%E2%84%A2-sotatercept-csrk-Reduced-the-Risk-of-Clinical-Worsening-Events-by-76-Compared-to-Placebo-in-Patients-Recently-Diagnosed-With-PAH-on-Background-Therapy-in-Phase-3-HYPERION-Trial/"}}
{"date": "2025-09-27", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-09-27 15:45:04", "publisher": "24/7 Wall Street", "title": "JP Morgan Says Stock Market Expensive: 5 Strong Buy Safe Dividend Stocks", "image": "https://images.financialmodelingprep.com/news/jp-morgan-says-stock-market-expensive-5-strong-buy-safe-20250927.jpg", "site": "247wallst.com", "text": "Markets often rally in anticipation of rate cuts but then decline when those cuts are implemented.", "url": "https://247wallst.com/investing/2025/09/27/jpmorgan-says-stock-market-expensive-5-strong-buy-safe-dividend-stocks-they-love/"}}
{"date": "2025-09-26", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-09-26 18:46:17", "publisher": "Zacks Investment Research", "title": "Merck (MRK) Outperforms Broader Market: What You Need to Know", "image": "https://images.financialmodelingprep.com/news/merck-mrk-outperforms-broader-market-what-you-need-to-20250926.jpg", "site": "zacks.com", "text": "In the closing of the recent trading day, Merck (MRK) stood at $78.56, denoting a +1.24% move from the preceding trading day.", "url": "https://www.zacks.com/stock/news/2758006/merck-mrk-outperforms-broader-market-what-you-need-to-know?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6-2758006"}}
{"date": "2025-09-26", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-09-26 16:50:24", "publisher": "CNBC Television", "title": "Many pharma companies already made U.S. investment promises, says Citi's Geoff Meacham", "image": "https://images.financialmodelingprep.com/news/many-pharma-companies-already-made-us-investment-promises-says-20250926.jpg", "site": "youtube.com", "text": "CNBC's Closing Bell Overtime team discusses President Trump's plan to impose a 100% tariff on all any branded or patented Pharmaceutical Product entering the U.S. with Geoff Meacham of Citi Research.", "url": "https://www.youtube.com/watch?v=Y8KXHmkqiCg"}}
{"date": "2025-09-26", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-09-26 12:11:49", "publisher": "Proactive Investors", "title": "Big Pharma braces for the next price cut", "image": "https://images.financialmodelingprep.com/news/big-pharma-braces-for-the-next-price-cut-20250926.jpeg", "site": "proactiveinvestors.com", "text": "Drugmakers know the script by now. Washington picks a handful of blockbuster medicines, haggles with their makers, and then publishes the maximum fair price that Medicare will pay.", "url": "https://www.proactiveinvestors.com/companies/news/1079281"}}
{"date": "2025-09-26", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-09-26 11:46:16", "publisher": "Seeking Alpha", "title": "Merck: Game-Changing Oncology Drugs Power Stock Surge", "image": "https://images.financialmodelingprep.com/news/merck-gamechanging-oncology-drugs-power-stock-surge-20250926.jpg", "site": "seekingalpha.com", "text": "Despite the challenges Merck's vaccine franchise has faced, demand for its anti-cancer medications remains as high as ever. Welireg sales reached $162 million in Q2 2025, an increase of 18.2% quarter-on-quarter, thanks in part to its label expansion on May 14. Strong performance from two cardiovascular 'stars,' Winrevair and Adempas, led Merck to buy back about $1.35 billion in shares in Q2 2025, more than quadrupling year-on-year.", "url": "https://seekingalpha.com/article/4826208-merck-game-changing-oncology-drugs-power-stock-surge"}}
{"date": "2025-09-26", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-09-26 10:41:28", "publisher": "Zacks Investment Research", "title": "MRK vs. BMY: Which Pharma Stock Is the Smarter Pick Now?", "image": "https://images.financialmodelingprep.com/news/mrk-vs-bmy-which-pharma-stock-is-the-smarter-pick-20250926.jpg", "site": "zacks.com", "text": "Merck and Bristol Myers face diverging growth paths, with Keytruda driving MRK's momentum and BMY navigating generic headwinds.", "url": "https://www.zacks.com/stock/news/2757646/mrk-vs-bmy-which-pharma-stock-is-the-smarter-pick-now?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2757646"}}
{"date": "2025-09-26", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-09-26 10:11:54", "publisher": "24/7 Wall Street", "title": "Goldman Sachs Sees 4 Rate Cuts by Next Summer: 5 High-Yield Dividend Winners", "image": "https://images.financialmodelingprep.com/news/goldman-sachs-sees-4-rate-cuts-by-next-summer-20250926.jpg", "site": "247wallst.com", "text": "Investors love dividend stocks because they offer a significant income stream and have massive total return potential.", "url": "https://247wallst.com/investing/2025/09/26/goldman-sachs-sees-4-rate-cuts-by-next-summer-5-high-yield-dividend-winners/"}}
{"date": "2025-09-25", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-09-25 10:54:31", "publisher": "Seeking Alpha", "title": "Merck: 25% Total Return CAGR Potential", "image": "https://images.financialmodelingprep.com/news/merck-25-total-return-cagr-potential-20250925.jpg", "site": "seekingalpha.com", "text": "Merck & Co. is rated a Strong Buy at $79.89, offering robust growth, a 4% yield, and significant undervaluation. MRK's pipeline, led by Keytruda derivatives and new blockbusters from acquisitions like Verona Pharma, is expected to offset patent expirations and drive future revenue. Dividend growth is projected at 6.5% CAGR, supported by a strong balance sheet, high profitability, and superior free cash flow versus peers.", "url": "https://seekingalpha.com/article/4825867-merck-25-percent-total-return-cagr-potential"}}
{"date": "2025-09-25", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-09-25 10:41:50", "publisher": "Zacks Investment Research", "title": "Here's Why Merck (MRK) is a Strong Value Stock", "image": "https://images.financialmodelingprep.com/news/heres-why-merck-mrk-is-a-strong-value-stock-20250925.jpg", "site": "zacks.com", "text": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.", "url": "https://www.zacks.com/stock/news/2757004/here-s-why-merck-mrk-is-a-strong-value-stock?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|zacks_education_value_score-2757004"}}
{"date": "2025-09-24", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-09-24 16:13:30", "publisher": "24/7 Wall Street", "title": "JP Morgan Says Economy Slowing Fast: 5 High-Yield Value Stock Fall Buys", "image": "https://images.financialmodelingprep.com/news/jp-morgan-says-economy-slowing-fast-5-highyield-value-20250924.jpg", "site": "247wallst.com", "text": "A value stock is generally a company that trades at a price lower than its fundamental value or what its performance suggests it should be worth.", "url": "https://247wallst.com/investing/2025/09/24/jpmorgan-says-economy-slowing-fast-5-high-yield-value-stock-fall-buys/"}}
{"date": "2025-09-24", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-09-24 13:19:39", "publisher": "CNBC Television", "title": "Merck's Keytruda gets an upgrade", "image": "https://images.financialmodelingprep.com/news/mercks-keytruda-gets-an-upgrade-20250924.jpg", "site": "youtube.com", "text": "CNBC's Angelica Peebles joins 'Squawk on the Street' with the latest news.", "url": "https://www.youtube.com/watch?v=86XnBzC9xsc"}}
{"date": "2025-09-24", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-09-24 09:13:14", "publisher": "CNBC Television", "title": "Merck CEO Rob Davis on FDA approval of Keytruda injection, navigating new vaccine landscape", "image": "https://images.financialmodelingprep.com/news/merck-ceo-rob-davis-on-fda-approval-of-keytruda-injection-20250924.jpg", "site": "youtube.com", "text": "CNBC's Angelica Peebles and Merck chairman and CEO Rob Davis join 'Squawk Box' to discuss the FDA's approval of the injectable version of Keytruda, pricing for the new injection, navigating the new vaccine landscape, demand for Merck's vaccines, future of drug pricing, and more.", "url": "https://www.youtube.com/watch?v=0msRdBWu4U4"}}
{"date": "2025-09-24", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-09-24 07:45:00", "publisher": "The Motley Fool", "title": "The Smartest Dividend Stock to Buy With $1,000 Right Now", "image": "https://images.financialmodelingprep.com/news/the-smartest-dividend-stock-to-buy-with-1000-right-20250924.jpg", "site": "fool.com", "text": "The winds of political change have hit the healthcare industry, with drug makers seemingly taking the brunt of the gale. Industry-leading companies like Pfizer (PFE 0.33%), Merck (MRK -0.63%), and Bristol Myers Squibb (BMY -0.31%) have seen their stocks fall and their yields rise.", "url": "https://www.fool.com/investing/2025/09/24/the-smartest-dividend-stock-to-buy-with-1000-right/"}}
{"date": "2025-09-23", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-09-23 07:00:00", "publisher": "Business Wire", "title": "Variational AI Enters Collaboration with Merck to Apply Generative AI to Drug Discovery", "image": "https://images.financialmodelingprep.com/news/variational-ai-enters-collaboration-with-merck-to-apply-generative-ai-20250923.jpg", "site": "businesswire.com", "text": "VANCOUVER, British Columbia--(BUSINESS WIRE)-- #AIDD--Variational AI enters Collaboration with Merck to apply Generative AI Drug Discovery platform to design and optimize novel small molecule therapeutics.", "url": "https://www.businesswire.com/news/home/20250923751722/en/Variational-AI-Enters-Collaboration-with-Merck-to-Apply-Generative-AI-to-Drug-Discovery/"}}
{"date": "2025-09-22", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-09-22 18:51:19", "publisher": "Zacks Investment Research", "title": "Merck (MRK) Stock Sinks As Market Gains: Here's Why", "image": "https://images.financialmodelingprep.com/news/merck-mrk-stock-sinks-as-market-gains-heres-why-20250922.jpg", "site": "zacks.com", "text": "The latest trading day saw Merck (MRK) settling at $80.4, representing a -1.36% change from its previous close.", "url": "https://www.zacks.com/stock/news/2755335/merck-mrk-stock-sinks-as-market-gains-here-s-why?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6v1-2755335"}}
{"date": "2025-09-22", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-09-22 11:26:14", "publisher": "Zacks Investment Research", "title": "Will the FDA's Nod for Subcutaneous Keytruda Ease Merck's Headwinds?", "image": "https://images.financialmodelingprep.com/news/will-the-fdas-nod-for-subcutaneous-keytruda-ease-mercks-headwinds-20250922.jpg", "site": "zacks.com", "text": "FDA clears MRK's Keytruda Qlex, a subcutaneous option that promises faster treatment and new patent protection amid looming headwinds.", "url": "https://www.zacks.com/stock/news/2754926/will-the-fda-s-nod-for-subcutaneous-keytruda-ease-merck-s-headwinds?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2754926"}}
{"date": "2025-09-22", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-09-22 08:30:00", "publisher": "The Motley Fool", "title": "3 Dirt-Cheap Stocks to Buy Right Now", "image": "https://images.financialmodelingprep.com/news/3-dirtcheap-stocks-to-buy-right-now-20250922.jpg", "site": "fool.com", "text": "The major market indexes are bumping against all-time highs. It's not surprising, therefore, that many stocks are trading at steep valuations.", "url": "https://www.fool.com/investing/2025/09/22/3-dirt-cheap-stocks-to-buy-right-now/"}}
{"date": "2025-09-22", "symbol": "MRK", "type": "stock_news", "result": {"symbol": "MRK", "publishedDate": "2025-09-22 06:02:58", "publisher": "Seeking Alpha", "title": "Merck: Undervalued Pharma Stock With Defensive Approach And Compelling Dividend Yield", "image": "https://images.financialmodelingprep.com/news/merck-undervalued-pharma-stock-with-defensive-approach-and-compelling-20250922.jpg", "site": "seekingalpha.com", "text": "Merck trades at 9.09x forward earnings, far below its 23.55x historical multiple and peers, while maintaining strong profitability and a 3.99% dividend yield. Blockbuster drug Keytruda, along with oncology pipeline and R&D focus, supports long-term growth despite near-term Gardasil sales decline. Heavy reliance on Keytruda, integration of new drugs, Gardasil sales volatility, and dependence on successful clinical trials could pressure revenue if outcomes disappoint.", "url": "https://seekingalpha.com/article/4824740-merck-undervalued-pharma-stock-with-defensive-approach-compelling-dividend-yield"}}
